-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IK4N60krADQ9wyB1S4t4cJLhCNby8N+Kwv7Mz8VLYPaZN5idtQtmOKZ3IeYY//ri jQEODqRVcRZ2oeawFG/zhw== 0000950117-03-000698.txt : 20030219 0000950117-03-000698.hdr.sgml : 20030219 20030219163113 ACCESSION NUMBER: 0000950117-03-000698 CONFORMED SUBMISSION TYPE: S-3/A PUBLIC DOCUMENT COUNT: 14 FILED AS OF DATE: 20030219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPECIALIZED PHARMACY SERVICES INC CENTRAL INDEX KEY: 0001141260 IRS NUMBER: 382143132 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-68 FILM NUMBER: 03572956 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVERCENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41011 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVERCENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PURCHASING CO GENERAL PARTNER INC CENTRAL INDEX KEY: 0001217933 IRS NUMBER: 611401040 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-11 FILM NUMBER: 03572898 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF TEXAS 2 LP CENTRAL INDEX KEY: 0001217931 IRS NUMBER: 113657397 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-12 FILM NUMBER: 03572899 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF TEXAS 1 LP CENTRAL INDEX KEY: 0001217929 IRS NUMBER: 760716554 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-13 FILM NUMBER: 03572900 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF PUEBLO LLC CENTRAL INDEX KEY: 0001217928 IRS NUMBER: 760716546 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-14 FILM NUMBER: 03572901 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF INDIANA LLC CENTRAL INDEX KEY: 0001217925 IRS NUMBER: 760716552 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-15 FILM NUMBER: 03572902 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF HICKORY LLC CENTRAL INDEX KEY: 0001217922 IRS NUMBER: 760716543 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-16 FILM NUMBER: 03572903 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF FLORIDA LP CENTRAL INDEX KEY: 0001217919 IRS NUMBER: 760716528 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-17 FILM NUMBER: 03572904 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE HEADQUARTERS LLC CENTRAL INDEX KEY: 0001217916 IRS NUMBER: 760720510 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-18 FILM NUMBER: 03572905 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE EXTENEDED PHARMA SERVICES LLC CENTRAL INDEX KEY: 0001217915 IRS NUMBER: 050523710 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-19 FILM NUMBER: 03572906 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE CR INC CENTRAL INDEX KEY: 0001217914 IRS NUMBER: 611395349 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-20 FILM NUMBER: 03572907 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATIONAL CARE FOR SENIORS LLC CENTRAL INDEX KEY: 0001217913 IRS NUMBER: 341972917 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-21 FILM NUMBER: 03572908 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS SERVICES INC CENTRAL INDEX KEY: 0001217910 IRS NUMBER: 341837567 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-22 FILM NUMBER: 03572909 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF WISCONSIN INC CENTRAL INDEX KEY: 0001217909 IRS NUMBER: 341866497 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-23 FILM NUMBER: 03572910 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF WASHINGTON INC CENTRAL INDEX KEY: 0001217907 IRS NUMBER: 341844193 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-24 FILM NUMBER: 03572911 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF VERMONT INC CENTRAL INDEX KEY: 0001217904 IRS NUMBER: 311526078 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-25 FILM NUMBER: 03572912 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF TEXAS INC CENTRAL INDEX KEY: 0001217901 IRS NUMBER: 341866495 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-26 FILM NUMBER: 03572913 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF TENNESSEE INC CENTRAL INDEX KEY: 0001217899 IRS NUMBER: 341866494 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-27 FILM NUMBER: 03572914 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF SOUTH CAROLINA INC CENTRAL INDEX KEY: 0001217896 IRS NUMBER: 311508225 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-28 FILM NUMBER: 03572915 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF RHODE ISLAND INC CENTRAL INDEX KEY: 0001217893 IRS NUMBER: 050429829 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-29 FILM NUMBER: 03572916 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF PENNSYLVANIA INC CENTRAL INDEX KEY: 0001217890 IRS NUMBER: 232679334 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-30 FILM NUMBER: 03572917 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF OREGON INC CENTRAL INDEX KEY: 0001217888 IRS NUMBER: 341836971 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-31 FILM NUMBER: 03572918 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF OKLAHOMA INC CENTRAL INDEX KEY: 0001217885 IRS NUMBER: 731499934 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-32 FILM NUMBER: 03572919 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF OHIO CENTRAL INDEX KEY: 0001217883 IRS NUMBER: 311257307 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-33 FILM NUMBER: 03572920 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF NORTH CAROLINA INC CENTRAL INDEX KEY: 0001217882 IRS NUMBER: 561889643 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-34 FILM NUMBER: 03572921 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF NEW YORK INC CENTRAL INDEX KEY: 0001217881 IRS NUMBER: 341854267 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-35 FILM NUMBER: 03572922 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF NEW MEXICO INC CENTRAL INDEX KEY: 0001217880 IRS NUMBER: 341866493 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-36 FILM NUMBER: 03572924 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF NEW JERSEY INC CENTRAL INDEX KEY: 0001217879 IRS NUMBER: 223395391 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-37 FILM NUMBER: 03572925 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF NEW HAMPSHIRE INC CENTRAL INDEX KEY: 0001217878 IRS NUMBER: 020468190 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-38 FILM NUMBER: 03572926 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF MONTANA INC CENTRAL INDEX KEY: 0001217877 IRS NUMBER: 341851710 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-39 FILM NUMBER: 03572927 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF MISSOURI INC CENTRAL INDEX KEY: 0001217876 IRS NUMBER: 341855274 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-40 FILM NUMBER: 03572928 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF MINNESOTA INC CENTRAL INDEX KEY: 0001217875 IRS NUMBER: 341866489 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-41 FILM NUMBER: 03572929 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF MICHIGAN INC CENTRAL INDEX KEY: 0001217874 IRS NUMBER: 341777940 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-42 FILM NUMBER: 03572930 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF MASSACHUSETTS INC CENTRAL INDEX KEY: 0001217873 IRS NUMBER: 311571275 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-43 FILM NUMBER: 03572931 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF MARYLAND INC CENTRAL INDEX KEY: 0001217871 IRS NUMBER: 311496240 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-44 FILM NUMBER: 03572932 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF KENTUCKY INC CENTRAL INDEX KEY: 0001217870 IRS NUMBER: 311521217 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-45 FILM NUMBER: 03572933 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF KANSAS INC CENTRAL INDEX KEY: 0001217869 IRS NUMBER: 341839712 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-46 FILM NUMBER: 03572934 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF IOWA INC CENTRAL INDEX KEY: 0001217868 IRS NUMBER: 311509013 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-47 FILM NUMBER: 03572935 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF INDIANA LLC CENTRAL INDEX KEY: 0001217867 IRS NUMBER: 341958652 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-48 FILM NUMBER: 03572936 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF INDIANA INC CENTRAL INDEX KEY: 0001217866 IRS NUMBER: 351954599 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-49 FILM NUMBER: 03572937 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF ILLINOIS INC CENTRAL INDEX KEY: 0001217865 IRS NUMBER: 341354510 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-50 FILM NUMBER: 03572938 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF FLORIDA INC CENTRAL INDEX KEY: 0001217864 IRS NUMBER: 341354510 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-51 FILM NUMBER: 03572939 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF CONNECTICUT INC CENTRAL INDEX KEY: 0001217861 IRS NUMBER: 061330453 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-52 FILM NUMBER: 03572940 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF CALIFORNIA INC CENTRAL INDEX KEY: 0001217859 IRS NUMBER: 311499819 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-53 FILM NUMBER: 03572941 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF BEACHWOOD INC CENTRAL INDEX KEY: 0001217856 IRS NUMBER: 341881410 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-54 FILM NUMBER: 03572942 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF ARKANSAS INC CENTRAL INDEX KEY: 0001217853 IRS NUMBER: 311490517 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-55 FILM NUMBER: 03572943 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MANAGEMENT & NETWORK SERVICES INC CENTRAL INDEX KEY: 0001217848 IRS NUMBER: 341819691 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-56 FILM NUMBER: 03572944 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE OF ARIZONA INC CENTRAL INDEX KEY: 0001217850 IRS NUMBER: 311573985 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-57 FILM NUMBER: 03572945 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HIGHLAND WHOLESALE LLC CENTRAL INDEX KEY: 0001217846 IRS NUMBER: 320006739 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-58 FILM NUMBER: 03572946 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEARTLAND REPACK SERVICES LLC CENTRAL INDEX KEY: 0001217845 IRS NUMBER: 611389057 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-59 FILM NUMBER: 03572947 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DIXON PHARMACY LLC CENTRAL INDEX KEY: 0001217844 IRS NUMBER: 362825587 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-60 FILM NUMBER: 03572948 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BEACHWOOD HEALTHCARE MANAGEMENT INC CENTRAL INDEX KEY: 0001217843 IRS NUMBER: 341868886 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-61 FILM NUMBER: 03572949 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: APS ACQUISITION LLC CENTRAL INDEX KEY: 0001217842 IRS NUMBER: 611401116 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-62 FILM NUMBER: 03572950 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PURCHASING CO LP CENTRAL INDEX KEY: 0001218289 IRS NUMBER: 611401039 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-63 FILM NUMBER: 03572951 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 EAST RIVERECENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41011 BUSINESS PHONE: 6593923300 MAIL ADDRESS: STREET 1: 100 EST RIVERCENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE INDIANA PARTNERSHIP HOLDING CO LLC CENTRAL INDEX KEY: 0001218283 IRS NUMBER: 161653107 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-64 FILM NUMBER: 03572952 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 EAST RIVERECENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41011 BUSINESS PHONE: 6593923300 MAIL ADDRESS: STREET 1: 100 EST RIVERCENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE CAPITAL TRUST III CENTRAL INDEX KEY: 0001218286 IRS NUMBER: 166539078 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-65 FILM NUMBER: 03572953 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 EAST RIVERECENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41011 BUSINESS PHONE: 6593923300 MAIL ADDRESS: STREET 1: 100 EST RIVERCENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE CAPITAL TRUST II CENTRAL INDEX KEY: 0001218285 IRS NUMBER: 16539077 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-66 FILM NUMBER: 03572954 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 EAST RIVERECENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41011 BUSINESS PHONE: 6593923300 MAIL ADDRESS: STREET 1: 100 EST RIVERCENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE CAPITAL TRUST I CENTRAL INDEX KEY: 0001218284 IRS NUMBER: 166539075 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-67 FILM NUMBER: 03572955 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 EAST RIVERECENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41011 BUSINESS PHONE: 6593923300 MAIL ADDRESS: STREET 1: 100 EST RIVERCENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WINSLOWS PHARMACY CENTRAL INDEX KEY: 0001141096 IRS NUMBER: 210692005 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-69 FILM NUMBER: 03572957 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WILLIAMSON DRUG CO INC CENTRAL INDEX KEY: 0001141095 IRS NUMBER: 540590067 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-70 FILM NUMBER: 03572958 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WESTHAVEN SERVICES CO CENTRAL INDEX KEY: 0001141094 IRS NUMBER: 341151322 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-71 FILM NUMBER: 03572959 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WEBER MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0001141092 IRS NUMBER: 311409572 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-72 FILM NUMBER: 03572960 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VITAL CARE INFUSIONS INC CENTRAL INDEX KEY: 0001141091 IRS NUMBER: 611336267 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-73 FILM NUMBER: 03572961 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VALUE PHARMACY INC CENTRAL INDEX KEY: 0001141090 IRS NUMBER: 042894741 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-74 FILM NUMBER: 03572962 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VALUE HEALTH CARE SERVICES INC CENTRAL INDEX KEY: 0001141089 IRS NUMBER: 311485530 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-75 FILM NUMBER: 03572963 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SWISH INC CENTRAL INDEX KEY: 0001141082 IRS NUMBER: 522005933 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-76 FILM NUMBER: 03572964 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TCPI ACQUISITION CORP CENTRAL INDEX KEY: 0001141081 IRS NUMBER: 311508476 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-77 FILM NUMBER: 03572965 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: THG ACQUISITION CORP CENTRAL INDEX KEY: 0001141080 IRS NUMBER: 311567102 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-78 FILM NUMBER: 03572966 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: THREE FORKS APOTHECARY INC CENTRAL INDEX KEY: 0001141079 IRS NUMBER: 610995656 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-100 FILM NUMBER: 03572967 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UC ACQUISITION CORP CENTRAL INDEX KEY: 0001141078 IRS NUMBER: 311414594 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-79 FILM NUMBER: 03572968 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERIOR CARE PHARMACY INC CENTRAL INDEX KEY: 0001141076 IRS NUMBER: 311543728 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-80 FILM NUMBER: 03572969 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STERLING HEALTHCARE SERVICES INC CENTRAL INDEX KEY: 0001141075 IRS NUMBER: 364031863 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-81 FILM NUMBER: 03572970 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPECIALIZED PATIENT CARE SERVICES INC CENTRAL INDEX KEY: 0001141074 IRS NUMBER: 631159534 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-82 FILM NUMBER: 03572971 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPECIALIZED HOME INFUSION OF MICHIGAN LLC CENTRAL INDEX KEY: 0001141072 IRS NUMBER: 383529442 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-83 FILM NUMBER: 03572972 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOUTHSIDE APOTHECARY INC CENTRAL INDEX KEY: 0001141071 IRS NUMBER: 611340804 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-84 FILM NUMBER: 03572973 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SHORE PHARMACEUTICAL PROVIDERS INC CENTRAL INDEX KEY: 0001141068 IRS NUMBER: 311425144 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-85 FILM NUMBER: 03572974 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SHC ACQUISITION CO LLC CENTRAL INDEX KEY: 0001141066 IRS NUMBER: 611346763 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-86 FILM NUMBER: 03572975 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROYAL CARE OF MICHIGAN LLC CENTRAL INDEX KEY: 0001141065 IRS NUMBER: 38352944 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-87 FILM NUMBER: 03572976 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROESCHENS HEALTHCARE CORP CENTRAL INDEX KEY: 0001141064 IRS NUMBER: 391084787 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-88 FILM NUMBER: 03572977 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PRN PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0001141060 IRS NUMBER: 351855784 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-89 FILM NUMBER: 03572978 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMED HOLDINGS INC CENTRAL INDEX KEY: 0001141057 IRS NUMBER: 364060882 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-90 FILM NUMBER: 03572979 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARM CORP OF MAINE LLC CENTRAL INDEX KEY: 0001141056 IRS NUMBER: 611339663 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-91 FILM NUMBER: 03572980 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACY CONSULTANTS INC CENTRAL INDEX KEY: 0001141055 IRS NUMBER: 570640737 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-92 FILM NUMBER: 03572981 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACY ASSOCIATES OF GLENS FALLS INC CENTRAL INDEX KEY: 0001141054 IRS NUMBER: 141554120 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-93 FILM NUMBER: 03572982 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACON CORP CENTRAL INDEX KEY: 0001141050 IRS NUMBER: 133498399 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-94 FILM NUMBER: 03572983 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LPI ACQUISITION CORP CENTRAL INDEX KEY: 0001141048 IRS NUMBER: 311501535 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-95 FILM NUMBER: 03572984 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PBM PLUS CENTRAL INDEX KEY: 0001141037 IRS NUMBER: 391789830 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-96 FILM NUMBER: 03572985 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF MAINE LLC CENTRAL INDEX KEY: 0001141035 IRS NUMBER: 311339662 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-97 FILM NUMBER: 03572986 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF MAINE HOLDING CO CENTRAL INDEX KEY: 0001141034 IRS NUMBER: 611365280 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-98 FILM NUMBER: 03572987 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF COLORADO LLC CENTRAL INDEX KEY: 0001141033 IRS NUMBER: 611347085 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-121 FILM NUMBER: 03572988 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY & SUPPLY SERVICES INC CENTRAL INDEX KEY: 0001141032 IRS NUMBER: 411730324 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-101 FILM NUMBER: 03572989 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACIES OF THE GREAT PLAINS HOLDING CO INC CENTRAL INDEX KEY: 0001141031 IRS NUMBER: 611386242 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-102 FILM NUMBER: 03572990 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACIES OF PA WEST INC CENTRAL INDEX KEY: 0001141030 IRS NUMBER: 251213193 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-103 FILM NUMBER: 03572991 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACIES OF PA EAST LLC CENTRAL INDEX KEY: 0001141029 IRS NUMBER: 611347894 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-104 FILM NUMBER: 03572992 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF THE MIDWEST INC CENTRAL INDEX KEY: 0001141027 IRS NUMBER: 311374275 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-105 FILM NUMBER: 03572993 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF TENNESSEE LLC CENTRAL INDEX KEY: 0001141026 IRS NUMBER: 611347088 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-106 FILM NUMBER: 03572994 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF SOUTH DAKOTA LLC CENTRAL INDEX KEY: 0001141024 IRS NUMBER: 611386243 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-107 FILM NUMBER: 03572995 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF NEBRASKA LLC CENTRAL INDEX KEY: 0001141023 IRS NUMBER: 611386244 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-108 FILM NUMBER: 03572996 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACY OF MASSACHUSETTS LLC CENTRAL INDEX KEY: 0001141022 IRS NUMBER: 611347087 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-109 FILM NUMBER: 03572997 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PHARMACEUTICS INC CENTRAL INDEX KEY: 0001141021 IRS NUMBER: 232745806 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-110 FILM NUMBER: 03572998 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PENNSYLVANIA MED SUPPLY LLC CENTRAL INDEX KEY: 0001141020 IRS NUMBER: 611347895 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-111 FILM NUMBER: 03572999 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE MANAGEMENT CO CENTRAL INDEX KEY: 0001141018 IRS NUMBER: 311256520 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-112 FILM NUMBER: 03573000 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE CLINICAL RESEARCH LLC CENTRAL INDEX KEY: 0001141014 IRS NUMBER: 141723594 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-113 FILM NUMBER: 03573001 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE CLINICAL RESEARCH INC CENTRAL INDEX KEY: 0001141013 IRS NUMBER: 521670189 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-114 FILM NUMBER: 03573002 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNIBILL SERVICES LLC CENTRAL INDEX KEY: 0001141011 IRS NUMBER: 611365732 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-115 FILM NUMBER: 03573003 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OFL CORP CENTRAL INDEX KEY: 0001141009 IRS NUMBER: 611357682 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-116 FILM NUMBER: 03573004 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OCR RA ACQUISITION CORP CENTRAL INDEX KEY: 0001141008 IRS NUMBER: 311442830 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-117 FILM NUMBER: 03573005 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NORTH SHORE PHARMACY SERVICES INC CENTRAL INDEX KEY: 0001141006 IRS NUMBER: 311428484 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-118 FILM NUMBER: 03573006 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NIV ACQUISITION CORP CENTRAL INDEX KEY: 0001141005 IRS NUMBER: 311501415 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-119 FILM NUMBER: 03573008 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NIHAN & MARTIN INC CENTRAL INDEX KEY: 0001141004 IRS NUMBER: 364004491 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-120 FILM NUMBER: 03573009 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MOSI ACQUISITION CORP CENTRAL INDEX KEY: 0001141003 IRS NUMBER: 311528353 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-142 FILM NUMBER: 03573010 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICAL SERVICES CONSORTIUM INC CENTRAL INDEX KEY: 0001141002 IRS NUMBER: 650357177 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-143 FILM NUMBER: 03573011 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICAL ARTS HEALTH CARE INC CENTRAL INDEX KEY: 0001141001 IRS NUMBER: 581640672 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-144 FILM NUMBER: 03573012 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MED WORLD ACQUISITION CORP CENTRAL INDEX KEY: 0001140998 IRS NUMBER: 611322120 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-145 FILM NUMBER: 03573013 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MANAGED HEALTHCARE INC CENTRAL INDEX KEY: 0001140996 IRS NUMBER: 311450845 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-146 FILM NUMBER: 03573014 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LO MED PRESCRIPTION SERVICES INC CENTRAL INDEX KEY: 0001140995 IRS NUMBER: 341396063 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-147 FILM NUMBER: 03573015 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LCPS ACQUISITION LLC CENTRAL INDEX KEY: 0001140994 IRS NUMBER: 611347084 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-148 FILM NUMBER: 03573016 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LANGSAM HEALTH SERVICES INC CENTRAL INDEX KEY: 0001140990 IRS NUMBER: 731391198 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-149 FILM NUMBER: 03573017 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JHC ACQUISITIION INC CENTRAL INDEX KEY: 0001140987 IRS NUMBER: 311494762 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-150 FILM NUMBER: 03573018 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTERLOCK PHARMACY SYSTEMS INC CENTRAL INDEX KEY: 0001140986 IRS NUMBER: 430951332 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-151 FILM NUMBER: 03573019 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HYTREE PHARMACY INC CENTRAL INDEX KEY: 0001140985 IRS NUMBER: 341090853 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-152 FILM NUMBER: 03573020 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HOME PHARMACY SERVICES INC CENTRAL INDEX KEY: 0001140981 IRS NUMBER: 370978331 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-153 FILM NUMBER: 03573021 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HOME CARE PHARMACY INC/NY CENTRAL INDEX KEY: 0001140980 IRS NUMBER: 311255845 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-154 FILM NUMBER: 03573022 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HMIS INC CENTRAL INDEX KEY: 0001140979 IRS NUMBER: 364124072 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-155 FILM NUMBER: 03573023 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HARDARDT GROUP INC CENTRAL INDEX KEY: 0001140978 IRS NUMBER: 223470357 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-156 FILM NUMBER: 03573024 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EVERGREEN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001140977 IRS NUMBER: 910883397 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-157 FILM NUMBER: 03573025 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EVERGREEN PHARMACEUTICAL OF CALIFORNIA INC CENTRAL INDEX KEY: 0001140976 IRS NUMBER: 611321151 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-158 FILM NUMBER: 03573026 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EURO BIO PHARM CLINICAL SERVICES INC CENTRAL INDEX KEY: 0001140975 IRS NUMBER: 232770328 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-159 FILM NUMBER: 03573027 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENLOE DRUGS INC CENTRAL INDEX KEY: 0001140974 IRS NUMBER: 311362346 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-160 FILM NUMBER: 03573028 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELECTRA ACQUISITION CORP CENTRAL INDEX KEY: 0001140973 IRS NUMBER: 311465189 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-161 FILM NUMBER: 03573029 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: D&R PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0001140970 IRS NUMBER: 610955886 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-162 FILM NUMBER: 03573030 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CTLP ACQUISITION CORP CENTRAL INDEX KEY: 0001140969 IRS NUMBER: 61138902 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-122 FILM NUMBER: 03573031 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CREEKSIDE MANAGED CARE PHARMACY INC CENTRAL INDEX KEY: 0001140967 IRS NUMBER: 611349188 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-123 FILM NUMBER: 03573032 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CP ACQUISITION CORP CENTRAL INDEX KEY: 0001140966 IRS NUMBER: 611317566 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-124 FILM NUMBER: 03573033 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COMPSCRIPT INC CENTRAL INDEX KEY: 0001140965 IRS NUMBER: 650506539 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-125 FILM NUMBER: 03573034 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COMPSCRIPT MOBILE INC CENTRAL INDEX KEY: 0001140964 IRS NUMBER: 593248505 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-126 FILM NUMBER: 03573035 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COMPSCRIPT BOCA INC CENTRAL INDEX KEY: 0001140963 IRS NUMBER: 650286244 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-127 FILM NUMBER: 03573036 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CIP ACQUISITION CORP CENTRAL INDEX KEY: 0001140962 IRS NUMBER: 311486402 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-128 FILM NUMBER: 03573037 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHP ACQUISITION CORP CENTRAL INDEX KEY: 0001140961 IRS NUMBER: 311483612 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-129 FILM NUMBER: 03573038 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CARE PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0001140960 IRS NUMBER: 311399042 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-130 FILM NUMBER: 03573039 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CAMPO MEDICAL PHARMACY INC CENTRAL INDEX KEY: 0001140959 IRS NUMBER: 721039948 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-131 FILM NUMBER: 03573040 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BPTX ACQUISITION CORP CENTRAL INDEX KEY: 0001140958 IRS NUMBER: 311563806 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-132 FILM NUMBER: 03573041 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BPNY ACQUISITION CORP CENTRAL INDEX KEY: 0001140957 IRS NUMBER: 311563804 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-133 FILM NUMBER: 03573042 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO PHARM INTERNATIONAL INC CENTRAL INDEX KEY: 0001140956 IRS NUMBER: 232794725 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-134 FILM NUMBER: 03573043 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BADGER ACQUISITION LLC CENTRAL INDEX KEY: 0001140955 IRS NUMBER: 522119866 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-135 FILM NUMBER: 03573044 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BADGER ACQUISITION OF TEXAS LLC CENTRAL INDEX KEY: 0001140953 IRS NUMBER: 522119915 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-136 FILM NUMBER: 03573045 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BADGER ACQUISITION OF TAMPA LLC CENTRAL INDEX KEY: 0001140951 IRS NUMBER: 522119893 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-137 FILM NUMBER: 03573046 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BADGER ACQUISITION OF ORLANDO LLC CENTRAL INDEX KEY: 0001140950 IRS NUMBER: 522119896 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-138 FILM NUMBER: 03573047 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BADGER ACQUISITION OF OHIO LLC CENTRAL INDEX KEY: 0001140949 IRS NUMBER: 522119875 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-139 FILM NUMBER: 03573048 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BADGER ACQUISITION OF MINNESOTA LLC CENTRAL INDEX KEY: 0001140948 IRS NUMBER: 522119871 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-140 FILM NUMBER: 03573049 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BADGER ACQUISITION OF KENTUCKY LLC CENTRAL INDEX KEY: 0001140947 IRS NUMBER: 522119911 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-141 FILM NUMBER: 03573050 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BADGER ACQUISITION OF BROOKSVILLE LLC CENTRAL INDEX KEY: 0001140946 IRS NUMBER: 522119870 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-163 FILM NUMBER: 03573051 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BACHS PHARMACY SERVICES LLC CENTRAL INDEX KEY: 0001140944 IRS NUMBER: 611346690 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-164 FILM NUMBER: 03573052 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMC TENNESSEE INC CENTRAL INDEX KEY: 0001140941 IRS NUMBER: 621696813 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-165 FILM NUMBER: 03573053 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMC NEW YORK INC CENTRAL INDEX KEY: 0001140940 IRS NUMBER: 364091917 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-166 FILM NUMBER: 03573054 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACP ACQUISITION CORP CENTRAL INDEX KEY: 0001140939 IRS NUMBER: 311568818 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-167 FILM NUMBER: 03573055 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACCU MED SERVICES INC CENTRAL INDEX KEY: 0001140938 IRS NUMBER: 311482519 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-168 FILM NUMBER: 03573056 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AAHS ACQUISITION CORP CENTRAL INDEX KEY: 0001140937 IRS NUMBER: 311567104 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-169 FILM NUMBER: 03573057 BUSINESS ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 8593923300 MAIL ADDRESS: STREET 1: C/O OMNICARE INC STREET 2: 100 E RIVER CENTER BLVD CITY: CONVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE INC CENTRAL INDEX KEY: 0000353230 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 311001351 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115 FILM NUMBER: 03573058 BUSINESS ADDRESS: STREET 1: 100 E RIVERCENTER BLVD STREET 2: STE 1600 CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 6063923300 MAIL ADDRESS: STREET 1: 100 E RIVERCENTER BLVD STREET 2: STE 1600 CITY: COVINGTON STATE: KY ZIP: 41101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS HEALTHCARE INC CENTRAL INDEX KEY: 0001004990 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 341816187 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-02 FILM NUMBER: 03573060 BUSINESS ADDRESS: STREET 1: 3201 ENTERPRISE PKWY STREET 2: STE 2200 CITY: BEACHWOOD STATE: OH ZIP: 44122 BUSINESS PHONE: 2165143350 MAIL ADDRESS: STREET 1: 100 EAST RIVERCENTER BLVD CITY: COVINGTON STATE: KY ZIP: 41011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNI CARE HEALTH SERVICES OF MAINE INC CENTRAL INDEX KEY: 0001217948 IRS NUMBER: 020468192 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-03 FILM NUMBER: 03573061 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPECIALIZED SERVICES OF MICHIGAN INC CENTRAL INDEX KEY: 0001217946 IRS NUMBER: 383637511 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-04 FILM NUMBER: 03573062 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RESCOT SYSTEMS GROUP INC CENTRAL INDEX KEY: 0001217943 IRS NUMBER: 23258908 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-05 FILM NUMBER: 03573063 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMASOURCE HEALTHCARE INC CENTRAL INDEX KEY: 0001217942 IRS NUMBER: 582066823 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-06 FILM NUMBER: 03573064 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACY HOLDING 2 LLC CENTRAL INDEX KEY: 0001217941 IRS NUMBER: 760716536 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-07 FILM NUMBER: 03573065 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACY HOLDING 1 LLC CENTRAL INDEX KEY: 0001217940 IRS NUMBER: 760716538 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-08 FILM NUMBER: 03573066 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE RESPIRATORY SERVICES LLC CENTRAL INDEX KEY: 0001217938 IRS NUMBER: 030465903 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-09 FILM NUMBER: 03573067 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE PURCHASING CO LTD PARTNER INC CENTRAL INDEX KEY: 0001217936 IRS NUMBER: 611401038 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-10 FILM NUMBER: 03573068 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NCS OF ILLINOIS INC CENTRAL INDEX KEY: 0001217911 IRS NUMBER: 341959046 FILING VALUES: FORM TYPE: S-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-103115-01 FILM NUMBER: 03573069 BUSINESS ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 100196092 BUSINESS PHONE: 2122506528 MAIL ADDRESS: STREET 1: DEWEY BALLANTINE LLP STREET 2: 1301 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 1001960092 S-3/A 1 a34428.txt OMNICARE, INC. AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON FEBRUARY 19, 2003 REGISTRATION NO. 333-103115 ________________________________________________________________________________ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------- AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ------------------- OMNICARE, INC. DELAWARE 31-1001351 OMNICARE CAPITAL TRUST I DELAWARE 16-6539075 OMNICARE CAPITAL TRUST II DELAWARE 16-6539077 OMNICARE CAPITAL TRUST III DELAWARE 16-6539078 (AND CERTAIN SUBSIDIARIES IDENTIFIED IN FOOTNOTE (*) BELOW) (Exact Name of Registrants) (State of Incorporation or (I.R.S. Employer Identification Organization) No.)
------------------- 100 EAST RIVERCENTER BOULEVARD, COVINGTON, KENTUCKY 41011 (859) 392-3300 (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Executive Offices) ------------------- CHERYL D. HODGES SENIOR VICE PRESIDENT AND SECRETARY OMNICARE, INC. 100 EAST RIVERCENTER BOULEVARD, COVINGTON, KENTUCKY 41011 (859) 392-3300 (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service) ------------------- COPY TO: MORTON A. PIERCE, ESQ. DEWEY BALLANTINE LLP 1301 AVENUE OF THE AMERICAS NEW YORK, NEW YORK 10019 (212) 259-8000 ------------------- APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: From time to time after this Registration Statement becomes effective. ------------------- If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. [ ] If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, please check the following box. [x] If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ] If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ] If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box. [ ] ------------------- THE REGISTRANTS HEREBY AMEND THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANTS SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR UNTIL THIS REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a), MAY DETERMINE. ________________________________________________________________________________ (footnote from previous page) (*) The following direct and indirect domestic subsidiaries of Omnicare, Inc. are Co-Registrants for the purpose of providing guarantees, if any, of payments of Debt Securities registered hereunder and are, unless otherwise indicated, organized under the laws of the state of Delaware and have the I.R.S. Employer Identification Number indicated: AAHS Acquisition Corp. (31-1567104); Accu-Med Services, Inc. (31-1482519); ACP Acquisition Corp. (31-1568818); AMC-New York, Inc. (36-4091917); AMC-Tennessee, Inc. (62-1696813); APS Acquisition LLC (61-1401116); Bach's Pharmacy Services, LLC (61-1346690); Badger Acquisition of Brooksville LLC (52-2119870); Badger Acquisition of Kentucky LLC (52-2119911); Badger Acquisition of Minnesota LLC (52-2119871); Badger Acquisition of Ohio LLC (52-2119875); Badger Acquisition of Orlando LLC (52-2119896); Badger Acquisition of Tampa LLC (52-2119893); Badger Acquisition of Texas LLC (52-2119915); Badger Acquisition LLC (52-2119866); Beachwood HealthCare Management, Inc. (34-1868886); Bio-Pharm International, Inc. (23-2794725); BPNY Acquisition Corp. (31-1563804); BPTX Acquisition Corp. (31-1563806); Campo's Medical Pharmacy, Inc., a Louisiana corporation (72-1039948); Care Pharmaceutical Services, LP (31-1399042); CHP Acquisition Corp. (31-1483612); CIP Acquisition Corp. (31-1486402); CompScript-Boca, LLC, a Florida limited liability company (65-0286244); CompScript-Mobile, Inc. (59-3248505); CompScript, Inc., a Florida corporation (65-0506539); CP Acquisition Corp., an Oklahoma corporation (61-1317566); Creekside Managed Care Pharmacy, Inc. (61-1349188); CTLP Acquisition LLC (61-1318902); D & R Pharmaceutical Services, Inc., a Kentucky corporation (61-0955886); Dixon Pharmacy LLC, an Illinois limited liability company (36-2825587); Electra Acquisition Corp. (31-1465189); Enloe Drugs LLC (31-1362346); Euro Bio-Pharm Clinical Services, Inc. (23-2770328); Evergreen Pharmaceutical of California, Inc., a California corporation (61-1321151); Evergreen Pharmaceutical, Inc., a Washington corporation (91-0883397); Heartland Repack Services LLC (61-1389057); Highland Wholesale LLC, an Ohio limited liability company (32-0006739); HMIS, Inc. (36-4124072); Home Care Pharmacy, Inc. (31-1255845); Home Pharmacy Services, LLC, a Missouri limited liability company (37-0978331); Hytree Pharmacy, Inc., an Ohio corporation (34-1090853); Interlock Pharmacy Systems, Inc., a Missouri corporation (43-0951332); JHC Acquisition LLC (31-1494762); Langsam Health Services, Inc. (73-1391198); LCPS Acquisition, LLC (61-1347084); Lo-Med Prescription Services, Inc., an Ohio corporation (34-1396063); LPI Acquisition Corp. (31-1501535); Managed Healthcare, Inc. (31-1450845); Management & Network Services, Inc., an Ohio corporation (34-1819691); Med World Acquisition Corp. (61-1322120); Medical Arts Health Care, Inc., a Georgia corporation (58-1640672); Medical Services Consortium, Inc., a Florida corporation (65-0357177); MOSI Acquisition Corp. (31-1528353); NCS HealthCare, Inc. (34-1816187); NCS HealthCare of Arizona, Inc., an Ohio corporation (31-1573985); NCS HealthCare of Arkansas, Inc., an Ohio corporation (31-1490517); NCS HealthCare of Beachwood, Inc., an Ohio corporation (34-1881410); NCS HealthCare of California, Inc., an Ohio corporation (31-1499819); NCS HealthCare of Connecticut, Inc., a Connecticut corporation (06-1330453); NCS HealthCare of Florida, Inc., an Ohio corporation (34-1843258); NCS HealthCare of Illinois, Inc., an Illinois corporation (37-1354510); NCS HealthCare of Indiana, Inc., an Indiana corporation (35-1954599); NCS HealthCare of Indiana LLC (34-1958652); NCS HealthCare of Iowa, Inc., an Ohio corporation (31-1509013); NCS HealthCare of Kansas, Inc., an Ohio corporation (34-1839712); NCS HealthCare of Kentucky, Inc., an Ohio corporation (31-1521217); NCS HealthCare of Maryland, Inc., an Ohio corporation (31-1496240); NCS HealthCare of Massachusetts, Inc., an Ohio corporation (31-1571275); NCS HealthCare of Michigan, Inc., an Ohio corporation (34-1777940); NCS HealthCare of Minnesota, Inc., an Ohio corporation (34-1866489); NCS HealthCare of Missouri, Inc., an Ohio corporation (34-1855274); NCS HealthCare of Montana, Inc., an Ohio corporation (34-1851710); NCS HealthCare of New Hampshire, Inc., a New Hampshire corporation (02-0468190); NCS HealthCare of New Jersey, Inc., a New Jersey corporation (22-3395391); NCS HealthCare of New Mexico, Inc., an Ohio corporation (34-1866493); NCS HealthCare of New York, Inc., an Ohio corporation (34-1854267); NCS HealthCare of North Carolina, Inc., a North Carolina corporation (56-1889643); NCS HealthCare of Ohio, Inc., an Ohio corporation (31-1257307); NCS HealthCare of Oklahoma, Inc., an Oklahoma corporation (73-1499934); NCS HealthCare of Oregon, Inc., an Ohio corporation (34-1836971); NCS HealthCare of Pennsylvania, Inc., a (footnote continued on next page) ii (footnote continued from previous page) Pennsylvania corporation (23-2679334); NCS HealthCare of Rhode Island, Inc., a Rhode Island corporation (05-0429829); NCS HealthCare of South Carolina, Inc., an Ohio corporation (31-1508225); NCS HealthCare of Tennessee, Inc., an Ohio corporation (34-1866494); NCS HealthCare of Texas, Inc., an Ohio corporation (34-1866495); NCS HealthCare of Vermont, Inc., an Ohio corporation (31-1526078); NCS HealthCare of Washington, Inc., an Ohio corporation (34-1844193); NCS HealthCare of Wisconsin, Inc., an Ohio corporation (34-1866497); NCS of Illinois, Inc., an Ohio Corporation (34-1959046); NCS Services, Inc., an Ohio corporation (34-1837567); National Care for Seniors LLC, an Ohio limited liability company (34-1972917); Nihan & Martin LLC (36-4004491); NIV Acquisition LLC (31-1501415); North Shore Pharmacy Services, Inc. (31-1428484); OCR-RA Acquisition Corp. (31-1442830); OFL Corp. (61-1357682); Omnibill Services LLC (61-1365732); Omnicare Clinical Research, Inc. (52-1670189); Omnicare Clinical Research, LLC (14-1723594); Omnicare CR Inc. (61-1395349); Omnicare Extended Pharma Services, LLC (05-0523710); Omnicare Headquarters LLC (76-0720510); Omnicare Indiana Partnership Holding Company LLC (16-1653107); Omnicare Management Company (31-1256520); Omnicare Pennsylvania Med Supply, LLC (61-1347895); Omnicare Pharmaceutics, Inc. (23-2745806); Omnicare Pharmacies of Maine Holding Company (61-1365280); Omnicare Pharmacies of Pennsylvania East, LLC (61-1347894); Omnicare Pharmacies of Pennsylvania West, Inc., a Pennsylvania corporation (25-1213193); Omnicare Pharmacies of the Great Plains Holding Company (61-1386242); Omnicare Pharmacy and Supply Services, Inc., a South Dakota corporation (41-1730324); Omnicare Pharmacy of Colorado, LLC (61-1347085); Omnicare Pharmacy of Florida, L.P. (76-0716528); Omnicare Pharmacy of Indiana, LLC (76-0716552); Omnicare Pharmacy of Maine LLC (61-1339662); Omnicare Pharmacy of Massachusetts LLC (61-1347087); Omnicare Pharmacy of Nebraska LLC (61-1386244); Omnicare Pharmacy of North Carolina, LLC (76-0716543); Omnicare Pharmacy of Pueblo, LLC (76-0716546); Omnicare Pharmacy of South Dakota LLC (61-1386243); Omnicare Pharmacy of Tennessee LLC (61-1347088); Omnicare Pharmacy of Texas 1, L.P. (76-0716554); Omnicare Pharmacy of Texas 2, L.P. (11-3657397); Omnicare Pharmacy of the Midwest, Inc. (31-1374275); Omnicare Purchasing Company LP (61-1401039); Omnicare Purchasing Company General Partner, Inc. (61-1401040); Omnicare Purchasing Company Limited Partner, Inc. (61-1401038); Omnicare Respiratory Services, LLC (03-0465903); PBM-Plus, Inc., a Wisconsin corporation (39-1789830); Pharmacon Corp., a New York corporation (13-3498399); Pharmacy Associates of Glens Falls, Inc., a New York corporation (14-1554120); Pharmacy Consultants, Inc., a South Carolina corporation (57-0640737); Pharmacy Holding #1, LLC (76-0716538); Pharmacy Holding #2, LLC (76-0716536); PharmaSource Healthcare, Inc., a Georgia corporation (58-2066823); Pharm-Corp of Maine LLC (61-1339663); Pharmed Holdings, Inc. (36-4060882); PRN Pharmaceutical Services, LP (35-1855784); Rescot Systems Group, Inc., a Pennsylvania corporation (23-2589308); Roeschen's Healthcare Corp., a Wisconsin corporation (39-1084787); Royal Care of Michigan LLC (38-3529444); SHC Acquisition Co, LLC (61-1346763); Shore Pharmaceutical Providers, Inc. (31-1425144); Southside Apothecary, Inc., a New York corporation (61-1340804); Specialized Home Infusion of Michigan LLC (38-3529442); Specialized Patient Care Services, Inc., an Alabama corporation (63-1159534); Specialized Pharmacy Services, Inc., a Michigan corporation (38-2143132); Specialized Services of Michigan, Inc. (38-3637511); Sterling Healthcare Services, Inc. (36-4031863); Superior Care Pharmacy, Inc. (31-1543728); Swish, Inc. (52-2005933); TCPI Acquisition Corp. (31-1508476); THG Acquisition Corp. (31-1567102); The Hardardt Group, Inc. (22-3470357); Three Forks Apothecary, Inc., a Kentucky corporation (61-0995656); UC Acquisition Corp. (31-1414594); Uni-Care Health Services of Maine, Inc., a New Hampshire corporation (02-0468192); Value Health Care Services, Inc. (31-1485530); Value Pharmacy, Inc., a Massachusetts corporation (04-2894741); Vital Care Infusions Supply, Inc., a New York corporation (61-1336267); Weber Medical Systems, LLC (31-1409572); Westhaven Services Co., an Ohio corporation (34-1151322); Williamson Drug Company, Incorporated, a Virginia corporation (54-0590067); and Winslow's Pharmacy, a New Jersey corporation (21-0692005). iii THE INFORMATION IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. NEITHER OMNICARE, INC. NOR ANY OMNICARE CAPITAL TRUST MAY SELL THESE SECURITIES UNTIL THE REGISTRATION STATEMENT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES AND IT IS NOT SOLICITING AN OFFER TO BUY THESE SECURITIES IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED. SUBJECT TO COMPLETION, DATED FEBRUARY 19, 2003 PROSPECTUS OMNICARE, INC. COMMON STOCK PREFERRED STOCK DEPOSITARY SHARES DEBT SECURITIES WARRANTS PURCHASE CONTRACTS UNITS OMNICARE CAPITAL TRUST I OMNICARE CAPITAL TRUST II OMNICARE CAPITAL TRUST III TRUST PREFERRED SECURITIES FULLY AND UNCONDITIONALLY GUARANTEED BY OMNICARE, INC. ------------------- We or, as applicable, the Omnicare Capital Trusts may offer from time to time the following types of securities: o shares of our common stock; o shares of our preferred stock, which may be issued in the form of depositary receipts representing a fraction of a share of preferred stock; o our debt securities, in one or more series, which may be senior debt securities or subordinated debt securities, in each case consisting of notes or other evidences of indebtedness; o warrants to purchase any of the other securities that may be sold under this prospectus; o trust preferred securities by one of the Omnicare Capital Trusts and fully and unconditionally guaranteed by us; o purchase contracts to acquire any of the other securities that may be sold under this prospectus; or o any combination of these securities, individually or as units. The securities will have an aggregate initial offering price of up to $850,000,000 or an equivalent amount in U.S. dollars if any securities are denominated in a currency other than U.S. dollars. The securities may be offered separately or together in any combination and as a separate series. This prospectus also covers guarantees, if any, of our payment obligations under any debt securities, which may be given by certain of our subsidiaries, on terms to be determined at the time of the offering. We will provide specific terms of these securities in supplements to this prospectus. You should read this prospectus and any prospectus supplement, as well as the documents incorporated or deemed to be incorporated by reference in this prospectus, carefully before you invest. Our common stock is traded on the New York Stock Exchange under the symbol "OCR." ------------------- NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. ------------------- We may sell these securities directly, through agents, dealers or underwriters as designated from time to time, or through a combination of these methods. We reserve the sole right to accept, and together with our agents, dealers and underwriters reserve the right to reject, in whole or in part, any proposed purchase of securities to be made directly or through agents, dealers or underwriters. If any agents, dealers or underwriters are involved in the sale of any securities, the relevant prospectus supplement will set forth any applicable commissions or discounts. Our net proceeds from the sale of securities also will be set forth in the relevant prospectus supplement. This prospectus may not be used to consummate sales of securities unless accompanied by the applicable prospectus supplement. THE DATE OF THIS PROSPECTUS IS , 2003. TABLE OF CONTENTS
PAGE ---- FORWARD-LOOKING STATEMENTS.................................. 2 RISK FACTORS................................................ 4 OUR COMPANY................................................. 9 THE OMNICARE CAPITAL TRUSTS................................. 9 USE OF PROCEEDS............................................. 10 RATIO OF EARNINGS TO FIXED CHARGES.......................... 10 GENERAL DESCRIPTION OF SECURITIES THAT WE MAY SELL.......... 11 DESCRIPTION OF COMMON STOCK................................. 11 DESCRIPTION OF PREFERRED STOCK.............................. 14 DESCRIPTION OF DEPOSITARY SHARES............................ 17 DESCRIPTION OF DEBT SECURITIES.............................. 20 DESCRIPTION OF WARRANTS..................................... 29 DESCRIPTION OF TRUST PREFERRED SECURITIES AND RELATED GUARANTEES................................................ 30 DESCRIPTION OF PURCHASE CONTRACTS........................... 40 DESCRIPTION OF UNITS........................................ 41 PLAN OF DISTRIBUTION........................................ 42 LEGAL MATTERS............................................... 43 EXPERTS..................................................... 43 WHERE YOU CAN FIND MORE INFORMATION......................... 43 DOCUMENTS INCORPORATED BY REFERENCE INTO THIS PROSPECTUS.... 43
------------------- We have not authorized any person to give any information or to make any representation in connection with this offering other than those contained or incorporated by reference in this prospectus, and, if given or made, the information or representation must not be relied upon as having been authorized by us. This prospectus does not constitute an offer to sell nor a solicitation of an offer to buy by anyone in any jurisdiction in which the offer or solicitation is not authorized, or in which the person is not qualified to do so or to any person to whom it is unlawful to make the offer or solicitation. Neither the delivery of this prospectus nor any sale under this prospectus shall, under any circumstances, create any implication that there has been no change in our affairs since the date of this prospectus, that the information contained in this prospectus is correct as of any time subsequent to its date, or that any information incorporated by reference in this prospectus is correct as of any time subsequent to its date. FORWARD-LOOKING STATEMENTS This prospectus contains and incorporates by reference certain statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include all statements regarding the intent, belief or current expectations with respect to the matters discussed or incorporated by reference in this prospectus (including statements as to "beliefs," "expectations," "anticipations," "intentions" or similar words) and all statements which are not statements of historical fact. These forward-looking statements involve known and unknown risks, uncertainties, contingencies and other factors that could cause results, performance or achievements to differ materially from those stated. These forward-looking statements and trends include those relating to expectations concerning our business outlook or position or future economic performance; the impact of our lowered cost structure; our financial condition; our strength in the geriatric pharmaceutical marketplace; the impact of the acquisition and integration of acquired companies; expectations concerning pharmaceutical price increases and the impact of pre-buys on costs and cash flows; purchasing leverage; the leveraging of costs; the impact of new business; the impact of penetration of new drugs; the impact of clinical and other programs; the impact of lower government reimbursement formulas in some states; trends concerning acuity and occupancy; the impact of our productivity, consolidation and cost reduction efforts; expectations concerning margins; trends concerning commencement or continuation of projects, new business wins and backlog at our contract research organization business; the impact of streamlining and cost reduction at our contract research organization operations; the operating environment in the long-term care and contract research organization industries; the impact of reimbursement trends and state and federal action with respect thereto; governmental pricing pressures due to economic downturns; the impact of healthcare funding issues; the impact of demographic trends; opportunities to contain healthcare costs while ensuring the well-being of the elderly population; expectations concerning growth; expectations concerning acquisitions; opportunities to expand our clinical programs; trends concerning the drug development marketplace; the adequacy and availability of our sources of liquidity, capital and financing; and the impact of new accounting rules and standards. Such risks, uncertainties, contingencies, assumptions and other factors, many of which are beyond our control, include without limitation: o overall economic, financial and business conditions; o delays and further reductions in reimbursement by the government and other payors to us and our customers as a result of pressure on federal and state budgets due to the continuing economic downturn and other factors; o the overall financial condition of our customers; o the ability to assess and react to the financial condition of customers; o the impact of consolidation in the pharmaceutical and long-term healthcare industries; o the impact of seasonality on our business; o the impact and pace of pharmaceutical price increases; o the ability of vendors to continue to provide products and services to us; o the effect of new government regulations, executive orders and/or legislative initiatives, including those relating to reimbursement and drug pricing policies and changes in the interpretation and application of these policies; o increases or decreases in reimbursement; o government budgetary pressures and shifting priorities; o efforts by payors to control costs; o the ability of clinical research projects to produce revenues in future periods; o our failure to obtain or maintain required regulatory approvals or licenses; 2 o the failure of the long-term care facilities we serve to maintain required regulatory approvals; o loss or delay of contract research organization contracts for regulatory or other reasons; o the outcome of litigation; o the ability to attract and retain needed management; o the ability to implement opportunities for improving productivity and lowering costs and to realize related anticipated benefits; o the integration of acquired companies, including NCS HealthCare, Inc. ("NCS"), and the ability to realize anticipated revenues, economies of scale, cost synergies and profitability; o the impact and pace of technological advances; o the ability to obtain or maintain rights to data, technology and other intellectual property; o trends for the continued growth of our business; o volatility in our stock price and in the financial markets generally; o changes in international economic and political conditions and currency fluctuations between the U.S. dollar and other currencies; o access to capital and financing; o pricing and other competitive factors in our industry; o variations in costs or expenses; o variations in our operating results; o the continued availability of suitable acquisition candidates; o the demand for our products and services; o changes in tax law and regulation; o changes in accounting rules and standards; and o other risks and uncertainties described in "Risk Factors" and elsewhere in this prospectus, including the documents incorporated by reference. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, our actual results, performance or achievements could differ materially from those expressed in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date thereof. Except as otherwise required by law, we do not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. 3 RISK FACTORS An investment in our securities involves a degree of risk. You should carefully consider the risk factors described below and other information included and incorporated by reference in this prospectus and the applicable prospectus supplement when determining whether or not to purchase the offered securities. If any of the following risks actually occurs, we could be materially adversely affected. In such case, you may lose all or part of your investment. RISKS RELATING TO OUR BUSINESS IF WE OR OUR CLIENT INSTITUTIONS FAIL TO COMPLY WITH MEDICAID AND MEDICARE REIMBURSEMENT REGULATIONS, OUR REVENUE COULD BE REDUCED, WE COULD BE SUBJECT TO PENALTIES AND WE COULD LOSE OUR ELIGIBILITY TO PARTICIPATE IN THESE PROGRAMS. Approximately one-half of our pharmacy services billings are directly reimbursed by government sponsored programs. These programs include Medicaid and, to a lesser extent, Medicare. The remainder of our billings are paid or reimbursed by individual residents, long-term care facilities and other third party payors, including private insurers. A portion of these revenues also are indirectly dependent on government programs. The table below represents our approximated payor mix for the last three years:
1999 2000 2001 ---- ---- ---- Private pay and long-term care facilities(1)................ 48% 46% 44% Medicaid.................................................... 40% 43% 44% Medicare(2)................................................. 3% 3% 3% Other private sources(3).................................... 9% 8% 9% --- --- --- Totals:................................................. 100% 100% 100% --- --- --- --- --- ---
- --------- (1) Includes payments from skilled nursing facilities on behalf of their Medicare-eligible residents. (2) Includes direct billing for medical supplies. (3) Includes our contract research organization revenues. For its fiscal year ended June 30, 2002, NCS' approximate payor mix was: 49% Medicaid, 45% private pay and long-term care facilities (includes payments from long-term care facilities on behalf of their Medicare-eligible residents), 1% Medicare (includes direct billing for medical supplies) and 5% other private sources. The Medicaid and Medicare programs are highly regulated. The failure, even if inadvertent, of us and/or our client institutions to comply with applicable reimbursement regulations could adversely affect our reimbursement under these programs and our ability to continue to participate in these programs. In addition, our failure to comply with these regulations could subject us to other penalties. CONTINUING EFFORTS TO CONTAIN HEALTHCARE COSTS MAY REDUCE OUR FUTURE REVENUE. Our sales and profitability are affected by the efforts of healthcare payors to contain or reduce the cost of healthcare by lowering reimbursement rates, limiting the scope of covered services, and negotiating reduced or capitated pricing arrangements. Any changes which lower reimbursement levels under Medicaid, Medicare or private pay programs, including managed care contracts, could reduce our future revenue. Furthermore, other changes in these reimbursement programs or in related regulations could reduce our future revenue. These changes may include modifications in the timing or processing of payments and other changes intended to limit or decrease the growth of Medicaid, Medicare or third party expenditures. 4 THE BALANCED BUDGET ACT OF 1997 AND OTHER HEALTHCARE-RELATED LEGISLATION HAS SIGNIFICANTLY IMPACTED OUR BUSINESS, AND FUTURE LEGISLATION AND REGULATIONS ARE LIKELY TO AFFECT US. In recent years, Congress has passed a number of federal laws that have effected major changes in the healthcare system. Several of these changes have had a significant impact on us. The Balanced Budget Act of 1997 sought to achieve a balanced federal budget by, among other things, changing the reimbursement policies applicable to various healthcare providers, including the introduction in 1998 of the Prospective Payment System for Medicare-eligible residents of skilled nursing facilities. Prior to the Prospective Payment System, skilled nursing facilities under Medicare were reimbursed for services based upon actual costs incurred in providing services, subject to limits. Now, the Prospective Payment System requires skilled nursing facilities to manage more carefully the cost of care for Medicare beneficiaries. Under the Prospective Payment System, Medicare pays skilled nursing facilities a fixed fee per patient per day based on the resident's medical condition and required level of assistance with activities of daily living. This fixed fee covers substantially all items and services furnished during a Medicare-covered stay, including pharmacy services. The Prospective Payment System initially resulted in a reduction in admissions of Medicare residents, particularly those requiring complex care, leading to a significant reduction of overall occupancy in the skilled nursing facilities we serve. As a result, we began experiencing lower utilization of our services and Prospective Payment System-related pricing pressure from our skilled nursing facility customers in 1999. The Balanced Budget Act of 1997 also imposed numerous other cost savings measures affecting Medicare skilled nursing facility services. Because of the significant reductions in reimbursement which occurred, the impact of the Prospective Payment System initially was to decrease occupancy for some facilities, to reduce the number of residents in these facilities requiring higher levels of medical care, to lower pricing and to produce an unfavorable payor mix for us. With respect to Medicaid, the Balanced Budget Act of 1997 repealed the "Boren Amendment" federal payment standard for payments to Medicaid nursing facilities effective October 1, 1997. This repeal gives states greater latitude in setting payment rates for nursing facilities. Budget constraints and other factors have caused some states to reduce Medicaid reimbursement to nursing facilities and states may continue to reduce or delay payments to nursing facilities in the future. The law also grants states greater flexibility to establish Medicaid managed care programs without the need to obtain a federal waiver. Although these waiver programs generally exempt institutional care, including nursing facility and institutional pharmacy services, these programs could ultimately change the Medicaid reimbursement system for long-term care. These changes could include moving reimbursement for pharmacy services from fee-for-service, or payment per procedure or service rendered, to a fixed amount per person utilizing managed care negotiated or capitated rates. In 1999 and again in 2000, Congress enacted legislation intended to reduce the impact of the Balanced Budget Act of 1997 on skilled nursing facilities. This legislation included increases in payment rates for some services and delays in the implementation of some Balanced Budget Act of 1997 requirements. It appears that this legislation stabilized the unfavorable operating trends attributable to the Prospective Payment System and helped to improve the financial condition of skilled nursing facilities and motivated them to increase admissions, particularly of higher acuity residents. However, certain of the increases in Medicare reimbursement for skilled nursing facilities expired in October 2002. This loss of Medicare revenues may have an adverse effect on the financial condition of many of our skilled nursing facility customers. While it is hoped that Congress will restore some or all of these payment amounts, no assurances can be given as to whether Congress will take such action. Further, some of the current payments to skilled nursing facilities will expire once the Centers for Medicare & Medicaid Services, or CMS, adopts a refined system for categorizing resident acuity. CMS has indicated that this change would not occur during federal fiscal year 2004 (October 1, 2003 -- September 30, 2004), but it is unknown when a refined system would be adopted, the form of the refined system or whether it would result in net increases or decreases in payments for Medicare skilled nursing facilities. 5 Further, in order to rein in healthcare costs, we anticipate that federal and state governments will continue to review and assess alternate healthcare delivery systems, payment methodologies and operational requirements for healthcare providers, including long-term care facilities and pharmacies. Given the continuous debate regarding the cost of healthcare, managed care and other healthcare issues, we cannot predict with any degree of certainty what additional healthcare initiatives, if any, will be implemented or the effect any future legislation or regulation will have on our business. Further, Medicaid and/or Medicare payment rates for pharmaceutical supplies and services may not continue to be based on current methodologies or remain comparable to present levels. In particular, the federal government is examining the appropriateness of using the "average wholesale price" as the basis for reimbursement for prescription drugs under Medicare Part B. In addition, legislative initiatives are being considered to expand Medicare coverage of prescription drugs, in some instances as part of a broad reform of the Medicare program. Any future healthcare legislation or regulation may adversely affect our business. IF WE FAIL TO COMPLY WITH LICENSURE REQUIREMENTS, FRAUD AND ABUSE LAWS OR OTHER APPLICABLE LAWS, WE MAY NEED TO CURTAIL OPERATIONS, AND COULD BE SUBJECT TO SIGNIFICANT PENALTIES. Our pharmacy business is subject to extensive and often changing federal, state and local regulations, and our pharmacies are required to be licensed in the states in which they are located or do business. While we continuously monitor the effects of regulatory activity on our operations and we currently have pharmacy licenses for each pharmacy we operate, the failure to obtain or renew any required regulatory approvals or licenses could adversely affect the continued operation of our business. The long-term care facilities that contract for our services are also subject to federal, state and local regulations and are required to be licensed in the states in which they are located. The failure by these long-term care facilities to comply with these or future regulations or to obtain or renew any required licenses could result in our inability to provide pharmacy services to these facilities and their residents. We are also subject to federal and state laws that prohibit some types of direct and indirect payments between healthcare providers. These laws, commonly known as the fraud and abuse laws, prohibit payments intended to induce or encourage the referral of patients to, or the recommendation of, a particular provider of items or services. Violation of these laws can result in loss of licensure, civil and criminal penalties and exclusion from the Medicaid, Medicare and other federal healthcare programs. We expend considerable resources in connection with our compliance efforts. We believe that we are in compliance in all material respects with state and federal regulations applicable to our business. FEDERAL AND STATE LAWS THAT PROTECT PATIENT HEALTH INFORMATION MAY INCREASE OUR COSTS AND LIMIT OUR ABILITY TO COLLECT AND USE THAT INFORMATION. Our company and the healthcare industry generally also are impacted by the Health Insurance Portability and Accountability Act of 1996, or HIPAA, which mandates, among other things, the adoption of standards to enhance the efficiency and simplify the administration of the healthcare system. HIPAA requires the Department of Health and Human Services to adopt standards for electronic transactions and code sets for basic healthcare transactions such as payment and remittance advice ("transaction standards"); privacy of individually identifiable healthcare information ("privacy standards"); security and electronic signatures ("security standards"), as well as unique identifiers for providers, employers, health plans and individuals; and enforcement. In many of our operations, we are a healthcare provider, required to comply in our operations with these standards and subject to significant civil and criminal penalties for failure to do so. In addition, we provide services to customers that also are healthcare providers and will be required to provide satisfactory written assurances to those customers that we will provide those services subject to the requirements of the privacy standards. HIPAA will require significant and costly changes for our company and others in the healthcare industry. The transaction standards have gone into effect, although we and most other covered entities in the healthcare industry have 6 received an extension until October 2003 to comply. The privacy standards generally require compliance by April 2003. No date is established for compliance with the security standards, since they have not yet been published in final form. Based on current information, we believe we will be able to fully comply with HIPAA requirements, however, at this time we cannot estimate the cost of compliance or if implementation of the HIPAA standards will result in an adverse effect on our operations or profitability, or that of our customers. WE ARE SUBJECT TO ADDITIONAL RISKS RELATING TO OUR ACQUISITION STRATEGY. One component of our strategy contemplates our making selected acquisitions. Acquisitions, including our acquisition of NCS, involve inherent uncertainties. These uncertainties include the effect on the acquired businesses of integration into a larger organization and the availability of management resources to oversee the operations of these businesses. The successful integration of acquired businesses, including NCS, will require, among others: o consolidation of financial and managerial functions and elimination of operational redundancies; o achievement of purchasing efficiencies; o the addition and integration of key personnel; and o the maintenance of existing business. Even though an acquired business may have experienced positive financial performance as an independent company prior to an acquisition, we cannot be sure that the business will continue to perform positively after an acquisition. We also may acquire businesses with unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations. We have policies and procedures to conduct reviews of potential acquisition candidates for compliance with healthcare laws and to conform the practices of acquired businesses to our standards and applicable laws. We also generally seek indemnification from sellers covering these matters. We may, however, incur material liabilities for past activities of acquired businesses, including NCS. We cannot be sure of the successful integration of NCS or any other acquisition or that an acquisition will not have an adverse impact on our results of operations or financial condition. WE OPERATE IN HIGHLY COMPETITIVE BUSINESSES. The long-term care pharmacy business is highly regionalized and, within a given geographic region of operations, highly competitive. Our largest competitors nationally are Pharmerica, Inc., a subsidiary of AmerisourceBergen Corporation, NeighborCare, Inc., a subsidiary of Genesis Health Ventures, Inc., Kindred Pharmacy Services, a division of Kindred Healthcare, Inc., and SunScript Pharmacy Corporation, a subsidiary of Sun Healthcare Group, Inc. In the geographic regions we serve, we also compete with numerous local retail pharmacies, local and regional institutional pharmacies and pharmacies owned by long-term care facilities. We compete on the basis of quality, cost-effectiveness and the increasingly comprehensive and specialized nature of our services, along with the clinical expertise, pharmaceutical technology and professional support we offer. Our contract research organization business competes against other full-service contract research organizations and client internal resources. The contract research organization industry is highly fragmented with a number of full-service contract research organizations and many small, limited-service providers, some of which serve only local markets. Clients choose a contract research organization based upon, among other reasons, reputation, references from existing clients, the client's relationship with the organization, the organization's experience with the particular type of project and/or therapeutic area of clinical development, the organization's ability to add value to the client's development plan, the organization's financial stability and the organization's ability to provide the full range of services required by the client. 7 WE ARE DEPENDENT ON OUR SENIOR MANAGEMENT TEAM AND OUR PHARMACY PROFESSIONALS. We are highly dependent upon the members of our senior management and our pharmacists and other pharmacy professionals. Our business is managed by a small number of key management personnel who have been extensively involved in the success of our business, including Joel F. Gemunder, our President and Chief Executive Officer. If we were unable to retain these persons, we might be adversely affected. Our industry is small and there is a limited pool of senior management personnel with significant experience in our industry. Accordingly, we believe we could experience significant difficulty in replacing key management personnel. Although we have employment contracts with our key management personnel, these contracts generally may be terminated without cause by either party. In addition, our continued success depends on our ability to attract and retain pharmacists and other pharmacy professionals. Competition for qualified pharmacists and other pharmacy professionals is strong. The loss of pharmacy personnel or the inability to attract, retain or motivate sufficient numbers of qualified pharmacy professionals could adversely affect our business. Although we generally have been able to meet our staffing requirements for pharmacists and other pharmacy professionals in the past, our inability to do so in the future could have a material adverse effect on us. 8 OUR COMPANY We are a leading provider of pharmaceutical care for the elderly. We are the nation's largest independent provider of professional pharmacy-related consulting and data management services to long-term healthcare institutions. Our client facilities include skilled nursing facilities, assisted living facilities, retirement centers, hospitals and other institutional healthcare facilities. We currently provide our pharmacy services to long-term care facilities comprising more than 950,000 beds in 47 states. We purchase, repackage and dispense pharmaceuticals, both prescription and non-prescription, and provide computerized medical record keeping and third-party billing for residents in those facilities. We also provide consultant pharmacist services, including evaluating monthly patient drug therapy, monitoring the control, distribution and administration of drugs within the nursing facility, and assisting in compliance with state and federal regulations. In addition, we provide ancillary services, such as administering medications and nutrition intravenously and furnishing dialysis and medical supplies. We offer clinical care planning, pharmaceutical support as well as financial software information systems to our client facilities. In addition, we provide operational software and support systems to other long-term care pharmacy providers across the United States. We also provide comprehensive clinical research services for the pharmaceutical and biotechnology industries in 28 countries. On January 15, 2003, we completed our tender offer for all of the outstanding shares of the common stock of NCS HealthCare, Inc., a leading provider of pharmaceutical and related services to long-term care facilities, including skilled nursing centers, assisted living facilities and hospitals. We accepted approximately 94% of the validly tendered shares of class A common stock of NCS and 100% of the validly tendered shares of class B common stock of NCS for payment. We subsequently acquired the remaining shares of class A common stock of NCS. Our net cash outlay, including estimated fees and expenses, to acquire NCS was approximately $167.0 million. In connection with the acquisition, we repaid approximately $325.5 million of outstanding NCS debt. We used cash on hand, working capital and available borrowing capacity under our existing credit facilities to finance the acquisition and the repayment of NCS' outstanding debt. Our principal executive offices are located at 100 East RiverCenter Boulevard, Covington, Kentucky, 41011, and our telephone number is (859) 392-3300. Our corporate website address is http://www.omnicare.com. Information contained on our website is not part of this prospectus. THE OMNICARE CAPITAL TRUSTS Each of Omnicare Capital Trust I, Omnicare Capital Trust II and Omnicare Capital Trust III is a statutory trust newly formed under Delaware law by us, as sponsor of each of the trusts, and Chase Manhattan Bank USA, National Association, as trustee in the State of Delaware pursuant to the Delaware Statutory Trust Act. The trusts have been formed solely: o for the possible sale of one or more series of trust preferred securities under this prospectus and the sale of trust common securities to us or one of our subsidiaries at the time of any sale of trust preferred securities; o to purchase a specific series of our subordinated debt securities with the proceeds of any sale of their securities; and o to engage in related activities. The principal office of each of the trusts is c/o Omnicare, Inc., 100 East RiverCenter Boulevard, Covington, Kentucky, 41011, and its telephone number is (859) 392-3300. 9 USE OF PROCEEDS Unless we indicate otherwise in an accompanying prospectus supplement, we intend to use the net proceeds from the sale of the securities offered by this prospectus for general corporate purposes, which may include, but not be limited to, refinancing of indebtedness, working capital, capital expenditures, acquisitions and repurchases and redemptions of securities. The Omnicare Capital Trusts will use all of the proceeds from the sale of trust preferred securities to purchase a specific series of our subordinated debt securities. RATIO OF EARNINGS TO FIXED CHARGES The following table sets forth our consolidated ratio of earnings to fixed charges for the periods indicated:
NINE MONTHS ENDED YEAR ENDED DECEMBER 31, SEPTEMBER 30, -------------------------------- ---------------- 1997 1998 1999 2000 2001 2001 2002 ---- ---- ---- ---- ---- ---- ---- Ratio of earnings to fixed charges (1)(2)...... 9.1x 5.3x 2.6x 2.2x 2.8x 2.7x 3.8x
- --------- (1) Our ratio of earnings to fixed charges has been computed by dividing earnings before income taxes plus fixed charges (excluding capitalized interest expense) by fixed charges. Fixed charges consist of interest expense on debt (including amortization of debt expense and capitalized interest) and one-third (the proportion deemed representative of the interest portion) of rent expense. (2) Our ratio of earnings to combined fixed charges and preferred stock dividends for the periods indicated above are the same as our ratios of earnings to fixed charges set forth above because we had no shares of preferred stock outstanding during the periods indicated and currently have no shares of preferred stock outstanding. 10 GENERAL DESCRIPTION OF SECURITIES THAT WE MAY SELL We, directly or through agents, dealers or underwriters that we may designate, may offer and sell, from time to time, up to $850,000,000 (or the equivalent in one or more foreign currencies or currency units) aggregate initial offering price of: o shares of our common stock; o shares of our preferred stock, which may be issued in the form of depositary receipts representing a fraction of a share of preferred stock; o our debt securities, in one or more series, which may be senior debt securities or subordinated debt securities, in each case consisting of notes or other evidences of indebtedness, and which may be guaranteed by certain of our subsidiaries; o warrants to purchase any of the other securities that may be sold under this prospectus; o trust preferred securities issued by one of the Omnicare Capital Trusts and fully and unconditionally guaranteed by us; o purchase contracts to acquire any of the other securities that may be sold under this prospectus; or o any combination of these securities, individually or as units. We may offer and sell these securities either individually or as units consisting of one or more of these securities, each on terms to be determined at the time of sale. We may issue debt securities and/or preferred stock that are exchangeable for and/or convertible into common stock or any of the other securities that may be sold under this prospectus. When particular securities are offered, a supplement to this prospectus will be delivered with this prospectus, which will describe the terms of the offering and sale of the offered securities. DESCRIPTION OF COMMON STOCK Our authorized capital stock consists of 200,000,000 shares of common stock, par value $1.00 per share, and 1,000,000 shares of preferred stock, no par value per share. We describe the preferred stock under the heading "Description of Preferred Stock." This section summarizes the general terms of our common stock that we may offer. The prospectus supplement relating to the common stock offered will state the number of shares offered, the initial offering price and the market price, dividend information and any other relevant information. The summaries in this section and the prospectus supplement do not describe every aspect of the common stock. When evaluating the common stock, you should also refer to all of the provisions of our charter, our by-laws and the Delaware General Corporation Law ("DGCL"). Our charter and by-laws are incorporated by reference in the registration statement. TERMS OF THE COMMON STOCK At December 31, 2002, approximately 94,301,500 shares of our common stock were outstanding. Our common stock has no preemptive rights and no redemption, sinking fund or conversion provisions. All shares of our common stock have one vote on any matter submitted to the vote of stockholders. Our common stock does not have cumulative voting rights. Upon our liquidation, the holders of our common stock are entitled to receive, on a pro rata basis, all assets then legally available for distribution after payment of debts and liabilities and preferences on preferred stock, if any. Holders of our common stock are entitled to receive dividends when and as declared by the board of directors out of funds legally available therefor (subject to the prior rights of preferred stock, if any). All outstanding shares of our common stock are fully paid and nonassessable. 11 RIGHTS AGREEMENT On June 2, 1999, we paid a dividend of one preferred share purchase right for each outstanding share of our common stock to the stockholders of record on that date. Each right entitles the registered holder to purchase one ten-thousandth of a share of our Series A Junior Participating Preferred Stock, at a price of $135.00 per one ten-thousandth of a share of Series A Junior Participating Preferred Stock, subject to adjustment. The description and terms of the rights are set forth in the Rights Agreement between us and First Chicago Trust Company of New York, as rights agent. Initially, the rights will be attached to all certificates of common stock and no separate rights certificates will be issued. Separate rights certificates evidencing the rights will be distributed to holders of record of our common stock as of the close of business on the earlier to occur of the tenth day (or such other day as our board of directors may determine) following (i) a public announcement that a person or group of affiliated or associated persons, referred to as an "Acquiring Person," has acquired beneficial ownership of 15% or more of the outstanding common shares or (ii) the commencement of, or announcement of an intention to make, a tender offer or exchange offer the consummation of which would result in the beneficial ownership by a person or group of 15% or more of the outstanding common shares. The rights will expire on June 2, 2009, unless extended or unless the rights are earlier redeemed or exchanged by us. Until a right is exercised, the holder thereof, as such, will have no rights as a stockholder of ours, including, without limitation, the right to vote or to receive dividends. If a person or group becomes an Acquiring Person, each holder of a right will thereafter have the right to receive, upon exercise, shares of our common stock (or, in certain circumstances, shares of Series A Junior Participating Preferred Stock or other similar securities of ours) having a value equal to two times the exercise price of the right and all rights that are, or (under certain circumstances specified in the Rights Agreement) were, beneficially owned by any Acquiring Person will be null and void. In the event that we are acquired in a merger or other business combination transaction or 50% or more of our consolidated assets or earning power are sold after a person or group has become an Acquiring Person, proper provision will be made so that each holder of a right will thereafter have the right to receive, upon the exercise thereof at the then current exercise price of the right, that number of shares of common stock of the acquiring company which at the time of such transaction will have a market value of two times the exercise price of the right. In the event that any person or group becomes an Acquiring Person, proper provision shall be made so that each holder of a right, other than rights beneficially owned by the Acquiring Person (which will thereafter be void), will thereafter have the right to receive upon exercise that number of shares of our common stock having a market value of two times the exercise price of the right. At any time after any person or group becomes an Acquiring Person and prior to the acquisition by such person or group of 50% or more of the outstanding shares of our common stock, our board of directors may exchange the rights (other than rights owned by such person or group which will have become void), in whole or in part, at an exchange ratio of one share of our common stock, or one ten-thousandth of a share of Series A Junior Participating Preferred Stock (or of a share of a class or series of our preferred stock having equivalent rights, preferences and privileges), per right (subject to adjustment). At any time prior to the distribution date, our board of directors may redeem the rights, in whole but not in part, at a price of $.01 per right. Immediately upon any such redemption, the right to exercise the rights will terminate and the only right of the holders of rights will be to receive the redemption price. PROVISIONS WITH POSSIBLE ANTI-TAKEOVER EFFECTS Certain provisions of our charter, by-laws and the DGCL may delay or prevent any transaction involving us that might result in a change of control. 12 Fair Price Provision. With certain exceptions, in the event a person, corporation or other entity owns 10% or more of our stock entitled to vote, a majority of the outstanding shares of our capital stock not so owned is required to authorize (i) any merger or consolidation of us with or into such corporation, (ii) any sale, lease, exchange or other disposition of all or a substantial part of our assets to or with such person, corporation or other entity or (iii) issuances and transfers of our securities to such person, corporation or other entity for assets and/or securities with a value of at least $5 million or for cash. Board of Directors. Our board of directors, when evaluating any offer of another party to make a tender or exchange offer for our equity securities, merge or consolidate with us, purchase or otherwise acquire all or substantially all of our assets, shall, in connection with the exercise of its judgment in determining what is in the best interests of us and our stockholders, give due consideration to all relevant factors, including the social and economic effects on our employees, customers, suppliers and other constituents and on the communities in which we operate or are located. Our charter also provides that directors may be removed without cause only by the holders of two-thirds of the shares of our capital stock then entitled to vote on the election of directors. Amendments to the Charter. The sections of our charter relating to the fair price and director removal provisions described above, as well as those relating to elimination of director liability, indemnification of directors and the ability of our board of directors to amend the by-laws, may only be repealed or amended with the approval of the holders of two-thirds of the outstanding shares of each class of our capital stock entitled to vote thereon as a class. Business Combinations. We are subject to Section 203 of the DGCL which restricts a wide range of transactions ("business combinations") between a corporation and an interested stockholder. An "interested stockholder" is, generally, any person who beneficially owns, directly or indirectly, 15% or more of the corporation's outstanding voting stock. Business combinations are broadly defined to include (i) mergers or consolidations with, (ii) sales or other dispositions of more than 10% of the corporation's assets to, (iii) certain transactions resulting in the issuance or transfer of any stock of the corporation or any subsidiary to, (iv) certain transactions resulting in an increase in the proportionate share of stock of the corporation or any subsidiary owned by, or (v) receipt of the benefit (other than proportionately as a stockholder) of any loans, advances or other financial benefits by an interested stockholder. Section 203 provides that an interested stockholder may not engage in a business combination with the corporation for a period of three years from the time of becoming an interested stockholder unless (a) the board of directors approved either the business combination or the transaction which resulted in the person becoming an interested stockholder prior to the time that person became an interested stockholder; (b) upon consummation of the transaction which resulted in the person becoming an interested stockholder, that person owned at least 85% of the corporation's voting stock (excluding shares owned by persons who are directors and also officers and shares owned by certain employee stock plans); or (c) the business combination is approved by the board of directors and authorized by the affirmative vote of at least 66 2/3% of the outstanding voting stock not owned by the interested stockholder. Future Issuances of Preferred Stock. We are not required to seek stockholder approval prior to designating any future series of preferred stock. Our board of directors could issue preferred stock in one or more transactions with terms which might make the acquisition of control of our company more difficult or costly. TRANSFER AGENT The transfer agent for our common stock is EquiServe Trust Company, N.A., Jersey City, New Jersey. 13 DESCRIPTION OF PREFERRED STOCK This section summarizes the general terms of the preferred stock that we may offer. The prospectus supplement relating to a particular series of preferred stock will describe the specific terms of that series, which may be in addition to or different from the general terms summarized in this section. The summaries in this section and the prospectus supplement do not describe every aspect of the preferred stock. If any particular terms of a series of preferred stock described in a prospectus supplement differ from any of the terms described in this prospectus, then the terms described in the applicable prospectus supplement will be deemed to supersede the terms described in this prospectus. When evaluating the preferred stock, you also should refer to all of the provisions of our charter, the applicable certificate of designation for the offered series of preferred stock and the DGCL. The applicable certificate of designation will be filed as an exhibit to or incorporated by reference in the registration statement. GENERAL Our board of directors is authorized to issue shares of preferred stock, in one or more series or classes, and to fix for each series voting powers and those preferences and relative, participating, optional or other special rights and those qualifications, limitations or restrictions as are permitted by the DGCL. Our board of directors is authorized to determine the terms for each series of preferred stock, and the prospectus supplement will describe the terms of any series of preferred stock being offered, including: o the designation of the shares and the number of shares that constitute the series; o the dividend rate (or the method of calculation thereof), if any, on the shares of the series and the priority as to payment of dividends with respect to other classes or series of our capital stock; o the dividend periods (or the method of calculation thereof); o the voting rights of the shares; o the liquidation preference and the priority as to payment of the liquidation preference with respect to other classes or series of our capital stock and any other rights of the shares of the series upon our liquidation or winding up; o whether or not and on what terms the shares of the series will be subject to redemption or repurchase at our option; o whether and on what terms the shares of the series will be convertible into or exchangeable for other securities; o whether depositary shares representing shares of the series of preferred stock will be offered and, if so, the fraction of a share of the series of preferred stock represented by each depositary share (see "Description of Depositary Shares" below); o whether the shares of the series of preferred stock will be listed on a securities exchange; o any special United States federal income tax considerations applicable to the series; and o the other rights and privileges and any qualifications, limitations or restrictions of the rights or privileges of the series. DIVIDENDS Holders of shares of preferred stock will be entitled to receive, when and as declared by our board of directors, dividends payable at the dates and at the rates, if any, per share per annum as set forth in the applicable prospectus supplement. Unless otherwise set forth in the applicable prospectus supplement, each series of preferred stock will rank junior as to dividends to any preferred stock that may be issued in the future that is expressly senior as to dividends to that preferred stock. If we should fail at any time to pay 14 accrued dividends on any senior shares at the time the dividends are payable, we may not pay any dividend on the junior preferred stock or redeem or otherwise repurchase shares of junior preferred stock until the accumulated but unpaid dividends on the senior shares have been paid or set aside for payment in full by us. Unless otherwise set forth in the applicable prospectus supplement, no dividends (other than in common stock or other capital stock ranking junior to the preferred stock of any series as to dividends and upon liquidation) may be declared or paid or set aside for payment, nor may any other distribution be declared or made upon the common stock, or any of our other capital stock ranking junior to or on a parity with the preferred stock of that series as to dividends, nor may any common stock or any of our other capital stock ranking junior to or on a parity with the preferred stock of that series as to dividends be redeemed, purchased or otherwise acquired for any consideration (or any monies be paid to or made available for a sinking fund for the redemption of any shares of any of that stock) by us (except by conversion into or exchange for other capital stock of ours ranking junior to the preferred stock of that series as to dividends) unless (i) if that series of preferred stock has a cumulative dividend, full cumulative dividends on the preferred stock of that series have been or contemporaneously are declared and paid or declared and a sum sufficient for the payment thereof set apart for all past dividend periods and the then current dividend period and (ii) if such series of preferred stock does not have a cumulative dividend, full dividends on the preferred stock of such series have been or contemporaneously are declared and paid or declared and a sum sufficient for the payment thereof set apart for payment for the then current dividend period. However, any monies deposited in any sinking fund with respect to any preferred stock in compliance with the provisions of the sinking fund may be applied to the purchase or redemption of that preferred stock in accordance with the terms of the sinking fund, regardless of whether at the time of the application full dividends, including cumulative dividends, upon shares of the preferred stock outstanding on the last dividend payment date have been paid or declared and set apart for payment. In addition, any junior or parity preferred stock or common stock may be converted into or exchanged for our stock ranking junior to the preferred stock as to dividends. The amount of dividends payable for the initial dividend period or any period shorter than a full dividend period will be computed on the basis of a 360-day year of twelve 30-day months, unless otherwise set forth in the applicable prospectus supplement. Accrued but unpaid dividends will not bear interest, unless otherwise set forth in the applicable prospectus supplement. CONVERTIBILITY No series of preferred stock will be convertible into, or exchangeable for, other securities or property except as set forth in the applicable prospectus supplement. REDEMPTION AND SINKING FUND No series of preferred stock will be redeemable or receive the benefit of a sinking fund except as set forth in the applicable prospectus supplement. LIQUIDATION RIGHTS Unless otherwise set forth in the applicable prospectus supplement, in the event of our liquidation, dissolution or winding up, the holders of shares of each series of preferred stock are entitled to receive out of our assets available for distribution to stockholders, before any distribution of assets is made to holders of (i) any other shares of preferred stock ranking junior to that series of preferred stock as to rights upon liquidation, dissolution or winding up and (ii) shares of common stock, liquidating distributions per share in the amount of the liquidation preference specified in the applicable prospectus supplement for that series of preferred stock plus any dividends accrued and accumulated but unpaid to the date of final distribution; but the holders of each series of preferred stock will not be entitled to receive the liquidating distribution of, plus such dividends on, those shares until the liquidation preference of any shares of our capital stock 15 ranking senior to that series of the preferred stock as to the rights upon liquidation, dissolution or winding up will have been paid (or a sum set aside therefor sufficient to provide for payment) in full. If upon our liquidation, dissolution or winding up, the amounts payable with respect to the preferred stock, and any other preferred stock ranking as to any distribution on a parity with the preferred stock are not paid in full, then the holders of the preferred stock and the other parity preferred stock will share ratably in any distribution of assets in proportion to the full respective preferential amount to which they are entitled. Unless otherwise specified in a prospectus supplement for a series of preferred stock, after payment of the full amount of the liquidating distribution to which they are entitled, the holders of shares of preferred stock will not be entitled to any further participation in any distribution of our assets. Neither a consolidation or merger of us with another corporation nor a sale of securities will be considered a liquidation, dissolution or winding up of us. VOTING RIGHTS The holders of each series or class of preferred stock we may issue will have no voting rights, except as required by law and as described below or in the applicable prospectus supplement. Our board of directors may, upon issuance of a series or class of preferred stock, grant voting rights to the holders of that series or class to elect additional board members if we fail to pay dividends in a timely fashion. Without the affirmative vote of a majority of the shares of any class of preferred stock then outstanding, we may not: o increase or decrease the aggregate number of authorized shares of that class; o increase or decrease the par value of the shares of that class; or o alter or change the powers, preferences or special rights of the shares of that class so as to affect them adversely. If the amendment would adversely alter or change the powers, preferences or special rights of one or more series of a class of preferred stock, but not the entire class, then only the shares of the affected series will have the right to vote on the amendment. MISCELLANEOUS The holders of our preferred stock will have no preemptive rights. All shares of preferred stock being offered by the applicable prospectus supplement will be fully paid and not liable to further calls or assessment by us. If we should redeem or otherwise reacquire shares of our preferred stock, then these shares will resume the status of authorized and unissued shares of preferred stock undesignated as to series, and will be available for subsequent issuance. NO OTHER RIGHTS The shares of a series of preferred stock will not have any preferences, voting powers or relative, participating, optional or other special rights except as set forth above or in the applicable prospectus supplement, our charter or the applicable certificate of designation or as otherwise required by law. TRANSFER AGENT AND REGISTRAR The transfer agent and registrar for each series of preferred stock will be designated in the applicable prospectus supplement. 16 DESCRIPTION OF DEPOSITARY SHARES GENERAL We may, at our option, elect to offer fractional shares rather than full shares of the preferred stock of a series. In the event that we exercise this option, we will issue receipts for depositary shares, each of which will represent a fraction (to be set forth in the prospectus supplement relating to a particular series of preferred stock) of a share of a particular series of preferred stock as described below. The shares of any series of preferred stock represented by depositary shares will be deposited under one or more deposit agreements among us, a depositary to be named in the applicable prospectus supplement, and the holders from time to time of depositary receipts issued thereunder. Subject to the terms of the applicable deposit agreement, each holder of a depositary share will be entitled, in proportion to the applicable fraction of a share of preferred stock represented by the depositary share, to all the rights and preferences of the preferred stock represented thereby (including, as applicable, dividend, voting, redemption, subscription and liquidation rights). The depositary shares will be evidenced by depositary receipts issued pursuant to the deposit agreement. Depositary receipts will be distributed to those persons purchasing the fractional shares of the related series of preferred stock. This section summarizes the general terms of the depositary shares that we may offer. The prospectus supplement relating to the depositary shares will describe the specific terms of the depositary shares which may be in addition to or different from the general terms summarized in this section. If any particular terms of the depositary shares or the deposit agreement described in a prospectus supplement differ from any of the terms described below, then the terms described below will be deemed to have been superseded by that prospectus supplement. When evaluating the depositary shares and preferred stock, you also should refer to the applicable deposit agreement and depositary receipt. The applicable deposit agreement and depositary receipt will be filed as exhibits to the registration statement or incorporated by reference in the registration statement. Immediately following our issuance of shares of a series of preferred stock that will be offered as fractional shares, we will deposit the shares with the depositary, which will then issue and deliver the depositary receipts to the purchasers thereof. Depositary receipts will only be issued evidencing whole depositary shares. A depositary receipt may evidence any number of whole depositary shares. Pending the preparation of definitive depositary receipts, the depositary may, upon our written order, issue temporary depositary receipts substantially identical to (and entitling the holders thereof to all the rights pertaining to) the definitive depositary receipts but not in definitive form. Definitive depositary receipts will be prepared thereafter without unreasonable delay, and such temporary depositary receipts will be exchangeable for definitive depositary receipts at our expense. DIVIDENDS AND OTHER DISTRIBUTIONS The depositary will distribute all dividends or other distributions received in respect of the related series of preferred stock to the record holders of depositary shares relating to the series of preferred stock in proportion to the number of the depositary shares owned by the holders. In the event of a distribution other than in cash, the depositary will distribute property received by it to the record holders of depositary shares entitled thereto in proportion to the number of depositary shares owned by the holders, unless the depositary determines that the distribution cannot be made proportionately among the holders or that it is not feasible to make the distributions, in which case the depositary may, with our approval, adopt any method it deems equitable and practicable for the purpose of effecting the distribution, including the sale (at public or private sale) of the securities or property thus received, or any part thereof, at the place or places and upon those terms as it may deem proper. 17 REDEMPTION OF DEPOSITARY SHARES If any series of the preferred stock underlying the depositary shares is subject to redemption, the depositary shares will be redeemed from the proceeds received by the depositary resulting from any redemption, in whole or in part, of the series of the preferred stock held by the depositary. The redemption price per depositary share will be equal to the applicable fraction of the redemption price per share payable with respect to the series of the preferred stock. If we redeem shares of a series of preferred stock held by the depositary, the depositary will redeem as of the same redemption date the number of depositary shares representing the shares of preferred stock so redeemed. If less than all of the depositary shares are to be redeemed, the depositary shares to be redeemed will be selected by lot or substantially equivalent method determined by the depositary. After the date fixed for redemption, the depositary shares so called for redemption will no longer be deemed to be outstanding and all rights of the holders of the depositary shares will cease, except the right to receive the monies payable upon redemption and any money or other property to which the holders of the depositary shares were entitled upon such redemption, upon surrender to the depositary of the depositary receipts evidencing the depositary shares. Any funds deposited by us with the depositary for any depositary shares that the holders thereof fail to redeem will be returned to us after a period of two years from the date the funds are so deposited. VOTING THE UNDERLYING PREFERRED STOCK Upon receipt of notice of any meeting at which the holders of any series of the preferred stock are entitled to vote, the depositary will mail the information contained in the notice of meeting to the record holders of the depositary shares relating to the series of preferred stock. Each record holder of the depositary shares on the record date (which will be the same date as the record date for the related series of preferred stock) will be entitled to instruct the depositary as to the exercise of the voting rights pertaining to the number of shares of the series of preferred stock represented by that holder's depositary shares. The depositary will endeavor, insofar as practicable, to vote or cause to be voted the number of shares of preferred stock represented by the depositary shares in accordance with the instructions, provided the depositary receives the instructions sufficiently in advance of the meeting to enable it to so vote or cause to be voted the shares of preferred stock, and we will agree to take all reasonable action that may be deemed necessary by the depositary in order to enable the depositary to do so. The depositary will abstain from voting shares of the preferred stock to the extent it does not receive specific instructions from the holders of depositary shares representing the preferred stock. WITHDRAWAL OF STOCK Upon surrender of the depositary receipts at the corporate trust office of the depositary and upon payment of the taxes, charges and fees provided for in the deposit agreement and subject to the terms thereof, the holder of the depositary shares evidenced thereby is entitled to delivery at such office, to or upon his or her order, of the number of whole shares of the related series of preferred stock and any money or other property, if any, represented by the depositary shares. Holders of depositary shares will be entitled to receive whole shares of the related series of preferred stock, but holders of the whole shares of preferred stock will not thereafter be entitled to deposit the shares of preferred stock with the depositary or to receive depositary shares therefor. If the depositary receipts delivered by the holder evidence a number of depositary shares in excess of the number of depositary shares representing the number of whole shares of the related series of preferred stock to be withdrawn, the depositary will deliver to the holder upon his or her order at the same time a new depositary receipt evidencing the excess number of depositary shares. 18 AMENDMENT AND TERMINATION OF A DEPOSIT AGREEMENT The form of depositary receipt evidencing the depositary shares of any series and any provision of the applicable deposit agreement may at any time and from time to time be amended by agreement between us and the depositary. However, any amendment that materially adversely alters the rights of the holders of depositary shares of any series will not be effective unless the amendment has been approved by the holders of at least a majority of the depositary shares of the series then outstanding. Every holder of a depositary receipt at the time the amendment becomes effective will be deemed, by continuing to hold the depositary receipt, to be bound by the deposit agreement as so amended. Notwithstanding the foregoing, in no event may any amendment impair the right of any holder of any depositary shares, upon surrender of the depositary receipts evidencing the depositary shares and subject to any conditions specified in the deposit agreement, to receive shares of the related series of preferred stock and any money or other property represented thereby, except in order to comply with mandatory provisions of applicable law. The deposit agreement may be terminated by us at any time upon not less than 60 days prior written notice to the depositary, in which case, on a date that is not later than 30 days after the date of the notice, the depositary shall deliver or make available for delivery to holders of depositary shares, upon surrender of the depositary receipts evidencing the depositary shares, the number of whole or fractional shares of the related series of preferred stock as are represented by the depositary shares. The deposit agreement shall automatically terminate after all outstanding depositary shares have been redeemed or there has been a final distribution in respect of the related series of preferred stock in connection with any liquidation, dissolution or winding up of us and the distribution has been distributed to the holders of depositary shares. CHARGES OF DEPOSITARY We will pay all transfer and other taxes and the governmental charges arising solely from the existence of the depositary arrangements. We will pay the charges of the depositary, including charges in connection with the initial deposit of the related series of preferred stock and the initial issuance of the depositary shares and all withdrawals of shares of the related series of preferred stock, except that holders of depositary shares will pay transfer and other taxes and governmental charges and any other charges as are expressly provided in the deposit agreement to be for their accounts. RESIGNATION AND REMOVAL OF DEPOSITARY The depositary may resign at any time by delivering to us written notice of its election to do so, and we may at any time remove the depositary. Any resignation or removal is to take effect upon the appointment of a successor depositary, which successor depositary must be appointed within 60 days after delivery of the notice of resignation or removal and must be a bank or trust company having its principal office in the United States and having a combined capital and surplus of at least $50,000,000. MISCELLANEOUS The depositary will forward to the holders of depositary shares all reports and communications from us that are delivered to the depositary and which we are required to furnish to the holders of the related preferred stock. The depositary's corporate trust office will be identified in the applicable prospectus supplement. Unless otherwise set forth in the applicable prospectus supplement, the depositary will act as transfer agent and registrar for depositary receipts and if shares of a series of preferred stock are redeemable, the depositary also will act as redemption agent for the corresponding depositary receipts. 19 DESCRIPTION OF DEBT SECURITIES We may issue debt securities either separately, or together with, or upon the conversion of or in exchange for, other securities. The debt securities may be our unsubordinated obligations, which we refer to as "senior debt securities," or our subordinated obligations, which we refer to as "subordinated debt securities." The subordinated debt securities of any series may be our senior subordinated obligations, subordinated obligations, junior subordinated obligations or may have such other ranking as will be described in the relevant prospectus supplement. We may issue any of these types of debt securities in one or more series. Our senior debt securities may be issued from time to time under a senior debt securities indenture. Our subordinated debt securities may be issued from time to time under a subordinated debt securities indenture. Each of the senior debt securities indenture and the subordinated debt securities indenture is referred to individually as an "indenture" and they are referred to collectively as the "indentures." Each trustee is referred to individually as a "trustee" and the trustees are collectively referred to as the "trustees." This section summarizes selected terms of the debt securities that we may offer. The applicable prospectus supplement and the form of applicable indenture relating to any particular debt securities offered will describe the specific terms of that series, which may be in addition to or different from the general terms summarized in this section. If any particular terms of the debt securities described in a prospectus supplement differ from any of the terms described in this prospectus, then the terms described in the applicable prospectus supplement will supersede the terms described in this prospectus. The following summary and any description of our debt securities contained in an applicable prospectus supplement do not describe every aspect of the applicable indenture or the debt securities. When evaluating the debt securities, you also should refer to all provisions of the applicable indenture and the debt securities. The forms of indentures have been filed as exhibits to the registration statement of which this prospectus is a part. When we refer to "Omnicare," "we," "us" or "our" in this section or when we otherwise refer to ourselves in this section, we mean Omnicare, Inc., excluding, unless otherwise expressly stated or the context requires, our subsidiaries. GENERAL We can issue an unlimited amount of debt securities under the indentures. However, certain of our existing or future debt agreements may limit the amount of debt securities we may issue. We can issue debt securities from time to time and in one or more series as determined by us. In addition, we can issue debt securities of any series with terms different from the terms of debt securities of any other series and the terms of particular debt securities within any series may differ from each other, all without the consent of the holders of previously issued series of debt securities. The applicable prospectus supplement relating to the series of debt securities will describe the specific terms of the debt securities being offered, including, where applicable, the following: o the title and series designation of the series of debt securities and whether the debt securities of the series will be senior debt securities or subordinated debt securities; o any limit on the aggregate principal amount of debt securities of the series; o the price or prices at which the debt securities of the series will be issued; o whether the debt securities of the series will be guaranteed and the terms of any such guarantees; o the date or dates on which the principal amount and premium, if any, are payable; o the interest rate or rates or the method for calculating the interest rate, which may be fixed or variable, at which the debt securities of the series will bear interest, if any, the date or dates from which interest will accrue and the interest payment date on which interest will be payable, subject to our right, if any, to defer or extend an interest payment date and the duration of that deferral or extension; 20 o the date or dates on which interest, if any, will be payable and the record dates for payment of interest; o the place or places where the principal and premium, if any, and interest, if any, will be payable and where the debt securities of the series can be surrendered for transfer, conversion or exchange; o our right, if any, to redeem the debt securities and the terms and conditions upon which the debt securities of the series may be redeemed, in whole or in part; o any mandatory or optional sinking fund or analogous provisions; o if the debt securities of the series will be secured, any provisions relating to the security provided; o whether the debt securities of the series are convertible or exchangeable into other debt or equity securities, and, if so, the terms and conditions upon which such conversion or exchange will be effected; o whether any portion of the principal amount of the debt securities of the series will be payable upon declaration or acceleration of the maturity thereof pursuant to an event of default; o whether the debt securities of the series, in whole or any specified part, will not be defeasible pursuant to the applicable indenture and, if other than by an officers' certificate, the manner in which any election by us to defease the debt securities of the series will be evidenced; o any deletions from, modifications of or additions to the events of default or our covenants pertaining to the debt securities of the series; o if other than U.S. dollars, the currency or currencies, including composite currencies, of payment of principal of, premium, if any, and interest, if any, on the debt securities of the series and whether the debt securities of the series may be satisfied and discharged other than as provided in the applicable indenture; o any terms applicable to debt securities of any series issued at an issue price below their stated principal amount, including the issue price thereof and the rate or rates at which the original issue discount will accrue; o whether the debt securities of the series are to be issued or delivered (whether at the time of original issuance or at the time of exchange of a temporary security of such series or otherwise), or any installment of principal or any premium or interest is to be payable only, upon receipt of certificates or other documents or satisfaction of other conditions in addition to those specified in the applicable indenture; o whether the debt securities of the series are to be issued in fully registered form without coupons or are to be issued in the form of one or more global securities in temporary global form or permanent global form; o whether the debt securities of the series are to be issued in registered or bearer form, the terms and conditions relating the applicable form, including, but not limited to, tax compliance, registration and transfer procedures and, if in registered form, the denominations in which we will issue the registered securities if other than $1,000 or a multiple thereof and, if in bearer form, the denominations in which we will issue the bearer securities; o any special United States federal income tax considerations applicable to the debt securities of the series; o any addition to or change in the covenants set forth in the indenture which apply to the debt securities of the series; and o any other terms of the debt securities of the series not inconsistent with the provisions of the applicable indenture. 21 The prospectus supplement relating to any series of subordinated debt securities being offered also will describe the subordination provisions applicable to that series, if different from the subordination provisions described in this prospectus. In addition, the prospectus supplement relating to a series of subordinated debt will describe our rights, if any, to defer payments of interest on the subordinated debt securities by extending the interest payment period. Debt securities may be issued as original issue discount securities to be sold at a discount below their principal amount or at a premium above their principal amount. In the event of an acceleration of the maturity of any original issue discount security, the amount payable to the holder upon acceleration will be determined in the manner described in the applicable prospectus supplement. The above is not intended to be an exclusive list of the terms that may be applicable to any debt securities and we are not limited in any respect in our ability to issue debt securities with terms different from or in addition to those described above or elsewhere in this prospectus, provided that the terms are not inconsistent with the applicable indenture. Any applicable prospectus supplement also will describe any special provisions for the payment of additional amounts with respect to the debt securities. GUARANTEES Debt securities may be guaranteed by certain of our domestic subsidiaries, if so provided in the applicable prospectus supplement. The prospectus supplement will describe the terms of any guarantees, including, among other things, the method for determining the identity of the guarantors and the conditions under which guarantees will be added or released. Any guarantees will be joint and several obligations of the guarantors. The obligations of each guarantor under its guarantee will be limited as necessary to prevent that guarantee from constituting a fraudulent conveyance or fraudulent transfer under applicable law. SUBORDINATION PROVISIONS RELATING TO SUBORDINATED DEBT Debt securities may be subject to contractual subordination provisions contained in the subordinated debt securities indenture. These subordination provisions may prohibit us from making payments on the subordinated debt securities in certain circumstances before a defined class of "senior indebtedness" is paid in full or during certain periods when a payment or other default exists with respect to certain senior indebtedness. If we issue subordinated debt securities, the applicable prospectus supplement relating to the subordinated debt securities will include a description of the subordination provisions and the definition of senior indebtedness that apply to the subordinated debt securities. If the trustee under the subordinated debt indenture or any holder of the series of subordinated debt securities receives any payment or distribution that is prohibited under the subordination provisions, then the trustee or the holders will have to repay that money to the holders of senior indebtedness. Even if the subordination provisions prevent us from making any payment when due on the subordinated debt securities of any series, we will be in default on our obligations under that series if we do not make the payment when due. This means that the trustee under the subordinated debt indenture and the holders of that series can take action against us, but they will not receive any money until the claims of the holders of senior indebtedness have been fully satisfied. Unless otherwise indicated in an applicable prospectus, if any series of subordinated debt securities is guaranteed by certain of our subsidiaries, then the guarantee will be subordinated to the senior indebtedness of such guarantor to the same extent as the subordinated debt securities are subordinated to the senior indebtedness. 22 CONVERSION AND EXCHANGE RIGHTS The debt securities of a series may be convertible into or exchangeable for any of our other securities, if at all, according to the terms and conditions of an applicable prospectus supplement. Such terms will include the conversion or exchange price and any adjustments thereto, the conversion or exchange period, provisions as to whether conversion or exchange will be mandatory, at our option or at the option of the holders of that series of debt securities and provisions affecting conversion or exchange in the event of the redemption of that series of debt securities. FORM, EXCHANGE, REGISTRATION AND TRANSFER The debt securities of a series may be issued as registered securities, as bearer securities (with or without coupons attached) or as both registered securities and bearer securities. Debt securities of a series may be issuable in whole or in part in the form of one or more global debt securities, as described below under "Global Debt Securities." Unless otherwise indicated in an applicable prospectus supplement, registered securities will be issuable in denominations of $1,000 and integral multiples thereof. Registered securities of any series will be exchangeable for other registered securities of the same series of any authorized denominations and of a like aggregate principal amount and tenor. Debt securities may be presented for exchange as provided above, and unless otherwise indicated in an applicable prospectus supplement, registered securities may be presented for registration of transfer, at the office or agency designated by us as registrar or co-registrar with respect to any series of debt securities, without service charge and upon payment of any taxes, assessments or other governmental charges as described in the applicable indenture. The transfer or exchange will be effected on the books of the registrar or any other transfer agent appointed by us upon the registrar or transfer agent, as the case may be, being satisfied with the documents of title and identity of the person making the request. We intend to initially ap point the trustee as registrar and the name of any different or additional registrar designated by us with respect to the debt securities of any series will be included in the applicable prospectus supplement. If a prospectus supplement refers to any transfer agents (in addition to the registrar) designated by us with respect to any series of debt securities, we may at any time rescind the designation of any transfer agent or approve a change in the location through which any transfer agent acts, except that, if debt securities of a series are issuable only as registered securities, we will be required to maintain a transfer agent in each place of payment for that series. We may at any time designate additional transfer agents with respect to any series of debt securities. In the event of any redemption of debt securities of any series, we will not be required to (i) issue, register the transfer of or exchange debt securities of that series during a period beginning at the opening of business 15 days before any selection of debt securities of that series to be redeemed and ending at the close of business on the day of mailing of the relevant notice of redemption and (ii) register the transfer of or exchange any registered security, or portion thereof, called for redemption, except the unredeemed portion of any registered security being redeemed in part. PAYMENT AND PAYING AGENTS Unless otherwise indicated in an applicable prospectus supplement, payment of principal of, premium, if any, and interest, if any, on registered securities will be made at the office of the paying agent or paying agents designated by us from time to time, except that at our option, payment of principal and premium, if any, or interest also may be made by wire transfer to an account maintained by the payee. Unless otherwise indicated in an applicable prospectus supplement, payment of any installment of interest on registered securities will be made to the person in whose name the registered security is registered at the close of business on the regular record date for the interest payment. Unless otherwise indicated in an applicable prospectus supplement, the trustee will be designated as our sole paying agent for payments with respect to debt securities which are issuable 23 solely as registered securities. Any paying agents outside the United States and any other paying agents in the United States initially designated by us for any series of debt securities will be named in an applicable prospectus supplement. We may at any time designate additional paying agents or rescind the designation of any paying agent or approve a change in the office through which any paying agent acts, except that, if debt securities of a series are issuable only as registered securities, we will be required to maintain a paying agent in each place of payment for that series. All monies paid by us to a paying agent for the payment of principal of, premium, if any, or interest, if any, on any debt security which remains unclaimed at the end of two years after that principal or interest will have become due and payable will be repaid to us, and the holder of the debt security or any coupon will thereafter look only to us for payment of those amounts. GLOBAL DEBT SECURITIES The debt securities of a series may be issued in whole or in part in global form. A global debt security will be deposited with, or on behalf of, a depositary, which will be identified in an applicable prospectus supplement. A global debt security may be issued in either registered or bearer form and in either temporary or permanent form. A global debt security may not be transferred except as a whole to the depositary for the debt security or to a nominee or successor of the depositary. If any debt securities of a series are issuable in global form, the applicable prospectus supplement will describe the circumstances, if any, under which beneficial owners of interests in a global debt security may exchange their interests for definitive debt securities of that series of like tenor and principal amount in any authorized form and denomination, the manner of payment of principal of, premium, if any, and interest, if any, on the global debt securities and the specific terms of the depositary arrangement with respect to any global debt security. COVENANTS Reports. Except as otherwise set forth in an applicable prospectus supplement, so long as any debt securities of a series are outstanding, we will furnish to the holders of debt securities of that series, within the time periods specified in the rules and regulations of the Securities and Exchange Commission, or SEC, (a) our reports on Forms 10-Q and 10-K, including a Management's Discussion and Analysis of Financial Condition and Results of Operations and, with respect to the annual information only, a report on the audited financial statements by our certified independent accountants and (b) all current reports on Form 8-K. We also will file a copy of all of the information and reports referred to in clauses (a) and (b) above with the SEC for public availability within the time periods specified in the SEC's rules and regulations (unless the SEC will not accept such a filing) and make such information available to securities analysts and prospective investors upon request. Any additional covenants with respect to any series of debt securities will be set forth in the applicable prospectus supplement. Unless otherwise indicated in an applicable prospectus supplement, the indentures do not include covenants restricting our ability to enter into a highly leveraged transaction, including a reorganization, restructuring, merger or similar transaction involving us that may adversely affect the holders of the debt securities, if the transaction is a permissible consolidation, merger or similar transaction. In addition, unless otherwise specified in an applicable prospectus supplement, the indentures do not afford the holders of the debt securities the right to require us to repurchase or redeem the debt securities in the event of a highly leveraged transaction. See "Merger, Consolidation and Sale of Assets." MERGER, CONSOLIDATION AND SALE OF ASSETS Except as otherwise set forth in an applicable prospectus supplement, we may not, directly or indirectly, (i) consolidate with or merge into any other person (whether or not we are the surviving corporation) or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all of our properties and assets, unless (a) either (x) we are the continuing 24 corporation, or (y) the person formed by or surviving any such consolidation or merger (if other than us) or to which such sale, assignment, transfer, conveyance or disposition will have been made is a corporation organized and existing under the laws of the United States, any state thereof or the District of Columbia and that person assumes all of our obligations under the debt securities of such series and the indenture relating thereto pursuant to agreements reasonably satisfactory to the applicable trustee; and (b) any other conditions specified in the applicable prospectus supplement. In addition, we may not, directly or indirectly, lease all or substantially all of our properties or assets in one or more related transactions to any other person. This "Merger, Consolidation and Sale of Assets" covenant will not apply to a sale, assignment, transfer, conveyance or other disposition of assets between or among us and any guarantors, if applicable. EVENTS OF DEFAULT AND REMEDIES Under each indenture, unless otherwise specified with respect to a series of debt securities, the following events will constitute an event of default with respect to any series of debt securities: o default for 30 days in the payment when due of any interest on any debt securities of that series; o default in payment when due of the principal of, or premium, if any, on any debt security of that series; o failure to comply with the provisions described under the caption "Merger, Consolidation or Sale of Assets;" o failure for 60 days after notice to comply with any of the other agreements in the indenture; o except as permitted by the indenture, if debt securities of a series are guaranteed, any guarantee shall be held in any final, non-appealable judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or any guarantor, or any person acting on behalf of any guarantor, shall deny, or disaffirm its obligations under its guarantee (unless such guarantor could be released from its guarantee in accordance with the applicable terms of the indenture); o certain events of bankruptcy or insolvency described in the indenture with respect to us or any of our Significant Subsidiaries; and o any other event of default applicable to the series of debt securities and set forth in the applicable prospectus supplement. Each indenture provides that in the case of an event of default arising from certain events of bankruptcy or insolvency relating to us with respect to a series of debt securities, all outstanding debt securities of that series will become due and payable immediately without further action or notice. If any other event of default occurs and is continuing, the trustee or the holders of at least 25% in principal amount of the then outstanding debt securities of that series may declare all the debt securities of that series to be due and payable immediately. Holders of the debt securities of a series may not enforce the indenture or the debt securities of that series except as provided in the indenture. Subject to certain limitations, holders of a majority in principal amount of the then outstanding debt securities of a series may direct the trustee in its exercise of any trust or power. The trustee may withhold from holders of the debt securities of a series notice of any continuing default or event of default if it determines that withholding notice is in their interest, except a default or event of default relating to the payment of principal or interest. Each indenture provides that we are required to deliver to the trustee annually a statement regarding compliance with the indenture. Upon becoming aware of any default or event of default, we are required to deliver to the trustee a statement specifying such default or event of default. The holders of a majority in aggregate principal amount of the debt securities of a series then outstanding by notice to the trustee may on behalf of the holders of all of the debt securities of 25 that series waive any existing default or event of default and its consequences under the indenture except a continuing default or event of default in the payment of interest or premium on, or the principal of, the debt securities of that series. Such limitations do not apply, however, to a suit instituted by a holder of any debt security for the enforcement of the payment of the principal of, premium, if any, and interest in respect of a debt security on the date specified for payment in the debt security. Unless otherwise specified with respect to a series of debt securities, the holders of at least a majority in aggregate principal amount of the then outstanding debt securities of that series may, on behalf of the holders of the debt securities of any series, waive any past defaults under the applicable indenture, other than (i) a default in any payment of the principal of, and premium, if any, or interest on, any debt security of the series or (ii) any default in respect of the covenants or provisions in the applicable indenture which may not be modified without the consent of the holder of each outstanding debt security of the series affected. For purposes of this section, "Significant Subsidiary" means any subsidiary that would be a "significant subsidiary" as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such Regulation is in effect on the date hereof. AMENDMENT, SUPPLEMENT AND WAIVER Each indenture permits us and the applicable trustee, with the consent of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of the series affected by the supplemental indenture, to execute a supplemental indenture to add provisions to, or change in any manner or eliminate any provisions of, the indenture with respect to that series of debt securities or modify in any manner the rights of the holders of the debt securities of that series and any related coupons under the applicable indenture. However, the supplemental indenture will not, without the consent of the holder of each outstanding debt security of that series affected thereby: o change the stated maturity of the principal of, or any installment of principal or interest on, the debt securities of that series or any premium payable upon redemption thereof; o reduce the principal amount of, or premium, if any, or the rate of interest on, the debt securities of that series; o change the place or currency of payment of principal and premium, if any, or interest, if any, on the debt securities of that series; o impair the right to institute suit for the enforcement of any payment after the stated maturity date on any debt securities of that series, or in the case of redemption, on or after the redemption date; o reduce the principal amount of outstanding debt securities of that series necessary to modify or amend or waive compliance with any provisions of the indenture; o release any applicable guarantor from any of its obligations under its guarantee or the indenture, except in accordance with the indenture; o modify the foregoing amendment and waiver provisions, except (i) to increase the percentage in principal amount of outstanding debt securities of any series necessary for such actions or (ii) to provide that certain other provisions of the indenture cannot be modified or waived without the consent of the holder of each debt security of a series affected thereby; and o change such other matters as may be specified in an applicable prospectus supplement for any series of debt securities. The indentures also permit us, the guarantors, if any, and the applicable trustee to execute a supplemental indenture without the consent of the holders of the debt securities: o to cure any ambiguity, defect or inconsistency; 26 o to provide for uncertificated debt securities in addition to or in place of certificated debt securities; o to provide for the assumption of our obligations or, if applicable, a guarantor's obligations to holders of debt securities of a series in the case of a merger or consolidation or sale of all or substantially all of our assets or, if applicable, a guarantor's assets; o to make any change that would provide any additional rights or benefits to the holders of debt securities of a series or that does not adversely affect the legal rights under the indenture of any such holder; o to comply with the requirements of SEC in order to effect or maintain the qualification of the indenture under the Trust Indenture Act; o to add a guarantor under the indenture; o to evidence and provide the acceptance of the appointment of a successor trustee under the applicable indenture; o to mortgage, pledge, hypothecate or grant a security interest in favor of the trustee for the benefit of the holders of debt securities of any series as additional security for the payment and performance of our or any applicable guarantor's obligations under the applicable indenture, in any property or assets; o to add to, change or eliminate any provisions of the applicable indenture (which addition, change or elimination may apply to one or more series of debt securities), provided that, any such addition, change or elimination (A) shall neither (i) apply to any debt security of any series created prior to the execution of such supplemental indenture and entitled to the benefit of such provision nor (ii) modify the rights of the holders of such debt securities with respect to such provisions or (B) shall become effective only when there is no such outstanding debt securities of such series; and o to establish the form and terms of debt securities of any series as permitted by the indenture. The holders of a majority in principal amount of outstanding debt securities of any series may waive compliance with certain restrictive covenants and provisions of the applicable indenture. DISCHARGE Unless otherwise indicated in an applicable prospectus supplement, each indenture provides that we may satisfy and discharge our obligations thereunder with respect to the debt securities of any series, when either: o all debt securities of that series that have been authenticated, except lost, stolen or destroyed debt securities of that series that have been replaced or paid and debt securities of that series for whose payment money has been deposited in trust and thereafter repaid to us, have been delivered to the trustee for cancellation; or o all debt securities of that series that have not been delivered to the trustee for cancellation have become due and payable by reason of the mailing of a notice of redemption or otherwise or will become due and payable within one year and we or, if applicable, any guarantor has irrevocably deposited or caused to be deposited with the trustee as trust funds in trust solely for the benefit of the holders of debt securities of that series, cash, non-callable U.S. government securities, or a combination thereof, in amounts as will be sufficient without consideration of any reinvestment of interest, to pay and discharge the entire indebtedness on the debt securities of that series not delivered to the trustee for cancellation for principal, premium, if any, and accrued interest to the date of maturity or redemption. 27 DEFEASANCE Unless otherwise indicated in an applicable prospectus supplement, each indenture provides that we may, at our option and at any time, elect to have all of our obligations discharged with respect to the outstanding debt securities of a series and, if applicable, all obligations of the guarantors discharged with respect to their guarantees ("legal defeasance") except for: o the rights of holders of the outstanding debt securities of that series to receive payments in respect of the principal of, or premium or interest, if any, on the debt securities of that series when such payments are due from the trust referred to below; o our obligations with respect to the debt securities of that series concerning issuing temporary securities, registration of securities, mutilated, destroyed, lost or stolen securities and the maintenance of an office or agency for payment and money for security payments held in trust; o the rights, powers, trusts, duties and immunities of the applicable trustee, our obligations and, if applicable, the guarantor's obligations in connection therewith; and o the legal defeasance provisions of the indenture. In addition, we may, at our option and at any time, elect to have our obligations and, if applicable, the guarantors' obligations released with respect to certain covenants in respect of the debt securities of any series that are described in the indenture ("covenant defeasance") and thereafter any omission to comply with those covenants will not constitute a default or event of default with respect to the debt securities of that series. In the event covenant defeasance occurs, certain events (not including non-payment, bankruptcy, receivership, rehabilitation and insolvency events) described under " -- Events of Default and Remedies" will no longer constitute an event of default with respect to the debt securities of that series. In order to exercise either legal defeasance or covenant defeasance we are required to meet specified conditions, including: we must irrevocably deposit with the trustee, in trust, for the benefit of the holders of the debt securities of that series, cash, non-callable U.S. government securities, or a combination thereof, in amounts as will be sufficient to pay the principal of, or premium and interest, if any, on the outstanding debt securities of that series on the stated maturity or on the applicable redemption date, as the case may be; in the case of legal defeasance, we have delivered to the applicable trustee an opinion of counsel reasonably acceptable to the trustee confirming that (a) we have received from, or there has been published by, the Internal Revenue Service a ruling or (b) since the date of the indenture, there has been a change in the applicable federal income tax law, in either case to the effect that, and based thereon such opinion of counsel will confirm that, the holders of the outstanding debt securities of that series will not recognize income, gain or loss for federal income tax purposes as a result of such legal defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such legal defeasance had not occurred; and in the case of covenant defeasance, we have delivered to the trustee an opinion of counsel reasonably acceptable to the trustee confirming that the holders of the outstanding debt securities of that series will not recognize income, gain or loss for federal income tax purposes as a result of such covenant defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such covenant defeasance had not occurred. THE TRUSTEES UNDER THE INDENTURES If a trustee becomes a creditor of ours or any guarantor, the indenture limits its right to obtain payment of claims in certain cases, or to realize on certain property received in respect of any such claim as security or otherwise. Each trustee will be permitted to engage in other transactions with us and/or the guarantors, if any; however, if any trustee acquires any conflicting 28 interest it must eliminate such conflict within 90 days, apply to the SEC for permission to continue or resign. The holders of a majority in principal amount of the then outstanding debt securities of a series will have the right to direct the time, method and place of conducting any proceeding for exercising any remedy available to the trustee, subject to certain exceptions. The indenture provides that in case an event of default occurs and is continuing, a trustee will be required, in the exercise of its power, to use the degree of care of a prudent person in the conduct of its own affairs. Subject to such provisions, a trustee will be under no obligation to exercise any of its rights or powers under the indenture at the request of any holder of debt securities, unless such holder has offered to the trustee security and indemnity satisfactory to it against any loss, liability or expense. APPLICABLE LAW The debt securities and the indentures will be governed by and construed in accordance with the laws of the State of New York. DESCRIPTION OF WARRANTS We may issue, either separately or together with other securities, warrants for the purchase of any of the other types of securities that we may sell under this prospectus. This section summarizes the general terms of the warrants that we may offer. The warrants will be issued under warrant agreements to be entered into between us and a bank or trust company, as warrant agent. The prospectus supplement relating to a particular series of warrants will describe the specific terms of that series, which may be in addition to or different from the general terms summarized in this section. The summaries in this section and the prospectus supplement do not describe every aspect of the warrants. If any particular terms of a series of warrants described in a prospectus supplement differ from any of the terms described in this prospectus, then the terms described in the applicable prospectus supplement will be deemed to supersede the terms described in this prospectus. When evaluating the warrants, you also should refer to all the provisions of the applicable warrant agreement, the certificates representing the warrants and the specific descriptions in the applicable prospectus supplement. The applicable warrant agreement and warrant certificates will be filed as exhibits to or incorporated by reference in the registration statement. GENERAL The prospectus supplement will describe the terms of the warrants in respect of which this prospectus is being delivered as well as the related warrant agreement and warrant certificates, including the following, where applicable: o the principal amount of, or the number of securities, as the case may be, purchasable upon exercise of each warrant and the initial price at which the principal amount or number of securities, as the case may be, may be purchased upon such exercise; o the designation and terms of the securities, if other than common stock, purchasable upon exercise thereof and of any securities, if other than common stock, with which the warrants are issued; o the procedures and conditions relating to the exercise of the warrants; o the date, if any, on and after which the warrants, and any securities with which the warrants are issued, will be separately transferable; o the offering price of the warrants, if any; o the date on which the right to exercise the warrants will commence and the date on which that right will expire; 29 o a discussion of any special United States federal income tax considerations applicable to the warrants; o whether the warrants represented by the warrant certificates will be issued in registered or bearer form, and, if registered, where they may be transferred and registered; o call provisions of the warrants, if any; o antidilution provisions of the warrants, if any; and o any other material terms of the warrants. EXERCISE OF WARRANTS Each warrant will entitle the holder to purchase for cash that principal amount of or number of securities, as the case may be, at the exercise price set forth in, or to be determined as set forth in, the applicable prospectus supplement relating to the warrants. Unless otherwise specified in the applicable prospectus supplement, warrants may be exercised at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement at any time up to 5:00 p.m. Eastern Standard Time on the expiration date set forth in the applicable prospectus supplement. After 5:00 p.m. Eastern Standard Time on the expiration date, unexercised warrants will become void. Upon receipt of payment and the warrant certificate properly completed and duly executed, we will, as soon as practicable, issue the securities purchasable upon exercise of the warrant. If less than all of the warrants represented by the warrant certificate are exercised, a new warrant certificate will be issued for the remaining amount of warrants. NO RIGHTS OF SECURITY HOLDER PRIOR TO EXERCISE Prior to the exercise of their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon the exercise of the warrants and will not be entitled to: o in the case of warrants to purchase debt securities, payments of principal of, premium, if any, or interest, if any, on the debt securities purchasable upon exercise; or o in the case of warrants to purchase equity securities, the right to vote or to receive dividend payments or similar distributions on the securities purchasable upon exercise. EXCHANGE OF WARRANT CERTIFICATES Warrant certificates will be exchangeable for new warrant certificates of different denominations at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement. DESCRIPTION OF TRUST PREFERRED SECURITIES AND RELATED GUARANTEES We may offer one or more series of trust preferred securities either separately, or together with, or upon the conversion of or in exchange for, other securities. The trust preferred securities will be issued by one of the Omnicare Capital Trusts under the terms of an amended trust agreement. Each amended trust agreement will be qualified as an indenture under the Trust Indenture Act. The property trustee of each trust will act as trustee for the trust preferred securities under each amended trust agreement for purposes of compliance with the provisions of the Trust Indenture Act. Each trust may issue only one series of trust preferred securities and one series of trust common securities. All of the trust common securities of each trust will be owned directly or indirectly by us. We will enter into a guarantee with respect to each series of trust preferred securities under which we will irrevocably and unconditionally agree to make certain payments to the holders of that series of trust preferred securities, subject to applicable subordination provisions, except that the guarantee will only apply when the trust has sufficient funds legally and immediately available to make those payments but has not made them. The proceeds from the sale of a series of trust preferred securities and any trust common securities will be used by the trust to purchase a specific series of our subordinated debt securities. 30 The payment terms of the subordinated debt securities will mirror the terms of that series of trust preferred securities and any trust common securities. Each series of subordinated debt securities will be issued under our subordinated debt securities indenture. Except as described in an applicable prospectus supplement, the features of the subordinated debt securities will be similar to the subordinated debt securities described above under "Description of Debt Securities." The series of subordinated debt securities purchased with the proceeds from the sale of a series of trust preferred securities and trust common securities by a trust, along with its rights under the amended trust agreement and other agreements described in this section, will be the sole assets of the trust, and our payments under the series of subordinated debt securities and the agreement as to expenses and liabilities between us and the trust will be the sole revenue of the trust. If we fail to make a payment on the series of subordinated debt securities issued to the trustee, the trust will not have sufficient funds to make related payments, including distributions, on the series of trust preferred securities. Our guarantee, when taken together with our obligations under the subordinated debt securities, the related indenture and the amended trust agreement, will provide a full and unconditional guarantee on a subordinated basis by us of payments due on the trust preferred securities. This section summarizes selected provisions of the amended trust agreement, the trust preferred securities and the related guarantees that we may offer. The applicable prospectus supplement relating to any particular trust preferred securities will describe the specific terms of that series, which may be in addition to or different from the general terms summarized in this section. If any particular terms of the trust preferred securities described in a prospectus supplement differ from any of the terms described in this prospectus, then the terms described in the applicable prospectus supplement will supersede the terms described in this prospectus. The following summary and any description of the trust preferred securities contained in an applicable prospectus supplement do not describe every aspect of the amended trust agreement, the trust preferred securities and related guarantees. When evaluating the trust preferred securities, you also should refer to all provisions of the amended trust agreement, guarantee agreement, subordinated debt securities indenture, agreement as to expenses and liabilities and certificate evidencing the trust preferred securities, which forms have been filed as exhibits to the registration statement of which this prospectus is a part. When we refer to "Omnicare," "we," "us" or "our" in this section or when we otherwise refer to ourselves in this section, we mean Omnicare, Inc., excluding, unless otherwise expressly stated or the context requires, our subsidiaries. References to trust securities below include trust preferred securities and trust common securities (all of which, with respect to any trust, will be directly or indirectly owned by us), collectively. GENERAL The applicable prospectus supplement relating to any series of trust preferred securities will describe the terms of the trust preferred securities, including, where applicable, the following: o the title of the trust preferred securities; o the liquidation amount and number of trust preferred securities issued; o any limit on the aggregate liquidation amount of the trust preferred securities; o whether the trust preferred securities may be represented initially by a trust preferred security in temporary or permanent global form, and if so, the initial depositary with respect to the temporary or permanent global debt security and whether and the circumstances under which beneficial owners of interests in any the temporary or permanent global debt security may exchange those interests for trust preferred securities of like tenor and of any authorized form and denomination; o the price or prices at which the trust preferred securities will be issued; 31 o the annual distribution rate or rates on the trust preferred securities or the method or methods, if any, used to calculate those rates, the payment date or dates and the record dates used to determine the holders who are to receive distributions; o the date or dates from which distributions on the trust preferred securities will be cumulative or the method or methods, if any, used to determine those dates; o the person to whom any distributions will be payable on any trust preferred securities, if other than the person in whose name the security is registered at the close of business on the regular record date for the payment of such interest; o the place or places where and the manner in which the distributions of and payments in redemption of the trust preferred securities will be payable, where the trust preferred securities of the series may be presented for transfer and, if applicable, conversion or exchange and where notices and demands in respect of the trust preferred securities may be served on us; o the period or periods within which, the price or prices at which and the terms and conditions upon which, the trust preferred securities may be redeemed, in whole or in part, at our option; o whether the trust preferred securities are convertible or exchangeable into our common stock or other securities, and, if so, the terms and conditions upon which the conversion or exchange will be effected, including the initial conversion or exchange price or rate and any adjustments thereto, the conversion or exchange period and other conversion or exchange provisions; o the terms and conditions, if any, upon which the subordinated debt securities issued to the trust and the related guarantee may be distributed to holders of those trust preferred securities and trust common securities; o any securities exchange on which the trust preferred securities will be listed; and o any other relevant rights, preferences, privileges, limitations or restrictions of the trust preferred securities. The interest rate and interest and other payment dates of each series of subordinated debt securities issued to a trust will correspond to the rate at which distributions will be paid and the distribution and other payment dates of the trust preferred securities of that trust. Holders of trust preferred securities will have no preemptive or similar rights. DISTRIBUTIONS Distributions on the trust preferred securities will be made on the dates payable to the extent that the trust has funds available for the payment of distributions in the trust's property account. The trust's funds available for distribution to the holders of the trust securities will be limited to payments received from us on the subordinated debt securities issued to the trust in connection with the issuance of the trust preferred securities. We will guarantee the payment of distributions out of monies held by the trust to the extent described below under " -- Description of the Guarantees." Distributions on the trust preferred securities will be payable to the holders named on the securities register of the trust at the close of business on the relevant record dates, which, as long as the trust preferred securities remain in book-entry only form, will be one business day prior to the relevant payment dates. Distributions will be paid through the property trustee who will hold amounts received in respect of the subordinated debt securities issued to the trust in the property account for the benefit of the holders of the trust securities. In the event that the trust preferred securities do not continue to remain in book-entry only form, the administrative trustees will have the right to select relevant record dates, which will be at least 15 days prior to the relevant payment dates. In the event that any date on which distributions are to be made on the trust preferred securities is not a business day, then payment of the distributions payable on that date will be made on the next succeeding day which is a business day and without any interest or other 32 payment in respect of that delay, except that, if that business day is in the next succeeding calendar year, the payment will be made on the immediately preceding business day, in each case with the same force and effect as if made on the payment date. DEFERRAL OF DISTRIBUTIONS With respect to any subordinated debt securities issued to a trust, we will have the right under the terms of the subordinated debt securities to defer payments of interest on the subordinated debt securities by extending the interest payment period from time to time on the subordinated debt securities. As a consequence of our extension of the interest payment period on subordinated debt securities held by a trust, distributions on the trust preferred securities would be deferred during any such extended interest payment period. The trust will give the holders of the trust preferred securities notice of an extension period upon their receipt of notice from us. If distributions are deferred, the deferred distributions and accrued interest will be paid to holders of record of the trust preferred securities as they appear on the books and records of the trust on the record date next following the termination of the deferral period. The terms of any subordinated debt securities issued to a trust, including the right to defer payments of interest, will be described in the applicable prospectus supplement. REDEMPTION The trust preferred securities have no stated maturity date, but will be redeemed upon the maturity of the subordinated debt securities issued to the trust or to the extent the subordinated debt securities are redeemed prior to maturity. The subordinated debt securities will mature on the date specified in the applicable prospectus supplement. The subordinated debt securities may be redeemed at our option, to the extent specified in the applicable prospectus supplement and also may be redeemed at any time, in whole although not in part, upon the occurrence of a tax event or an investment company event as described below under " -- Special Event Redemption." Upon maturity of the subordinated debt securities issued to the trust, the proceeds of their repayment simultaneously will be applied to redeem all outstanding trust securities at the redemption price. Upon the redemption of the subordinated debt securities, the trust will use the cash it receives upon redemption to redeem trust securities having an aggregate principal amount equal to the aggregate principal amount of the subordinated debt securities so redeemed at the redemption price. Before such redemption, holders of trust securities will be given not less than 30 nor more than 60 days' notice. In the event that fewer than all of the outstanding trust securities are to be redeemed, the trust securities will be redeemed proportionately. Special Event Redemption Upon the occurrence of a tax event or an investment company act event, we will have the option to redeem the subordinated debt securities in whole but not in part (and thus cause the redemption of the trust preferred securities). A tax event means that the trust has received an opinion of tax counsel to the effect that, as a result of any amendment to, change or announced proposed change in, the laws or regulations of the United States or any of its political subdivisions or taxing authorities, or written administrative or judicial decision, interpretation or application of these laws and regulations, there is more than an insubstantial risk that: o the trust is or will be subject to United States federal income tax with respect to income accrued or received on the subordinated debt securities issued to trust; o interest payable to the trust on the subordinated debt securities is not or will not be deductible, in whole or in part, by us for United States federal income tax purposes; or o the trust is or will be subject to more than a de minimis amount of other taxes, duties or other governmental charges. 33 An investment company event means that the trust has received an opinion of counsel to the effect that, as a result of an amendment to or change in the applicable laws or regulations, or written administrative or judicial decision, interpretation or application of these laws and regulations, there is more than an insubstantial risk that the trust is or will be considered an investment company required to be registered under the Investment Company Act of 1940, as amended. Redemption Procedures A trust may not redeem fewer than all of the outstanding trust securities unless all accumulated and unpaid distributions have been paid on all trust securities for all distribution periods terminating on or prior to the date of redemption. If fewer than all of the outstanding trust securities are to be redeemed, the trust securities will be redeemed proportionately. If (a) a trust gives a notice of redemption of trust securities (which notice may not be conditional) and (b) we have paid to the property trustee a sufficient amount of cash in connection with the related redemption or maturity of the subordinated debt securities issued to the trust, then on or before the redemption date, the property trustee will deposit with the paying agent funds sufficient to pay the applicable redemption price. Upon surrender of the trust securities to the paying agent, the holders of the trust securities will be paid the applicable redemption price plus accumulated distributions to the redemption date. Once notice of redemption is given, distributions will cease to accumulate and all rights of holders of trust preferred securities called for redemption will cease, except the right of the holders to receive the redemption price plus accumulated distributions. If any redemption date is not a business day, then payment of the redemption price payable on such date will be made on the next succeeding day that is a business day, without any interest or other payment in respect of any such delay. However, if such business day falls in the next calendar year, such payment will be made on the immediately preceding business day. We or our subsidiaries may, at any time, and from time to time, purchase outstanding trust securities by tender, in the open market or by private agreement. DISSOLUTION Each amended trust agreement will state that the trust will be dissolved: o upon our bankruptcy or the filing of a certificate of dissolution or its equivalent with respect to us; o 90 days after the revocation of our charter, but only if the charter is not reinstated during that 90-day period; o upon entry of a court order for the dissolution of the trust; o upon the redemption of all of the trust securities; o upon the distribution of the related subordinated debt securities directly to the holders of the trust securities; or o if prior to the issuance of the trust securities, when we and the administrative trustees have consented to dissolution of the trust. In the event of a dissolution, after the trust pays all amounts owed to creditors, the holders of the trust securities will be entitled to receive, depending on the circumstances of the dissolution, either: o subordinated debt securities issued to the trust in connection with the issuance of the trust preferred securities in a total principal amount equal to the total liquidation amount of the trust securities; or o cash equal to the total liquidation amount of each trust security specified in the applicable prospectus supplement, plus accumulated and unpaid distributions to the date of payment. 34 If the trust cannot pay the full amount due on its trust securities because insufficient assets are available for payment, then the amounts payable by the trust on its trust securities will be paid proportionately. However, if an event of default under the related subordinated debt indenture occurs, the total amounts due on the trust preferred securities will be paid before any distribution on the trust common securities. We will have the right at any time to dissolve a trust and, after satisfaction of the liabilities of creditors of the trust, if any, and cause the distribution of subordinated debt securities issued to the trust to the holders of the trust securities in a total stated principal amount equal to the total stated liquidation amount of the trust securities then outstanding. This right is optional and wholly within our discretion. TRUST EVENTS OF DEFAULT Unless otherwise specified with respect to a series of trust preferred securities, under each amended trust agreement, the following events will constitute a trust event of default with respect to any series of trust preferred securities: o the occurrence of an event of default under the subordinated indenture (see "Description of Debt Securities -- Event of Default and Remedies"); o default by the trust in the payment when due of any distribution with respect to that series of trust preferred securities, and continuation of the default for a period of 30 days; o default by the trust when due in the payment of the redemption price of that series of trust preferred securities; o default in performance or breach, in any material respect, of any covenant or warranty of the trustees, and continuation of the default or breach for a period of 60 days after appropriate written notice under the amended trust agreement; or o the occurrence of events of bankruptcy or insolvency with respect to the trust, and a successor property trustee is not appointed within 60 days thereof. Upon the occurrence of a trust event of default, the property trustee will have the right under the subordinated debt securities indenture to declare the principal of, interest on and premium, if any, on the subordinated debt securities issued to the trust to be immediately due and payable. If a property trustee fails to enforce its rights under the amended trust agreement or the subordinated debt securities indenture to the fullest extent permitted by law and, subject to the terms of the amended trust agreement and the subordinated debt securities indenture, any holder of trust securities may sue us, or seek other remedies, to enforce the property trustee's rights under the amended trust agreement or the subordinated debt securities indenture without first instituting a legal proceeding against the property trustee or any other person. If a trust event of default occurs and is continuing as a result of our failure to pay the principal of, interest on or premium, if any, on the subordinated debt securities issued to the trust when payable, then a holder of the trust preferred securities may directly sue us or seek other remedies, to collect its proportionate share of payments owed. MERGER, CONSOLIDATION AND SALE OF ASSETS A trust may not consolidate, merge with or into, or be replaced by or convey, transfer or lease its properties and assets substantially as an entirety to any other entity (each, a merger event), except as described above under " -- Dissolution," as described below or as described in the applicable prospectus supplement. A trust may, at our request and with the consent of a majority of its administrative trustees (but without the consent of the holders of its trust securities, the Delaware trustee or the property trustee), consolidate, merge with or into, or be replaced by, or convey, transfer or lease its properties or assets substantially as an entirety to, another trust, provided that: 35 o the successor entity either (a) assumes all of the obligations of the trust relating to its trust securities or (b) substitutes other securities for the trust preferred securities that are substantially similar to the trust preferred securities, so long as the successor securities rank the same as the trust preferred securities for distributions and payments; o we appoint a trustee of the successor entity who has the same powers and duties as the property trustee of the trust, as the holder of the subordinated debt securities issued to the trust; o the trust preferred securities are listed, or any successor securities will be listed upon notice of issuance, on the same securities exchange or other organization that the trust preferred securities are then listed; o the merger event does not cause the trust preferred securities or successor securities to be downgraded by any nationally recognized rating agency; o the merger event does not adversely affect the rights, preferences and privileges of the holders of the trust preferred securities or successor securities in any material way, other than with respect to any dilution of the holders' interest in the new entity; o the successor entity has a purpose substantially identical to that of the trust; o prior to the merger event, we have received an opinion of counsel stating that (a) the merger event does not adversely affect the rights, preferences and privileges of the holders of the trust preferred securities or any successor securities in any material way, other than with respect to any dilution of the holders' interest in the new entity and (b) following the merger event, neither the trust nor the successor entity will be required to register as an investment company under the Investment Company Act; and o we guarantee the obligations of the successor entity under the successor securities in the same manner as in the guarantee. In addition, unless all of the holders of the trust preferred securities and trust common securities approve otherwise, the trust will not consolidate, merge with or into, or be replaced by, or convey, transfer or lease its properties or assets substantially as an entirety to, any other entity or permit any other entity to consolidate, merge with or into, or replace it, if, in the opinion of tax counsel, the transaction would cause the trust or the successor entity to be classified other than as a grantor trust for United States federal income tax purposes. AMENDMENT OF AMENDED TRUST AGREEMENT The amended trust agreement may be amended from time to time by us and the property trustee with the consent of the holders of at least a majority of the aggregate liquidation amount of the affected trust preferred securities and upon receipt by the property trustee of an opinion of counsel to the effect that such amendment will not affect the trust's status as a grantor trust or the trust's exemption under the Investment Company Act. The amended trust agreement may be amended from time to time by us and the property trustee, without the consent of the holders of the trust preferred securities, to: o cure any ambiguity, defect or inconsistency or add to our covenants, restrictions or other obligations, so long as the amendment does not adversely affect in any material respect the interests of any holder of trust preferred securities; o ensure the applicable trust's classification as a grantor trust for United States federal income tax purposes and conform to any change in the Investment Company Act, the Trust Indenture Act or the rules and regulations under either law; and o modify, eliminate or add to any provisions of an amended trust agreement to the extent necessary to ensure that the applicable trust will not be required to register as an investment company under the Investment Company Act. Notwithstanding the foregoing, without the consent of each affected holder of trust securities, the amended trust agreement may not be amended to: 36 o change the amount or timing of any distribution of the trust securities or otherwise adversely affect the amount of any distribution required to be made in respect of the trust securities on a specified date; o restrict the right of a holder of trust securities to institute suit for the enforcement of payment of the distribution on or after the specified date; or o change the consent required to amend the amended trust agreement. VOTING RIGHTS The holders of trust securities have no voting rights except as discussed under " -- Merger, Consolidation and Sale of Assets" above and " -- Description of the Guarantees" below and as otherwise required by law and the amended trust agreement. The holders of a majority of the total liquidation amount of the trust preferred securities have the right to: o direct the time, method and place of conducting any proceeding for any remedy available to the property trustee; or o direct the exercise of any trust or power conferred upon the property trustee under the amended trust agreement, including the right to direct the property trustee, as the holder of the subordinated debt securities issued to the trust, to o exercise the remedies available under the subordinated debt securities indenture with respect to the subordinated debt securities; o consent to any amendment or modification of the subordinated indenture if consent is required with respect to the subordinated debt securities; or o waive any past event of default under the subordinated debt securities indenture that is waivable. Before taking any of the foregoing actions, the property trustee must obtain an opinion of tax counsel stating that, as a result of that action, the trust will continue to be classified as a grantor trust for United States federal income tax purposes. If a vote by the holders of trust preferred securities is taken or a consent is obtained, any trust preferred securities owned by us or our affiliates will, for purposes of the vote or consent, be treated as if they were not outstanding, which will have the following consequences: o we and our affiliates will not be able to vote on or consent to matters requiring the vote or consent of holders of trust preferred securities; and o any trust preferred securities owned by us or our affiliates will not be counted in determining whether the required percentage of votes or consents has been obtained. INFORMATION CONCERNING THE PROPERTY TRUSTEE The property trustee and/or one or more of its affiliates may be a lender under our credit agreements and may provide other commercial banking, investment banking and other services to us and/or our subsidiaries and affiliates. The property trustee will be permitted to engage in other transactions with us and/or our subsidiaries and affiliates; however, if the property trustee acquires any conflicting interest, as defined in the Trust Indenture Act, it must eliminate the conflict or resign. The property trustee, other than during the occurrence and continuance of a trust event of default, undertakes to perform only the duties that are specifically described in the amended trust agreement and, upon a trust event of default, must use the same degree of care and skill as a prudent person would exercise or use in the conduct of its own affairs. Subject to this provision, the property trustee is under no obligation to exercise any of the powers given it by the applicable amended trust agreement at the request of any holder of trust preferred securities unless it is 37 offered reasonable security or indemnity against the costs, expenses and liabilities that it might incur. APPLICABLE LAW The amended trust agreements and the trust preferred securities will be governed by and construed in accordance with the laws of the State of Delaware. MISCELLANEOUS Initially, there will be three administrative trustees of each trust. The administrative trustees may be officers or employees of ours or entities affiliated with us. The administrative trustees are authorized and directed to conduct the affairs of and, among other things, to operate the trust in a way that, (a) will not cause it to be deemed to be an investment company required to be registered under the Investment Company Act; or (b) will cause it to be classified as a grantor trust for United States federal income tax purposes; and will cause the subordinated debt securities it holds to be treated as our indebtedness for United States federal income tax purposes. The administrative trustees are authorized to take any action, so long as it is consistent with applicable law, the certificate of trust and the amended trust agreement, that they determine to be necessary or desirable for those purposes. DESCRIPTION OF THE GUARANTEES We will execute a guarantee for the benefit of the holders of each series of trust preferred securities. Each guarantee will be qualified as an indenture under the Trust Indenture Act. The applicable prospectus supplement with respect to the trust preferred securities will identify the guarantee trustee. The terms of the guarantee will be those set forth in the guarantee and those made part of the guarantee by the Trust Indenture Act. The guarantee trustee will hold each guarantee for the benefit of the holders of the trust preferred securities to which it relates. General We will irrevocably and unconditionally agree under each guarantee to pay the guarantee payments that are set forth below, to the extent specified in that guarantee, to the holders of the trust preferred securities to which the guarantee relates, to the extent that the guarantee payments are not paid by or on behalf of the related trust. We are required to pay the guarantee payments to the extent specified in the relevant guarantee regardless of any defense, right of set-off or counterclaim that we may have or may assert against any person. The following payments and distributions on the trust preferred securities of a trust are guarantee payments: o any accrued and unpaid distributions required to be paid on the trust preferred securities of the trust, but only to the extent that the trust has funds legally and immediately available for those distributions; o the redemption price for any trust preferred securities that the trust calls for redemption, including all accrued and unpaid distributions to the redemption date, but only to the extent that the trust has funds legally and immediately available for the payment; and o upon a dissolution, winding-up or termination of the trust, other than in connection with the distribution of subordinated debt securities to the holders of trust securities of the trust or the redemption of all the trust preferred securities of the trust, the lesser of: o the sum of the liquidation amount and all accrued and unpaid distributions on the trust preferred securities of the trust to the payment date, to the extent that the trust has funds legally and immediately available for the payment; and o the amount of assets of the trust remaining available for distribution to holders of the trust preferred securities of the trust in liquidation of the trust. 38 We may satisfy our obligation to make a guarantee payment by making that payment directly to the holders of the related trust preferred securities or by causing the trust to make the payment to those holders. Each guarantee will be a full and unconditional guarantee, subject to certain subordination provisions of the guarantee payments, with respect to the related trust preferred securities from the time of issuance of those trust preferred securities, except that the guarantee will only apply to the payment of distributions and other payments on the trust preferred securities when the trust has sufficient funds legally and immediately available to make those distributions or other payments. If we do not make the required payments on the subordinated debt securities that the property trustee holds under a trust, that trust will not make the related payments on its trust preferred securities. Subordination Our obligations under each guarantee will be unsecured obligations of ours. Those obligations will rank: o subordinate and junior in right of payment to all of our other liabilities, other than obligations or liabilities that rank equal in priority or subordinate by their terms; o equal in priority with the senior most preferred stock now or later issued by us and with any guarantee now or later issued by us in respect of any preferred stock of any of our affiliates; and o senior to our common stock. Each guarantee will be a guarantee of payment and not of collection. This means that the guaranteed party may institute a legal proceeding directly against us, as guarantor, to enforce its rights under the guarantee without first instituting a legal proceeding against any other person or entity. The terms of the trust preferred securities will provide that each holder of the trust preferred securities, by accepting those trust preferred securities, agrees to the subordination provisions and other terms of the related guarantee. Amendments and Assignment We may amend the guarantee without the consent of any holder of the trust preferred securities to which the guarantee relates if the amendment does not materially adversely affect the rights of those holders. We may otherwise amend the guarantee with the approval of the holders of at least a majority in liquidation amount of the trust preferred securities to which the guarantee relates. Except as otherwise set forth in an applicable prospectus supplement, we may assign our obligations under the guarantee only in connection with a merger, consolidation or sale of assets permitted under the subordinate debt indenture. All guarantees and agreements contained in each guarantee shall bind our successors, assigns, receivers, trustees and representatives and shall inure to the benefit of the holders of the related trust preferred securities then outstanding. Termination The guarantee will terminate and be of no further effect when: o the redemption price of the trust preferred securities to which it relates is fully paid; o we distribute the related subordinated debt securities to the holders of those trust preferred securities; or o the amounts payable upon liquidation of the related trust are fully paid. Each guarantee will remain in effect or will be reinstated if at any time any holder of the related trust preferred securities must restore payment of any sums paid to that holder with respect to those trust preferred securities or under that guarantee. 39 Events of Default An event of default will occur under any guarantee if we fail to perform any of our payment obligations under the guarantee. The holders of a majority in liquidation amount of the trust preferred securities of any series may waive any past event of default and its consequences on behalf of all of the holders of the trust preferred securities of that series. The guarantee trustee is entitled to enforce the guarantee for the benefit of the holders of the trust preferred securities of a series if an event of default occurs under the related guarantee. The holders of a majority in liquidation amount of the trust preferred securities to which a guarantee relates have the right to direct the time, method and place of conducting any proceeding for any remedy available to the guarantee trustee with respect to that guarantee or to direct the exercise of any trust or power that the guarantee trustee holds under that guarantee. Any holder of the related trust preferred securities may institute a legal proceeding directly against us to enforce that holder's rights under the guarantee without first instituting a legal proceeding against the guarantee trustee or any other person or entity. Information Concerning the Guarantee Trustee The guarantee trustee and/or one or more of its affiliates may be a lender under our credit agreements and may provide other commercial banking, investment banking and other services to us and/or our subsidiaries and affiliates. The guarantee trustee will be permitted to engage in other transactions with us and/or our subsidiaries and affiliates; however, if the guarantee trustee acquires any conflicting interest, as defined in the Trust Indenture Act, it must eliminate the conflict or resign. The guarantee trustee will perform only those duties that are specifically set forth in each guarantee unless an event of default under the guarantee occurs and is continuing. In case an event of default occurs and is continuing, the guarantee trustee will exercise the same degree of care as a prudent person would exercise in the conduct of its own affairs. Subject to those provisions, the guarantee trustee is under no obligation to exercise any of its powers under any guarantee at the request of any holder of the related trust preferred securities unless that holder offers reasonable indemnity to the guarantee trustee against the costs, expenses and liabilities which it might incur as a result. Applicable Law The guarantees will be governed by and construed in accordance with the laws of the State of New York. Agreement as to Expenses and Liabilities We will enter into an agreement as to expenses and liabilities in connection with each amended trust agreement which will provide that we will, with certain exceptions, irrevocably and unconditionally guarantee the full payment of any indebtedness, expenses or liabilities of the related trust to each person or entity to whom that trust becomes indebted or liable. The exceptions are the obligations of the trust to pay to the holders of the related trust preferred securities or other similar interests in the trust the amounts due to the holders under the terms of those trust preferred securities or those similar interests. DESCRIPTION OF PURCHASE CONTRACTS We may, from time to time, issue purchase contracts, including contracts obligating holders to purchase from us and us to sell to the holders, a specified principal amount of debt securities or a specified number of shares of common stock or preferred stock or any of the other securities that we may sell under this prospectus at a future date or dates. The consideration payable upon settlement of the purchase contracts may be fixed at the time the purchase contracts are issued or may be determined by a specific reference to a formula set forth in the purchase contracts. The purchase contracts may be issued separately or as part of units consisting of a purchase contract and other securities or obligations issued by us or third parties, including United States treasury securities, securing the holders' obligations to purchase the relevant securities under the purchase contracts. The purchase contracts may require us to make periodic payments to the holders of the 40 purchase contracts or units or vice versa, and the payments may be unsecured or prefunded on some basis. The purchase contracts may require holders to secure their obligations under the purchase contracts. The prospectus supplement will describe, among other things, the material terms of any purchase contracts and of the securities being sold pursuant to such purchase contracts, a discussion of any special United States federal income tax considerations applicable to the purchase contracts and any material provisions governing the purchase contracts that differ from those described above. The description in the prospectus supplement will not necessarily be complete and will be qualified in its entirety by reference to the purchase contracts, and, if applicable, collateral arrangements and depositary arrangements, relating to the purchase contracts. DESCRIPTION OF UNITS We may, from time to time, issue units comprised of one or more of the other securities that may be offered under this prospectus, in any combination. Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately at any time, or at any time before a specified date. Any applicable prospectus supplement will describe, among other things, the material terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately, any material provisions relating to the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units, a discussion of any special United States federal income tax considerations applicable to the units, and any material provisions of the governing unit agreement that differ from those described above. 41 PLAN OF DISTRIBUTION We and, in the case of trust preferred securities, an Omnicare Capital Trust may sell the securities to one or more underwriters for public offering and sale by them or may sell the securities to investors through agents or dealers. Any underwriter or agent involved in the offer and sale of the securities will be named in the applicable prospectus supplement. We and, in the case of trust preferred securities, an Omnicare Capital Trust also reserve the right to sell securities directly to investors in those jurisdictions where we are authorized to do so. The distribution of securities may be effected from time to time in one or more transactions at a fixed price or prices, which may be changed, or from time to time at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. We and, in the case of trust preferred securities, an Omnicare Capital Trust also may, from time to time, authorize underwriters acting as our agents to offer and sell the securities upon the terms and conditions set forth in any prospectus supplement. In connection with the sale of the securities, underwriters may be deemed to have received compensation from us or an Omnicare Capital Trust in the form of underwriting discounts or commissions and may also receive commissions from purchasers of the securities for whom they may act as agent. If a dealer is utilized in the sale of the securities in respect of which this prospectus is delivered, we or, in the case of trust preferred securities, an Omnicare Capital Trust may sell the securities to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale. Any underwriting compensation paid by us or an Omnicare Capital Trust to underwriters or agents in connection with the offering of the securities, and any discounts, concessions or commissions allowed by underwriters to participating dealers, will be set forth in an applicable prospectus supplement. Underwriters, dealers and agents participating in the distribution of the securities may be deemed to be underwriters under the Securities Act of 1933, and any discounts and commissions received by them and any profit realized by them on resale of the securities may be deemed to be underwriting discounts and commissions under the Securities Act of 1933. Underwriters, dealers and agents may be entitled under agreements with us and, in the case of trust preferred securities, an Omnicare Capital Trust to indemnification against and contribution toward certain civil liabilities, including liabilities under the Securities Act of 1933, and to reimbursement by us and, in the case of trust preferred securities, an Omnicare Capital Trust for certain expenses. Securities offered may be a new issue of securities with no established trading market. Any underwriters to whom or agents through whom these securities are sold by us for public offering and sale may make a market in these securities, but such underwriters or agents will not be obligated to do so and may discontinue any market making at any time without notice. No assurance can be given as to the liquidity of or the trading market for any such securities. If so indicated in an applicable prospectus supplement, we and/or an Omnicare Capital Trust may authorize dealers acting as our agents to solicit offers by institutions to purchase the securities from us at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on the date or dates stated in the prospectus supplement. Each delayed delivery contract will be for an amount not less than, and the aggregate principal amount or offering price of the securities sold pursuant to delayed delivery contracts will not be less nor more than, the respective amounts stated in the prospectus supplement. Institutions with whom delayed delivery contracts, when authorized, may be entered into include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and other institutions, but will in all cases be subject to approval by us and/or an Omnicare Capital Trust. The securities also may be offered and sold, if so indicated in the prospectus supplement, in connection with a remarketing upon their purchase, in accordance with a redemption or repayment pursuant to their terms, or otherwise, by one or more firms ("remarketing firms"), acting as principals for their own accounts or as agents for us and/or an Omnicare Capital Trust. Any 42 remarketing firm will be identified and the terms of its agreement, if any, with us and its compensation will be described in the applicable prospectus supplement. Remarketing firms may be deemed to be underwriters in connection with the securities remarketed thereby. Remarketing firms may be entitled under agreements which may be entered into with us and/or an Omnicare Capital Trust to indemnification by us against certain liabilities, including liabilities under the Securities Act of 1933. One or more of the underwriters, dealers or agents, and/or one or more of their respective affiliates, may be a lender under our credit agreements and may provide other commercial banking, investment banking and other services to us and/or our subsidiaries and affiliates in the ordinary course of business. LEGAL MATTERS Legal matters with respect to the validity of the securities being offered hereby will be passed on for us by Dewey Ballantine LLP, New York, New York. Richards, Layton & Finger, P.A., Wilmington, Delaware will pass on certain matters for us with respect to the trust preferred securities. EXPERTS The consolidated financial statements incorporated in this prospectus by reference to the Annual Report on Form 10-K of Omnicare, Inc. for the year ended December 31, 2001 have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, independent accountants, given on the authority of said firm as experts in auditing and accounting. WHERE YOU CAN FIND MORE INFORMATION We file annual, quarterly and special reports, proxy statements and other information required by the Securities Exchange Act of 1934 with the SEC. You may read and copy any document we file at the following public reference room maintained by the SEC: 450 Fifth Street, N.W. Judiciary Plaza Washington, D.C., 20549 Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. Our filings also are available on the SEC's website at http://www.sec.gov. Copies of these reports, proxy statements and other information also can be inspected at the following address: New York Stock Exchange 20 Broad Street New York, New York 10005 This prospectus constitutes part of a registration statement on Form S-3 that we filed with the SEC under the Securities Act of 1933. As permitted by the rules and regulations of the SEC, this prospectus omits some of the information, exhibits and undertakings included in the registration statement. You may read and copy the information omitted from this prospectus but contained in the registration statement, as well as the periodic reports and other information we file with the SEC, at the public reference facilities maintained by the SEC in Washington, D.C. DOCUMENTS INCORPORATED BY REFERENCE INTO THIS PROSPECTUS We have elected to "incorporate by reference" certain information into this prospectus. By incorporating by reference, we can disclose important information to you by referring you to another document we have filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus, except for information incorporated by reference that is superseded by information contained in this prospectus, any applicable prospectus 43 supplement or any document we subsequently file with the SEC that is incorporated or deemed to be incorporated by reference in this prospectus. Likewise, any statement in this prospectus or any document which is incorporated or deemed to be incorporated by reference herein will be deemed to have been modified or superseded to the extent that any statement contained in any applicable prospectus supplement or any document that we subsequently file with the SEC that is incorporated or deemed to be incorporated by reference herein modifies or supersedes that statement. We are incorporating by reference the following documents that we have previously filed with the SEC (other than information in such documents that is deemed not to be filed): (a) Annual Report on Form 10-K for the fiscal year ended December 31, 2001, filed March 28, 2002 and as amended on Form 10-K/A filed August 13, 2002; (b) Quarterly Reports on Form 10-Q for the quarters ended March 31, 2002, June 30, 2002 and September 30, 2002, filed May 14, 2002, August 14, 2002 and November 14, 2002, respectively; (c) Current Reports on Form 8-K, filed July 29, 2002, August 14, 2002, August 19, 2002, January 30, 2003 and February 14, 2003; and (d) Description of our common stock set forth in our Registration Statement on Form 8-A, filed November 25, 1981. Any further filings we make with the SEC pursuant to Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934 prior to the termination of the offering of the securities made hereby also will be incorporated by reference in this prospectus (other than information in such documents that is deemed not to be filed). You may request a copy of our filings by writing or telephoning us at the following address: Omnicare, Inc. Attention: Peter Laterza -- Vice President and General Counsel 100 East RiverCenter Boulevard Covington, Kentucky 41011 (859) 392-3300 Descriptions in this prospectus, in any prospectus supplement or in any document incorporated by reference herein or therein of contracts or other documents are not necessarily complete, and in each instance, reference is made to the copies of these contracts or other documents filed as exhibits to the, or incorporated by reference in, the prospectus. 44 PART II INFORMATION NOT REQUIRED IN PROSPECTUS ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION The table below sets forth the various expenses and costs to be incurred by Omnicare, Inc. in connection with the sale and distribution of the securities offered hereby. All the amounts shown are estimated except the SEC Registration Fee. SEC Registration Fee........................................ $ 78,200 Accounting fees and expenses................................ 100,000 Legal fees and expenses..................................... 200,000 Printing and engraving expenses............................. 100,000 Rating agencies' fees....................................... 200,000 Trustee's and registrar's fees and expenses................. 50,000 Miscellaneous expenses...................................... 71,800 -------- Total:.................................................. $800,000 -------- --------
ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS The Restated Certificate of Incorporation of Omnicare, Inc. provides that a director of Omnicare, Inc. will not be liable to Omnicare, Inc. or its stockholders for monetary damages for breach of fiduciary duty as a director, to the full extent permitted by the Delaware General Corporation Law (the "DGCL"), as amended or interpreted from time to time. In addition, the Restated Certificate of Incorporation of Omnicare, Inc. states that Omnicare, Inc. shall, to the full extent permitted by the DGCL, as amended or interpreted from time to time, indemnify all directors, officers and employees whom it may indemnify pursuant thereto and, in addition, Omnicare, Inc. may, to the extent permitted by the DGCL, indemnify agents of Omnicare, Inc. or other persons. Section 145 of the DGCL permits indemnification against expenses, fines, judgments and settlements incurred by any director, officer or employee of a company in the event of pending or threatened civil, criminal, administrative or investigative proceeding, if such person was, or was threatened to be made, a party by reason of the fact that he or she is or was a director, officer, or employee of the company. Section 145 also provides that the indemnification provided for therein shall not be deemed exclusive of any other rights to which those seeking indemnification may otherwise be entitled. In addition, Omnicare, Inc. maintains a directors' and officers' liability insurance policy. Under each of the amended trust agreements, (a) Omnicare, Inc. shall, to the full extent permitted by applicable law, indemnify each trustee and their respective affiliates, officers, directors, shareholders, employees, representatives and agents and any employee and agent of the trust or it affiliates (collectively, the "Indemnified Persons") and (b) no Indemnified Persons shall be liable to the applicable trust or its respective affiliates, employees or agents; except if, in either (a) or (b) above, such Indemnified Person breached its standard of care as provided in the applicable amended trust agreement. ITEM 16. EXHIBITS
EXHIBIT NO. DESCRIPTION --- ----------- *1.1 Form of Underwriting Agreement with respect to the Common Stock, Preferred Stock, Depositary Shares, Debt Securities, Warrants, Trust Preferred Securities, Purchase Contracts and Units. 3.1 Restated Certificate of Incorporation of Omnicare, Inc. (incorporated herein by reference to our Annual Report on Form 10-K for the fiscal year ended December 31,
II-1
EXHIBIT NO. DESCRIPTION --- ----------- 1996), as amended by a Certificate of Amendment (incorporated herein by reference to Exhibit 3.2 to our registration statement on Form S-4 dated May 26, 1998). 3.2 By-Laws of Omnicare, Inc., as amended (incorporated herein by reference to our registration statement on Form S-3 dated September 28, 1998). 4.1 Form of Senior Debt Securities Indenture (including form of Senior Debt Securities). 4.2 Form of Subordinated Debt Securities Indenture (including form of Subordinated Debt Securities). *4.3 Form of Deposit Agreement (including form of Depositary Receipt). *4.4 Form of Warrant Agreement (including form of Warrant Certificate). *4.5 Form of Purchase Contract (including form of Purchase Contract Certificate) and, if applicable, Pledge Agreement. *4.6 Form of Unit Agreement (including form of Unit Certificate). *4.7 Certificate of Designation of Preferred Stock. *4.8 Form of Preferred Stock Certificate. 4.9 Rights Agreement, dated as of May 17, 1999, between Omnicare, Inc. and First Chicago Trust Company of New York, as Rights Agent (incorporated herein by reference to Exhibit 4.4 to our Current Report on Form 8-K dated May 18, 1999). 4.10 Certificate of Trust of Omnicare Capital Trust I. 4.11 Trust Agreement of Omnicare Capital Trust I. 4.12 Certificate of Trust of Omnicare Capital Trust II. 4.13 Trust Agreement of Omnicare Capital Trust II. 4.14 Certificate of Trust of Omnicare Capital Trust III. 4.15 Trust Agreement of Omnicare Capital Trust III. 4.16 Form of Amended and Restated Trust Agreement of the Omnicare Capital Trusts relating to Trust Preferred Securities. 4.17 Form of Trust Preferred Security (included in Exhibit 4.16). 4.18 Form of Guarantee Agreement of Omnicare, Inc. relating to Trust Preferred Securities. 4.19 Form of Agreement as to Expenses and Liabilities relating to Trust Preferred Securities (included in Exhibit 4.16). 5.1 Opinion of Dewey Ballantine LLP. 5.2 Opinion of Richards, Layton & Finger, P.A., Delaware counsel. 'D'12.1 Computation of Ratio of Earnings to Fixed Charges. 23.1 Consent of Dewey Ballantine LLP (included in its opinion filed as Exhibit 5.1). 23.2 Consent of Richards, Layton & Finger, P.A. (included in its opinion filed as Exhibit 5.2). 23.3 Consent of Independent Auditors (PricewaterhouseCoopers LLP). 'D'24 Powers of Attorney. **25.1 Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Trustee under the Senior Debt Securities Indenture. **25.2 Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Trustee under the Subordinated Debt Securities Indenture. **25.3 Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Trustee under Guarantee Agreement of Omnicare, Inc. relating to Trust Preferred Securities. **25.4 Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Trustee under Amended and Restated Trust Agreement of the Omnicare Capital Trusts relating to Trust Preferred Securities.
- --------- * To be filed with a post-effective amendment to the Registration Statement or incorporated by reference from a Current Report on Form 8-K. ** To be filed separately pursuant to Trust Indenture Act Section 305(b)(2). 'D' Previously filed. ITEM 17. UNDERTAKINGS (a) Each undersigned registrant hereby undertakes: (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: II-2 (i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in the volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement; and (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; provided, however, that paragraphs 1(i) and 1(ii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement; (2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment will be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; and (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. (b) Each undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant's annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities and Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. (c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrants pursuant to the foregoing provisions, or otherwise, each registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by such registrant of expenses incurred or paid by a director, officer or controlling person of such registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, such registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue. (d) Each undersigned registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the Commission under Section 305(b)(2) of the Act. II-3 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on the 18th day of February, 2003. OMNICARE, INC. By: /s/ CHERYL D. HODGES .................................. CHERYL D. HODGES SENIOR VICE PRESIDENT AND SECRETARY Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * Chairman; Director February 18, 2003 ......................................... EDWARD L. HUTTON * President and Chief Executive Officer; February 18, 2003 ......................................... Director JOEL F. GEMUNDER * Executive Vice President -- Operations; February 18, 2003 ......................................... Director PATRICK E. KEEFE * Senior Vice President -- Professional February 18, 2003 ......................................... Services and Purchasing; Director TIMOTHY E. BIEN * Senior Vice President and Chief February 18, 2003 ......................................... Financial Officer; Director DAVID W. FROESEL, JR. /s/ CHERYL D. HODGES Senior Vice President and Secretary; February 18, 2003 ......................................... Director CHERYL D. HODGES Director ......................................... CHARLES H. ERHART, JR. * Director February 18, 2003 ......................................... SANDRA E. LANEY * Director February 18, 2003 ......................................... ANDREA R. LINDELL, DNSC, RN * Director February 18, 2003 ......................................... SHELDON MARGEN, M.D. * Director February 18, 2003 ......................................... KEVIN J. MCNAMARA * Director February 18, 2003 ......................................... JOHN T. TIMONEY *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-4 Pursuant to the requirement of the Securities Act of 1933, Omnicare Capital Trust I certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on the 18th day of February, 2003. OMNICARE CAPITAL TRUST I BY: OMNICARE, INC., AS SPONSOR By: /s/ CHERYL D. HODGES .................................. CHERYL D. HODGES SENIOR VICE PRESIDENT AND SECRETARY Pursuant to the requirement of the Securities Act of 1933, Omnicare Capital Trust II certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on the 18th day of February, 2003. OMNICARE CAPITAL TRUST II BY: OMNICARE, INC., AS SPONSOR By: /s/ CHERYL D. HODGES .................................. CHERYL D. HODGES SENIOR VICE PRESIDENT AND SECRETARY Pursuant to the requirement of the Securities Act of 1933, Omnicare Capital Trust III certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on the 18th day of February, 2003. OMNICARE CAPITAL TRUST III BY: OMNICARE, INC., AS SPONSOR By: /s/ CHERYL D. HODGES .................................. CHERYL D. HODGES SENIOR VICE PRESIDENT AND SECRETARY II-5 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. AAHS ACQUISITION CORP. By: * .................................. GARY W. KADLEC PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... GARY W. KADLEC * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ..................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-6 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. ACCU-MED SERVICES, INC. By: * .................................. THOMAS LUDEKE PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... THOMAS LUDEKE * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-7 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. ACP ACQUISITION CORP. By: * .................................. LEO P. FINN PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... LEO P. FINN * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ..................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-8 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. AMC-NEW YORK, INC. By: * .................................. JEFFREY M. STAMPS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JEFFREY M. STAMPS * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ......................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-9 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. AMC-TENNESSEE, INC. By: * .................................. JULIE FRAZIER PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... JULIE FRAZIER * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ..................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-10 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. APS ACQUISITION LLC BADGER ACQUISITION LLC CTLP ACQUISITION LLC DIXON PHARMACY LLC ENLOE DRUGS LLC HOME PHARMACY SERVICES, LLC JHC ACQUISITION LLC By: Sole Member: OMNICARE HOLDING COMPANY By: * .................................. JOEL F. GEMUNDER PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JOEL F. GEMUNDER * Treasurer February 18, 2003 ......................................... THOMAS R. MARSH /s/ CHERYL D. HODGES Director February 18, 2003 ......................................... CHERYL D. HODGES *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-11 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. NIHAN & MARTIN LLC NIV ACQUISITION LLC OMNIBILL SERVICES LLC OMNICARE INDIANA PARTNERSHIP HOLDING COMPANY LLC OMNICARE RESPIRATORY SERVICES, LLC WEBER MEDICAL SYSTEMS LLC By: Sole Member: OMNICARE HOLDING COMPANY By: * .................................. JOEL F. GEMUNDER PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JOEL F. GEMUNDER * Treasurer February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... CHERYL D. HODGES *By: /s/ CHERYL D. HODGES ..................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-12 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. BACH'S PHARMACY SERVICES, LLC By: Sole Member: BACH'S PHARMACY (EAST), INC. By: * .................................. JEFFREY M. STAMPS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... JEFFREY M. STAMPS * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-13 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. BADGER ACQUISITION OF BROOKSVILLE LLC BADGER ACQUISITION OF KENTUCKY LLC BADGER ACQUISITION OF MINNESOTA LLC BADGER ACQUISITION OF OHIO LLC BADGER ACQUISITION OF ORLANDO LLC BADGER ACQUISITION OF TAMPA LLC BADGER ACQUISITION OF TEXAS LLC By: Sole Member: BADGER ACQUISITION LLC By: * .................................. LEO P. FINN PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... LEO P. FINN * Vice President February 18, 2003 ......................................... BRADLEY S. ABBOTT * Treasurer February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ..................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-14 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. BEACHWOOD HEALTHCARE MANAGEMENT, INC. By: * .................................. REGIS T. ROBBINS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... REGIS T. ROBBINS * Treasurer February 18, 2003 ......................................... RANDALL V. GAJ * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ..................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-15 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. BIO-PHARM INTERNATIONAL, INC. By: * .................................. DAVID MORRA PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... DAVID MORRA * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-16 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. BPNY ACQUISITION CORP. BPTX ACQUISITION CORP. By: * .................................. LEO P. FINN PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... LEO P. FINN * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-17 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. CAMPO'S MEDICAL PHARMACY, INC. By: * .................................. JOSEPH L. DUPUY PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... JOSEPH L. DUPUY * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ....................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-18 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. CARE PHARMACEUTICAL SERVICES, LP PRN PHARMACEUTICAL SERVICES, LP By: General Partner OMNICARE INDIANA PARTNERSHIP HOLDING COMPANY, LLC By: * .................................. JOEL F. GEMUNDER PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JOEL F. GEMUNDER * Treasurer February 18, 2003 ......................................... THOMAS R. MARSH /s/ CHERYL D. HODGES Director February 18, 2003 ......................................... CHERYL D. HODGES *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-19 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. CHP ACQUISITION CORP. By: * .................................. ROBERT A. FUSCO PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... ROBERT A. FUSCO * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-20 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. CIP ACQUISITION CORP. By: * .................................. EARL L. CARTER PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... EARL L. CARTER * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-21 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. COMPSCRIPT -- BOCA, LLC By: Sole Member: COMPSCRIPT, INC. By: * .................................. DAVID WEST CHIEF OPERATING OFFICER Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * Chief Operating Officer February 18, 2003 ......................................... DAVID WEST * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-22 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. COMPSCRIPT -- MOBILE, INC. By: * .................................. DAVID WEST PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... DAVID WEST * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-23 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. COMPSCRIPT, INC. By: * .................................. DAVID WEST CHIEF OPERATING OFFICER Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * Chief Operating Officer February 18, 2003 ......................................... DAVID WEST * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-24 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. CP ACQUISITION CORP. By: * .................................. LEO P. FINN PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... LEO P. FINN * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-25 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. CREEKSIDE MANAGED CARE PHARMACY, INC. By: * .................................. DAVID W. MEDINA PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... DAVID W. MEDINA * Treasurer February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-26 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. D & R PHARMACEUTICAL SERVICES, INC. By: * .................................. JEFFREY M. STAMPS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JEFFREY M. STAMPS * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ....................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-27 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. ELECTRA ACQUISITION CORP. By: * .................................. JEFFREY M. STAMPS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... JEFFREY M. STAMPS * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-28 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. EURO BIO-PHARM CLINICAL SERVICES, INC. By: * .................................. DAVID MORRA PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... DAVID MORRA * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-29 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. EVERGREEN PHARMACEUTICAL OF CALIFORNIA, INC. By: * .................................. THOMAS SCHLEIGH PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... THOMAS SCHLEIGH * Treasurer; Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-30 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. EVERGREEN PHARMACEUTICAL, INC. By: * .................................. DAVID J. DOANE PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... DAVID J. DOANE * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-31 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. HEARTLAND REPACK SERVICES LLC By: Sole Member: OMNICARE MANAGEMENT COMPANY By: /s/ CHERYL D. HODGES .................................. CHERYL D. HODGES VICE PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JOEL F. GEMUNDER * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT /s/ CHERYL D. HODGES Director February 18, 2003 ......................................... CHERYL D. HODGES *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-32 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. HIGHLAND WHOLESALE LLC By: Sole Member: NCS HEALTHCARE OF KENTUCKY, INC. By: * .................................. MICHAEL J. MASCALI PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... MICHAEL J. MASCALI * Treasurer February 18, 2003 ......................................... RANDALL V. GAJ * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-33 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. HMIS, INC. By: * .................................. LEO P. FINN PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... LEO P. FINN * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-34 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. HOME CARE PHARMACY, INC. By: * .................................. MICHAEL J. ARNOLD PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... MICHAEL J. ARNOLD * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-35 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. HYTREE PHARMACY, INC. By: * .................................. ROLF SCHRADER PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... ROLF SCHRADER * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-36 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. INTERLOCK PHARMACY SYSTEMS, INC. By: * .................................. MARK E. PRICE PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... MARK E. PRICE * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-37 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. LANGSAM HEALTH SERVICES, INC. By: * .................................. JOSEPH L. DUPUY PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JOSEPH L. DUPUY * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-38 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. LCPS ACQUISITION, LLC By: Sole Member: LANGSAM HEALTH SERVICES, INC. By: * .................................. JOSEPH L. DUPUY PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JOSEPH L. DUPUY * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-39 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. LO-MED PRESCRIPTION SERVICES, INC. By: * .................................. ANTHONY SOLARO PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... ANTHONY SOLARO * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ....................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-40 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. LPI ACQUISITION CORP. By: * .................................. A. SAMUEL ENLOE PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... A. SAMUEL ENLOE * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-41 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. MANAGED HEALTHCARE, INC. By: * .................................. CHRISTOPHER DALE PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... CHRISTOPHER DALE * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-42 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. MANAGEMENT & NETWORK SERVICES, INC. By: * .................................. REGIS T. ROBBINS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... REGIS T. ROBBINS * Treasurer February 18, 2003 ......................................... RANDALL V. GAJ * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-43 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. MEDICAL ARTS HEALTH CARE, INC. By: * .................................. HAL J. HENDERSON PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... HAL J. HENDERSON * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-44 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. MEDICAL SERVICES CONSORTIUM, INC. By: * .................................. JOSEPH L. DUPUY PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... JOSEPH L. DUPUY * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-45 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. MED WORLD ACQUISITION CORP. By: * .................................. MICHAEL ROSENBLUM PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... MICHAEL ROSENBLUM * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-46 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. MOSI ACQUISITION CORP. By: * .................................. LINDA BUTLER PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... LINDA BUTLER * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-47 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. NCS HEALTHCARE OF ARIZONA, INC. NCS HEALTHCARE OF ARKANSAS, INC. NCS HEALTHCARE OF CONNECTICUT, INC. NCS HEALTHCARE OF FLORIDA, INC. NCS HEALTHCARE OF INDIANA, INC. NCS HEALTHCARE OF IOWA, INC. NCS HEALTHCARE OF KANSAS, INC. NCS HEALTHCARE OF KENTUCKY, INC. NCS HEALTHCARE OF MARYLAND, INC. NCS HEALTHCARE OF MASSACHUSETTS, INC. NCS HEALTHCARE OF MICHIGAN, INC. NCS HEALTHCARE OF MINNESOTA, INC. NCS HEALTHCARE OF MISSOURI, INC. NCS HEALTHCARE OF MONTANA, INC. By: * .................................. MICHAEL J. MASCALI PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... MICHAEL J. MASCALI * Treasurer February 18, 2003 ......................................... RANDALL V. GAJ * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-48 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. NCS HEALTHCARE OF NEW HAMPSHIRE, INC. NCS HEALTHCARE OF NEW JERSEY, INC. NCS HEALTHCARE OF NEW MEXICO, INC. NCS HEALTHCARE OF NEW YORK, INC. NCS HEALTHCARE OF NORTH CAROLINA, INC. NCS HEALTHCARE OF OHIO, INC. NCS HEALTHCARE OF OKLAHOMA, INC. NCS HEALTHCARE OF OREGON, INC. NCS HEALTHCARE OF PENNSYLVANIA, INC. By: * .................................. MICHAEL J. MASCALI PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... MICHAEL J. MASCALI * Treasurer February 18, 2003 ......................................... RANDALL V. GAJ * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-49 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. NCS HEALTHCARE OF RHODE ISLAND, INC. NCS HEALTHCARE OF SOUTH CAROLINA, INC. NCS HEALTHCARE OF TENNESSEE, INC. NCS HEALTHCARE OF TEXAS, INC. NCS HEALTHCARE OF VERMONT, INC. NCS HEALTHCARE OF WASHINGTON, INC. NCS HEALTHCARE OF WISCONSIN, INC. NCS OF ILLINOIS, INC. NCS SERVICES, INC. By: * .................................. MICHAEL J. MASCALI PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... MICHAEL J. MASCALI * Treasurer February 18, 2003 ......................................... RANDALL V. GAJ * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-50 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. NCS HEALTHCARE OF BEACHWOOD, INC. By: * .................................. REGIS T. ROBBINS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... REGIS T. ROBBINS * Treasurer February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-51 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. NCS HEALTHCARE OF CALIFORNIA, INC. By: * .................................. MICHAEL J. MASCALI PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... MICHAEL J. MASCALI * Treasurer February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-52 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. NCS HEALTHCARE OF ILLINOIS, INC. By: * .................................. REGIS T. ROBBINS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... REGIS T. ROBBINS * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-53 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. NCS HEALTHCARE OF INDIANA LLC By: Managing Member: NCS HEALTHCARE OF INDIANA, INC. By: * .................................. MICHAEL J. MASCALI PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... MICHAEL J. MASCALI * Treasurer February 18, 2003 ......................................... RANDALL V. GAJ * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-54 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. NCS HEALTHCARE, INC. By: * .................................. JOEL F. GEMUNDER PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... JOEL F. GEMUNDER * Chief Financial Officer; Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. * Director February 18, 2003 ......................................... PATRICK E. KEEFE *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-55 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. NATIONAL CARE FOR SENIORS LLC By: Sole Member: NCS HEALTHCARE OF KENTUCKY, INC. By: * .................................. MICHAEL J. MASCALI PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... MICHAEL J. MASCALI * Treasurer February 18, 2003 ......................................... RANDALL V. GAJ * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-56 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. NORTH SHORE PHARMACY SERVICES, INC. By: * .................................. JEFFREY M. STAMPS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... JEFFREY M. STAMPS * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-57 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OCR-RA ACQUISITION CORP. By: * .................................. JEFFREY M. STAMPS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JEFFREY M. STAMPS * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-58 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OFL CORP. By: * .................................. LEO P. FINN PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... LEO P. FINN * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-59 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE CLINICAL RESEARCH, INC. By: * .................................. DAVID MORRA CHIEF EXECUTIVE OFFICER Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * Chief Executive Officer; Director February 18, 2003 ......................................... DAVID MORRA * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-60 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE CLINICAL RESEARCH, LLC By: Sole Member: OMNICARE CLINICAL RESEARCH, INC. By: * .................................. DAVID MORRA CHIEF EXECUTIVE OFFICER Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * Chief Executive Officer; Director February 18, 2003 ......................................... DAVID MORRA * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-61 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE CR INC. By: * .................................. DAVID MORRA CHIEF EXECUTIVE OFFICER Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * Chief Executive Officer; Director February 18, 2003 ......................................... DAVID MORRA * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-62 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE EXTENDED PHARMA SERVICES, LLC By: Sole Member: OMNICARE MANAGEMENT COMPANY By: /s/ CHERYL D. HODGES .................................. CHERYL D. HODGES VICE PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JOEL F. GEMUNDER * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT /s/ CHERYL D. HODGES Director February 18, 2003 ......................................... CHERYL D. HODGES *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-63 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE HEADQUARTERS LLC By: * .................................. REGIS T. ROBBINS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Manager February 18, 2003 ......................................... REGIS T. ROBBINS * Manager February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-64 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE MANAGEMENT COMPANY By: /s/ CHERYL D. HODGES ........................... CHERYL D. HODGES VICE PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JOEL F. GEMUNDER * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT /s/ CHERYL D. HODGES Director February 18, 2003 ......................................... CHERYL D. HODGES *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-65 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PENNSYLVANIA MED SUPPLY, LLC By: Sole Member: OMNICARE PHARMACIES OF PENNSYLVANIA WEST, INC. By: * .................................. DANIEL CARTO PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... DANIEL CARTO * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-66 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACEUTICS, INC. By: * .................................. DAVID MORRA PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... DAVID MORRA * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-67 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACIES OF MAINE HOLDING COMPANY By: * .................................. JEFFREY M. STAMPS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... JEFFREY M. STAMPS * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-68 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACIES OF PENNSYLVANIA EAST, LLC By: Sole Member: OMNICARE PHARMACIES OF PENNSYLVANIA WEST, INC. By: * .................................. DANIEL L. CARTO PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... DANIEL L. CARTO * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-69 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACIES OF PENNSYLVANIA WEST, INC. By: * .................................. DANIEL CARTO PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... DANIEL CARTO * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-70 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACIES OF THE GREAT PLAINS HOLDING COMPANY By: * .................................. GARY W. KADLEC PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... GARY W. KADLEC * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-71 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACY AND SUPPLY SERVICES, INC. By: * .................................. GARY W. KADLEC PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... GARY W. KADLEC * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-72 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACY OF COLORADO LLC By: Managing Member: LANGSAM HEALTH SERVICES, INC. By: * .................................. JOSEPH L. DUPUY PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JOSEPH L. DUPUY * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-73 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACY OF FLORIDA, L.P. By: Its General Partner PHARMACY HOLDING #2, LLC By: * .................................. REGIS T. ROBBINS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Manager February 18, 2003 ......................................... REGIS T. ROBBINS * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Manager February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-74 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACY OF INDIANA, LLC OMNICARE PHARMACY OF NORTH CAROLINA, LLC OMNICARE PHARMACY OF PUEBLO, LLC PHARMACY HOLDING #1, LLC PHARMACY HOLDING #2, LLC By: Sole Member: APS ACQUISITION LLC By: * .................................. REGIS T. ROBBINS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Manager February 18, 2003 ......................................... REGIS T. ROBBINS * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Manager February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-75 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACY OF MAINE LLC By: Sole Member: OMNICARE PHARMACIES OF MAINE HOLDING COMPANY By: * .................................. JEFFREY M. STAMPS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... JEFFREY M. STAMPS * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-76 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACY OF MASSACHUSETTS LLC By: Sole Member: LANGSAM HEALTH SERVICES, INC. By: * .................................. JOSEPH L. DUPUY PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JOSEPH L. DUPUY * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-77 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACY OF NEBRASKA LLC OMNICARE PHARMACY OF SOUTH DAKOTA LLC By: Sole Member: OMNICARE PHARMACIES OF THE GREAT PLAINS HOLDING COMPANY By: * .................................. GARY W. KADLEC PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... GARY W. KADLEC * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-78 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACY OF TENNESSEE LLC By: Sole Member: LANGSAM HEALTH SERVICES, INC. By: * .................................. JOSEPH L. DUPUY PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JOSEPH L. DUPUY * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-79 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACY OF TEXAS 1, L.P. OMNICARE PHARMACY OF TEXAS 2, L.P. By: Its General Partner PHARMACY HOLDING #2, LLC By: * .................................. REGIS T. ROBBINS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Manager February 18, 2003 ......................................... REGIS T. ROBBINS * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Manager February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-80 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PHARMACY OF THE MIDWEST, INC. By: * .................................. A. SAMUEL ENLOE PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... A. SAMUEL ENLOE * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-81 SIGNATURE Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PURCHASING COMPANY GENERAL PARTNER, INC. OMNICARE PURCHASING COMPANY LIMITED PARTNER, INC. By: * .................................. PATRICK E. KEEFE PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... PATRICK E. KEEFE * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-82 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. OMNICARE PURCHASING COMPANY LP By: Its General Partner OMNICARE PURCHASING COMPANY GENERAL PARTNER, INC. By: * .................................. PATRICK E. KEEFE PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... PATRICK E. KEEFE * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ....................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-83 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. PBM-PLUS, INC. By: * .................................. THOMAS W. LUDEKE PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... THOMAS W. LUDEKE * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-84 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. PHARMACON CORP. By: * .................................. WILLIAM J. LYONS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... WILLIAM J. LYONS * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-85 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. PHARMACY ASSOCIATES OF GLENS FALLS, INC. By: * .................................. JEFFREY M. STAMPS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JEFFREY M. STAMPS * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-86 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. PHARMACY CONSULTANTS, INC. By: * .................................. LEO P. FINN PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... LEO P. FINN * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-87 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. PHARMASOURCE HEALTHCARE, INC. By: * .................................. MICHAEL J. MASCALI PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... MICHAEL J. MASCALI * Treasurer February 18, 2003 ......................................... RANDALL V. GAJ * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-88 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. PHARM-CORP OF MAINE LLC By: Sole Member: OMNICARE PHARMACIES OF MAINE HOLDING COMPANY By: * .................................. JEFFREY M. STAMPS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... JEFFREY M. STAMPS * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-89 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. PHARMED HOLDINGS, INC. By: * .................................. JOSEPH L. DUPUY PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JOSEPH L. DUPUY * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-90 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. RESCOT SYSTEMS GROUP, INC. By: * .................................. REGIS T. ROBBINS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... REGIS T. ROBBINS * Treasurer February 18, 2003 ......................................... RANDALL V. GAJ * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-91 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. ROESCHEN'S HEALTHCARE CORP. By: * .................................. PETER HOVIS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... PETER HOVIS * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-92 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. ROYAL CARE OF MICHIGAN LLC By: Sole Member: SPECIALIZED PHARMACY SERVICES, INC. By: * .................................. DANIEL E. LOHMEIER PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... DANIEL E. LOHMEIER * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-93 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. SHC ACQUISITION CO, LLC By: Sole Member: HMIS, INC. By: * .................................. LEO P. FINN PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... LEO P. FINN * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-94 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. SHORE PHARMACEUTICAL PROVIDERS, INC. By: * .................................. PAUL B. MEYEROFF PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... PAUL B. MEYEROFF * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-95 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. SOUTHSIDE APOTHECARY, INC. By: * .................................. NANCY STRASSNER PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... NANCY STRASSNER * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-96 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. SPECIALIZED HOME INFUSION OF MICHIGAN LLC By: Sole Member: SPECIALIZED PHARMACY SERVICES, INC. By: * .................................. DANIEL E. LOHMEIER PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... DANIEL E. LOHMEIER * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-97 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. SPECIALIZED PATIENT CARE SERVICES, INC. By: * .................................. LEO P. FINN PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... LEO P. FINN * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ....................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-98 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. SPECIALIZED PHARMACY SERVICES, INC. SPECIALIZED SERVICES OF MICHIGAN, INC. By: * .................................. DANIEL E. LOHMEIER PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... DANIEL E. LOHMEIER * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-99 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. STERLING HEALTHCARE SERVICES, INC. By: * .................................. JOSEPH L. DUPUY PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JOSEPH L. DUPUY * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-100 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. SUPERIOR CARE PHARMACY, INC. By: * .................................. MICHAEL WOOD PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... MICHAEL WOOD * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-101 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. SWISH, INC. By: * .................................. DAVID MORRA PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... DAVID MORRA * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-102 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. TCPI ACQUISITION CORP. By: * .................................. GARY W. KADLEC PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... GARY W. KADLEC * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-103 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. THG ACQUISITION CORP. By: * .................................. DAVID J. DOANE PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... DAVID J. DOANE * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-104 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. THE HARDARDT GROUP, INC. By: * .................................. DAVID MORRA PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... DAVID MORRA * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-105 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. THREE FORKS APOTHECARY, INC. By: * .................................. SCARLET LITTERAL PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... SCARLET LITTERAL * Treasurer; Director February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-106 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. UC ACQUISITION CORP. By: * .................................. JACKIE ALKER PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... JACKIE ALKER * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-107 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. UNI-CARE HEALTH SERVICES OF MAINE, INC. By: * .................................. MICHAEL J. MASCALI PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... MICHAEL J. MASCALI * Treasurer February 18, 2003 ......................................... RANDALL V. GAJ * Director February 18, 2003 ......................................... DAVID W. FROESEL, JR. *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-108 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. VALUE HEALTH CARE SERVICES, INC. By: * .................................. LAWRENCE J. SOBEL PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... LAWRENCE J. SOBEL * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-109 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. VALUE PHARMACY, INC. WILLIAMSON DRUG COMPANY, INCORPORATED By: * .................................. JEFFREY M. STAMPS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... JEFFREY M. STAMPS * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-110 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. VITAL CARE INFUSIONS SUPPLY, INC. By: * .................................. STANLEY KAPLAN PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... STANLEY KAPLAN * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ....................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-111 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. WESTHAVEN SERVICES CO. By: * .................................. GARY W. KADLEC PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President; Director February 18, 2003 ......................................... GARY W. KADLEC * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-112 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Covington, Commonwealth of Kentucky, on February 18, 2003. WINSLOW'S PHARMACY By: * .................................. JEFFREY M. STAMPS PRESIDENT Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE --------- ----- ---- * President February 18, 2003 ......................................... JEFFREY M. STAMPS * Treasurer February 18, 2003 ......................................... BRADLEY S. ABBOTT * Director February 18, 2003 ......................................... THOMAS R. MARSH * Director February 18, 2003 ......................................... REGIS T. ROBBINS *By: /s/ CHERYL D. HODGES ...................................... CHERYL D. HODGES ATTORNEY-IN-FACT
II-113 EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION - ----------- ----------- *1.1 Form of Underwriting Agreement with respect to the Common Stock, Preferred Stock, Depositary Shares, Debt Securities, Warrants, Trust Preferred Securities, Purchase Contracts and Units. 3.1 Restated Certificate of Incorporation of Omnicare, Inc. (incorporated herein by reference to our Annual Report on Form 10-K for the fiscal year ended December 31, 1996), as amended by a Certificate of Amendment (incorporated herein by reference to Exhibit 3.2 to our registration statement on Form S-4 dated May 26, 1998). 3.2 By-Laws of Omnicare, Inc., as amended (incorporated herein by reference to our registration statement on Form S-3 dated September 28, 1998). 4.1 Form of Senior Debt Securities Indenture (including form of Senior Debt Securities). 4.2 Form of Subordinated Debt Securities Indenture (including form of Subordinated Debt Securities). *4.3 Form of Deposit Agreement (including form of Depositary Receipt). *4.4 Form of Warrant Agreement (including form of Warrant Certificate). *4.5 Form of Purchase Contract (including form of Purchase Contract Certificate) and, if applicable, Pledge Agreement. *4.6 Form of Unit Agreement (including form of Unit Certificate). *4.7 Certificate of Designation of Preferred Stock. *4.8 Form of Preferred Stock Certificate. 4.9 Rights Agreement, dated as of May 17, 1999, between Omnicare, Inc. and First Chicago Trust Company of New York, as Rights Agent (incorporated herein by reference to Exhibit 4.4 to our Current Report on Form 8-K dated May 18, 1999). 4.10 Certificate of Trust of Omnicare Capital Trust I. 4.11 Trust Agreement of Omnicare Capital Trust I. 4.12 Certificate of Trust of Omnicare Capital Trust II. 4.13 Trust Agreement of Omnicare Capital Trust II. 4.14 Certificate of Trust of Omnicare Capital Trust III. 4.15 Trust Agreement of Omnicare Capital Trust III. 4.16 Form of Amended and Restated Trust Agreement of the Omnicare Capital Trusts relating to Trust Preferred Securities. 4.17 Form of Trust Preferred Security (included in Exhibit 4.16). 4.18 Form of Guarantee Agreement of Omnicare, Inc. relating to Trust Preferred Securities. 4.19 Form of Agreement as to Expenses and Liabilities relating to Trust Preferred Securities (included in Exhibit 4.16). 5.1 Opinion of Dewey Ballantine LLP. 5.2 Opinion of Richards, Layton & Finger, P.A., Delaware counsel. 'D'12.1 Computation of Ratio of Earnings to Fixed Charges. 23.1 Consent of Dewey Ballantine LLP (included in its opinion filed as Exhibit 5.1). 23.2 Consent of Richards, Layton & Finger, P.A. (included in its opinion filed as Exhibit 5.2). 23.3 Consent of Independent Auditors (PricewaterhouseCoopers LLP). 'D'24 Powers of Attorney. **25.1 Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Trustee under the Senior Debt Securities Indenture. **25.2 Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Trustee under the Subordinated Debt Securities Indenture. **25.3 Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Trustee under Guarantee Agreement of Omnicare, Inc. relating to Trust Preferred Securities. **25.4 Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Trustee under Amended and Restated Trust Agreement of the Omnicare Capital Trusts relating to Trust Preferred Securities.
- --------- * To be filed with a post-effective amendment to the Registration Statement or incorporated by reference from a Current Report on Form 8-K. ** To be filed separately pursuant to Trust Indenture Act Section 305(b)(2). 'D' Previously filed. II-114 STATEMENT OF DIFFERENCES ------------------------ The dagger symbol shall be expressed as................................ 'D' The section symbol shall be expressed as...............................'SS'
EX-4 3 ex4-1.txt EXHIBIT 4.1 Exhibit 4.1 ================================================================================ OMNICARE, INC. SENIOR DEBT SECURITIES -------------------- INDENTURE Dated as of [_________] -------------------- -------------------- [_________] Trustee -------------------- ================================================================================ CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section - --------------- ----------------- 310(a)(1)................................................... 7.10 (a)(2)................................................... 7.10 (a)(3)................................................... N.A. (a)(4)................................................... N.A. (a)(5)................................................... 7.10 (b)...................................................... 7.10 (c)...................................................... N.A. 311(a)...................................................... 7.11 (b)...................................................... 7.11 (c)...................................................... N.A. 312(a)...................................................... 2.07 (b)...................................................... 13.03 (c)...................................................... 13.03 313(a)...................................................... 7.06 (b)(1)................................................... 7.06 (b)(2)................................................... 7.07 (c)...................................................... 7.06; 13.02 (d)...................................................... 7.06 314(a)...................................................... 4.03; 13.02 (b)...................................................... 10.02 (c)(1)................................................... 13.04 (c)(2)................................................... 13.04 (c)(3)................................................... N.A. (d)...................................................... N.A. (e)...................................................... 13.05 (f)...................................................... N.A. 315(a)...................................................... 7.01 (b)...................................................... 7.05, 13.02 (c)...................................................... 7.01 (d)...................................................... 7.01 (e)...................................................... 6.11 316(a)(last sentence)....................................... 2.11 (a)(1)(A)................................................ 6.05 (a)(1)(B)................................................ 6.04 (a)(2)................................................... N.A. (b)...................................................... 6.07 (c)...................................................... 2.14 317(a)(1)................................................... 6.08 (a)(2)................................................... 6.09 (b)...................................................... 2.06 318(a)...................................................... 13.01 (b)...................................................... N.A. (c)...................................................... 12.01 N.A. means not applicable. * This Cross Reference Table is not part of this Indenture. TABLE OF CONTENTS
Page ---- ARTICLE 1. DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01 Definitions.......................................................................1 Section 1.02 Other Definitions.................................................................6 Section 1.03 Incorporation by Reference of Trust Indenture Act.................................6 Section 1.04 Rules of Construction.............................................................7 ARTICLE 2. THE SECURITIES Section 2.01 Form Generally....................................................................7 Section 2.02 Securities in Global Form.........................................................7 Section 2.03 Title and Terms...................................................................8 Section 2.04 Execution, Authentication, Delivery and Dating...................................10 Section 2.05 Registrar and Paying Agent.......................................................11 Section 2.06 Paying Agent to Hold Money in Trust..............................................12 Section 2.07 Holder Lists.....................................................................12 Section 2.08 Registration, Registration of Transfer and Exchange..............................12 Section 2.09 Replacement Securities...........................................................14 Section 2.10 Outstanding Securities...........................................................14 Section 2.11 Treasury Securities..............................................................15 Section 2.12 Temporary Securities.............................................................15 Section 2.13 Cancellation.....................................................................15 Section 2.14 Payment of Interest..............................................................16 Section 2.15 Persons Deemed Owners............................................................16 Section 2.16 Computation of Interest..........................................................16 Section 2.17 CUSIP Numbers....................................................................17 ARTICLE 3. REDEMPTION AND PREPAYMENT Section 3.01 Right to Redeem; Notices to Trustee..............................................17 Section 3.02 Selection of Securities to Be Redeemed...........................................17 Section 3.03 Notice of Redemption to Holders..................................................17 Section 3.04 Effect of Notice of Redemption...................................................18 Section 3.05 Deposit of Redemption Price......................................................18 Section 3.06 Securities Redeemed in Part......................................................19 ARTICLE 4. COVENANTS Section 4.01 Payment of Securities............................................................19 Section 4.02 Maintenance of Office or Agency..................................................19 Section 4.03 Reports..........................................................................20 Section 4.04 Compliance Certificate...........................................................20
i ARTICLE 5. SUCCESSORS Section 5.01 Merger, Consolidation, or Sale of Assets.........................................20 Section 5.02 Successor Corporation Substituted................................................21 ARTICLE 6. DEFAULTS AND REMEDIES Section 6.01 Events of Default................................................................21 Section 6.02 Acceleration.....................................................................22 Section 6.03 Other Remedies...................................................................23 Section 6.04 Waiver of Past Defaults..........................................................23 Section 6.05 Control by Majority..............................................................23 Section 6.06 Limitation on Suits..............................................................23 Section 6.07 Rights of Holders of Securities to Receive Payment and Convert...................24 Section 6.08 Collection Suit by Trustee.......................................................24 Section 6.09 Trustee May File Proofs of Claim.................................................24 Section 6.10 Priorities.......................................................................25 Section 6.11 Undertaking for Costs............................................................25 ARTICLE 7. TRUSTEE Section 7.01 Duties of Trustee................................................................25 Section 7.02 Rights of Trustee................................................................26 Section 7.03 Individual Rights of Trustee.....................................................27 Section 7.04 Trustee's Disclaimer.............................................................27 Section 7.05 Notice of Defaults...............................................................27 Section 7.06 Reports by Trustee to Holders of the Securities..................................27 Section 7.07 Compensation and Indemnity.......................................................28 Section 7.08 Replacement of Trustee...........................................................28 Section 7.09 Successor Trustee by Merger, etc.................................................29 Section 7.10 Eligibility; Disqualification....................................................29 Section 7.11 Preferential Collection of Claims Against Company................................30 ARTICLE 8. LEGAL DEFEASANCE AND COVENANT DEFEASANCE Section 8.01 Option to Effect Legal Defeasance or Covenant Defeasance.........................30 Section 8.02 Legal Defeasance and Discharge...................................................30 Section 8.03 Covenant Defeasance..............................................................30 Section 8.04 Conditions to Legal or Covenant Defeasance.......................................31 Section 8.05 Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous Provisions................................................31 Section 8.06 Repayment to Company.............................................................32 Section 8.07 Reinstatement....................................................................32
ii ARTICLE 9. AMENDMENT, SUPPLEMENT AND WAIVER Section 9.01 Without Consent of Holders of Securities.........................................33 Section 9.02 With Consent of Holders of Securities............................................34 Section 9.03 Compliance with Trust Indenture Act..............................................35 Section 9.04 Revocation and Effect of Consents................................................35 Section 9.05 Notation on or Exchange of Securities............................................35 Section 9.06 Trustee to Sign Amendments, etc..................................................35 Section 9.07 Effect of Supplemental Indentures................................................36 ARTICLE 10. SINKING FUNDS Section 10.01 Applicability of Article.........................................................36 Section 10.02 Satisfaction of Sinking Fund Payments with Securities............................36 Section 10.03 Redemption of Securities for Sinking Fund........................................36 ARTICLE 11. SECURITY GUARANTEES Section 11.01 Applicability of this Article....................................................37 Section 11.02 Guarantee........................................................................37 Section 11.03 Limitation on Guarantor Liability................................................38 Section 11.04 Release of Guarantors............................................................38 ARTICLE 12. SATISFACTION AND DISCHARGE Section 12.01 Satisfaction and Discharge.......................................................38 Section 12.02 Application of Trust Money.......................................................39 ARTICLE 13. MISCELLANEOUS Section 13.01 Trust Indenture Act Controls.....................................................39 Section 13.02 Notices..........................................................................39 Section 13.03 Communication by Holders of Securities with Other Holders of Securities..........40 Section 13.04 Certificate and Opinion as to Conditions Precedent...............................40 Section 13.05 Statements Required in Certificate or Opinion....................................41 Section 13.06 Rules by Trustee and Agents......................................................41 Section 13.07 No Personal Liability of Directors, Officers, Employees and Stockholders.........42 Section 13.08 Governing Law....................................................................42 Section 13.09 No Adverse Interpretation of Other Agreements....................................42 Section 13.10 Successors.......................................................................42 Section 13.11 Severability.....................................................................42 Section 13.12 Counterpart Originals............................................................42 Section 13.13 Table of Contents, Headings, etc.................................................42
iii EXHIBITS Exhibit A FORM OF SECURITY iv INDENTURE dated as of [_______] between Omnicare, Inc., a Delaware corporation (the "Company"), and [____________], as trustee (the "Trustee"). The Company has duly authorized the execution and delivery of this Indenture (as defined herein) to provide for the issuance from time to time of its debentures, notes or other evidences of indebtedness (herein called the "Securities") to be issued in one or more series as provided in this Indenture. For and in consideration of the premises and purchase of the Securities by the Holders (as defined herein) thereof, it is mutually covenanted and agreed, for the equal and ratable benefit of the Holders of the Securities of each series thereof as follows: ARTICLE 1. DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01 Definitions. "Affiliate" of any specified Person means any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person. For purposes of this definition, "control", as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise; provided that beneficial ownership of 10% or more of the Voting Stock of a Person shall be deemed to be control. For purposes of this definition, the terms "controlling," "controlled by" and "under common control with" have correlative meanings. "Agent" means any Registrar, Paying Agent or co-registrar. "Bankruptcy Law" means Title 11, U.S. Code or any similar federal or state law for the relief of debtors. "Bearer Security" means any Security, including any interest coupons appertaining thereto, that does not provide for the identification of the Holder thereof. "Board of Directors" means the board of directors of the Company (or any duly authorized committee thereof); "Board Resolution" means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors and to be in full force and effect on the date of such certification, and delivered to the Trustee. "Business Day" means any day other than a Legal Holiday. "Capital Lease Obligation" means, at the time any determination is to be made, the amount of the liability in respect of a capital lease that would at that time be required to be capitalized on a balance sheet in accordance with GAAP. "Capital Stock" means: (a) in the case of a corporation, corporate stock; (b) in the case of an association or business entity, any and all shares, interests, participations, rights or other equivalents (however designated) of corporate stock; (c) in the case of a partnership or limited liability company, partnership or membership interests (whether general or limited); and (d) any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person. "Company" means Omnicare, Inc., and any and all successors thereto. "Company Order" means a written order signed in the name of the Company by an Officer and delivered to the Trustee or, with respect to Sections 2.04, 2.08, 2.09, 2.12 and 9.05 any other employee of the Company named in an Officers' Certificate delivered to the Trustee. "Corporate Trust Office of the Trustee" shall be at the address of the Trustee specified in Section 13.02 hereof or such other address as to which the Trustee may give notice to the Company. "Default" means any event that is, or with the passage of time or the giving of notice or both would be, an Event of Default. "Depositary" means, with respect to the Securities issuable or issued in whole or in part in global form, the Person specified pursuant to Section 2.03(a) hereof as the Depositary with respect to the Securities, and any and all successors thereto appointed as depositary hereunder and having become such pursuant to the applicable provision of this Indenture. "Discount Security" means any Security which provides for an amount less than the principal amount thereof to be due and payable upon a declaration of acceleration of the maturity thereof pursuant to Section 6.02 hereof. "Domestic Subsidiary" means any Restricted Subsidiary organized under the laws of the United States or any state of the United States or the District of Columbia. "Equity Interests" means Capital Stock and all warrants, options or other rights to acquire Capital Stock (but excluding any debt security that is convertible into, or exchangeable for, Capital Stock). "Exchange Act" means the Securities Exchange Act of 1934, as amended. "GAAP" means generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as have been approved by a significant segment of the accounting profession, which are in effect on the date of determination. "Global Security" or "Global Securities" means any Security or Securities, as the case may be, in the form established pursuant to Section 2.02 evidencing all or a part of a series of Securities issued to the Depositary of such series or its nominee and registered in the name of such Depositary or nominee. "Government Securities" means direct obligations of, or obligations guaranteed by, the United States of America, and the payment for which the United States pledges its full faith and credit. 2 "Guarantee" means a guarantee other than by endorsement of negotiable instruments for collection in the ordinary course of business, direct or indirect, in any manner including, without limitation, by way of a pledge of assets or through letters of credit or reimbursement agreements in respect thereof, of all or any part of any Indebtedness. "Guarantor" means with respect to Securities of any series, any Domestic Subsidiary who has guaranteed the Company's obligations under this Indenture and with respect to such series of Securities pursuant to Article 12 hereof; provided that upon the release and discharge of any Person from its Security Guarantee in accordance with this Indenture, such Person shall cease to be a Guarantor. "Hedging Obligations" means, with respect to any specified Person, the obligations of such Person under (a) interest rate swap agreements, interest rate cap agreements and interest rate collar agreements and (b) other agreements or arrangements designed to protect such Person against fluctuations in interest rates or foreign exchange rates. "Holder" means a Person in whose name a Security is registered. "Indebtedness" means, with respect to any specified Person, any indebtedness of such Person, whether or not contingent: (a) in respect of borrowed money; (b) evidenced by bonds, notes, debentures or similar instruments or letters of credit (or reimbursement agreements in respect thereof); (c) in respect of banker's acceptances; (d) representing Capital Lease Obligations; (e) representing the balance deferred and unpaid of the purchase price of any property; or (f) representing any Hedging Obligations, if and to the extent any of the preceding items (other than letters of credit and Hedging Obligations) would appear as a liability upon a balance sheet of the specified Person prepared in accordance with GAAP. In addition, the term "Indebtedness" includes all Indebtedness of others secured by a Lien on any asset of the specified Person (whether or not such Indebtedness is assumed by the specified Person) and, to the extent not otherwise included, the Guarantee by the specified Person of any indebtedness of any other Person, in each case limited to the maximum amount of liability of the specified Person with respect to such Lien or Guarantee on the date in question. Notwithstanding anything in the foregoing to the contrary, Indebtedness shall not include trade payables or accrued expenses for property or services incurred in the ordinary course of business. The amount of any Indebtedness issued with original issue discount will be the accreted value of such Indebtedness. "Indenture" means this Indenture, as amended or supplemented from time to time. "Interest Payment Date," when used with respect to any Security, means the Stated Maturity of an installment of interest on such Security. 3 "Legal Holiday" means a Saturday, a Sunday or a day on which banking institutions in the City of New York or at a place of payment are authorized by law, regulation or executive order to remain closed. If a payment date is a Legal Holiday at a place of payment, payment may be made at that place on the next succeeding day that is not a Legal Holiday, and no interest shall accrue on such payment for the intervening period. "Lien" means, with respect to any asset, any mortgage, lien, pledge, charge, security interest or encumbrance of any kind in respect of such asset, whether or not filed, recorded or otherwise perfected under applicable law, including any conditional sale or other title retention agreement, any lease in the nature thereof, any option or other agreement to sell or give a security interest in and any filing of or agreement to give any financing statement under the Uniform Commercial Code (or equivalent statutes) of any jurisdiction. "Obligations" means any principal, interest, penalties, fees, indemnifications, reimbursements, damages and other liabilities payable under the documentation governing any Indebtedness. "Officer" means, with respect to any Person, the Chairman of the Board, the Chief Executive Officer, the President, the Chief Operating Officer, the Chief Financial Officer, the Treasurer, any Assistant Treasurer, the Controller, the Secretary or any Vice-President of such Person. "Officers' Certificate" means a certificate signed on behalf of the Company or, if applicable, a Guarantor, by two Officers of the Company, one of whom must be the principal executive officer, the principal financial officer, the treasurer or the principal accounting officer of the Company, that meets the requirements of Section 13.05 hereof. "Opinion of Counsel" means, as to the Company or, if applicable, a Guarantor, an opinion from legal counsel who is reasonably acceptable to the Trustee, that meets the requirements of Section 13.05 hereof. The counsel may be an employee of or counsel to the Company, any Subsidiary of the Company or the Trustee. "Person" means any individual, corporation, partnership, joint venture, association, joint-stock company, trust, unincorporated organization, limited liability company or government or other entity. "Redemption Date," when used with respect to any Security to be redeemed, shall mean the date specified for redemption of such Security in accordance with the terms of such Security and this Indenture. "Redemption Price," when used with respect to any Security to be redeemed, means the price at which it is to be redeemed pursuant to this Indenture. "Registered Security" means any Security in the form (to the extent applicable thereto) established pursuant to Section 2.01 hereof which is registered on the books of the Registrar. "Regular Record Date" for the interest payable on any Interest Payment Date on the Registered Securities of any series means the date specified for that purpose as contemplated by Section 2.03(a) hereof. "Representative" means the indenture trustee or other trustee, agent or representative for any Senior Debt. 4 "Responsible Officer," when used with respect to the Trustee, means any officer within the Corporate Trust Administration of the Trustee (or any successor group of the Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers and also means, with respect to a particular corporate trust matter, any other officer to whom such matter is referred because of his knowledge of and familiarity with the particular subject. "Restricted Subsidiary" means any direct or indirect Subsidiary of the Company other than an Unrestricted Subsidiary. "SEC" means the Securities and Exchange Commission. "Securities Act" means the Securities Act of 1933, as amended. "Security Guarantee" means, with respect to the Securities of any series, the Guarantee with respect to the Securities of such series by each Guarantor pursuant to Article 12 hereof and a supplemental indenture. "Securities" has the meaning assigned to it in the preamble to this Indenture. "Significant Subsidiary" means any Subsidiary that would be a "significant subsidiary" as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such Regulation is in effect on the date hereof. "Special Record Date" for the payment of any Defaulted Interest on the Registered Securities of any issue means a date fixed by the Trustee pursuant to Section 2.14 hereof. "Stated Maturity" means, with respect to any installment of interest or principal on any series of Indebtedness, the date on which the payment of interest or principal was scheduled to be paid in the original documentation governing such Indebtedness, and will not include any contingent obligations to repay, redeem or repurchase any such interest or principal prior to the date originally scheduled for the payment thereof. "Subsidiary" means, (a) any corporation more than 50% of the outstanding securities having ordinary voting power of which shall at the time be owned or controlled, directly or indirectly, by the Company and/or by one or more of its Restricted Subsidiaries, or (b) any partnership, limited liability company, association, joint venture or similar business organization more than 50% of the ownership interests having ordinary voting power of which shall at the time be so owned or controlled. "TIA" means the Trust Indenture Act of 1939 (15 U.S.C. 'SS''SS' 77aaa-77bbbb) as in effect on the date on which this Indenture is qualified under the TIA. "Trustee" means the party named as such above until a successor replaces it in accordance with the applicable provisions of this Indenture and thereafter means the successor serving hereunder. "Unrestricted Subsidiary" means any Subsidiary of the Company that is designated by the Board of Directors as an Unrestricted Subsidiary pursuant to a Board Resolution, but only to the extent that such Subsidiary: (a) has no Indebtedness other than Indebtedness that is without recourse to the Company or its Restricted Subsidiaries; 5 (b) is not party to any agreement, contract, arrangement or understanding with the Company or any Restricted Subsidiary unless the terms of any such agreement, contract, arrangement or understanding are not materially less favorable to the Company or such Restricted Subsidiary than those that might be obtained at the time from Persons who are not Affiliates of the Company; (c) is a Person with respect to which neither the Company nor any of its Restricted Subsidiaries has any (a) continuing direct or indirect obligation to subscribe for additional Equity Interests or (b) direct or indirect obligation to maintain or preserve such Person's financial condition or to cause such Person to achieve any specified levels of operating results; and (d) has not guaranteed or otherwise directly or indirectly provided credit support for any Indebtedness of the Company or any of its Restricted Subsidiaries. "Voting Stock" of any Person as of any date means the Capital Stock of such Person that is at the time entitled to vote in the election of the Board of Directors of such Person. Section 1.02 Other Definitions. Defined in Term Section - ---- ---------- "Bankruptcy Law" ........................................... 4.01 "Covenant Defeasance" ...................................... 8.03 "Defaulted Interest" ....................................... 2.14 "Event of Default" ......................................... 6.01 "Legal Defeasance" ......................................... 8.02 "Paying Agent" ............................................. 2.05 "Registrar" ................................................ 2.05 Section 1.03 Incorporation by Reference of Trust Indenture Act. Whenever this Indenture refers to a provision of the TIA, the provision is incorporated by reference in and made a part of this Indenture. The following TIA terms used in this Indenture have the following meanings: "indenture securities" means the Securities; "indenture security Holder" means a Holder of a Security; "indenture to be qualified" means this Indenture; "indenture trustee" or "institutional trustee" means the Trustee; and "obligor" on the Securities and the Security Guarantees means the Company and the Guarantors, respectively, and any successor obligor upon the Securities and the Security Guarantees, respectively. All other terms used in this Indenture that are defined by the TIA, defined by TIA reference to another statute or defined by SEC rule under the TIA have the meanings so assigned to them. 6 Section 1.04 Rules of Construction. Unless the context otherwise requires: (a) a term has the meaning assigned to it; (b) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; (c) "or" is not exclusive; (d) words in the singular include the plural, and in the plural include the singular; (e) provisions apply to successive events and transactions; and (f) references to sections of or rules under the Securities Act shall be deemed to include substitute, replacement of successor sections or rules adopted by the SEC from time to time. ARTICLE 2. THE SECURITIES Section 2.01 Form Generally The Securities of each series shall be substantially in the form of Exhibit A hereto or in such other form as shall be established by delivery to the Trustee of an Officers' Certificate or in one or more indentures supplemental hereto, in each case with such appropriate insertions, omissions, substitutions and other variations as are required or permitted by this Indenture, and may have such letters, numbers or other marks of identification and such legends or endorsements placed thereon as may be required to comply with the rules of any securities exchange or as may, consistently herewith, be determined by the Officers executing such Securities as evidenced by their execution of the Securities. The permanent Securities shall be printed, lithographed, engraved or cord processed or produced by any combination of these methods or may be produced in any other manner, provided that such method is permitted by the rules of any securities exchange on which such Securities may be listed, all as determined by the Officers executing such Securities as evidenced by their execution of such Securities. Section 2.02 Securities in Global Form If Securities of a series are issuable as a Global Security, as specified as contemplated by Section 2.03(a) hereof, then, notwithstanding clause (9) of Section 2.03(a) hereof and the provisions of Section 2.03(b) hereof, any such Global Security shall represent such of the outstanding Securities of such series as shall be specified therein and may provide that it shall represent the aggregate principal amount of outstanding Securities from time to time endorsed thereon or otherwise notated on the books and records of the Registrar and that the aggregate principal amount of outstanding Securities represented thereby may from time to time be reduced or increased, as appropriate, to reflect exchanges and redemptions. Any endorsement of a Global Security to reflect the aggregate principal amount of any increase or decrease in the amount of outstanding Securities represented thereby shall be made by the Trustee in such manner and upon instructions given by the Holder thereof as required by Section 2.08 hereof. Global Securities may be issued in either registered or bearer form and in either temporary or permanent form. Permanent Global Securities will be issued in definitive form. 7 The provisions of the last sentence of Section 2.04 hereof shall apply to any Security represented by a Global Security if such Security was never issued and sold by the Company, and the Company delivers to the Trustee the Security in global form together with written instructions (which need not comply with Section 13.04 or 13.05 hereof and need not be accompanied by an Opinion of Counsel) with regard to the reduction in the principal amount of Securities represented thereby, together with the written statement contemplated by the last sentence of Section 2.04 hereof. Notwithstanding the provisions of Sections 2.02 and 2.14 hereof, unless otherwise specified as contemplated by Section 2.03(a) hereof, payment of principal of and any interest on any Global Security shall be made to the person or persons specified therein. None of the Company, the Guarantor, if any, the Trustee of such series of Securities, any Paying Agent or Registrar will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests of a Global Security or for maintaining, supervising or reviewing any records relating to such beneficial ownership interests. Section 2.03 Title and Terms. (a) The aggregate principal amount of Securities which may be authenticated and delivered under this Indenture is unlimited. The Securities may be issued in one or more series. There shall be established and, subject to Section 2.04 hereof, set forth, or determined in the manner provided, in an Officers' Certificate or established in one or more indentures supplemental hereto, prior to the issuances of Securities of any series, any or all of the following, as applicable: (1) the title and series designation of the Securities of the series (which shall distinguish the Securities of the series from all other Securities); (2) any limit upon the aggregate principal amount of the Securities of the series which may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon registration of, transfer of, or in exchange for, or in lieu of, other Securities of the series pursuant to Sections 2.08, 2.09, 2.12, 3.06, 9.05 or 10.03 hereof and except for any Securities which, pursuant to Section 2.04 hereof, are deemed never to have been authenticated and delivered hereunder); (3) the price or prices at which the Securities of the series will be issued; (4) if the Securities of the series will be guaranteed and the terms of any such Security Guarantees; (5) the date or dates on which the principal amount and premium, if any, of the Securities of the series is payable; (6) the interest rate or rates or the method for calculating the interest rate, which may be fixed or variable, of the Securities of the series, the date or dates from which any such interest shall accrue and the Interest Payment Dates on which such interest shall be payable, subject to the right, if any, of the Company to defer or extend an Interest Payment Date and the duration of such deferral or extension; (7) the place or places where, subject to the provisions of Section 4.02 hereof, the principal of, premium, if any, and interest on Securities of the series will be payable and where any Securities of the series may be surrendered for registration of transfer, Securities of the series may be 8 surrendered for exchange and notices and demands to or upon the Company in respect of the Securities of the series and this Indenture may be served; (8) the right, if any, to redeem the Securities of the series and the terms and conditions upon which Securities of the series may be redeemed, in whole or in part; (9) any mandatory or optional sinking fund or analogous provisions; (10) whether the Securities of the series will be secured and any provisions relating to the security provided; (11) if and the terms and conditions upon which the Securities of the series may or must be converted into securities of the Company or exchanged for securities of the Company or another enterprise; (12) if other than the principal amount thereof, the portion of the principal amount of any Securities of the series which shall be payable upon declaration of acceleration of the maturity thereof pursuant to Section 6.02 hereof; (13) whether the Securities of the series, in whole or any specified part, shall not be defeasible pursuant to Section 8.04 or 8.05 hereof or both such Sections and, if other than by an Officers' Certificate, the manner in which any election by the Company to defease such Securities shall be evidenced; (14) any addition to or change in the Events of Default which apply to any Securities of the series and any change in the right of the Trustee or the requisite Holders of such Securities to declare the principal amount thereof due and payable pursuant to Section 6.02 hereof; (15) if other than U.S. dollars, the currency or currencies in which payment of the principal of, premium, if any, and interest on the Securities of the series shall be payable and whether the Securities of the series may be satisfied and discharged other than as provided in Article 8 hereof; (16) any terms applicable to Original Issue Discount, if any, (as that term is defined in the Internal Revenue Code of 1986 and the Regulations thereunder) including the rate or rates at which such Original Issue Discount, if any, shall accrue; (17) if the Securities of the series may be issued or delivered (whether upon original issuance or upon exchange of a temporary Security of such series or otherwise), or any installment of principal of, or any premium or interest is payable, only upon receipt of certain certificates or other documents or satisfaction of other conditions in addition to those specified in this Indenture, the form and terms of such certificates, documents or conditions; (18) whether the Securities of the series may be represented initially by a Security in temporary or permanent global form and, if so, the Depositary with respect to any such temporary or permanent Global Security, and if other than as provided in Section 2.08 or 2.12 hereof, as applicable, whether and the circumstances under which beneficial owners of interests in any such temporary or permanent Global Security may exchange such interests for Securities of such series and of like tenor of any authorized form and denomination; (19) whether Securities of the series are to be issued as Registered Securities, Bearer Securities or both, the terms and conditions relating to the applicable form, including, but not limited to, tax 9 compliance, registration and transfer procedures and, if in registered form, the denominations in which any Registered Securities of the series will be issuable if other than denominations of $1,000 and any integral multiple thereof and if in bearer form, the denominations in which any Bearer Securities will be issuable; (20) any special United States federal income tax considerations applicable to the Securities of the series; (21) any addition to or change in the covenants set forth in Article 4 which apply to Securities of the series; and (22) any other terms of the Securities of the series (which terms shall not be inconsistent with the provisions of this Indenture, except as permitted by Section 9.01(i) hereof). All Securities of any one series shall be substantially identical except as to denomination and the rate or rates of interest, if any, and Stated Maturity, the date from which interest, if any, shall accrue and except as may otherwise be provided in or pursuant to an Officers' Certificate pursuant to this Section 2.03(a) or in any indenture supplemental hereto. All Securities of any one series need not be issued at the same time and, unless otherwise provided, a series may be reopened for issuances of additional Securities of such series or for the establishment of additional terms with respect to the Securities of such series. If any of the terms of the series are established by action taken pursuant to a Board Resolution, a copy of any appropriate record of such action shall be certified by the Secretary or an Assistant Secretary of the Company and delivered to the Trustee at or prior to the delivery of the Officers' Certificate setting forth the terms of the series. (b) Unless otherwise provided as contemplated by Section 2.03(a) hereof with respect to any series of Securities, the Securities of such series shall be issuable in denominations of $1,000 or integral multiples thereof. Section 2.04 Execution, Authentication, Delivery and Dating Two Officers shall sign the Securities for the Company by manual or facsimile signature. If an Officer whose signature is on a Security no longer holds that office at the time a Security is authenticated, the Security shall nevertheless be valid. A Security shall not be valid until authenticated by the manual signature of the Trustee. The signature shall be conclusive evidence that the Security has been authenticated under this Indenture. At any time and from time to time after the execution and delivery of this Indenture (and subject to delivery of an Officers' Certificate or a supplemental indenture as set forth in Section 2.03(a) hereof with respect to the initial issuance of Securities of any series), the Company may deliver Securities of any series executed by the Company to the Trustee for authentication, together with a Company Order for the authentication and delivery of such Securities; and the Trustee in accordance with such Company Order shall authenticate and deliver such Securities. If the forms or terms of the Securities of the series have been established in or pursuant to one or more Officers' Certificates as permitted by Sections 2.01 and 2.03(a) hereof, in authenticating such Securities, and accepting the additional responsibilities under this Indenture in relation to such Securities, the Trustee shall be entitled to receive, and shall be fully protected in relying upon, an Opinion of Counsel stating: 10 (a) that the form or forms and terms of such Securities have been duly authorized by the Company and established in conformity with the provisions of this Indenture; and (b) that such Securities when authenticated and delivered by the Trustee or its authenticating agent and issued by the Company in the manner and subject to any conditions specified in such Opinion of Counsel, will constitute legal, valid and binding obligations of the Company, enforceable in accordance with their terms, subject to customary exceptions. Notwithstanding the provisions of Section 2.03(a) hereof and of the preceding paragraph, if all Securities of a series are not to be originally issued at one time, it shall not be necessary to deliver the Officers' Certificate otherwise required pursuant to Section 2.03(a) hereof and the Opinion of Counsel required by the preceding paragraph at or prior to the time of authentication of each Security of such series if such documents are delivered at or prior to the authentication upon original issuance of the first Security of such series to be issued. Each Security shall be dated the date of its authentication. No Security shall be entitled to any benefit under this Indenture or be valid or obligatory for any purpose unless there appears on such Security a certificate of authentication substantially in the form provided for herein duly executed by the Trustee by manual signature of an authorized signatory, and such certificate upon any Security shall be conclusive evidence, and the only evidence, that such Security has been duly authenticated and delivered hereunder. The Trustee's certificate of authentication shall be in substantially the following form: This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. [______________________], as Trustee By: Authorized Officer Notwithstanding the foregoing, if any Security shall have been duly authenticated and delivered hereunder but never issued and sold by the Company, and the Company shall deliver such Security to the Trustee for cancellation as provided in Section 2.13 hereof together with a written statement (which need not comply with Section 13.04 or 13.05 hereof and need not be accompanied by an Opinion of Counsel) stating that such Security has never been issued and sold by the Company, for all purposes of this Indenture such Security shall be deemed never to have been authenticated and delivered hereunder and shall never be entitled to the benefits of this Indenture. Section 2.05 Registrar and Paying Agent. The Company shall maintain, with respect to each series of Securities, an office or agency where such Securities may be presented for registration of transfer or for exchange ("Registrar") and an office or agency where Securities may be presented for payment ("Paying Agent"). The Registrar shall keep a register of the Securities and of their transfer and exchange. The Company may appoint one or more co-registrars and one or more additional paying agents. The term "Registrar" includes any co-registrar and the term "Paying Agent" includes any additional paying agent. The Company may change any Paying Agent or Registrar without notice to any Holder. The Company shall notify the Trustee in writing of the 11 name and address of any Agent not a party to this Indenture. If the Company fails to appoint or maintain another entity as Registrar or Paying Agent, the Trustee shall act as such. The Company or any of its Subsidiaries may act as Paying Agent or Registrar. The Company initially appoints the Trustee to act as the Registrar and Paying Agent. Section 2.06 Paying Agent to Hold Money in Trust. The Company shall require each Paying Agent other than the Trustee to agree in writing that the Paying Agent will hold in trust for the benefit of Holders of Securities of any series or the Trustee all money held by the Paying Agent for the payment of principal, premium, if any, or interest on such series of Securities, and will notify the Trustee of any default by the Company in making any such payment. While any such default continues, the Trustee may require a Paying Agent to pay all money held by it to the Trustee. The Company at any time may require a Paying Agent to pay all money held by it to the Trustee. Upon payment over to the Trustee, the Paying Agent (if other than the Company or a Subsidiary) shall have no further liability for the money. If the Company or a Subsidiary acts as Paying Agent, it shall segregate and hold in a separate trust fund for the benefit of the Holders all money held by it as Paying Agent. Upon any bankruptcy or reorganization proceedings relating to the Company, the Trustee shall serve as Paying Agent for the Securities. Section 2.07 Holder Lists. The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of all Holders of each series of Securities and shall otherwise comply with TIA 'SS' 312(a). If the Trustee is not the Registrar, the Company shall furnish to the Trustee at least seven Business Days before each interest payment date and at such other times as the Trustee may request in writing, a list in such form and as of such date as the Trustee may reasonably require of the names and addresses of the Holders of such series of Securities and the Company shall otherwise comply with TIA 'SS' 312(a). Section 2.08 Registration, Registration of Transfer and Exchange. Upon surrender for registration of transfer of any Securities of a series at an office or agency of the Company designated pursuant to Section 4.02 hereof for such purpose, the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the designated transferee or transferees, one or more new Securities of the same series of any authorized denominations, of a like aggregate principal amount. The Company shall not charge a service charge for any registration of transfer or exchange, but the Company may require payment of a sum sufficient to pay all taxes, assessments or other governmental charges that may be imposed in connection with the transfer or exchange of the Securities from the Holder requesting such transfer or exchange (other than any exchange of a temporary Security for a permanent Security not involving any change in ownership or any exchange pursuant to Section 2.12, 3.06, 9.05 or 10.3 hereof, not involving any transfer). Notwithstanding any other provisions (other than the provisions set forth in the sixth and seventh paragraphs) of this Section 2.08, a Security in global form representing all or a portion of the Securities of a series may not be transferred except as a whole by the Depositary for such series to a nominee of such Depositary or by a nominee of such Depositary to such Depositary or another nominee of such Depositary or by such Depositary or any such nominee to a successor Depositary for such series or a nominee of such successor Depositary. 12 At the option of the Holder of Securities of any series, Securities of such series may be exchanged for other Securities of the same series of any authorized denomination or denominations of a like aggregate principal amount and tenor, upon surrender of the Securities to be exchanged at such office or agency. Whenever any Securities are so surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and deliver, the Securities which the Holder making the exchange is entitled to receive. Unless otherwise specified as contemplated by Section 2.03(a) hereof, if the Securities of any series shall have been issued in the form of one or more Global Securities, such series of Securities in global form will be exchanged for Securities of such series in permanent form if (i) the Depositary for the Securities of such series notifies the Company that it is unwilling or unable to continue as Depositary for the Securities of such series and a successor Depositary for the Securities of such series is not appointed by the Company within 120 days after the Company receives such notice, (ii) the Company in its sole discretion determines that the Securities of such series shall no longer be represented by such Global Security or Securities or (iii) an Event of Default with respect to the Securities of such series shall have occurred and be continuing. In any such event the Company will execute, and the Trustee, upon receipt of a Company Order for the authentication and delivery of permanent Securities of such series, will authenticate and deliver Securities of such series in permanent form and in an aggregate principal amount equal to the principal amount of the Security or Securities in global form representing such series in exchange for such Security or Securities in global form. Notwithstanding the foregoing, except as otherwise specified in the preceding paragraph or as contemplated by Section 2.03(a) hereof, any Global Security shall be exchangeable only as provided in this paragraph. If the beneficial owners of interests in a Global Security are entitled to exchange such interests for permanent Securities of such series and of like principal amount and tenor but of another authorized form and denomination, as specified as contemplated by Section 2.03(a) hereof, then without unnecessary delay but in any event not later than the earliest date on which such interests may be so exchanged, the Company shall deliver to the Trustee permanent Securities in aggregate principal amount equal to the principal amount of such Global Security, executed by the Company. On or after the earliest date on which such interests may be so exchanged, such Global Security shall be surrendered by the Depositary with respect thereto to the Trustee, as the Company's agent for such purpose, to be exchanged, in whole or from time to time in part, for permanent Securities without charge and the Trustee shall authenticate and deliver, in exchange for each portion of such Global Security, an equal aggregate principal amount of permanent Securities of the same series of authorized denominations and of like tenor as the portion of such Global Security to be exchanged which shall be in the form of Securities, or any combination thereof, as shall be specified by the beneficial owner thereof; provided, however, that notwithstanding the last paragraph of this Section 2.08 hereof, no such exchanges may occur during a period beginning at the opening of business 15 days before any selection of Securities of that series to be redeemed and ending on the relevant Redemption Date. If a Registered Security is issued in exchange for any portion of a Global Security after the close of business at the office or agency where such exchange occurs on (i) any Regular Record Date and before the opening of business at such office or agency on the relevant Interest Payment Date, or (ii) any Special Record Date and before the opening of business at such office or agency on the related proposed date for payment of Defaulted Interest (as defined herein), interest or Defaulted Interest, as the case may be, will not be payable on such Interest Payment Date or proposed date for payment, as the case may be, in respect of such Security, but will be payable on such Interest Payment Date or proposed date for payment, as the case may be, only to the Person to whom interest in respect of such portion of such Global Security is payable in accordance with the provisions of this Indenture. Upon the exchange of a Security in global form for Securities in permanent form, such Security in global form shall be cancelled by the Trustee. All cancelled Securities held by the Trustee shall be 13 destroyed by the Trustee and a certificate of their destruction delivered to the Company unless the Company directs, by Company Order, that the Trustee shall cancel Securities and deliver a certificate of destruction to the Company. Securities issued in exchange for a Security in global form pursuant to this Section 2.08 hereof shall be registered in such names and in such authorized denominations as the Depositary for such Security in global form, pursuant to instructions from its direct or indirect participants or otherwise, shall instruct the Trustee in writing. The Trustee shall deliver such Securities as instructed in writing by the Depositary. All Securities issued upon any registration of transfer or exchange of Securities shall be the valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under this Indenture, as the Securities surrendered upon such registration of transfer or exchange. Every Security presented or surrendered for registration of transfer or for exchange shall be duly endorsed, or be accompanied by a written instrument of transfer in form satisfactory to the Company and the Registrar duly executed, by the Holder thereof or his attorney duly authorized in writing. The Company shall not be required (i) to issue, register the transfer of or exchange any Securities of any series during a period beginning at the opening of 15 Business Days before any selection of Securities of such series to be redeemed and ending at the close of business on the day of the mailing of the relevant notice of redemption or (ii) to register the transfer of or exchange any Security of any series so selected for redemption, in whole or in part, except the unredeemed portion of any Security being redeemed in part. Section 2.09 Replacement Securities. If any mutilated Security is surrendered to the Trustee or the Company and the Trustee receives evidence to its satisfaction of the destruction, loss or theft of any Security, the Company shall issue and the Trustee, upon receipt of a Company Order, shall authenticate a replacement Security if the Trustee's requirements are met. If required by the Trustee or the Company, an indemnity bond must be supplied by the Holder that is sufficient in the judgment of the Trustee and the Company to protect the Company, the Trustee, any Agent and any authenticating agent from any loss that any of them may suffer if a Security is replaced. The Company may charge for its expenses in replacing a Security. Every replacement Security is an additional obligation of the Company and shall be entitled to all of the benefits of this Indenture equally and proportionately with all other Securities duly issued hereunder. Section 2.10 Outstanding Securities. The Securities of any series outstanding at any time are all the Securities of such series authenticated by the Trustee except for those canceled by it, those delivered to it for cancellation, those reductions in the interest in a Global Security effected by the Trustee in accordance with the provisions hereof, and those described in this Section as not outstanding. Except as set forth in Section 2.11 hereof, a Security does not cease to be outstanding because the Company or an Affiliate of the Company holds the Security. Subject to the foregoing, only Securities outstanding at the time of such determination shall be considered in any such determination (including, without limitation, determinations pursuant to Articles 6 and 9 hereof). In addition, in determining whether the Holders of the requisite principal amount of outstanding Securities have given or concurred in any request, demand, authorization, direction, notice, consent or waiver hereunder, (i) the principal amount of a Discount Security that shall be deemed to be outstanding shall be the amount of the principal thereof that would be due and payable as of the date of such determination upon acceleration of the maturity thereof pursuant to Section 6.02 14 hereof and (ii) the principal amount of a Security denominated in a foreign currency or currencies shall be the dollar equivalent, as determined on the date of original issuance of such Security, of the principal amount (or, in the case of a Discount Security, the dollar equivalent on the date of original issuance of such Security of the amount determined as provided in (i) above) of such Security. If a Security is replaced pursuant to Section 2.09 hereof, it ceases to be outstanding unless the Trustee receives proof satisfactory to it that the replaced Security is held by a bona fide purchaser. If the principal amount of any Security is considered paid under Section 4.01 hereof, it ceases to be outstanding and interest on it ceases to accrue. If the Paying Agent (other than the Company, a Subsidiary or an Affiliate of any thereof) holds, on a redemption date or maturity date, money sufficient to pay Securities payable on that date, then on and after that date such Securities shall be deemed to be no longer outstanding and shall cease to accrue interest. Section 2.11 Treasury Securities. In determining whether the Holders of the required principal amount of Securities of any series have concurred in any direction, waiver or consent, Securities of such series owned by the Company, or by any Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company, shall be considered as though not outstanding, except that for the purposes of determining whether the Trustee shall be protected in relying on any such direction, waiver or consent, only Securities of that series that the Trustee knows are so owned shall be so disregarded. Section 2.12 Temporary Securities. Until certificates representing Securities of any series are ready for delivery, the Company may prepare and the Trustee, upon receipt of a Company Order, shall authenticate temporary Securities. Temporary Securities shall be substantially in the form of certificated Securities but may have variations that the Company considers appropriate for temporary Securities and as shall be reasonably acceptable to the Trustee. Without unreasonable delay, the Company shall prepare and the Trustee shall authenticate definitive Securities of the same series in exchange for temporary Securities. Holders of temporary Securities of any series shall be entitled to all of the benefits of this Indenture as permanent Securities of the same series. Section 2.13 Cancellation. The Company at any time may deliver Securities to the Trustee for cancellation. The Registrar and Paying Agent shall forward to the Trustee any Securities surrendered to them for registration of transfer, exchange or payment. The Trustee and no one else shall cancel all Securities surrendered for registration of transfer, exchange, payment, replacement or cancellation and shall destroy canceled Securities (subject to the record retention requirement of the Exchange Act). Certification of the destruction of all canceled Securities shall be delivered to the Company. The Company may not issue new Securities to replace Securities that it has paid or that have been delivered to the Trustee for cancellation. 15 Section 2.14 Payment of Interest. Unless otherwise provided as contemplated by Section 2.03(a) hereof with respect to any series of Securities, interest on any Security which is payable, and is punctually paid or duly provided for, on any Interest Payment Date shall be paid to the person in whose name that Security (or one or more predecessor Securities) is registered at the close of business on the Regular Record Date for such interest. If the Company defaults in a payment of interest on the Securities of any series which is payable ("Defaulted Interest"), it shall pay the Defaulted Interest in any lawful manner plus, to the extent lawful, interest payable on the Defaulted Interest, to the Persons who are Holders of the series on a subsequent Special Record Date, in each case at the rate provided in the Securities of that series and in Section 4.01 hereof. The Company shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each Securities of a series and the date of the proposed payment. The Company shall fix or cause to be fixed each such Special Record Date and payment date, provided that no such Special Record Date shall be less than 10 days prior to the related payment date for such Defaulted Interest. At least 15 days before the Special Record Date, the Company (or, upon the written request of the Company, the Trustee in the name and at the expense of the Company) shall mail or cause to be mailed to Holders of the series a notice that states the Special Record Date, the related payment date and the amount of such interest to be paid. Subject to the foregoing provisions of this Section 2.14 and Section 2.08 hereof, each Security delivered under this Indenture upon registration of transfer of or in exchange for or in lieu of any other Security shall carry the rights to interest accrued and unpaid, and to accrue, which were carried by such other Security. Section 2.15 Persons Deemed Owners. Prior to due presentment of a Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the person in whose name such Security is registered as the owner of such Security for the purpose of receiving payment of principal of and (except as otherwise specified as contemplated by Section 2.03(a) hereof and subject to Sections 2.08 and 2.14 hereof) interest on such Security and for all other purposes whatsoever, whether or not such Security be overdue, and neither the Company, the Trustee nor any agent of the Company or the Trustee shall be affected by notice to the contrary. None of the Company, the Trustee, any Paying Agent or the Registrar will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests of a Security in global form or for maintaining, supervising or reviewing any records relating to such beneficial ownership interests. Section 2.16 Computation of Interest. Except as otherwise specified as contemplated by Section 2.03(a) hereof for Securities of any series, (i) interest on any Securities which bear interest at a fixed rate shall be computed on the basis of a 360-day year comprised of twelve 30-day months and (ii) interest on any Securities which bear interest at a variable rate shall be computed on the basis of the actual number of days in an interest period divided by 360. 16 Section 2.17 CUSIP Numbers. The Company, in issuing the Securities, may use "CUSIP" numbers (if then generally in use) and, if so, the Trustee shall use "CUSIP" numbers in notices of redemption as a convenience to Holders; provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities of a series or as contained in any notice of a redemption and that reliance may be placed only on the other identification numbers printed on the Securities of such series, and any such redemption shall not be affected by any defect in or omission of such numbers. The Company will promptly notify the Trustee of any change in the "CUSIP" numbers. ARTICLE 3. REDEMPTION AND PREPAYMENT Section 3.01 Right to Redeem; Notices to Trustee. Securities of any series which are redeemable before their Stated Maturity shall be redeemable in accordance with their terms and (except as otherwise specified as contemplated by Section 2.03(a) hereof for Securities of any series) in accordance with this Article 3. If the Company elects to redeem Securities of any series, it shall furnish to the Trustee, at least 35 days (or such shorter period as may be acceptable to the Trustee) but not more than 75 days before a redemption date, an Officers' Certificate setting forth (i) the clause of this Indenture pursuant to which the redemption shall occur, (ii) the Redemption Date, (iii) the principal amount of Securities of such series to be redeemed, (iv) any other information necessary to identify the Securities of such series to be redeemed and (v) the Redemption Price. Section 3.02 Selection of Securities to Be Redeemed. Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to any series of Securities, if less than all of the Securities of a series are to be redeemed or purchased in an offer to purchase at any time, the Trustee will select the Securities to be redeemed or purchased among the Holders of the Securities of that Series in compliance with the requirements of the principal national securities exchange, if any, on which the Securities are listed or, if the Securities are not so listed, on a pro rata basis, by lot or in accordance with any other method the Trustee considers fair and appropriate. In the event of partial redemption by lot, the particular Securities to be redeemed shall be selected, unless otherwise provided herein, not less than 30 nor more than 60 days prior to the Redemption Date by the Trustee from the outstanding Securities not previously called for redemption. The Trustee shall promptly notify the Company in writing of the Securities selected for redemption and, in the case of any Security selected for partial redemption, the principal amount thereof to be redeemed. Unless otherwise specified as contemplated by Section 2.03(a) hereof, Securities and portions of Securities selected will be in amounts of $1,000 or whole multiples of $1,000. Except as provided in the preceding sentence, provisions of this Indenture that apply to Securities called for redemption also apply to portions of Securities called for redemption. Section 3.03 Notice of Redemption to Holders. Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to any series of Securities, at least 30 days but not more than 60 days before a Redemption Date, the Company shall mail or cause to be mailed, by first class mail, a notice of redemption to each Holder whose Securities are to be redeemed at its registered address. The notice shall identify the Securities to be redeemed and shall state: 17 (a) the Redemption Date; (b) the Redemption Price; (c) if less than all the outstanding Securities of any series are to be redeemed, the identification (and in the case of partial redemption, the principal amount) of the particular Security to be redeemed; (d) that, after the Redemption Date upon surrender of such Security, a new Security or Securities in principal amount equal to the unredeemed portion shall be issued upon cancellation of the original Security; (e) the name and address of the Paying Agent; (f) that Securities called for redemption must be surrendered to the Paying Agent to collect the Redemption Price; (g) that, unless the Company defaults in making such redemption payment, interest, if any, on Securities called for redemption ceases to accrue on and after the Redemption Date; (h) the paragraph of the Securities and/or Section of this Indenture pursuant to which the Securities called for redemption are being redeemed; (i) that the redemption is for a sinking fund, if such is the case; and (j) that no representation is made as to the correctness or accuracy of the CUSIP number, if any, listed in such notice or printed on the Securities. At the Company's request, the Trustee shall give the notice of redemption in the Company's name and at its expense; provided, however, that the Company shall have delivered to the Trustee, at least 45 days prior to the Redemption Date (or such shorter period as may be acceptable to the Trustee), an Officers' Certificate requesting that the Trustee give such notice and setting forth the information to be stated in such notice as provided in the preceding paragraph. Notwithstanding the foregoing, a redemption notice may be mailed more than 60 days prior to the Redemption Date if the notice is issued in connection with a defeasance of the Securities or satisfaction and discharge of this Indenture. Section 3.04 Effect of Notice of Redemption. Once notice of redemption is mailed in accordance with Section 3.03 hereof, Securities called for redemption become irrevocably due and payable on the Redemption Date at the Redemption Price. A notice of redemption may not be conditional. Section 3.05 Deposit of Redemption Price. Prior to 12:00 noon (Eastern Standard Time) on the Redemption Date, the Company shall deposit with the Trustee or with the Paying Agent money sufficient to pay the Redemption Price of and accrued interest on all Securities of a series to be redeemed on that date. The Trustee or the Paying Agent shall promptly return to the Company any money deposited with the Trustee or the Paying Agent by the 18 Company in excess of the amounts necessary to pay the Redemption Price of, and accrued interest on, all Securities to be redeemed. If the Company complies with the provisions of the preceding paragraph, on and after the Redemption Date, interest shall cease to accrue on the Securities or the portions of Securities called for redemption. If a Security is redeemed on or after a Regular Record Date but on or prior to the related Interest Payment Date, then any accrued and unpaid interest shall be paid to the Person in whose name such Security was registered at the close of business on such Regular Record Date. If any Security called for redemption shall not be so paid upon surrender for redemption because of the failure of the Company to comply with the preceding paragraph, interest shall be paid on the unpaid principal from the Redemption Date until such principal is paid, and to the extent lawful on any interest not paid on such unpaid principal, in each case at the rate provided in the Securities and in Section 4.01 hereof. Section 3.06 Securities Redeemed in Part. Upon surrender of a Security that is redeemed in part, the Company shall issue and, upon the Company's written request, the Trustee shall authenticate for the Holder at the expense of the Company a new Security equal in principal amount to the unredeemed portion of the Security surrendered. ARTICLE 4. COVENANTS Section 4.01 Payment of Securities. The Company shall pay or cause to be paid the principal of, premium, if any, and interest on the Securities on the dates and in the manner provided in the Securities. Principal, premium, if any, and interest shall be considered paid on the date due if the Paying Agent, if other than the Company or a Subsidiary thereof, holds as of 10:00 a.m. Eastern Standard Time on the due date money deposited by the Company in immediately available funds and designated for and sufficient to pay all principal, premium, if any, and interest then due. Section 4.02 Maintenance of Office or Agency. The Company shall maintain in each place of payment for any series of Securities an office or agency (which may be an office of the Trustee or an affiliate of the Trustee, Registrar or co-registrar) where Securities of a series may be surrendered for registration of transfer or for exchange and where notices and demands to or upon the Company in respect of the Securities of such series and this Indenture may be served. The Company shall give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee. The Company also may from time to time designate one or more other offices or agencies where the Securities of a series may be presented or surrendered for any or all such purposes and may from time to time rescind such designations; provided, however, that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain an office or agency in each place of payment for Securities of any series for such purposes. The Company shall give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any such other office or agency. 19 With respect to any Global Security, and except as otherwise may be specified for such Global Security as contemplated by Section 2.03(a) hereof, the Corporate Trust Office for the Trustee shall be the place of payment where such Global Security may be presented or surrendered for payment or for registration of transfer or exchange, or where successor Securities may be delivered in exchange therefore, provided, however, that any such payment, presentation, surrender or delivery effected pursuant to the procedures of the Depositary for such Global Security shall be deemed to have been effected at the place of payment for such Global Security in accordance with the provisions of this Indenture. The Company hereby designates the Corporate Trust Office of the Trustee as one such office or agency of the Company in accordance with Section 2.04 hereof. Section 4.03 Reports. Whether or not required by the rules and regulations of the SEC, so long as any Securities of any series are outstanding, the Company shall furnish to the Holders of such series of Securities (i) all quarterly and annual financial information that would be required to be contained in a filing with the SEC on Forms 10-Q and 10-K if the Company were required to file such forms, including a "Management's Discussion and Analysis of Financial Condition and Results of Operations" and, with respect to the annual information only, a report thereon by the Company's certified independent accountants and (ii) all current reports that would be required to be filed with the SEC on Form 8-K if the Company were required to file such reports, in each case, within the time periods specified in the SEC's rules and regulations. In addition, whether or not required by the rules and regulations of the SEC, the Company shall file a copy of all such information and reports with the SEC for public availability within the time periods specified in the SEC's rules and regulations (unless the SEC will not accept such a filing) and make such information available to securities analysts and prospective investors upon request. The Company shall at all times comply with TIA 'SS' 314(a). Section 4.04 Compliance Certificate. (a) The Company and each Guarantor, if any, (to the extent that such Guarantor is so required under the TIA) shall deliver to the Trustee, within 120 days after the end of each fiscal year, an Officers' Certificate stating that a review of the activities of the Company and its Subsidiaries during the preceding fiscal year has been made under the supervision of the signing Officers with a view to determining whether the Company has kept, observed, performed and fulfilled its obligations under this Indenture, and further stating, as to each such Officer signing such certificate, that to the best of his or her knowledge the Company has kept, observed, performed and fulfilled each and every covenant contained in this Indenture and is not in default in the performance or observance of any of the terms, provisions and conditions of this Indenture (or, if a Default or Event of Default shall have occurred, describing all such Defaults or Events of Default of which he or she may have knowledge and what action the Company is taking or proposes to take with respect thereto) and that to the best of his or her knowledge no event has occurred and remains in existence by reason of which payments on account of the principal of or interest, if any, on the Securities is prohibited or if such event has occurred, a description of the event and what action the Company is taking or proposes to take with respect thereto. ARTICLE 5. SUCCESSORS Section 5.01 Merger, Consolidation, or Sale of Assets. Unless otherwise specified as contemplated by Section 2.03(a) hereof, the Company shall not, directly or indirectly: (1) consolidate or merge with or into another Person (whether or not the Company 20 is the surviving corporation); or (2) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets of the Company and its Restricted Subsidiaries taken as a whole, in one or more related transactions, to another Person; unless: (a) either: (i) the Company is the surviving corporation; or (ii) the Person formed by or surviving any such consolidation or merger (if other than the Company) or to which such sale, assignment, transfer, conveyance or other disposition has been made is a corporation organized or existing under the laws of the United States, any state of the United States or the District of Columbia; or (b) the Person formed by or surviving any such consolidation or merger (if other than the Company) or the Person to which such sale, assignment, transfer, conveyance or other disposition has been made assumes all the obligations of the Company under the Securities and this Indenture pursuant to a supplemental indenture reasonably satisfactory to the Trustee. In addition, the Company may not, directly or indirectly, lease all or substantially all of the properties or assets of the Company and its Restricted Subsidiaries, taken as a whole, in one or more related transactions, to any other Person. This Section 5.01 will not apply to a sale, assignment, transfer, conveyance or other disposition of assets between or among the Company and any of the Guarantors, as applicable. Section 5.02 Successor Corporation Substituted. Upon any consolidation or merger, or any sale, assignment, transfer, conveyance, transfer or other disposition of all or substantially all of the properties or assets of the Company and its Restricted Subsidiaries, taken as a whole in accordance with the provisions of Section 5.01 hereof, the successor Person formed by such consolidation or into which the Company is merged or to which such sale, assignment, transfer, conveyance or other disposition is made, shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor had been named as the Company therein. When a successor assumes all the obligations of its predecessor under this Indenture and the Securities following a consolidation or merger, or any sale, assignment, transfer, conveyance, transfer or other disposition of 90% or more of the assets of the predecessor in accordance with the foregoing provisions, the predecessor shall be released from those obligations. ARTICLE 6. DEFAULTS AND REMEDIES Section 6.01 Events of Default. Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to any series of Securities, an "Event of Default" occurs, with respect to each series of Securities individually, if: (a) the Company defaults in the payment when due of interest on the Securities of such series and such default continues for a period of 30 days; (b) the Company defaults in the payment when due of principal of or premium, if any, on the Securities of such series when the same becomes due and payable at maturity, upon redemption or otherwise; 21 (c) the Company fails to comply with any of the provisions of Section 5.01 hereof if applicable to such series of Securities; (d) the Company fails to observe or perform any other covenant or other agreement in this Indenture applicable to such series of Securities or the Securities of such series for 60 days after notice to the Company by the Trustee or the Holders of at least 25% in aggregate principal amount of the Securities of such series then outstanding voting as a single class; (e) the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary pursuant to or within the meaning of Bankruptcy Law: (i) commences a voluntary case, (ii) consents to the entry of an order for relief against it in an involuntary case, (iii) consents to the appointment of a custodian of it or for all or substantially all of its property, (iv) makes a general assignment for the benefit of its creditors, or (v) generally is not paying its debts as they become due; (f) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: (i) is for relief against the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary in an involuntary case; (ii) appoints a custodian of the Company or any of its Restricted Subsidiaries or for all or substantially all of the property of the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary; or (iii) orders the liquidation of the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary; and the order or decree remains unstayed and in effect for 60 consecutive days; (g) except as permitted by this Indenture, any Security Guarantee relating to such series of Securities is held in any final, non-appealable judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or any Guarantor relating to such series of Securities, or any Person acting on behalf of any such Guarantor, shall deny or disaffirm its obligations under such Guarantor's Security Guarantee (unless such Guarantor could be released from its Guarantee in accordance with this Indenture and as specified pursuant to Section 2.03(a) hereof); or (h) any other Event of Default provided with respect to the Securities of that series, which is specified in a supplemental indenture hereto or an Officers' Certificate, in accordance with Section 2.03(a) hereof. Section 6.02 Acceleration. If any Event of Default (other than an Event of Default specified in clause (e) or (f) of Section 6.01 hereof with respect to the Company) occurs and is continuing, the Trustee or the Holders of at least 22 25% in principal amount of the then outstanding Securities of that series may declare all the Securities of that series to be due and payable immediately. Upon any such declaration, the Securities of that series shall become due and payable immediately. Notwithstanding the foregoing, if an Event of Default specified in clause (e) or (f) of Section 6.01 hereof occurs with respect to the Company, all outstanding Securities of that series shall be due and payable immediately without further action or notice. The Holders of a majority in aggregate principal amount of the then outstanding Securities of a series by written notice to the Trustee may on behalf of all of the Holders of such series of Securities rescind an acceleration and its consequences if all existing Events of Default (except nonpayment of principal, interest or premium that has become due solely because of the acceleration) have been cured or waived. Section 6.03 Other Remedies. If an Event of Default with respect to a series of Securities occurs and is continuing, the Trustee may pursue any available remedy to collect the payment of principal, premium, if any, and interest on the Securities of such series or to enforce the performance of any provision of the Securities of such series or this Indenture. The Trustee may maintain a proceeding even if it does not possess any of the Securities of a series or does not produce any of them in the proceeding. A delay or omission by the Trustee or any Holder of a Security of such series in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. All remedies are cumulative to the extent permitted by law. Section 6.04 Waiver of Past Defaults. Holders of not less than a majority in aggregate principal amount of the then outstanding Securities of a series by notice to the Trustee may on behalf of the Holders of all of the Securities of such series waive an existing Default or Event of Default and its consequences hereunder, except a continuing Default or Event of Default in the payment of the principal of, premium, if any, or interest on, the Securities of that series (including in connection with an offer to purchase) (provided, however, that the Holders of a majority in aggregate principal amount of the then outstanding Securities of a series may rescind an acceleration and its consequences, including any related payment default that resulted from such acceleration). Upon any such waiver, such Default shall cease to exist, and any Event of Default arising therefrom shall be deemed to have been cured for every purpose of this Indenture; but no such waiver shall extend to any subsequent or other Default or impair any right consequent thereon. Section 6.05 Control by Majority. Holders of a majority in principal amount of the then outstanding Securities of any series may direct the time, method and place of conducting any proceeding for exercising any remedy available to the Trustee or exercising any trust or power conferred on it. However, the Trustee may refuse to follow any direction that conflicts with law or this Indenture that the Trustee determines may be unduly prejudicial to the rights of other Holders of such Securities or that may involve the Trustee in personal liability. Section 6.06 Limitation on Suits. A Holder of any Security of any series may pursue a remedy with respect to this Indenture or such series of Securities only if: 23 (a) the Holder of a Security of such series gives to the Trustee written notice of a continuing Event of Default; (b) the Holders of at least 25% in principal amount of the then outstanding Securities of such series make a written request to the Trustee to pursue the remedy; (c) the Holder of a Security of such series or Holders of Securities of such series offer and, if requested, provide to the Trustee indemnity satisfactory to the Trustee against any loss, liability or expense; (d) the Trustee does not comply with the request within 60 days after receipt of the request and the offer and, if requested, the provision of indemnity; and (e) during such 60-day period the Holders of a majority in principal amount of the then outstanding Securities of such series do not give the Trustee a direction inconsistent with the request. A Holder of any Security may not use this Indenture to prejudice the rights of another Holder or to obtain a preference or priority over another Holder. Section 6.07 Rights of Holders of Securities to Receive Payment and Convert. Notwithstanding any other provision of this Indenture, the Holder of any Security shall have the right to receive payment of principal of, premium, if any, and interest on such Security, on or after the respective due dates expressed in such Security (including in connection with an offer to purchase), or to bring suit for the enforcement of any such payment on or after such respective dates shall not be impaired or affected without the consent of such Holder. Section 6.08 Collection Suit by Trustee. If an Event of Default specified in Section 6.01(a) or (b) hereof occurs and is continuing, the Trustee is authorized to recover judgment in its own name and as trustee of an express trust against the Company for the whole amount of principal of, premium, if any, and interest remaining unpaid on the Securities of any series and interest on overdue principal and, to the extent lawful, interest and such further amount as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel. Section 6.09 Trustee May File Proofs of Claim. The Trustee is authorized to file such proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and the Holders of the Securities of any series allowed in any judicial proceedings relative to the Company (or any other obligor upon the Securities of that series), its creditors or its property and shall be entitled and empowered to collect, receive and distribute any money or other property payable or deliverable on any such claims and any custodian in any such judicial proceeding is hereby authorized by each Holder to make such payments to the Trustee, and in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.07 hereof. To the extent that the payment of any such compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.07 hereof out of the estate in any such proceeding, shall be 24 denied for any reason, payment of the same shall be secured by a Lien on, and shall be paid out of, any and all distributions, dividends, money, securities and other properties that the Holders may be entitled to receive in such proceeding whether in liquidation or under any plan of reorganization or arrangement or otherwise. Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Securities or the rights of any Holder, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding. Section 6.10 Priorities. If the Trustee collects any money pursuant to this Article 6, it shall pay out the money in the following order: First: to the Trustee, its agents and attorneys for amounts due under Section 7.07 hereof, including payment of all compensation, expense and liabilities incurred, and all advances made, by the Trustee and the costs and expenses of collection; Second: to Holders of Securities for amounts due and unpaid on the Securities of any series for principal, premium, if any, and interest, ratably, without preference or priority of any kind, according to the amounts due and payable on the Securities of that series for principal, premium, if any and interest, respectively; and Third: to the Company or to such party as a court of competent jurisdiction shall direct. The Trustee may fix a record date and payment date for any payment to Holders of Securities pursuant to this Section 6.10. Section 6.11 Undertaking for Costs. In any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken or omitted by it as a Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys' fees, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section 6.11 does not apply to a suit by the Trustee, a suit by a Holder of a Security of any series pursuant to Section 6.07 hereof, or a suit by Holders of more than 10% in principal amount of the then outstanding Securities of any series. ARTICLE 7. TRUSTEE Section 7.01 Duties of Trustee. (a) If an Event of Default with respect to the Securities of any series has occurred and is continuing, the Trustee shall exercise such of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in its exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person's own affairs. (b) With respect to the Securities of any series, except during the continuance of an Event of Default with respect to Securities of such series: 25 (i) the duties of the Trustee shall be determined solely by the express provisions of this Indenture and the Trustee need perform only those duties that are specifically set forth in this Indenture and no others, and no implied covenants or obligations shall be read into this Indenture against the Trustee; and (ii) in the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture. However, the Trustee shall examine the certificates and opinions to determine whether or not they conform to the requirements of this Indenture. (c) The Trustee may not be relieved from liabilities for its own negligent action, its own negligent failure to act, or its own willful misconduct, except that: (i) this paragraph does not limit the effect of paragraph (b) of this Section 7.01; (ii) the Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer, unless it is proved that the Trustee was negligent in ascertaining the pertinent facts; and (iii) the Trustee shall not be liable with respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 6.05 hereof. (d) Whether or not therein expressly so provided, every provision of this Indenture that in any way relates to the Trustee is subject to paragraphs (a), (b), and (c) of this Section 7.01. (e) No provision of this Indenture shall require the Trustee to expend or risk its own funds or incur any liability. The Trustee shall be under no obligation to exercise any of its rights and powers under this Indenture at the request of any Holders, unless such Holder shall have offered to the Trustee security and indemnity satisfactory to it against any loss, liability or expense. (f) The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law. Section 7.02 Rights of Trustee. (a) The Trustee may conclusively rely upon any document believed by it to be genuine and to have been signed or presented by the proper Person. The Trustee need not investigate any fact or matter stated in the document. (b) Before the Trustee acts or refrains from acting, it may require an Officers' Certificate or an Opinion of Counsel or both. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on such Officers' Certificate or Opinion of Counsel. The Trustee may consult with counsel and the written advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection from liability in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon. (c) The Trustee may act through its attorneys and agents and shall not be responsible for the misconduct or negligence of any agent appointed with due care. 26 (d) The Trustee shall not be liable for any action it takes or omits to take in good faith that it believes to be authorized or within the rights or powers conferred upon it by this Indenture. (e) Unless otherwise specifically provided in this Indenture, any demand, request, direction or notice from the Company or any Guarantor, if applicable, shall be sufficient if signed by an Officer of the Company or Guarantor, as applicable. (f) The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request or direction of any of the Holders unless such Holders shall have offered to the Trustee reasonable security or indemnity against the costs, expenses and liabilities that might be incurred by it in compliance with such request or direction. Section 7.03 Individual Rights of Trustee. The Trustee in its individual or any other capacity may become the owner or pledgee of Securities and may otherwise deal with the Company or any Affiliate of the Company with the same rights it would have if it were not Trustee. However, in the event that the Trustee acquires any conflicting interest, it must eliminate such conflict within 90 days, apply to the SEC for permission to continue as Trustee or resign. Any Agent may do the same with like rights and duties. The Trustee is also subject to Sections 7.10 and 7.11 hereof. Section 7.04 Trustee's Disclaimer. The Trustee shall not be responsible for and makes no representation as to the validity or adequacy of this Indenture or the Securities, it shall not be accountable for the Company's use of the proceeds from the Securities or any money paid to the Company or upon the Company's direction under any provision of this Indenture, it shall not be responsible for the use or application of any money received by any Paying Agent other than the Trustee, and it shall not be responsible for any statement or recital herein or any statement in the Securities or any other document in connection with the sale of the Securities or pursuant to this Indenture other than its certificate of authentication. Section 7.05 Notice of Defaults. If a Default or Event of Default occurs and is continuing with respect to a series of Securities and if it is known to the Trustee, the Trustee shall mail to Holders of Securities of such series a notice of the Default or Event of Default within 90 days after it occurs. Except in the case of a Default or Event of Default in payment of principal of, premium, if any, or interest on any Security, the Trustee may withhold the notice if and so long as a committee of its Responsible Officers in good faith determines that withholding the notice is in the interests of the Holders of the Securities. Section 7.06 Reports by Trustee to Holders of the Securities. Within 60 days after each ________ beginning with the ________ following the date of this Indenture, and for so long as Securities of any series remain outstanding, the Trustee shall mail to the Holders of the Securities of such series a brief report dated as of such reporting date that complies with TIA 'SS' 313(a) (but if no event described in TIA 'SS' 313(a) has occurred within the twelve months preceding the reporting date, no report need be transmitted). The Trustee also shall comply with TIA 'SS' 313(b)(2). The Trustee also shall transmit by mail all reports as required by TIA 'SS' 313(c). A copy of each report at the time of its mailing to the Holders of Securities shall be mailed to the Company and filed with the SEC and each stock exchange on which the Securities are listed in 27 accordance with TIA 'SS' 313(d). The Company shall promptly notify the Trustee when the Securities are listed on any stock exchange. Section 7.07 Compensation and Indemnity. The Company shall pay to the Trustee from time to time reasonable compensation for its acceptance of this Indenture and services hereunder. The Trustee's compensation shall not be limited by any law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee promptly upon request for all reasonable disbursements, advances and expenses incurred or made by it in addition to the compensation for its services. Such expenses shall include the reasonable compensation, disbursements and expenses of the Trustee's agents and counsel. The Company shall indemnify the Trustee against any and all losses, liabilities or expenses incurred by it arising out of or in connection with the acceptance or administration of its duties under this Indenture, including the costs and expenses of enforcing this Indenture against the Company (including this Section 7.07) and defending itself against any claim (whether asserted by the Company or any Holder or any other person) or liability in connection with the exercise or performance of any of its powers or duties hereunder, except to the extent any such loss, liability or expense may be attributable to its negligence or bad faith. The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. Failure by the Trustee to so notify the Company shall not relieve the Company of its obligations hereunder. The Company shall defend the claim and the Trustee shall cooperate in the defense. The Trustee may have separate counsel and the Company shall pay the reasonable fees and expenses of such counsel. The Company need not pay for any settlement made without its consent, which consent shall not be unreasonably withheld. The obligations of the Company under this Section 7.07 shall survive the satisfaction and discharge of this Indenture. To secure the Company's payment obligations in this Section 7.07, the Trustee shall have a Lien prior to the Securities on all money or property held or collected by the Trustee, except that held in trust to pay principal and interest on particular Securities. Such Lien shall survive the satisfaction and discharge of this Indenture. When the Trustee incurs expenses or renders services after an Event of Default specified in Section 6.01(e) or (f) hereof occurs, the expenses and the compensation for the services (including the fees and expenses of its agents and counsel) are intended to constitute expenses of administration under any Bankruptcy Law. The Trustee shall comply with the provisions of TIA 'SS' 313(b)(2) to the extent applicable. Section 7.08 Replacement of Trustee. A resignation or removal of the Trustee and appointment of a successor Trustee shall become effective only upon the successor Trustee's acceptance of appointment as provided in this Section 7.08. The Trustee may resign in writing at any time and be discharged from the trust hereby created by so notifying the Company. The Holders of a majority in principal amount of the then outstanding Securities of any series may remove the Trustee by so notifying the Trustee and the Company in writing. The Company may remove the Trustee if: (a) the Trustee fails to comply with Section 7.10 hereof; 28 (b) the Trustee is adjudged a bankrupt or an insolvent or an order for relief is entered with respect to the Trustee under any Bankruptcy Law; (c) a custodian or public officer takes charge of the Trustee or its property; or (d) the Trustee becomes incapable of acting. If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any reason, the Company shall promptly appoint a successor Trustee. Within one year after the successor Trustee takes office, the Holders of a majority in principal amount of the then outstanding Securities of any series may appoint a successor Trustee to replace the successor Trustee appointed by the Company. If a successor Trustee does not take office within 60 days after the retiring Trustee resigns or is removed, the retiring Trustee, the Company, or the Holders of at least 10% in principal amount of the then outstanding Securities of any series may petition any court of competent jurisdiction for the appointment of a successor Trustee. If the Trustee, after written request by any Holder who has been a Holder for at least six months, fails to comply with Section 7.10 hereof, such Holder may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Thereupon, the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee under this Indenture. The successor Trustee shall mail a notice of its succession to Holders. The retiring Trustee shall promptly transfer all property held by it as Trustee to the successor Trustee, provided all sums owing to the Trustee hereunder have been paid and subject to the Lien provided for in Section 7.07 hereof. Notwithstanding replacement of the Trustee pursuant to this Section 7.08, the Company's obligations under Section 7.07 hereof shall continue for the benefit of the retiring Trustee. Section 7.09 Successor Trustee by Merger, etc. If the Trustee consolidates, merges or converts into, or transfers all or substantially all of its corporate trust business to, another corporation, the successor corporation without any further act shall be the successor Trustee. Section 7.10 Eligibility; Disqualification. There shall at all times be a Trustee hereunder that is a corporation organized and doing business under the laws of the United States of America or of any state thereof that is authorized under such laws to exercise corporate trustee power, that is subject to supervision or examination by federal or state authorities and that has a combined capital and surplus of at least $100 million as set forth in its most recent published annual report of condition. This Indenture shall always have a Trustee who satisfies the requirements of TIA 'SS''SS' 310(a)(1), (2) and (5). The Trustee is subject to TIA 'SS' 310(b). 29 Section 7.11 Preferential Collection of Claims Against Company. The Trustee is subject to TIA 'SS' 311(a), excluding any creditor relationship listed in TIA 'SS' 311(b). A Trustee who has resigned or been removed shall be subject to TIA 'SS' 311(a) to the extent indicated therein. ARTICLE 8. LEGAL DEFEASANCE AND COVENANT DEFEASANCE Section 8.01 Option to Effect Legal Defeasance or Covenant Defeasance. Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to Securities of a particular series, the Company may elect, at its option, at any time, to have either Section 8.02 or 8.03 hereof be applied to all outstanding Securities of any series designated pursuant to Section 2.03(a) hereof as being defeasible (the "Defeased Securities") in accordance with any additional requirements provided pursuant to Section 2.03(a) hereof and upon compliance with the conditions set forth below in this Article 8. Any such election shall be evidenced by a Board Resolution set forth in an Officers' Certificate or in another manner specified as contemplated by Section 2.03(a) hereof for such Securities. Section 8.02 Legal Defeasance and Discharge. Upon the Company's exercise under Section 8.01 hereof of the option (if any) to have this Section 8.02 applied to any Securities of any series, the Company shall, subject to the satisfaction of the conditions set forth in Section 8.04 hereof, be deemed to have been discharged from its obligations with respect to all outstanding Defeased Securities on the date the conditions set forth below are satisfied (hereinafter, "Legal Defeasance"). For this purpose, Legal Defeasance means that the Company shall be deemed to have paid and discharged the entire Indebtedness represented by the outstanding Defeased Securities, which shall thereafter be deemed to be "outstanding" only for the purposes of Section 8.05 hereof and the other Sections of this Indenture referred to in (a) and (b) below, and to have satisfied all its other obligations under such Defeased Securities and this Indenture (and the Trustee, on demand of and at the expense of the Company, shall execute proper instruments acknowledging the same), except for the following provisions which shall survive until otherwise terminated or discharged hereunder: (a) the rights of Holders of outstanding Defeased Securities to receive solely from the trust fund under Section 8.04 hereof, and as more fully set forth in such Section, payments in respect of the principal of, premium, if any, and interest on such Defeased Securities when such payments are due, (b) the Company's obligations with respect to such Defeased Securities under Article 2 and Section 4.01 hereof, (c) the rights, powers, trusts, duties and immunities of the Trustee hereunder and the Company's obligations in connection therewith and (d) this Article 8. Subject to compliance with this Article 8, the Company may exercise its option under this Section 8.02 notwithstanding the prior exercise of its option under Section 8.03 hereof. Section 8.03 Covenant Defeasance. Upon the Company's exercise under Section 8.01 hereof of the option (if any) to have this Section 8.03 applied to any Securities of any series the Company and, if applicable, each Guarantor shall, subject to the satisfaction of the conditions set forth in Section 8.04 hereof, be released from its obligations under Sections 4.03, 4.05 and 4.06 hereof and Articles 5 and 12 hereof and such other provisions as may be provided as contemplated by Section 2.03(a) hereof with respect to Securities of a particular series and with respect to the outstanding Defeased Securities on and after the date the conditions set forth in Section 8.04 hereof are satisfied (hereinafter, "Covenant Defeasance"), and the Defeased Securities shall thereafter be deemed not "outstanding" for the purposes of any direction, 30 waiver, consent or declaration or act of Holders of such Defeased Securities (and the consequences of any thereof) in connection with such covenants, but shall continue to be deemed "outstanding" for all other purposes hereunder (it being understood that such Defeased Securities shall not be deemed outstanding for accounting purposes). For this purpose, Covenant Defeasance means that, with respect to the outstanding Defeased Securities, the Company and, if applicable, each Guarantor may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth in any such covenant, whether directly or indirectly, by reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other document and such omission to comply shall not constitute a Default or an Event of Default under Section 6.01 hereof, but, except as specified above, the remainder of this Indenture and such Defeased Securities shall be unaffected thereby. In addition, upon the Company's exercise under Section 8.01 hereof of the option applicable to this Section 8.03 hereof, subject to the satisfaction of the conditions set forth in Section 8.04 hereof and Sections 6.01(c), (d) and (g) hereof shall not constitute Events of Default. Section 8.04 Conditions to Legal or Covenant Defeasance. The following shall be the conditions to the application of either Section 8.02 or 8.03 hereof to a series of outstanding Securities: Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to any series of Securities, in order to exercise either Legal Defeasance or Covenant Defeasance: (a) the Company must irrevocably deposit with the Trustee, in trust, for the benefit of the Holders, cash, non-callable Government Securities, or a combination thereof, in such amounts as will be sufficient to pay the principal of, premium, if any, and interest on the outstanding Securities of such series on the stated date for payment thereof or on the applicable redemption date, as the case may be; (b) in the case of an election under Section 8.02 hereof, the Company shall have delivered to the Trustee an Opinion of Counsel confirming that (A) the Company has received from, or there has been published by, the Internal Revenue Service a ruling or (B) since the date this Indenture was first executed, there has been a change in the applicable federal income tax law, in either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, the Holders of the outstanding Securities of such series will not recognize income, gain or loss for federal income tax purposes as a result of such Legal Defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not occurred; and (c) in the case of an election under Section 8.03 hereof, the Company shall have delivered to the Trustee an Opinion of Counsel confirming that the Holders of the outstanding Securities of such series will not recognize income, gain or loss for federal income tax purposes as a result of such Covenant Defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Covenant Defeasance had not occurred. Section 8.05 Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous Provisions. Subject to Section 8.06 hereof, all money and non-callable Government Securities (including the proceeds thereof) deposited with the Trustee (or other qualifying trustee, collectively for purposes of this Section 8.05, the "Trustee") pursuant to Section 8.04 hereof in respect of the outstanding Defeased Securities shall be held in trust and applied by the Trustee, in accordance with the provisions of such Defeased Securities and this Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as Paying Agent) as the Trustee may determine, to the Holders of such 31 Defeased Securities of all sums due and to become due thereon in respect of principal, premium, if any, and interest, but such money need not be segregated from other funds except to the extent required by law. The Company shall pay and indemnify the Trustee against any tax, fee or other charge imposed on or assessed against the cash or non-callable Government Securities deposited pursuant to Section 8.04 hereof or the principal and interest received in respect thereof other than any such tax, fee or other charge which by law is for the account of the Holders of the outstanding Defeased Securities. Anything in this Article 8 to the contrary notwithstanding, the Trustee shall deliver or pay to the Company from time to time upon the request of the Company any money or non-callable Government Securities held by it as provided in Section 8.04 hereof which in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee are in excess of the amount thereof that would then be required to be deposited to effect an equivalent Legal Defeasance or Covenant Defeasance. Section 8.06 Repayment to Company. Any money deposited with the Trustee or any Paying Agent, or then held by the Company, in trust for the payment of the principal of, premium, if any, or interest on any Securities of a series and remaining unclaimed for two years after such principal, and premium, if any, or interest has become due and payable shall be paid to the Company on its request or (if then held by the Company) shall be discharged from such trust; and the Holder of such series of Securities shall thereafter look only to the Company for payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust money, and all liability of the Company as trustee thereof, shall thereupon cease; provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment, may at the expense of the Company cause to be published once, in The New York Times and The Wall Street Journal (national edition), notice that such money remains unclaimed and that, after a date specified therein, which shall not be less than 30 days from the date of such notification or publication, any unclaimed balance of such money then remaining will be repaid to the Company. Section 8.07 Reinstatement. If the Trustee or Paying Agent is unable to apply any cash or non-callable Government Securities in accordance with Section 8.02 or 8.03 hereof, as the case may be, by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, then the Company's obligations under this Indenture and the Defeased Securities shall be revived and reinstated as though no deposit had occurred pursuant to Section 8.02 or 8.03 hereof until such time as the Trustee or Paying Agent is permitted to apply all such money in accordance with Section 8.02 or 8.03 hereof, as the case may be; provided, however, that, if the Company makes any payment of principal of, premium, if any, or interest on any Defeased Securities following the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Defeased Securities to receive such payment from the money held by the Trustee or Paying Agent. 32 ARTICLE 9. AMENDMENT, SUPPLEMENT AND WAIVER Section 9.01 Without Consent of Holders of Securities. Notwithstanding Section 9.02 hereof, the Company, the Guarantors, if any, and the Trustee at any time and from time to time may amend this Indenture or enter into one or more indentures supplemental hereto without the consent of any Holder of a Security for any of the following purposes: (a) to cure any ambiguity, defect or inconsistency; (b) to provide for uncertificated Securities in addition to or in place of certificated Securities in a manner that does not materially adversely affect any Holder; (c) to provide for the assumption of the Company's or, if applicable, a Guarantor's obligations to the Holders of the Securities or a series by a successor pursuant to Article 5 or 11 hereof; (d) to make any change that would provide any additional rights or benefits to the Holders or that does not adversely affect the legal rights hereunder of any Holder; (e) to comply with requirements of the SEC in order to effect or maintain the qualification of this Indenture under the TIA; (f) to add a Guarantor with respect to Securities of any series; (g) to evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to the Securities of one or more series and to add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee, pursuant to the requirements of Section 7.08 hereof; (h) to mortgage, pledge, hypothecate or grant a security interest in favor of the Trustee for the benefit of the Holders of Securities of any series as additional security for the payment and performance of the Company's or, if applicable, a Guarantor's obligations herein in any property or assets; (i) to add to, change or eliminate any of the provisions of this Indenture (which addition, change or elimination may apply to one or more series of Securities), provided that, any such addition, change or elimination (A) shall neither (i) apply to any Security of any series created prior to the execution of such supplemental indenture and entitled to the benefit of such provision nor (ii) modify the rights of the Holder of any such Security with respect to such provision or (B) shall become effective only when there is no such outstanding Security; or (j) to establish the form and terms of Securities of any series permitted by Sections 2.01 and 2.03(a) hereof, respectively. Upon the request of the Company accompanied by a Board Resolution authorizing the execution of any such amended or supplemental Indenture, and upon receipt by the Trustee of the documents described in Section 7.02 hereof, the Trustee shall join with the Company and, if applicable, the Guarantors in the execution of any amended or supplemental Indenture authorized or permitted by the terms of this Indenture and to make any further appropriate agreements and stipulations that may be 33 therein contained, but the Trustee shall not be obligated to enter into such amended or supplemental Indenture that affects its own rights, duties or immunities under this Indenture or otherwise. Section 9.02 With Consent of Holders of Securities. Except as provided below in this Section 9.02, the Company and the Trustee may amend this Indenture or the Securities of any series with the consent of the Holders of at least a majority in principal amount of the Securities of such series then outstanding voting as a single class (including consents obtained in connection with a tender offer or exchange offer for, or purchase of, such Securities), and, subject to Sections 6.04 and 6.07 hereof, any existing Default or Event of Default with respect to a particular series of Securities (other than a Default or Event of Default in the payment of the principal of, premium, if any, or interest on such Securities, except a payment default resulting from an acceleration that has been rescinded) or compliance with any provision of this Indenture or such Securities may be waived with the consent of the Holders of a majority in principal amount of the then outstanding Securities of such series voting as a single class (including consents obtained in connection with a tender offer or exchange offer for, or purchase of, such Securities). Upon the request of the Company accompanied by a Board Resolution authorizing the execution of any such amended or supplemental Indenture, and upon the filing with the Trustee of evidence satisfactory to the Trustee of the consent of the Holders of Securities as aforesaid, and upon receipt by the Trustee of the documents described in Section 7.02 hereof, the Trustee shall join with the Company and, if applicable, the Guarantors in the execution of such amended or supplemental Indenture unless such amended or supplemental Indenture directly affects the Trustee's own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such amended or supplemental Indenture. It shall not be necessary for the consent of the Holders of Securities under this Section 9.02 to approve the particular form of any proposed amendment or waiver, but it shall be sufficient if such consent approves the substance thereof. After an amendment, supplement or waiver under this Section 9.02 becomes effective, the Company shall mail to the Holders of Securities affected thereby a notice briefly describing the amendment, supplement or waiver. Any failure of the Company to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such amended or supplemental indenture or waiver. Subject to Sections 6.04 and 6.07 hereof and except as otherwise provided below in this Section 9.02, the Holders of a majority in aggregate principal amount of the Securities of any series then outstanding voting as a single class may waive compliance in a particular instance by the Company with any provision of this Indenture or the Securities of such series. However, without the consent of each Holder affected, an amendment or waiver under this Section 9.02 may not (with respect to any Securities of such series held by a non-consenting Holder): (a) change the Stated Maturity of, the principal of, or any installment of principal or interest on, any such Security, or reduce the principal amount thereof or the rate of interest thereon or any premium payable upon redemption thereof or reduce the amount of principal of or premium, if any, on any such Discount Security that would be due and payable upon a declaration of acceleration of maturity thereof pursuant to Section 6.02 hereof, or change the place of payment where, or change the coin or currency in which, any principal of, or any installment of interest on, any such Security is payable, or impair the right to institute suit for the enforcement of any such payment on or after the Stated Maturity thereof (or, in the case of redemption, on or after the Redemption Date); 34 (b) reduce the percentage in principal amount of the outstanding Securities of any series, the consent of whose Holders is required for any such amendment or supplemental indenture, or the consent of whose Holders is required for any waiver (of compliance with certain provisions of this Indenture or certain defaults hereunder and their consequences) with respect to the Securities of such series provided for in this Indenture; (c) modify any of the provisions of this Section 9.02 or Section 6.04 or 6.07 hereof, except to increase the percentage of outstanding Securities of such series required for such actions to provide that certain other provisions of this Indenture cannot be modified or waived without the consent of the Holder of each outstanding Security of a series affected thereby; (d) release any applicable Guarantor from any of its obligations under its Security Guarantee or this Indenture, except in accordance with the terms of this Indenture; or (e) change such other matters as may be specified pursuant to Section 2.03(a) hereof. Section 9.03 Compliance with Trust Indenture Act. Every amendment or supplement to this Indenture or the Securities of any series shall be set forth in a amended or supplemental Indenture that complies with the TIA as then in effect. Section 9.04 Revocation and Effect of Consents. Until an amendment, supplement or waiver becomes effective, a consent to it by a Holder of a Security is a continuing consent by the Holder of a Security and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting Holder's Security, even if notation of the consent is not made on any Security. However, any such Holder of a Security or subsequent Holder of a Security may revoke the consent as to its Securities if the Trustee receives written notice of revocation before the date the waiver, supplement or amendment becomes effective. An amendment, supplement or waiver becomes effective in accordance with its terms and thereafter binds every Holder. Section 9.05 Notation on or Exchange of Securities. The Trustee may place an appropriate notation about an amendment, supplement or waiver on any Security of a series thereafter authenticated. The Company in exchange for all Securities of a series may issue and the Trustee shall, upon receipt of a Company Order, authenticate new Securities of such series that reflect the amendment, supplement or waiver. Failure to make the appropriate notation or issue a new Security shall not affect the validity and effect of such amendment, supplement or waiver. Section 9.06 Trustee to Sign Amendments, etc. The Trustee shall sign any amended or supplemental Indenture authorized pursuant to this Article 9 if the amendment or supplement does not adversely affect the rights, duties, liabilities or immunities of the Trustee. The Company may not sign an amendment or supplemental Indenture until the Board of Directors approves it. In executing any amended or supplemental indenture, the Trustee shall be entitled to receive and (subject to Section 7.01 hereof) shall be fully protected in relying upon, in addition to the documents required by Section 13.04 hereof, an Officers' Certificate and an Opinion of Counsel stating that the execution of such amended or supplemental indenture is authorized or permitted by this Indenture. 35 Section 9.07 Effect of Supplemental Indentures. Upon the execution of any supplemental indenture under this Article 9, this Indenture shall be modified in accordance therewith, and such supplemental indenture shall form a part of this Indenture for all purposes; and every Holder of Securities theretofore or thereafter authenticated and delivered hereunder shall be bound thereby, except to the extent otherwise set forth thereon. ARTICLE 10. SINKING FUNDS Section 10.01 Applicability of Article. The provisions of this Article 10 shall be applicable to any sinking fund for the retirement of Securities of a series, except as otherwise specified as contemplated by Section 2.03(a) hereof for Securities of such series. The minimum amount of any sinking fund payment provided for by the terms of Securities of any series is herein referred to as a "Mandatory Sinking Fund Payment," and any payment in excess of such minimum amount provided for by the terms of Securities of any series is herein referred to as an "Optional Sinking Fund Payment." If provided for by the terms of Securities of any series, the cash amount of any sinking fund payment may be subject to reduction as provided in Section 10.02 hereof. Each sinking fund payment shall be applied to the redemption of Securities of any series as provided for by the terms of the Securities of such series. Section 10.02 Satisfaction of Sinking Fund Payments with Securities. The Company (a) may deliver outstanding Securities of a series with the same issue date, interest rate and Stated Maturity (other than any previously called for redemption) and (b) may apply as a credit Securities of a series with the same issue date, interest rate and Stated Maturity which have been redeemed either at the election of the Company pursuant to the terms of such Securities or through the application of permitted optional sinking fund payments pursuant to the terms of such Securities, in each case in satisfaction of all or any part of any mandatory sinking fund payment with respect to the Securities of such series with the same issue date, interest rate and Stated Maturity; provided, that such Securities have not been previously so credited. Such Securities shall be received and credited for such purpose by the Trustee at the Redemption Price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly. Section 10.03 Redemption of Securities for Sinking Fund. Not less than 60 days (or such shorter period as shall be acceptable to the Trustee) prior to each sinking fund payment date for any series of Securities, the Company will deliver to the Trustee an Officers' Certificate specifying the amount of the next ensuing sinking fund payment for that series pursuant to the terms of that series, the portion thereof, if any, which is to be satisfied by payment of cash and the portion thereof, if any, which is to be satisfied by delivering and crediting Securities of that series pursuant to Section 10.02 hereof and will also deliver to the Trustee any Securities to be so delivered. Not less than 30 days before each such sinking fund payment date the Trustee shall select the Securities to be redeemed upon such sinking fund payment date in the manner specified in Section 3.02 hereof and cause notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided in Section 3.03 hereof. Such notice having been duly given, the redemption of such Securities shall be made upon the terms and in the manner stated in Sections 3.04 and 3.06 hereof. 36 ARTICLE 11. SECURITY GUARANTEES Section 11.01 Applicability of this Article. Except as otherwise specified as contemplated by Section 2.03(a) hereof, the provisions of this Article 11 will be applicable to any series of Securities which is to be guaranteed by one or more Guarantors. Section 11.02 Guarantee Subject to this Article 11, each of the Guarantors hereby, jointly and severally, unconditionally guarantees to each Holder of Securities of a particular series as to which it is a Guarantor authenticated and delivered by the Trustee and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of this Indenture, the Securities of such series or the obligations of the Company hereunder or thereunder, that: (a) the principal of, premium, if any, and interest on the Securities of such series will be promptly paid in full when due, whether at maturity, by acceleration, redemption or otherwise, and interest on the overdue principal of and premium, if any, and interest on the Securities of such series, if any, if lawful, and all other obligations of the Company to the Holders or the Trustee hereunder or thereunder will be promptly paid in full or performed, all in accordance with the terms hereof and thereof; and (b) in case of any extension of time of payment or renewal of any Securities of such series or any of such other obligations, that same will be promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at stated maturity, by acceleration or otherwise. Failing payment when due of any amount so guaranteed or any performance so guaranteed for whatever reason, the Guarantors shall be jointly and severally obligated to pay the same immediately. Each Guarantor agrees that this is a guarantee of payment and not a guarantee of collection. Subject to this Article 11, the Guarantors hereby, jointly and severally, agree that their obligations hereunder shall be unconditional, irrespective of the validity, regularity or enforceability of the Securities of a series or this Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder of the Securities of such series with respect to any provisions hereof or thereof, the recovery of any judgment against the Company, any action to enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a guarantor. Each Guarantor hereby waives diligence, presentment, demand of payment, filing of claims with a court in the event of insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, protest, notice and all demands whatsoever and covenant that this Security Guarantee shall not be discharged except by complete performance of the obligations contained in the Securities of such series and this Indenture. If any Holder or the Trustee is required by any court or otherwise to return to the Company, the Guarantors or any custodian, trustee, liquidator or other similar official acting in relation to either the Company or the Guarantors, any amount paid by either to the Trustee or such Holder, this Security Guarantee, to the extent theretofore discharged, shall be reinstated in full force and effect. Each Guarantor agrees that it shall not be entitled to any right of subrogation in relation to the Holders in respect of any obligations guaranteed hereby until payment in full of all obligations guaranteed hereby. Each Guarantor further agrees that, as between the Guarantors, on the one hand, and the Holders and the Trustee, on the other hand, (x) the maturity of the obligations guaranteed hereby may be accelerated as provided in Article 6 hereof for the purposes of this Security Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of the obligations guaranteed hereby, and (y) in the event of any declaration of acceleration of such obligations as provided 37 in Article 6 hereof, such obligations (whether or not due and payable) shall forthwith become due and payable by the Guarantors for the purpose of this Security Guarantee. The Guarantors shall have the right to seek contribution from any non-paying Guarantor so long as the exercise of such right does not impair the rights of the Holders under the Security Guarantee. Section 11.03 Limitation on Guarantor Liability. Each Guarantor, and by its acceptance of Securities of a series, each Holder, hereby confirms that it is the intention of all such parties that the Security Guarantee of such Guarantor not constitute a fraudulent transfer or conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to any Security Guarantee. To effectuate the foregoing intention, the Trustee, the Holders and the Guarantors hereby irrevocably agree that the obligations of such Guarantor shall be limited to the maximum amount as will, after giving effect to all other contingent and fixed liabilities of such Guarantor that are relevant under such laws, and after giving effect to any collections from, rights to receive contribution from or payments made by or on behalf of any other Guarantor in respect of the obligations of such other Guarantor under this Article 11, result in the obligations of such Guarantor under its Security Guarantee not constituting a fraudulent transfer or conveyance. Section 11.04 Release of Guarantors. The Security Guarantee of a Guarantor with respect to any series of Securities will be released under the circumstances specified for such series of Securities pursuant to Section 2.03(a) hereof. ARTICLE 12. SATISFACTION AND DISCHARGE Section 12.01 Satisfaction and Discharge. Except as otherwise contemplated by 2.03(a) hereof, this Indenture will cease to be of further effect with respect to any series of Securities specified by the Company, and the Trustee, at the expense of the Company, will execute proper instruments acknowledging satisfaction and discharge of this Indenture as to such series when: (a) either: (i) all Securities of such series that have been authenticated (except lost, stolen or destroyed Securities of such series that have been replaced or paid and Securities of such series for whose payment money has theretofore been deposited in trust and thereafter repaid to the Company) have been delivered to the Trustee for cancellation; or (ii) all Securities of such series that have not been delivered to the Trustee for cancellation have become due and payable by reason of the mailing of a notice of redemption or otherwise or will become due and payable within one year and the Company or, if applicable, any Guarantor has irrevocably deposited or caused to be deposited with the Trustee as trust funds in trust solely for the benefit of the Holders, cash, non-callable Government Securities, or a combination thereof, in such amounts as will be sufficient without consideration of any reinvestment of interest, to pay and discharge the entire indebtedness on the such Securities not delivered to the Trustee for cancellation for principal, premium, if any, and accrued interest to the date of maturity or redemption; 38 (b) the Company or, if applicable, any Guarantor has paid or caused to be paid all sums payable by it under this Indenture; and (c) the Company or, if applicable, any Guarantor has delivered an Officers' Certificate and an Opinion of Counsel to the Trustee stating that all conditions precedent to satisfaction and discharge have been satisfied or waived. Notwithstanding the satisfaction and discharge of this Indenture, if money shall have been deposited with the Trustee pursuant to subclause (ii) of clause (a) of this Section 12.01, the provisions of Sections 12.02 and 8.06 hereof shall survive. Section 12.02 Application of Trust Money. Subject to the provisions of Section 8.06 hereof, all money deposited with the Trustee pursuant to Section 12.01 hereof shall be held in trust and applied by it, in accordance with the provisions of the Securities of a series and this Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as its own Paying Agent) as the Trustee may determine, to the Persons entitled thereto, of the principal (and premium, if any) and interest for whose payment such money has been deposited with the Trustee; but such money need not be segregated from other funds except to the extent required by law. If the Trustee or Paying Agent is unable to apply any money or Government Securities in accordance with Section 12.01 hereof by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company's obligations and, if applicable, any Guarantor's obligations under this Indenture and the Securities of such series shall be revived and reinstated as though no deposit had occurred pursuant to Section 11.01 hereof; provided that if the Company has made any payment of principal of, premium, if any, or interest on any Securities of such series because of the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of Securities of such series to receive such payment from the money or Government Securities held by the Trustee or Paying Agent. ARTICLE 13. MISCELLANEOUS Section 13.01 Trust Indenture Act Controls. If any provision of this Indenture limits, qualifies or conflicts with the duties imposed by TIA Section 318(c), the imposed duties shall control. If any provision of this Indenture modifies or excludes any provision of the TIA that may be so modified or excluded, the latter provision shall be deemed to apply to this Indenture as so modified or excluded, as the case may be. Section 13.02 Notices. Any notice or communication by the Company, any Guarantor or the Trustee to the others is duly given if in writing and delivered in Person or mailed by first class mail (registered or certified, return receipt requested), telex, telecopier or overnight air courier guaranteeing next day delivery, to the others' address: 39 If to the Company and/or any Guarantor: Omnicare, Inc. 100 East RiverCenter Boulevard Covington, Kentucky 41011 Telecopier No.: (859) 392-3360 Attention: General Counsel With a copy to: Dewey Ballantine LLP 1301 Avenue of the Americas New York, New York 10019 Telecopier No.: (212) 259-6333 Attention: Morton A. Pierce, Esq. If to the Trustee: [_____________] [_____________] [_____________] [_____________] Telecopier No.: [_____________] Attention: [_____________] The Company, any Guarantor or the Trustee, by notice to the others may designate additional or different addresses for subsequent notices or communications. Any notice or communication to a Holder shall be mailed by first class mail, certified or registered, return receipt requested, or by overnight air courier guaranteeing next day delivery to its address shown on the register kept by the Registrar. Any notice or communication also shall be so mailed to any Person described in TIA 'SS' 313(c), to the extent required by the TIA. Failure to mail a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders. If the Company mails a notice or communication to Holders, it shall mail a copy to the Trustee and each Agent at the same time. Section 13.03 Communication by Holders of Securities with Other Holders of Securities. Holders may communicate pursuant to TIA 'SS' 312(b) with other Holders with respect to their rights under this Indenture or the Securities. The Company, the Trustee, the Registrar and anyone else shall have the protection of TIA 'SS' 312(c). Section 13.04 Certificate and Opinion as to Conditions Precedent. Upon any request or application by the Company to the Trustee to take any action under this Indenture, the Company shall furnish to the Trustee: (a) an Officers' Certificate in form and substance reasonably satisfactory to the Trustee (which shall include the statements set forth in Section 13.05 hereof) stating that, in the opinion of the signers, all conditions precedent and covenants, if any, provided for in this Indenture relating to the proposed action have been satisfied or waived; and 40 (b) an Opinion of Counsel in form and substance reasonably satisfactory to the Trustee (which shall include the statements set forth in Section 13.05 hereof) stating that, in the opinion of such counsel, all such conditions precedent and covenants have been satisfied or waived. Section 13.05 Statements Required in Certificate or Opinion. Each certificate or opinion with respect to compliance with a condition or covenant provided for in this Indenture (other than a certificate provided pursuant to TIA 'SS' 314(a)(4)) shall comply with the provisions of TIA 'SS' 314(e) and shall include: (a) a statement that the Person making such certificate or opinion has read such covenant or condition; (b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; (c) a statement that, in the opinion of such Person, he or she has made such examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been satisfied or waived; and (d) a statement as to whether or not, in the opinion of such Person, such condition or covenant has been satisfied or waived. In any case where several matters are required to be certified by, or covered by an opinion of, any specified Person, it is not necessary that all such matters be certified by, or covered by the opinion of, only one such Person, or that they be so certified or covered by only one document, but one such Person may certify or give an opinion with respect to some matters and one or more other such Persons as to other matters, and any such Person may certify or give an opinion as to such matters in one or several documents. Any certificate or opinion of an Officer of the Company may be based insofar as it relates to legal matters, upon a certificate or opinion of, or representations by, counsel, unless such Officer knows, or in the exercise of reasonable care should know, that the certificate or opinion or representations with respect to the matters upon which his certificate or opinion or representations is based are erroneous. Any such certificate or opinion of counsel may be based, insofar as it relates to factual matters, upon a certificate or opinion of, or representations by, an officer or officers of the Company stating that the information with respect to such factual matters is in the possession of the Company, unless such counsel knows, or in the exercise of reasonable care should know, that the certificate or opinion or representations with respect to such matters are erroneous. Where any Person is required to make, give or execute two or more applications, requests, consents, certificates, statements, opinions or other instruments under this Indenture, they may, but need not, be consolidated and form one instrument. Section 13.06 Rules by Trustee and Agents. The Trustee may make reasonable rules for action by or at a meeting of Holders. The Registrar or Paying Agent may make reasonable rules and set reasonable requirements for its functions. 41 Section 13.07 No Personal Liability of Directors, Officers, Employees and Stockholders. No past, present or future director, officer, employee, incorporator or stockholder of the Company or any Guarantor, as such, shall have any liability for any obligations of the Company or such Guarantor under the Securities, the Security Guarantees, this Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting a Security waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Securities. Section 13.08 Governing Law. THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS INDENTURE AND THE SECURITIES, WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY. Section 13.09 No Adverse Interpretation of Other Agreements. This Indenture may not be used to interpret any other indenture, loan or debt agreement of the Company or its Subsidiaries or of any other Person. Any such indenture, loan or debt agreement may not be used to interpret this Indenture. Section 13.10 Successors. All agreements of the Company in this Indenture and the Securities shall bind its successors. All agreements of the Trustee in this Indenture shall bind its successors. All agreements of each applicable Guarantor in this Indenture shall bind its successors, except as otherwise provided pursuant to Section 12.05 hereof. Section 13.11 Severability. In case any provision in this Indenture or in the Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. Section 13.12 Counterpart Originals. The parties may sign any number of copies of this Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. Section 13.13 Table of Contents, Headings, etc. The Table of Contents, Cross-Reference Table and Headings of the Articles and Sections of this Indenture have been inserted for convenience of reference only, are not to be considered a part of this Indenture and shall in no way modify or restrict any of the terms or provisions hereof. [Signatures on following page] 42 SIGNATURES Dated as of [__________] OMNICARE, INC. By: ------------------------------------ Name: Title: Attest: - -------------------------------- Name: Title: [______________] By: ------------------------------------ Name: Title: Attest - -------------------------------- Authorized Signatory Date: 43 EXHIBIT A [Face of Security] - -------------------------------------------------------------------------------- CUSIP ____________ [TITLE OF SECURITIES] No. ___ $____________ OMNICARE, INC. promises to pay to ______________________________________ or registered assigns, the principal sum of __________________________________________________________ Interest Payment Dates [_________] and [__________], commencing on [__________] Record Dates: [___________] and [____________] Dated: _______________, ____ OMNICARE, INC. By: ------------------------------------ Name: Title: By: ------------------------------------ Name: Title: This is one of the Securities referred to in the within-mentioned Indenture: [______________], as Trustee By: -------------------------------------- Authorized Signatory - -------------------------------------------------------------------------------- A-1 [Back of Security] [TITLE OF SECURITIES] [Insert the Global Security Legend, if applicable pursuant to the provisions of this Indenture] [Insert any legend required by the Internal Revenue Code and the regulations thereunder] Capitalized terms used herein shall have the meanings assigned to them in this Indenture referred to below unless otherwise indicated. 1. Interest. Omnicare, Inc., a Delaware corporation (herein the "Company" which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to _____________________, or registered assigns, the principal sum of _________ [Dollars] [if other than Dollars, substitute other currency units] on ________, _____ [if the Security is to bear interest prior to Stated Maturity, insert -- , and to pay interest thereon from _______________ or from the most recent Interest Payment Date to which interest has been paid or duly provided for], [semiannually] [if other than semi-annual interest at a fixed rate, insert frequency of payment and payment dates] on _______ and _______ in each year, commencing ___________, and at the Stated Maturity thereof, at [if the Security is to bear interest at a fixed rate, insert -- the rate of __% per annum], [if the Security is to bear interest at a rate determined with reference to one or more formula, refer to description index below] until the principal hereof is paid or made available for payment] [if applicable, insert -- , and (to the extent that the payment of such interest shall be legally enforceable) at [if the Security is to bear interest at a fixed rate, insert -- the rate of % per annum on any overdue principal and premium and on any overdue installment of interest from the dates such amounts are due until they are paid or made available for payment]. Interest shall be computed on the basis of [a 360-day year of twelve 30-day months] [if another basis of calculating interest is to be different, insert a description of such method.] 2. Method of Payment. The Company will pay interest on the Securities on each [__________] and [__________] to the Persons who are registered Holders of the relevant Securities at the close of business on the [__________] or [__________] next preceding the Interest Payment Date, even if such Securities are canceled after such record date and on or before such Interest Payment Date, except as provided in Section 2.14 of this Indenture with respect to Defaulted Interest. The Securities will be payable as to principal, premium, if any, and interest at the office or agency of the Company maintained for such purpose in [__________], [if applicable, insert --; provided, however, that at the option of the Company payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the list provided by the Company to the Registrar and provided, further, that if this Security is a Global Security, payment may be made pursuant to the applicable procedures of the Depositary as permitted in said Indenture]. Such payment shall be in such coin or currency of [the United States of America] [insert other currency or currency unit, if applicable] as at the time of payment is legal tender for payment of public and private debts. 3. Paying Agent and Registrar. Initially, the Trustee under this Indenture, will act as Paying Agent and Registrar. The Company may change any Paying Agent or Registrar without notice to any Holder. The Company or any of its Subsidiaries may act in any such capacity. A-2 4. Indenture. This Security is one of a duly authorized issue of Securities of the Company issued and to be issued in one or more series under an Indenture, dated as of ________, _____ (herein called the "Indenture"), between the Company and _______________, as Trustee (herein called the "Trustee" which term includes any successor trustee under the Indenture), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered. The terms of the Securities include those stated in this Indenture and those made part of this Indenture by reference to the Trust Indenture Act of 1939, as amended (15 U.S. Code 'SS' 77aaa-77bbbb). The Securities are subject to all such terms, and Holders are referred to this Indenture and such Act for a statement of such terms. To the extent any provision of this Security conflicts with the express provisions of this Indenture, the provisions of this Indenture shall govern and be controlling. 5. Redemption. [If applicable, insert -- The Securities of this series are subject to redemption upon not less than 30 days notice by mail, [if applicable, insert -- (1) on _________ in any year commencing with the year _____ and ending with the year _____ through operation of the sinking fund for this series at a Redemption Price equal to 100% of the principal amount, and (2)] at any time [if applicable, insert -- on or after ________, _____], as a whole or in part, at the election of the Company, at the following Redemption Prices (expressed as percentages of the principal amount): if redeemed [if applicable insert -- on or before ________, ___%, and if redeemed] during the 12-month period beginning of the ________ years indicated, Year Redemption Price Year Redemption Price and thereafter at a Redemption Price equal to ______% of the principal amount, together in the case of any such redemption [if applicable, insert -- (whether through operation of the sinking fund or otherwise)] with accrued interest to the Redemption Date, but interest installments whose Stated Maturity is on or prior to such Redemption Date will be payable to the Holders of such Securities, or one or more Predecessor Securities, of record at the close of business on the relevant Record Dates referred to on the face hereof, all as provided in the Indenture.] [If applicable, insert -- The Securities of this series are subject to redemption upon not less than 30 days notice by mail, (1) on ________ in any year commencing with the year _____ and ending with the year _____ through operation of the sinking fund for this series at the Redemption Prices for redemption through operation of the sinking fund (expressed as percentages of the principal amount) set forth in the table below, and (2) at any time [if applicable, insert -- on or after ____________], as a whole or in part, at the election of the Company, at the Redemption Prices for redemption otherwise than through operation of the sinking fund (expressed as percentages of the principal amount) set forth in the table below: If redeemed during the 12-month period beginning ___________ of the years indicated, Redemption Price for Redemption Redemption Price for Redemption Otherwise Than Through Operation of the Year Through Operation of the Sinking Fund Sinking Fund ---- ------------------------------------- ---------------------------------------
A-3 and thereafter at a Redemption Price equal to ___% of the principal amount, together in the case of any such redemption (whether through operation of the sinking fund or otherwise) with accrued interest to the Redemption Date, but interest installments whose Stated Maturity is on or prior to such Redemption Date will be payable to the Holders of such securities, or one or more Predecessor Securities, of record at the close of business on the relevant Record Date referred to on the face hereof, all as provided in the Indenture.] [If applicable, insert -- The sinking fund for this series provides for the redemption on ________ in each year beginning with the year ____ and ending with the year _____ of [if applicable, insert -- not less than $_____________ ("mandatory sinking fund") and not more than] $___________ aggregate principal amount of Securities of this series. Securities of this series acquired or redeemed by the Company otherwise than through [mandatory] sinking fund payments may be credited against subsequent [if applicable, insert -- mandatory] sinking fund payments otherwise required to be made [if applicable, insert -- in the inverse order in which they become due].] [If applicable, insert -- The Securities are subject to redemption, as a whole at any time or in part from time to time, at the sole election of the Company, upon not less than 30 or more than 60 days notice by mail to the Trustee at a Redemption Price equal to $____.] [If applicable, insert -- The Holder of this Security shall have the right to require the Company to pay this Security in full on ____________, __ by giving the Company or the Registrar written notice of the exercise of such right not less than 30 or more than 60 days prior to such date.] [If the Security is subject to redemption, insert -- In the event of redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof.] [If applicable, insert -- This Security is not subject to redemption prior to maturity.] 6. Denominations, Transfer, Exchange. [If applicable, insert -- The Securities of this series are issuable only in registered form without coupons in denominations of $___________ and any integral multiple thereof.] As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering the same. A Holder may register the transfer or exchange of the Security as provided in the Indenture and subject to certain limitations therein set forth. The Registrar may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay any taxes and fees required by law or permitted by the Indenture. [If applicable, insert -- The Securities of this series will be represented by one or more Global Securities registered in the name of ____________, (the "Depositary"), or a nominee of the Depositary. So long as the Depositary, or its nominee, is the registered holder and owner of this Global Security, the Depositary or such nominee, as the case may be, will be considered the sole owner and holder of the Securities for all purposes under the Indenture. The Global Security may be transferred, in whole and not in part, only to the Depositary or another nominee of the Depositary. The Depositary will credit, on its book-entry registration and transfer system, the respective principal amounts of the Securities represented by such Global Security to the accounts of institutions that have accounts with the Depositary or its nominee ("participants"). Ownership of beneficial interests in a Global Security will be shown on, and the transfer of those ownership interests will be effected through, records maintained by the Depositary A-4 (with respect to participants' interests) and such participants (with respect to the owners of beneficial interests in such Global Security).] [If applicable, insert -- The Securities represented by this Global Security are exchangeable for Securities in permanent form of like tenor as such Global Security in denominations of $1,000 and in any greater amount that is an integral multiple thereof if (i) the Depositary notifies the Company that it is unwilling or unable to continue as Depositary for this Global Security or if at any time the Depositary ceases to be a clearing agency registered under the Securities Exchange Act of 1934, as amended, (ii) the Company in its discretion at any time determines not to have all of the Securities of this series represented by the Global Security and notifies the Trustee thereof, or (iii) an Event of Default has occurred and is continuing with respect to the Securities. Any Security that is exchangeable pursuant to the preceding sentence is exchangeable only for Securities of this series.] No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 7. Persons Deemed Owners. The registered Holder of a Security may be treated as its owner for all purposes. 8. Amendment, Supplement and Waiver. Subject to certain exceptions, this Indenture and the Securities may be amended or supplemented with the consent of the Holders of at least a majority in principal amount of the then outstanding Securities of each series affected by such amendment or supplement and any existing default or compliance with any provision may be waived with the consent of the Holders of a majority in principal amount of the then outstanding Securities of each series affected by such waiver. Without the consent of any Holder of a Securities of each series affected by such amendment or supplement, this Indenture and the Securities may be amended or supplemented to, among other things, (a) cure any ambiguity, defect or inconsistency; (b) provide for uncertificated Securities in addition to or in place of certificated Securities; (c) provide for the assumption of the Company's obligations to Holders of the Securities in case of a merger or consolidation; (d) to make any change that would provide any additional rights or benefits to the Holders of Securities or that does not adversely affect the legal rights under the Indenture of any Holder; (e) to comply with the requirements of the SEC in order to effect or maintain the qualification of this Indenture under the Trust Indenture Act; (f) to allow any Guarantor to execute a supplemental indenture to this Indenture; (g) evidence or provide for acceptance of appointment of a successor Trustee; (h) mortgage, hypothecate or grant a security interest in favor of the Trustee for the benefit of the Holders of Securities of any series as additional security for the payment and performance of the Company's or, if applicable, the Guarantor's obligations herein in any property or assets; or (i) add to, change or eliminate any of the provisions of this Indenture (which addition, change or elimination may apply to one or more series of Securities), provided that, any such addition, change or elimination set forth in clause (i) above (A) shall neither (x) apply to any Security of any series created prior to the execution of such supplemental indenture and entitled to the benefit of such provision nor (y) modify the rights of the Holder of any such Security with respect to such provision or (B) shall become effective only when there is no such outstanding Security. 9. Defaults and Remedies. Events of Default include: (a) default for 30 days in the payment when due of interest on the Securities; (b) default in payment when due of principal of or premium, if any, on the Securities; (c) A-5 failure by the Company to comply with Section 5.01 of the Indenture; (d) failure by the Company for 60 days to comply with certain other agreements in this Indenture or the Securities; (e) certain events of bankruptcy or insolvency with respect to the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary; and (f) except as permitted by the Indenture, any applicable Security Guarantee shall be held in any judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or any Guarantor or any Person acting on its behalf shall deny or disaffirm its obligations under such Guarantor's Security Guarantee. If any Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in principal amount of the then outstanding Securities may declare all the Securities to be due and payable. Notwithstanding the foregoing, in the case of an Event of Default arising from certain events of bankruptcy or insolvency involving the Company, all outstanding Securities will become due and payable without further action or notice. Holders may not enforce this Indenture or the Securities except as provided in the Indenture. Subject to certain limitations, Holders of a majority in principal amount of the then outstanding Securities may direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of the Securities notice of any continuing Default or Event of Default (except a Default or Event of Default relating to the payment of principal or interest) if it determines that withholding notice is in their interest. The Holders of a majority in aggregate principal amount of the Securities then outstanding by notice to the Trustee may on behalf of the Holders of all of the Securities waive any existing Default or Event of Default and its consequences under this Indenture except a continuing Default or Event of Default in the payment of interest on, or the principal of, the Securities. The Company is required to deliver to the Trustee annually a statement regarding compliance with this Indenture, and the Company is required upon becoming aware of any Default or Event of Default, to deliver to the Trustee a statement specifying such Default or Event of Default. 10. Trustee Dealings with Company. The Trustee, in its individual or any other capacity, may make loans to, accept deposits from, and perform services for the Company or its Affiliates, and may otherwise deal with the Company or its Affiliates, as if it were not the Trustee. 11. No Recourse Against Others. A director, officer, employee, incorporator or stockholder, of the Company, as such, shall not have any liability for any obligations of the Company or the Guarantors under the Securities or this Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting a Security waives and releases all such liability. The waiver and release are part of the consideration for the issuance of the Securities. 12. [If applicable, insert - Guarantees. The payment by the Company of the principal of and interest on the Security is fully and unconditionally guaranteed on a joint and several basis by each of the Guarantors on the terms set forth in the Indenture.] 13. Authentication. This Security shall not be valid until authenticated by the manual signature of the Trustee or an authenticating agent. 14. Abbreviations. A-6 Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 15. CUSIP Numbers. Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers to be printed on the Securities and the Trustee may use CUSIP numbers in notices of redemption as a convenience to Holders. No representation is made as to the accuracy of such numbers either as printed on the Securities or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. The Company will furnish to any Holder upon written request and without charge a copy of this Indenture. Requests may be made to: Omnicare, Inc. 100 East RiverCenter Boulevard Covington, Kentucky 41011 Attention: General Counsel A-7 ASSIGNMENT FORM To assign this Security, fill in the form below: (I) or (we) assign and transfer this Security to: ______________________________ (Insert assignee's legal name) ________________________________________________________________________________ (Insert assignee's soc. sec. or tax I.D. no.) ________________________________________________________________________________ ________________________________________________________________________________ ________________________________________________________________________________ ________________________________________________________________________________ (Print or type assignee's name, address and zip code) and irrevocably appoint ________________________________________________________ to transfer this Security on the books of the Company. The agent may substitute another to act for him. Date: _______________ Your Signature: ---------------------------------- (Sign exactly as your name appears on the face of this Security) Signature Guarantee*: ------------------------- * Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). A-8 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL SECURITY* The following exchanges of a part of this Global Security for an interest in another Global Security or for a Definitive Security, or exchanges of a part of another Global Security or Definitive Security for an interest in this Global Security, have been made: Principal Amount of this Global Security Amount of decrease in Amount of increase in following such Signature of authorized Principal Amount of Principal Amount of decrease officer of Trustee or Date of Exchange this Global Security this Global Security (or increase) Security Custodian - ---------------- --------------------- --------------------- -------------------- -----------------------
- ---------- * This schedule should be included only if the Security is issued in global form. A-9
EX-4 4 ex4-2.txt EXHIBIT 4.2 Exhibit 4.2 ================================================================================ OMNICARE, INC. SUBORDINATED DEBT SECURITIES -------------------- INDENTURE Dated as of [_________] -------------------- -------------------- [_________] Trustee -------------------- ================================================================================ CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section - --------------- ----------------- 310(a)(1)................................................... 7.10 (a)(2)................................................... 7.10 (a)(3)................................................... N.A. (a)(4)................................................... N.A. (a)(5)................................................... 7.10 (b)...................................................... 7.10 (c)...................................................... N.A. 311(a)...................................................... 7.11 (b)...................................................... 7.11 (c)...................................................... N.A. 312(a)...................................................... 2.07 (b)...................................................... 14.03 (c)...................................................... 14.03 313(a)...................................................... 7.06 (b)(1)................................................... 7.06 (b)(2)................................................... 7.07 (c)...................................................... 7.06; 14.02 (d)...................................................... 7.06 314(a)...................................................... 4.03; 14.02 (b)...................................................... 11.02 (c)(1)................................................... 14.04 (c)(2)................................................... 14.04 (c)(3)................................................... N.A. (d)...................................................... N.A. (e)...................................................... 14.05 (f)...................................................... N.A. 315(a)...................................................... 7.01 (b)...................................................... 7.05, 14.02 (c)...................................................... 7.01 (d)...................................................... 7.01 (e)...................................................... 6.11 316(a) (last sentence)...................................... 2.11 (a)(1)(A)................................................ 6.05 (a)(1)(B)................................................ 6.04 (a)(2)................................................... N.A. (b)...................................................... 6.07 (c)...................................................... 2.14 317(a)(1)................................................... 6.08 (a)(2)................................................... 6.09 (b)...................................................... 2.06 318(a)...................................................... 14.01 (b)...................................................... N.A. (c)...................................................... 13.01 N.A. means not applicable. * This Cross Reference Table is not part of this Indenture. TABLE OF CONTENTS
Page ---- ARTICLE 1. DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01 Definitions............................................................................................1 Section 1.02 Other Definitions......................................................................................7 Section 1.03 Incorporation by Reference of Trust Indenture Act......................................................7 Section 1.04 Rules of Construction..................................................................................8 ARTICLE 2. THE SECURITIES Section 2.01 Form Generally.........................................................................................8 Section 2.02 Securities in Global Form..............................................................................9 Section 2.03 Title and Terms........................................................................................9 Section 2.04 Execution, Authentication, Delivery and Dating........................................................12 Section 2.05 Registrar and Paying Agent............................................................................13 Section 2.06 Paying Agent to Hold Money in Trust...................................................................13 Section 2.07 Holder Lists..........................................................................................13 Section 2.08 Registration, Registration of Transfer and Exchange...................................................14 Section 2.09 Replacement Securities................................................................................15 Section 2.10 Outstanding Securities................................................................................16 Section 2.11 Treasury Securities...................................................................................16 Section 2.12 Temporary Securities..................................................................................16 Section 2.13 Cancellation..........................................................................................17 Section 2.14 Payment of Interest...................................................................................17 Section 2.15 Persons Deemed Owners.................................................................................17 Section 2.16 Computation of Interest...............................................................................18 Section 2.17 CUSIP Numbers.........................................................................................18 ARTICLE 3. REDEMPTION AND PREPAYMENT Section 3.01 Right to Redeem; Notices to Trustee...................................................................18 Section 3.02 Selection of Securities to Be Redeemed................................................................18 Section 3.03 Notice of Redemption to Holders.......................................................................19 Section 3.04 Effect of Notice of Redemption........................................................................20 Section 3.05 Deposit of Redemption Price...........................................................................20 Section 3.06 Securities Redeemed in Part...........................................................................20 ARTICLE 4. COVENANTS Section 4.01 Payment of Securities.................................................................................20 Section 4.02 Maintenance of Office or Agency.......................................................................20 Section 4.03 Reports...............................................................................................21 Section 4.04 Compliance Certificate................................................................................21
i ARTICLE 5. SUCCESSORS Section 5.01 Merger, Consolidation, or Sale of Assets..............................................................22 Section 5.02 Successor Corporation Substituted.....................................................................22 ARTICLE 6. DEFAULTS AND REMEDIES Section 6.01 Events of Default.....................................................................................23 Section 6.02 Acceleration..........................................................................................24 Section 6.03 Other Remedies........................................................................................24 Section 6.04 Waiver of Past Defaults...............................................................................24 Section 6.05 Control by Majority...................................................................................25 Section 6.06 Limitation on Suits...................................................................................25 Section 6.07 Rights of Holders of Securities to Receive Payment and Convert........................................25 Section 6.08 Collection Suit by Trustee............................................................................25 Section 6.09 Trustee May File Proofs of Claim......................................................................26 Section 6.10 Priorities............................................................................................26 Section 6.11 Undertaking for Costs.................................................................................26 ARTICLE 7. TRUSTEE Section 7.01 Duties of Trustee.....................................................................................27 Section 7.02 Rights of Trustee.....................................................................................28 Section 7.03 Individual Rights of Trustee..........................................................................28 Section 7.04 Trustee's Disclaimer..................................................................................28 Section 7.05 Notice of Defaults....................................................................................28 Section 7.06 Reports by Trustee to Holders of the Securities.......................................................29 Section 7.07 Compensation and Indemnity............................................................................29 Section 7.08 Replacement of Trustee................................................................................30 Section 7.09 Successor Trustee by Merger, etc......................................................................31 Section 7.10 Eligibility; Disqualification.........................................................................31 Section 7.11 Preferential Collection of Claims Against Company.....................................................31 ARTICLE 8. LEGAL DEFEASANCE AND COVENANT DEFEASANCE Section 8.01 Option to Effect Legal Defeasance or Covenant Defeasance..............................................31 Section 8.02 Legal Defeasance and Discharge........................................................................31 Section 8.03 Covenant Defeasance...................................................................................32 Section 8.04 Conditions to Legal or Covenant Defeasance............................................................32 Section 8.05 Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous Provisions........................................................................33 Section 8.06 Repayment to Company..................................................................................33 Section 8.07 Reinstatement.........................................................................................33
ii ARTICLE 9. AMENDMENT, SUPPLEMENT AND WAIVER Section 9.01 Without Consent of Holders of Securities..............................................................34 Section 9.02 With Consent of Holders of Securities.................................................................35 Section 9.03 Compliance with Trust Indenture Act...................................................................36 Section 9.04 Revocation and Effect of Consents.....................................................................36 Section 9.05 Notation on or Exchange of Securities.................................................................36 Section 9.06 Trustee to Sign Amendments, etc.......................................................................36 Section 9.07 Effect of Supplemental Indentures.....................................................................37 ARTICLE 10. SINKING FUNDS Section 10.01 Applicability of Article..............................................................................37 Section 10.02 Satisfaction of Sinking Fund Payments with Securities.................................................37 Section 10.03 Redemption of Securities for Sinking Fund.............................................................37 ARTICLE 11. SUBORDINATION Section 11.01 Agreement to Subordinate..............................................................................38 Section 11.02 Liquidation; Dissolution; Bankruptcy..................................................................38 Section 11.03 Default on Designated Senior Debt.....................................................................38 Section 11.04 Acceleration of Securities............................................................................39 Section 11.05 When Distribution Must Be Paid Over...................................................................39 Section 11.06 Notice by Company.....................................................................................39 Section 11.07 Subrogation...........................................................................................39 Section 11.08 Relative Rights.......................................................................................40 Section 11.09 Subordination May Not Be Impaired by Company..........................................................40 Section 11.10 Distribution or Notice to Representative..............................................................40 Section 11.11 Rights of Trustee and Paying Agent....................................................................40 Section 11.12 Authorization to Effect Subordination.................................................................41 ARTICLE 12. SECURITY GUARANTEES Section 12.01 Applicability of this Article.........................................................................41 Section 12.02 Guarantee.............................................................................................41 Section 12.03 Subordination of Security Guarantee...................................................................42 Section 12.04 Limitation on Guarantor Liability.....................................................................42 Section 12.05 Release of Guarantors.................................................................................42 ARTICLE 13. SATISFACTION AND DISCHARGE Section 13.01 Satisfaction and Discharge............................................................................43 Section 13.02 Application of Trust Money............................................................................43
iii ARTICLE 14. MISCELLANEOUS Section 14.01 Trust Indenture Act Controls..........................................................................44 Section 14.02 Notices...............................................................................................44 Section 14.03 Communication by Holders of Securities with Other Holders of Securities...............................45 Section 14.04 Certificate and Opinion as to Conditions Precedent....................................................45 Section 14.05 Statements Required in Certificate or Opinion.........................................................45 Section 14.06 Rules by Trustee and Agents...........................................................................46 Section 14.07 No Personal Liability of Directors, Officers, Employees and Stockholders..............................46 Section 14.08 Governing Law.........................................................................................46 Section 14.09 No Adverse Interpretation of Other Agreements.........................................................46 Section 14.10 Successors............................................................................................46 Section 14.11 Severability..........................................................................................47 Section 14.12 Counterpart Originals.................................................................................47 Section 14.13 Table of Contents, Headings, etc......................................................................47 EXHIBITS Exhibit A FORM OF SECURITY
iv INDENTURE dated as of [_______] between Omnicare, Inc., a Delaware corporation (the "Company"), and [____________], as trustee (the "Trustee"). The Company has duly authorized the execution and delivery of this Indenture (as defined herein) to provide for the issuance from time to time of its debentures, notes or other evidences of indebtedness (herein called the "Securities") to be issued in one or more series as provided in this Indenture. For and in consideration of the premises and purchase of the Securities by the Holders (as defined herein) thereof, it is mutually covenanted and agreed, for the equal and ratable benefit of the Holders of the Securities of each series thereof as follows: ARTICLE 1. DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01 Definitions. "Affiliate" of any specified Person means any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person. For purposes of this definition, "control", as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise; provided that beneficial ownership of 10% or more of the Voting Stock of a Person shall be deemed to be control. For purposes of this definition, the terms "controlling," "controlled by" and "under common control with" have correlative meanings. "Agent" means any Registrar, Paying Agent or co-registrar. "Bankruptcy Law" means Title 11, U.S. Code or any similar federal or state law for the relief of debtors. "Bearer Security" means any Security, including any interest coupons appertaining thereto, that does not provide for the identification of the Holder thereof. "Board of Directors" means the board of directors of the Company (or any duly authorized committee thereof); "Board Resolution" means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors and to be in full force and effect on the date of such certification, and delivered to the Trustee. "Business Day" means any day other than a Legal Holiday. "Capital Lease Obligation" means, at the time any determination is to be made, the amount of the liability in respect of a capital lease that would at that time be required to be capitalized on a balance sheet in accordance with GAAP. "Capital Stock" means: (a) in the case of a corporation, corporate stock; (b) in the case of an association or business entity, any and all shares, interests, participations, rights or other equivalents (however designated) of corporate stock; (c) in the case of a partnership or limited liability company, partnership or membership interests (whether general or limited); and (d) any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person. "Company" means Omnicare, Inc., and any and all successors thereto. "Company Order" means a written order signed in the name of the Company by an Officer and delivered to the Trustee or, with respect to Sections 2.04, 2.08, 2.09, 2.12 and 9.05 any other employee of the Company named in an Officers' Certificate delivered to the Trustee. "Corporate Trust Office of the Trustee" shall be at the address of the Trustee specified in Section 14.02 hereof or such other address as to which the Trustee may give notice to the Company. "Credit Agreement" means the credit agreement, dated ____________, among the Company, _______, as syndication agent, the lenders party thereto, and _____________ as administrative agent, including any related notes, guarantees, collateral documents, instruments and agreements executed in connection therewith, and in each case as amended (including, without limitation, as to principal amount), modified, renewed, refunded, replaced or refinanced from time to time (whether or not with the original agents or lenders and whether or not contemplated under the original agreement relating thereto). "Default" means any event that is, or with the passage of time or the giving of notice or both would be, an Event of Default. "Depositary" means, with respect to the Securities issuable or issued in whole or in part in global form, the Person specified pursuant to Section 2.03(a) hereof as the Depositary with respect to the Securities, and any and all successors thereto appointed as depositary hereunder and having become such pursuant to the applicable provision of this Indenture. "Designated Senior Debt" means (a) any Indebtedness outstanding under the Credit Agreement; and (b) after payment in full of all Obligations under the Credit Agreement, any other Senior Debt permitted under this Indenture the principal amount of which is $35.0 million or more and that has been designated by the Company as "Designated Senior Debt." "Discount Security" means any Security which provides for an amount less than the principal amount thereof to be due and payable upon a declaration of acceleration of the maturity thereof pursuant to Section 6.02 hereof. "Domestic Subsidiary" means any Restricted Subsidiary organized under the laws of the United States or any state of the United States or the District of Columbia. "Equity Interests" means Capital Stock and all warrants, options or other rights to acquire Capital Stock (but excluding any debt security that is convertible into, or exchangeable for, Capital Stock). "Exchange Act" means the Securities Exchange Act of 1934, as amended. 2 "GAAP" means generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as have been approved by a significant segment of the accounting profession, which are in effect on the date of determination. "Global Security" or "Global Securities" means any Security or Securities, as the case may be, in the form established pursuant to Section 2.02 evidencing all or a part of a series of Securities issued to the Depositary of such series or its nominee and registered in the name of such Depositary or nominee. "Government Securities" means direct obligations of, or obligations guaranteed by, the United States of America, and the payment for which the United States pledges its full faith and credit. "Guarantee" means a guarantee other than by endorsement of negotiable instruments for collection in the ordinary course of business, direct or indirect, in any manner including, without limitation, by way of a pledge of assets or through letters of credit or reimbursement agreements in respect thereof, of all or any part of any Indebtedness. "Guarantor" means with respect to Securities of any series, any Domestic Subsidiary who has guaranteed the Company's obligations under this Indenture and with respect to such series of Securities pursuant to Article 12 hereof; provided that upon the release and discharge of any Person from its Security Guarantee in accordance with this Indenture, such Person shall cease to be a Guarantor. "Hedging Obligations" means, with respect to any specified Person, the obligations of such Person under (a) interest rate swap agreements, interest rate cap agreements and interest rate collar agreements and (b) other agreements or arrangements designed to protect such Person against fluctuations in interest rates or foreign exchange rates. "Holder" means a Person in whose name a Security is registered. "Indebtedness" means, with respect to any specified Person, any indebtedness of such Person, whether or not contingent: (a) in respect of borrowed money; (b) evidenced by bonds, notes, debentures or similar instruments or letters of credit (or reimbursement agreements in respect thereof); (c) in respect of banker's acceptances; (d) representing Capital Lease Obligations; (e) representing the balance deferred and unpaid of the purchase price of any property; or (f) representing any Hedging Obligations, if and to the extent any of the preceding items (other than letters of credit and Hedging Obligations) would appear as a liability upon a balance sheet of the specified Person prepared in accordance with GAAP. In addition, the term "Indebtedness" includes all Indebtedness of others secured by a Lien on any asset of the specified Person (whether or not such Indebtedness is assumed by the specified Person) and, to the extent not otherwise included, the Guarantee by the specified Person of any indebtedness of any other Person, in each case limited to the maximum amount of liability of the specified Person with respect 3 to such Lien or Guarantee on the date in question. Notwithstanding anything in the foregoing to the contrary, Indebtedness shall not include trade payables or accrued expenses for property or services incurred in the ordinary course of business. The amount of any Indebtedness issued with original issue discount will be the accreted value of such Indebtedness. "Indenture" means this Indenture, as amended or supplemented from time to time. "Interest Payment Date," when used with respect to any Security, means the Stated Maturity of an installment of interest on such Security. "Legal Holiday" means a Saturday, a Sunday or a day on which banking institutions in the City of New York or at a place of payment are authorized by law, regulation or executive order to remain closed. If a payment date is a Legal Holiday at a place of payment, payment may be made at that place on the next succeeding day that is not a Legal Holiday, and no interest shall accrue on such payment for the intervening period. "Lien" means, with respect to any asset, any mortgage, lien, pledge, charge, security interest or encumbrance of any kind in respect of such asset, whether or not filed, recorded or otherwise perfected under applicable law, including any conditional sale or other title retention agreement, any lease in the nature thereof, any option or other agreement to sell or give a security interest in and any filing of or agreement to give any financing statement under the Uniform Commercial Code (or equivalent statutes) of any jurisdiction. "Obligations" means any principal, interest, penalties, fees, indemnifications, reimbursements, damages and other liabilities payable under the documentation governing any Indebtedness. "Officer" means, with respect to any Person, the Chairman of the Board, the Chief Executive Officer, the President, the Chief Operating Officer, the Chief Financial Officer, the Treasurer, any Assistant Treasurer, the Controller, the Secretary or any Vice-President of such Person. "Officers' Certificate" means a certificate signed on behalf of the Company or, if applicable, a Guarantor, by two Officers of the Company, one of whom must be the principal executive officer, the principal financial officer, the treasurer or the principal accounting officer of the Company, that meets the requirements of Section 14.05 hereof. "Opinion of Counsel" means, as to the Company or, if applicable, a Guarantor, an opinion from legal counsel who is reasonably acceptable to the Trustee, that meets the requirements of Section 14.05 hereof. The counsel may be an employee of or counsel to the Company, any Subsidiary of the Company or the Trustee. "Permitted Junior Securities" means Equity Interests in the Company or any Guarantor or debt securities that are subordinated to all Senior Debt and any debt securities issued in exchange for Senior Debt to substantially the same extent as, or to a greater extent than, the Securities of a series and the related Security Guarantees, if any, are subordinated to Senior Debt pursuant to this Indenture. "Person" means any individual, corporation, partnership, joint venture, association, joint-stock company, trust, unincorporated organization, limited liability company or government or other entity. 4 "Redemption Date," when used with respect to any Security to be redeemed, shall mean the date specified for redemption of such Security in accordance with the terms of such Security and this Indenture. "Redemption Price," when used with respect to any Security to be redeemed, means the price at which it is to be redeemed pursuant to this Indenture. "Registered Security" means any Security in the form (to the extent applicable thereto) established pursuant to Section 2.01 hereof which is registered on the books of the Registrar. "Regular Record Date" for the interest payable on any Interest Payment Date on the Registered Securities of any series means the date specified for that purpose as contemplated by Section 2.03(a) hereof. "Representative" means the indenture trustee or other trustee, agent or representative for any Senior Debt. "Responsible Officer," when used with respect to the Trustee, means any officer within the Corporate Trust Administration of the Trustee (or any successor group of the Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers and also means, with respect to a particular corporate trust matter, any other officer to whom such matter is referred because of his knowledge of and familiarity with the particular subject. "Restricted Subsidiary" means any direct or indirect Subsidiary of the Company other than an Unrestricted Subsidiary. "SEC" means the Securities and Exchange Commission. "Securities Act" means the Securities Act of 1933, as amended. "Security Guarantee" means, with respect to the Securities of any series, the Guarantee with respect to the Securities of such series by each Guarantor pursuant to Article 12 hereof and a supplemental indenture. "Securities" has the meaning assigned to it in the preamble to this Indenture. "Senior Debt" of the Company or a Guarantor, as the case may be, means, with respect to the Securities of any series and any applicable Security Guarantee thereof (except as otherwise specified as contemplated by Section 2.03(a) hereof): (a) all obligations of the Company or any Guarantor, as the case may be, related to the Credit Agreement, whether for principal, premium, if any, interest, including interest accruing after the filing of, or which would have accrued but for the filing of, a petition by or against the Company or such Guarantor under applicable bankruptcy laws, whether or not such interest is lawfully allowed as a claim after such filing, and all other amounts payable in connection therewith, including, without limitation, any fees, premiums, penalties, expenses, reimbursements, indemnities, damages and other liabilities; and (b) the principal of, premium, if any, and interest on all other Indebtedness of the Company or any Guarantor, as the case may be, other than the Securities, and all Hedging Obligations, in each case whether outstanding on the date of this Indenture or thereafter created, incurred or assumed, unless, in the case of any particular Indebtedness or Hedging Obligation, the instrument creating or evidencing the 5 Indebtedness or Hedging Obligation expressly provides that such Indebtedness or Hedging Obligation shall not be senior in right of payment to the Securities. Notwithstanding the foregoing, "Senior Debt" does not include: (a) Indebtedness evidenced by the Securities and the Security Guarantees; (b) Indebtedness of the Company or any applicable Guarantor that is expressly subordinated in right of payment to any Senior Debt of the Company or such Guarantor or the Securities or the applicable Security Guarantee; (c) Indebtedness of the Company or any applicable Guarantor that by operation of law is subordinate to any general unsecured obligations of the Company or such Guarantor; (d) Indebtedness of the Company or any applicable Guarantor to the extent incurred in violation of any covenant prohibiting the incurrence of Indebtedness applicable to the Securities of such series or the Security Guarantee thereof; (e) any liability for federal, state or local taxes or other taxes, owed or owing by the Company or any applicable Guarantor; (f) accounts payable or other liabilities owed or owing by the Company or any applicable Guarantor to trade creditors, including guarantees thereof or instruments evidencing such liabilities; (g) amounts owed by the Company or any applicable Guarantor for compensation to employees or for services rendered to the Company or such Guarantor; (h) Indebtedness of the Company or any applicable Guarantor to any Restricted Subsidiary or any other Affiliate of the Company or such Guarantor; (i) Capital Stock of the Company or any applicable Guarantor; (j) Indebtedness which when incurred and without respect to any election under Section 1111(b) of Title 11 of the U.S. Code is without recourse to the Company or any Restricted Subsidiary; and (k) other Indebtedness identified for any series of Securities pursuant to Section 2.03(a) hereof. "Significant Subsidiary" means any Subsidiary that would be a "significant subsidiary" as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such Regulation is in effect on the date hereof. "Special Record Date" for the payment of any Defaulted Interest on the Registered Securities of any issue means a date fixed by the Trustee pursuant to Section 2.14 hereof. "Stated Maturity" means, with respect to any installment of interest or principal on any series of Indebtedness, the date on which the payment of interest or principal was scheduled to be paid in the original documentation governing such Indebtedness, and will not include any contingent obligations to repay, redeem or repurchase any such interest or principal prior to the date originally scheduled for the payment thereof. 6 "Subsidiary" means, (a) any corporation more than 50% of the outstanding securities having ordinary voting power of which shall at the time be owned or controlled, directly or indirectly, by the Company and/or by one or more of its Restricted Subsidiaries, or (b) any partnership, limited liability company, association, joint venture or similar business organization more than 50% of the ownership interests having ordinary voting power of which shall at the time be so owned or controlled. "TIA" means the Trust Indenture Act of 1939 (15 U.S.C. 'SS''SS'77aaa-77bbbb) as in effect on the date on which this Indenture is qualified under the TIA. "Trustee" means the party named as such above until a successor replaces it in accordance with the applicable provisions of this Indenture and thereafter means the successor serving hereunder. "Unrestricted Subsidiary" means any Subsidiary of the Company that is designated by the Board of Directors as an Unrestricted Subsidiary pursuant to a Board Resolution, but only to the extent that such Subsidiary: (a) has no Indebtedness other than Indebtedness that is without recourse to the Company or its Restricted Subsidiaries; (b) is not party to any agreement, contract, arrangement or understanding with the Company or any Restricted Subsidiary unless the terms of any such agreement, contract, arrangement or understanding are not materially less favorable to the Company or such Restricted Subsidiary than those that might be obtained at the time from Persons who are not Affiliates of the Company; (c) is a Person with respect to which neither the Company nor any of its Restricted Subsidiaries has any (a) continuing direct or indirect obligation to subscribe for additional Equity Interests or (b) direct or indirect obligation to maintain or preserve such Person's financial condition or to cause such Person to achieve any specified levels of operating results; and (d) has not guaranteed or otherwise directly or indirectly provided credit support for any Indebtedness of the Company or any of its Restricted Subsidiaries. "Voting Stock" of any Person as of any date means the Capital Stock of such Person that is at the time entitled to vote in the election of the Board of Directors of such Person. Section 1.02 Other Definitions. Defined in Term Section - ---- ---------- "Bankruptcy Law" .......................................... 4.01 "Covenant Defeasance"...................................... 8.03 "Defaulted Interest"....................................... 2.14 "Designated Senior Debt"................................... 10.2 "Event of Default"......................................... 6.01 "Legal Defeasance"......................................... 8.02 "Paying Agent"............................................. 2.05 "Registrar"................................................ 2.05 Section 1.03 Incorporation by Reference of Trust Indenture Act. Whenever this Indenture refers to a provision of the TIA, the provision is incorporated by reference in and made a part of this Indenture. 7 The following TIA terms used in this Indenture have the following meanings: "indenture securities" means the Securities; "indenture security Holder" means a Holder of a Security; "indenture to be qualified" means this Indenture; "indenture trustee" or "institutional trustee" means the Trustee; and "obligor" on the Securities and the Security Guarantees means the Company and the Guarantors, respectively, and any successor obligor upon the Securities and the Security Guarantees, respectively. All other terms used in this Indenture that are defined by the TIA, defined by TIA reference to another statute or defined by SEC rule under the TIA have the meanings so assigned to them. Section 1.04 Rules of Construction. Unless the context otherwise requires: (a) a term has the meaning assigned to it; (b) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; (c) "or" is not exclusive; (d) words in the singular include the plural, and in the plural include the singular; (e) provisions apply to successive events and transactions; and (f) references to sections of or rules under the Securities Act shall be deemed to include substitute, replacement of successor sections or rules adopted by the SEC from time to time. ARTICLE 2. THE SECURITIES Section 2.01 Form Generally The Securities of each series shall be substantially in the form of Exhibit A hereto or in such other form as shall be established by delivery to the Trustee of an Officers' Certificate or in one or more indentures supplemental hereto, in each case with such appropriate insertions, omissions, substitutions and other variations as are required or permitted by this Indenture, and may have such letters, numbers or other marks of identification and such legends or endorsements placed thereon as may be required to comply with the rules of any securities exchange or as may, consistently herewith, be determined by the Officers executing such Securities as evidenced by their execution of the Securities. The permanent Securities shall be printed, lithographed, engraved or cord processed or produced by any combination of these methods or may be produced in any other manner, provided that such method is permitted by the rules of any securities exchange on which such Securities may be listed, all as determined by the Officers executing such Securities as evidenced by their execution of such Securities. 8 Section 2.02 Securities in Global Form. If Securities of a series are issuable as a Global Security, as specified as contemplated by Section 2.03(a) hereof, then, notwithstanding clause (9) of Section 2.03(a) hereof and the provisions of Section 2.03(b) hereof, any such Global Security shall represent such of the outstanding Securities of such series as shall be specified therein and may provide that it shall represent the aggregate principal amount of outstanding Securities from time to time endorsed thereon or otherwise notated on the books and records of the Registrar and that the aggregate principal amount of outstanding Securities represented thereby may from time to time be reduced or increased, as appropriate, to reflect exchanges and redemptions. Any endorsement of a Global Security to reflect the aggregate principal amount of any increase or decrease in the amount of outstanding Securities represented thereby shall be made by the Trustee in such manner and upon instructions given by the Holder thereof as required by Section 2.08 hereof. Global Securities may be issued in either registered or bearer form and in either temporary or permanent form. Permanent Global Securities will be issued in definitive form. The provisions of the last sentence of Section 2.04 hereof shall apply to any Security represented by a Global Security if such Security was never issued and sold by the Company, and the Company delivers to the Trustee the Security in global form together with written instructions (which need not comply with Section 14.04 or 14.05 hereof and need not be accompanied by an Opinion of Counsel) with regard to the reduction in the principal amount of Securities represented thereby, together with the written statement contemplated by the last sentence of Section 2.04 hereof. Notwithstanding the provisions of Sections 2.02 and 2.14 hereof, unless otherwise specified as contemplated by Section 2.03(a) hereof, payment of principal of and any interest on any Global Security shall be made to the person or persons specified therein. None of the Company, the Guarantor, if any, the Trustee of such series of Securities, any Paying Agent or Registrar will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests of a Global Security or for maintaining, supervising or reviewing any records relating to such beneficial ownership interests. Section 2.03 Title and Terms. (a) The aggregate principal amount of Securities which may be authenticated and delivered under this Indenture is unlimited. The Securities may be issued in one or more series. There shall be established and, subject to Section 2.04 hereof, set forth, or determined in the manner provided, in an Officers' Certificate or established in one or more indentures supplemental hereto, prior to the issuances of Securities of any series, any or all of the following, as applicable: (1) the title and series designation of the Securities of the series (which shall distinguish the Securities of the series from all other Securities); (2) any limit upon the aggregate principal amount of the Securities of the series which may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon registration of, transfer of, or in exchange for, or in lieu of, other Securities of the series pursuant to Sections 2.08, 2.09, 2.12, 3.06, 9.05 or 10.03 hereof and except for any Securities which, pursuant to Section 2.04 hereof, are deemed never to have been authenticated and delivered hereunder); (3) the price or prices at which the Securities of the series will be issued; 9 (4) if the Securities of the series will be guaranteed and the terms of any such Security Guarantees; (5) the date or dates on which the principal amount and premium, if any, of the Securities of the series is payable; (6) the interest rate or rates or the method for calculating the interest rate, which may be fixed or variable, of the Securities of the series, the date or dates from which any such interest shall accrue and the Interest Payment Dates on which such interest shall be payable, subject to the right, if any, of the Company to defer or extend an Interest Payment Date and the duration of such deferral or extension; (7) the place or places where, subject to the provisions of Section 4.02 hereof, the principal of, premium, if any, and interest on Securities of the series will be payable and where any Securities of the series may be surrendered for registration of transfer, Securities of the series may be surrendered for exchange and notices and demands to or upon the Company in respect of the Securities of the series and this Indenture may be served; (8) the right, if any, to redeem the Securities of the series and the terms and conditions upon which Securities of the series may be redeemed, in whole or in part; (9) any mandatory or optional sinking fund or analogous provisions; (10) whether the Securities of the series will be secured and any provisions relating to the security provided; (11) if and the terms and conditions upon which the Securities of the series may or must be converted into securities of the Company or exchanged for securities of the Company or another enterprise; (12) if other than the principal amount thereof, the portion of the principal amount of any Securities of the series which shall be payable upon declaration of acceleration of the maturity thereof pursuant to Section 6.02 hereof; (13) whether the Securities of the series, in whole or any specified part, shall not be defeasible pursuant to Section 8.04 or 8.05 hereof or both such Sections and, if other than by an Officers' Certificate, the manner in which any election by the Company to defease such Securities shall be evidenced; (14) any addition to or change in the Events of Default which apply to any Securities of the series and any change in the right of the Trustee or the requisite Holders of such Securities to declare the principal amount thereof due and payable pursuant to Section 6.02 hereof; (15) if other than U.S. dollars, the currency or currencies in which payment of the principal of, premium, if any, and interest on the Securities of the series shall be payable and whether the Securities of the series may be satisfied and discharged other than as provided in Article 8 hereof; (16) any terms applicable to Original Issue Discount, if any, (as that term is defined in the Internal Revenue Code of 1986 and the Regulations thereunder) including the rate or rates at which such Original Issue Discount, if any, shall accrue; 10 (17) if the Securities of the series may be issued or delivered (whether upon original issuance or upon exchange of a temporary Security of such series or otherwise), or any installment of principal of, or any premium or interest is payable, only upon receipt of certain certificates or other documents or satisfaction of other conditions in addition to those specified in this Indenture, the form and terms of such certificates, documents or conditions; (18) whether the Securities of the series may be represented initially by a Security in temporary or permanent global form and, if so, the Depositary with respect to any such temporary or permanent Global Security, and if other than as provided in Section 2.08 or 2.12 hereof, as applicable, whether and the circumstances under which beneficial owners of interests in any such temporary or permanent Global Security may exchange such interests for Securities of such series and of like tenor of any authorized form and denomination; (19) whether Securities of the series are to be issued as Registered Securities, Bearer Securities or both, the terms and conditions relating to the applicable form, including, but not limited to, tax compliance, registration and transfer procedures and, if in registered form, the denominations in which any Registered Securities of the series will be issuable if other than denominations of $1,000 and any integral multiple thereof and if in bearer form, the denominations in which any Bearer Securities will be issuable; (20) any special United States federal income tax considerations applicable to the Securities of the series; (21) any addition to or change in the covenants set forth in Article 4 hereof which apply to Securities of the series; (22) whether the subordination provisions of Article 11 hereof apply to the Securities of the series or any different subordination provisions, including a different definition of "Senior Debt," apply to the Securities of the series; and (23) any other terms of the Securities of the series (which terms shall not be inconsistent with the provisions of this Indenture, except as permitted by Section 9.01(i) hereof). All Securities of any one series shall be substantially identical except as to denomination and the rate or rates of interest, if any, and Stated Maturity, the date from which interest, if any, shall accrue and except as may otherwise be provided in or pursuant to an Officers' Certificate pursuant to this Section 2.03(a) or in any indenture supplemental hereto. All Securities of any one series need not be issued at the same time and, unless otherwise provided, a series may be reopened for issuances of additional Securities of such series or for the establishment of additional terms with respect to the Securities of such series. If any of the terms of the series are established by action taken pursuant to a Board Resolution, a copy of any appropriate record of such action shall be certified by the Secretary or an Assistant Secretary of the Company and delivered to the Trustee at or prior to the delivery of the Officers' Certificate setting forth the terms of the series. (b) Unless otherwise provided as contemplated by Section 2.03(a) hereof with respect to any series of Securities, the Securities of such series shall be issuable in denominations of $1,000 or integral multiples thereof. 11 Section 2.04 Execution, Authentication, Delivery and Dating. Two Officers shall sign the Securities for the Company by manual or facsimile signature. If an Officer whose signature is on a Security no longer holds that office at the time a Security is authenticated, the Security shall nevertheless be valid. A Security shall not be valid until authenticated by the manual signature of the Trustee. The signature shall be conclusive evidence that the Security has been authenticated under this Indenture. At any time and from time to time after the execution and delivery of this Indenture (and subject to delivery of an Officers' Certificate or a supplemental indenture as set forth in Section 2.03(a) hereof with respect to the initial issuance of Securities of any series), the Company may deliver Securities of any series executed by the Company to the Trustee for authentication, together with a Company Order for the authentication and delivery of such Securities; and the Trustee in accordance with such Company Order shall authenticate and deliver such Securities. If the forms or terms of the Securities of the series have been established in or pursuant to one or more Officers' Certificates as permitted by Sections 2.01 and 2.03(a) hereof, in authenticating such Securities, and accepting the additional responsibilities under this Indenture in relation to such Securities, the Trustee shall be entitled to receive, and shall be fully protected in relying upon, an Opinion of Counsel stating: (a) that the form or forms and terms of such Securities have been duly authorized by the Company and established in conformity with the provisions of this Indenture; and (b) that such Securities when authenticated and delivered by the Trustee or its authenticating agent and issued by the Company in the manner and subject to any conditions specified in such Opinion of Counsel, will constitute legal, valid and binding obligations of the Company, enforceable in accordance with their terms, subject to customary exceptions. Notwithstanding the provisions of Section 2.03(a) hereof and of the preceding paragraph, if all Securities of a series are not to be originally issued at one time, it shall not be necessary to deliver the Officers' Certificate otherwise required pursuant to Section 2.03(a) hereof and the Opinion of Counsel required by the preceding paragraph at or prior to the time of authentication of each Security of such series if such documents are delivered at or prior to the authentication upon original issuance of the first Security of such series to be issued. Each Security shall be dated the date of its authentication. No Security shall be entitled to any benefit under this Indenture or be valid or obligatory for any purpose unless there appears on such Security a certificate of authentication substantially in the form provided for herein duly executed by the Trustee by manual signature of an authorized signatory, and such certificate upon any Security shall be conclusive evidence, and the only evidence, that such Security has been duly authenticated and delivered hereunder. The Trustee's certificate of authentication shall be in substantially the following form: This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. [______________________], as Trustee By: 12 Authorized Officer Notwithstanding the foregoing, if any Security shall have been duly authenticated and delivered hereunder but never issued and sold by the Company, and the Company shall deliver such Security to the Trustee for cancellation as provided in Section 2.13 hereof together with a written statement (which need not comply with Section 14.04 or 14.05 hereof and need not be accompanied by an Opinion of Counsel) stating that such Security has never been issued and sold by the Company, for all purposes of this Indenture such Security shall be deemed never to have been authenticated and delivered hereunder and shall never be entitled to the benefits of this Indenture. Section 2.05 Registrar and Paying Agent. The Company shall maintain, with respect to each series of Securities, an office or agency where such Securities may be presented for registration of transfer or for exchange ("Registrar") and an office or agency where Securities may be presented for payment ("Paying Agent"). The Registrar shall keep a register of the Securities and of their transfer and exchange. The Company may appoint one or more co-registrars and one or more additional paying agents. The term "Registrar" includes any co-registrar and the term "Paying Agent" includes any additional paying agent. The Company may change any Paying Agent or Registrar without notice to any Holder. The Company shall notify the Trustee in writing of the name and address of any Agent not a party to this Indenture. If the Company fails to appoint or maintain another entity as Registrar or Paying Agent, the Trustee shall act as such. The Company or any of its Subsidiaries may act as Paying Agent or Registrar. The Company initially appoints the Trustee to act as the Registrar and Paying Agent. Section 2.06 Paying Agent to Hold Money in Trust. The Company shall require each Paying Agent other than the Trustee to agree in writing that the Paying Agent will hold in trust for the benefit of Holders of Securities of any series or the Trustee all money held by the Paying Agent for the payment of principal, premium, if any, or interest on such series of Securities, and will notify the Trustee of any default by the Company in making any such payment. While any such default continues, the Trustee may require a Paying Agent to pay all money held by it to the Trustee. The Company at any time may require a Paying Agent to pay all money held by it to the Trustee. Upon payment over to the Trustee, the Paying Agent (if other than the Company or a Subsidiary) shall have no further liability for the money. If the Company or a Subsidiary acts as Paying Agent, it shall segregate and hold in a separate trust fund for the benefit of the Holders all money held by it as Paying Agent. Upon any bankruptcy or reorganization proceedings relating to the Company, the Trustee shall serve as Paying Agent for the Securities. Section 2.07 Holder Lists. The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of all Holders of each series of Securities and shall otherwise comply with TIA 'SS'312(a). If the Trustee is not the Registrar, the Company shall furnish to the Trustee at least seven Business Days before each interest payment date and at such other times as the Trustee may request in writing, a list in such form and as of such date as the Trustee may reasonably require of the names and addresses of the Holders of such series of Securities and the Company shall otherwise comply with TIA 'SS'312(a). 13 Section 2.08 Registration, Registration of Transfer and Exchange. Upon surrender for registration of transfer of any Securities of a series at an office or agency of the Company designated pursuant to Section 4.02 hereof for such purpose, the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the designated transferee or transferees, one or more new Securities of the same series of any authorized denominations, of a like aggregate principal amount. The Company shall not charge a service charge for any registration of transfer or exchange, but the Company may require payment of a sum sufficient to pay all taxes, assessments or other governmental charges that may be imposed in connection with the transfer or exchange of the Securities from the Holder requesting such transfer or exchange (other than any exchange of a temporary Security for a permanent Security not involving any change in ownership or any exchange pursuant to Section 2.12, 3.06, 9.05 or 10.3 hereof, not involving any transfer). Notwithstanding any other provisions (other than the provisions set forth in the sixth and seventh paragraphs) of this Section 2.08, a Security in global form representing all or a portion of the Securities of a series may not be transferred except as a whole by the Depositary for such series to a nominee of such Depositary or by a nominee of such Depositary to such Depositary or another nominee of such Depositary or by such Depositary or any such nominee to a successor Depositary for such series or a nominee of such successor Depositary. At the option of the Holder of Securities of any series, Securities of such series may be exchanged for other Securities of the same series of any authorized denomination or denominations of a like aggregate principal amount and tenor, upon surrender of the Securities to be exchanged at such office or agency. Whenever any Securities are so surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and deliver, the Securities which the Holder making the exchange is entitled to receive. Unless otherwise specified as contemplated by Section 2.03(a) hereof, if the Securities of any series shall have been issued in the form of one or more Global Securities, such series of Securities in global form will be exchanged for Securities of such series in permanent form if (i) the Depositary for the Securities of such series notifies the Company that it is unwilling or unable to continue as Depositary for the Securities of such series and a successor Depositary for the Securities of such series is not appointed by the Company within 120 days after the Company receives such notice, (ii) the Company in its sole discretion determines that the Securities of such series shall no longer be represented by such Global Security or Securities or (iii) an Event of Default with respect to the Securities of such series shall have occurred and be continuing. In any such event the Company will execute, and the Trustee, upon receipt of a Company Order for the authentication and delivery of permanent Securities of such series, will authenticate and deliver Securities of such series in permanent form and in an aggregate principal amount equal to the principal amount of the Security or Securities in global form representing such series in exchange for such Security or Securities in global form. Notwithstanding the foregoing, except as otherwise specified in the preceding paragraph or as contemplated by Section 2.03(a) hereof, any Global Security shall be exchangeable only as provided in this paragraph. If the beneficial owners of interests in a Global Security are entitled to exchange such interests for permanent Securities of such series and of like principal amount and tenor but of another authorized form and denomination, as specified as contemplated by Section 2.03(a) hereof, then without unnecessary delay but in any event not later than the earliest date on which such interests may be so exchanged, the Company shall deliver to the Trustee permanent Securities in aggregate principal amount equal to the principal amount of such Global Security, executed by the Company. On or after the earliest date on which such interests may be so exchanged, such Global Security shall be surrendered by the Depositary with respect thereto to the Trustee, as the Company's agent for such purpose, to be exchanged, 14 in whole or from time to time in part, for permanent Securities without charge and the Trustee shall authenticate and deliver, in exchange for each portion of such Global Security, an equal aggregate principal amount of permanent Securities of the same series of authorized denominations and of like tenor as the portion of such Global Security to be exchanged which shall be in the form of Securities, or any combination thereof, as shall be specified by the beneficial owner thereof; provided, however, that notwithstanding the last paragraph of this Section 2.08 hereof, no such exchanges may occur during a period beginning at the opening of business 15 days before any selection of Securities of that series to be redeemed and ending on the relevant Redemption Date. If a Registered Security is issued in exchange for any portion of a Global Security after the close of business at the office or agency where such exchange occurs on (i) any Regular Record Date and before the opening of business at such office or agency on the relevant Interest Payment Date, or (ii) any Special Record Date and before the opening of business at such office or agency on the related proposed date for payment of Defaulted Interest (as defined herein), interest or Defaulted Interest, as the case may be, will not be payable on such Interest Payment Date or proposed date for payment, as the case may be, in respect of such Security, but will be payable on such Interest Payment Date or proposed date for payment, as the case may be, only to the Person to whom interest in respect of such portion of such Global Security is payable in accordance with the provisions of this Indenture. Upon the exchange of a Security in global form for Securities in permanent form, such Security in global form shall be cancelled by the Trustee. All cancelled Securities held by the Trustee shall be destroyed by the Trustee and a certificate of their destruction delivered to the Company unless the Company directs, by Company Order, that the Trustee shall cancel Securities and deliver a certificate of destruction to the Company. Securities issued in exchange for a Security in global form pursuant to this Section 2.08 hereof shall be registered in such names and in such authorized denominations as the Depositary for such Security in global form, pursuant to instructions from its direct or indirect participants or otherwise, shall instruct the Trustee in writing. The Trustee shall deliver such Securities as instructed in writing by the Depositary. All Securities issued upon any registration of transfer or exchange of Securities shall be the valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under this Indenture, as the Securities surrendered upon such registration of transfer or exchange. Every Security presented or surrendered for registration of transfer or for exchange shall be duly endorsed, or be accompanied by a written instrument of transfer in form satisfactory to the Company and the Registrar duly executed, by the Holder thereof or his attorney duly authorized in writing. The Company shall not be required (i) to issue, register the transfer of or exchange any Securities of any series during a period beginning at the opening of 15 Business Days before any selection of Securities of such series to be redeemed and ending at the close of business on the day of the mailing of the relevant notice of redemption or (ii) to register the transfer of or exchange any Security of any series so selected for redemption, in whole or in part, except the unredeemed portion of any Security being redeemed in part. Section 2.09 Replacement Securities. If any mutilated Security is surrendered to the Trustee or the Company and the Trustee receives evidence to its satisfaction of the destruction, loss or theft of any Security, the Company shall issue and the Trustee, upon receipt of a Company Order, shall authenticate a replacement Security if the Trustee's requirements are met. If required by the Trustee or the Company, an indemnity bond must be supplied by the Holder that is sufficient in the judgment of the Trustee and the Company to protect the Company, the 15 Trustee, any Agent and any authenticating agent from any loss that any of them may suffer if a Security is replaced. The Company may charge for its expenses in replacing a Security. Every replacement Security is an additional obligation of the Company and shall be entitled to all of the benefits of this Indenture equally and proportionately with all other Securities duly issued hereunder. Section 2.10 Outstanding Securities. The Securities of any series outstanding at any time are all the Securities of such series authenticated by the Trustee except for those canceled by it, those delivered to it for cancellation, those reductions in the interest in a Global Security effected by the Trustee in accordance with the provisions hereof, and those described in this Section as not outstanding. Except as set forth in Section 2.11 hereof, a Security does not cease to be outstanding because the Company or an Affiliate of the Company holds the Security. Subject to the foregoing, only Securities outstanding at the time of such determination shall be considered in any such determination (including, without limitation, determinations pursuant to Articles 6 and 9 hereof). In addition, in determining whether the Holders of the requisite principal amount of outstanding Securities have given or concurred in any request, demand, authorization, direction, notice, consent or waiver hereunder, (i) the principal amount of a Discount Security that shall be deemed to be outstanding shall be the amount of the principal thereof that would be due and payable as of the date of such determination upon acceleration of the maturity thereof pursuant to Section 6.02 hereof and (ii) the principal amount of a Security denominated in a foreign currency or currencies shall be the dollar equivalent, as determined on the date of original issuance of such Security, of the principal amount (or, in the case of a Discount Security, the dollar equivalent on the date of original issuance of such Security of the amount determined as provided in (i) above) of such Security. If a Security is replaced pursuant to Section 2.09 hereof, it ceases to be outstanding unless the Trustee receives proof satisfactory to it that the replaced Security is held by a bona fide purchaser. If the principal amount of any Security is considered paid under Section 4.01 hereof, it ceases to be outstanding and interest on it ceases to accrue. If the Paying Agent (other than the Company, a Subsidiary or an Affiliate of any thereof) holds, on a redemption date or maturity date, money sufficient to pay Securities payable on that date, then on and after that date such Securities shall be deemed to be no longer outstanding and shall cease to accrue interest. Section 2.11 Treasury Securities. In determining whether the Holders of the required principal amount of Securities of any series have concurred in any direction, waiver or consent, Securities of such series owned by the Company, or by any Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company, shall be considered as though not outstanding, except that for the purposes of determining whether the Trustee shall be protected in relying on any such direction, waiver or consent, only Securities of that series that the Trustee knows are so owned shall be so disregarded. Section 2.12 Temporary Securities. Until certificates representing Securities of any series are ready for delivery, the Company may prepare and the Trustee, upon receipt of a Company Order, shall authenticate temporary Securities. Temporary Securities shall be substantially in the form of certificated Securities but may have variations that the Company considers appropriate for temporary Securities and as shall be reasonably acceptable to 16 the Trustee. Without unreasonable delay, the Company shall prepare and the Trustee shall authenticate definitive Securities of the same series in exchange for temporary Securities. Holders of temporary Securities of any series shall be entitled to all of the benefits of this Indenture as permanent Securities of the same series. Section 2.13 Cancellation. The Company at any time may deliver Securities to the Trustee for cancellation. The Registrar and Paying Agent shall forward to the Trustee any Securities surrendered to them for registration of transfer, exchange or payment. The Trustee and no one else shall cancel all Securities surrendered for registration of transfer, exchange, payment, replacement or cancellation and shall destroy canceled Securities (subject to the record retention requirement of the Exchange Act). Certification of the destruction of all canceled Securities shall be delivered to the Company. The Company may not issue new Securities to replace Securities that it has paid or that have been delivered to the Trustee for cancellation. Section 2.14 Payment of Interest. Unless otherwise provided as contemplated by Section 2.03(a) hereof with respect to any series of Securities, interest on any Security which is payable, and is punctually paid or duly provided for, on any Interest Payment Date shall be paid to the person in whose name that Security (or one or more predecessor Securities) is registered at the close of business on the Regular Record Date for such interest. If the Company defaults in a payment of interest on the Securities of any series which is payable ("Defaulted Interest"), it shall pay the Defaulted Interest in any lawful manner plus, to the extent lawful, interest payable on the Defaulted Interest, to the Persons who are Holders of the series on a subsequent Special Record Date, in each case at the rate provided in the Securities of that series and in Section 4.01 hereof. The Company shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each Securities of a series and the date of the proposed payment. The Company shall fix or cause to be fixed each such Special Record Date and payment date, provided that no such Special Record Date shall be less than 10 days prior to the related payment date for such Defaulted Interest. At least 15 days before the Special Record Date, the Company (or, upon the written request of the Company, the Trustee in the name and at the expense of the Company) shall mail or cause to be mailed to Holders of the series a notice that states the Special Record Date, the related payment date and the amount of such interest to be paid. Subject to the foregoing provisions of this Section 2.14 and Section 2.08 hereof, each Security delivered under this Indenture upon registration of transfer of or in exchange for or in lieu of any other Security shall carry the rights to interest accrued and unpaid, and to accrue, which were carried by such other Security. Section 2.15 Persons Deemed Owners. Prior to due presentment of a Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the person in whose name such Security is registered as the owner of such Security for the purpose of receiving payment of principal of and (except as otherwise specified as contemplated by Section 2.03(a) hereof and subject to Sections 2.08 and 2.14 hereof) interest on such Security and for all other purposes whatsoever, whether or not such Security be overdue, and neither the Company, the Trustee nor any agent of the Company or the Trustee shall be affected by notice to the contrary. 17 None of the Company, the Trustee, any Paying Agent or the Registrar will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests of a Security in global form or for maintaining, supervising or reviewing any records relating to such beneficial ownership interests. Section 2.16 Computation of Interest. Except as otherwise specified as contemplated by Section 2.03(a) hereof for Securities of any series, (i) interest on any Securities which bear interest at a fixed rate shall be computed on the basis of a 360-day year comprised of twelve 30-day months and (ii) interest on any Securities which bear interest at a variable rate shall be computed on the basis of the actual number of days in an interest period divided by 360. Section 2.17 CUSIP Numbers. The Company, in issuing the Securities, may use "CUSIP" numbers (if then generally in use) and, if so, the Trustee shall use "CUSIP" numbers in notices of redemption as a convenience to Holders; provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities of a series or as contained in any notice of a redemption and that reliance may be placed only on the other identification numbers printed on the Securities of such series, and any such redemption shall not be affected by any defect in or omission of such numbers. The Company will promptly notify the Trustee of any change in the "CUSIP" numbers. ARTICLE 3. REDEMPTION AND PREPAYMENT Section 3.01 Right to Redeem; Notices to Trustee. Securities of any series which are redeemable before their Stated Maturity shall be redeemable in accordance with their terms and (except as otherwise specified as contemplated by Section 2.03(a) hereof for Securities of any series) in accordance with this Article 3. If the Company elects to redeem Securities of any series, it shall furnish to the Trustee, at least 35 days (or such shorter period as may be acceptable to the Trustee) but not more than 75 days before a redemption date, an Officers' Certificate setting forth (i) the clause of this Indenture pursuant to which the redemption shall occur, (ii) the Redemption Date, (iii) the principal amount of Securities of such series to be redeemed, (iv) any other information necessary to identify the Securities of such series to be redeemed and (v) the Redemption Price. Section 3.02 Selection of Securities to Be Redeemed. Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to any series of Securities, if less than all of the Securities of a series are to be redeemed or purchased in an offer to purchase at any time, the Trustee will select the Securities to be redeemed or purchased among the Holders of the Securities of that Series in compliance with the requirements of the principal national securities exchange, if any, on which the Securities are listed or, if the Securities are not so listed, on a pro rata basis, by lot or in accordance with any other method the Trustee considers fair and appropriate. In the event of partial redemption by lot, the particular Securities to be redeemed shall be selected, unless otherwise provided herein, not less than 30 nor more than 60 days prior to the Redemption Date by the Trustee from the outstanding Securities not previously called for redemption. The Trustee shall promptly notify the Company in writing of the Securities selected for redemption and, in the case of any Security selected for partial redemption, the principal amount thereof to be redeemed. Unless otherwise specified as contemplated by Section 2.03(a) hereof, Securities and 18 portions of Securities selected will be in amounts of $1,000 or whole multiples of $1,000. Except as provided in the preceding sentence, provisions of this Indenture that apply to Securities called for redemption also apply to portions of Securities called for redemption. Section 3.03 Notice of Redemption to Holders. Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to any series of Securities, at least 30 days but not more than 60 days before a Redemption Date, the Company shall mail or cause to be mailed, by first class mail, a notice of redemption to each Holder whose Securities are to be redeemed at its registered address. The notice shall identify the Securities to be redeemed and shall state: (a) the Redemption Date; (b) the Redemption Price; (c) if less than all the outstanding Securities of any series are to be redeemed, the identification (and in the case of partial redemption, the principal amount) of the particular Security to be redeemed; (d) that, after the Redemption Date upon surrender of such Security, a new Security or Securities in principal amount equal to the unredeemed portion shall be issued upon cancellation of the original Security; (e) the name and address of the Paying Agent; (f) that Securities called for redemption must be surrendered to the Paying Agent to collect the Redemption Price; (g) that, unless the Company defaults in making such redemption payment, interest, if any, on Securities called for redemption ceases to accrue on and after the Redemption Date; (h) the paragraph of the Securities and/or Section of this Indenture pursuant to which the Securities called for redemption are being redeemed; (i) that the redemption is for a sinking fund, if such is the case; and (j) that no representation is made as to the correctness or accuracy of the CUSIP number, if any, listed in such notice or printed on the Securities. At the Company's request, the Trustee shall give the notice of redemption in the Company's name and at its expense; provided, however, that the Company shall have delivered to the Trustee, at least 45 days prior to the Redemption Date (or such shorter period as may be acceptable to the Trustee), an Officers' Certificate requesting that the Trustee give such notice and setting forth the information to be stated in such notice as provided in the preceding paragraph. Notwithstanding the foregoing, a redemption notice may be mailed more than 60 days prior to the Redemption Date if the notice is issued in connection with a defeasance of the Securities or satisfaction and discharge of this Indenture. 19 Section 3.04 Effect of Notice of Redemption. Once notice of redemption is mailed in accordance with Section 3.03 hereof, Securities called for redemption become irrevocably due and payable on the Redemption Date at the Redemption Price. A notice of redemption may not be conditional. Section 3.05 Deposit of Redemption Price. Prior to 12:00 noon (Eastern Standard Time) on the Redemption Date, the Company shall deposit with the Trustee or with the Paying Agent money sufficient to pay the Redemption Price of and accrued interest on all Securities of a series to be redeemed on that date. The Trustee or the Paying Agent shall promptly return to the Company any money deposited with the Trustee or the Paying Agent by the Company in excess of the amounts necessary to pay the Redemption Price of, and accrued interest on, all Securities to be redeemed. If the Company complies with the provisions of the preceding paragraph, on and after the Redemption Date, interest shall cease to accrue on the Securities or the portions of Securities called for redemption. If a Security is redeemed on or after a Regular Record Date but on or prior to the related Interest Payment Date, then any accrued and unpaid interest shall be paid to the Person in whose name such Security was registered at the close of business on such Regular Record Date. If any Security called for redemption shall not be so paid upon surrender for redemption because of the failure of the Company to comply with the preceding paragraph, interest shall be paid on the unpaid principal from the Redemption Date until such principal is paid, and to the extent lawful on any interest not paid on such unpaid principal, in each case at the rate provided in the Securities and in Section 4.01 hereof. Section 3.06 Securities Redeemed in Part. Upon surrender of a Security that is redeemed in part, the Company shall issue and, upon the Company's written request, the Trustee shall authenticate for the Holder at the expense of the Company a new Security equal in principal amount to the unredeemed portion of the Security surrendered. ARTICLE 4. COVENANTS Section 4.01 Payment of Securities. The Company shall pay or cause to be paid the principal of, premium, if any, and interest on the Securities on the dates and in the manner provided in the Securities. Principal, premium, if any, and interest shall be considered paid on the date due if the Paying Agent, if other than the Company or a Subsidiary thereof, holds as of 10:00 a.m. Eastern Standard Time on the due date money deposited by the Company in immediately available funds and designated for and sufficient to pay all principal, premium, if any, and interest then due. Section 4.02 Maintenance of Office or Agency. The Company shall maintain in each place of payment for any series of Securities an office or agency (which may be an office of the Trustee or an affiliate of the Trustee, Registrar or co-registrar) where Securities of a series may be surrendered for registration of transfer or for exchange and where notices and demands to or upon the Company in respect of the Securities of such series and this Indenture may be served. The Company shall give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such 20 presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee. The Company also may from time to time designate one or more other offices or agencies where the Securities of a series may be presented or surrendered for any or all such purposes and may from time to time rescind such designations; provided, however, that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain an office or agency in each place of payment for Securities of any series for such purposes. The Company shall give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any such other office or agency. With respect to any Global Security, and except as otherwise may be specified for such Global Security as contemplated by Section 2.03(a) hereof, the Corporate Trust Office for the Trustee shall be the place of payment where such Global Security may be presented or surrendered for payment or for registration of transfer or exchange, or where successor Securities may be delivered in exchange therefore, provided, however, that any such payment, presentation, surrender or delivery effected pursuant to the procedures of the Depositary for such Global Security shall be deemed to have been effected at the place of payment for such Global Security in accordance with the provisions of this Indenture. The Company hereby designates the Corporate Trust Office of the Trustee as one such office or agency of the Company in accordance with Section 2.04 hereof. Section 4.03 Reports. Whether or not required by the rules and regulations of the SEC, so long as any Securities of any series are outstanding, the Company shall furnish to the Holders of such series of Securities (i) all quarterly and annual financial information that would be required to be contained in a filing with the SEC on Forms 10-Q and 10-K if the Company were required to file such forms, including a "Management's Discussion and Analysis of Financial Condition and Results of Operations" and, with respect to the annual information only, a report thereon by the Company's certified independent accountants and (ii) all current reports that would be required to be filed with the SEC on Form 8-K if the Company were required to file such reports, in each case, within the time periods specified in the SEC's rules and regulations. In addition, whether or not required by the rules and regulations of the SEC, the Company shall file a copy of all such information and reports with the SEC for public availability within the time periods specified in the SEC's rules and regulations (unless the SEC will not accept such a filing) and make such information available to securities analysts and prospective investors upon request. The Company shall at all times comply with TIA 'SS'314(a). Section 4.04 Compliance Certificate. (a) The Company and each Guarantor, if any, (to the extent that such Guarantor is so required under the TIA) shall deliver to the Trustee, within 120 days after the end of each fiscal year, an Officers' Certificate stating that a review of the activities of the Company and its Subsidiaries during the preceding fiscal year has been made under the supervision of the signing Officers with a view to determining whether the Company has kept, observed, performed and fulfilled its obligations under this Indenture, and further stating, as to each such Officer signing such certificate, that to the best of his or her knowledge the Company has kept, observed, performed and fulfilled each and every covenant contained in this Indenture and is not in default in the performance or observance of any of the terms, provisions and conditions of this Indenture (or, if a Default or Event of Default shall have occurred, describing all such Defaults or Events of Default of which he or she may have knowledge and what action the Company is taking or proposes to take with respect thereto) and that to the best of his or her knowledge no event has occurred and remains in existence by reason of which payments on account of the principal of or interest, 21 if any, on the Securities is prohibited or if such event has occurred, a description of the event and what action the Company is taking or proposes to take with respect thereto. ARTICLE 5. SUCCESSORS Section 5.01 Merger, Consolidation or Sale of Assets. Unless otherwise specified as contemplated by Section 2.03(a) hereof, the Company shall not, directly or indirectly: (1) consolidate or merge with or into another Person (whether or not the Company is the surviving corporation); or (2) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets of the Company and its Restricted Subsidiaries taken as a whole, in one or more related transactions, to another Person; unless: (a) either: (i) the Company is the surviving corporation; or (ii) the Person formed by or surviving any such consolidation or merger (if other than the Company) or to which such sale, assignment, transfer, conveyance or other disposition has been made is a corporation organized or existing under the laws of the United States, any state of the United States or the District of Columbia; or (b) the Person formed by or surviving any such consolidation or merger (if other than the Company) or the Person to which such sale, assignment, transfer, conveyance or other disposition has been made assumes all the obligations of the Company under the Securities and this Indenture pursuant to a supplemental indenture reasonably satisfactory to the Trustee. In addition, the Company may not, directly or indirectly, lease all or substantially all of the properties or assets of the Company and its Restricted Subsidiaries, taken as a whole, in one or more related transactions, to any other Person. This Section 5.01 will not apply to a sale, assignment, transfer, conveyance or other disposition of assets between or among the Company and any of the Guarantors, as applicable. Section 5.02 Successor Corporation Substituted. Upon any consolidation or merger, or any sale, assignment, transfer, conveyance, transfer or other disposition of all or substantially all of the properties or assets of the Company and its Restricted Subsidiaries, taken as a whole in accordance with the provisions of Section 5.01 hereof, the successor Person formed by such consolidation or into which the Company is merged or to which such sale, assignment, transfer, conveyance or other disposition is made, shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor had been named as the Company therein. When a successor assumes all the obligations of its predecessor under this Indenture and the Securities following a consolidation or merger, or any sale, assignment, transfer, conveyance, transfer or other disposition of 90% or more of the assets of the predecessor in accordance with the foregoing provisions, the predecessor shall be released from those obligations. 22 ARTICLE 6. DEFAULTS AND REMEDIES Section 6.01 Events of Default. Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to any series of Securities, an "Event of Default" occurs, with respect to each series of Securities individually, if: (a) the Company defaults in the payment when due of interest on the Securities of such series and such default continues for a period of 30 days; (b) the Company defaults in the payment when due of principal of or premium, if any, on the Securities of such series when the same becomes due and payable at maturity, upon redemption or otherwise; (c) the Company fails to comply with any of the provisions of Section 5.01 hereof if applicable to such series of Securities; (d) the Company fails to observe or perform any other covenant or other agreement in this Indenture applicable to such series of Securities or the Securities of such series for 60 days after notice to the Company by the Trustee or the Holders of at least 25% in aggregate principal amount of the Securities of such series then outstanding voting as a single class; (e) the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary pursuant to or within the meaning of Bankruptcy Law: (i) commences a voluntary case, (ii) consents to the entry of an order for relief against it in an involuntary case, (iii) consents to the appointment of a custodian of it or for all or substantially all of its property, (iv) makes a general assignment for the benefit of its creditors, or (v) generally is not paying its debts as they become due; (f) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: (i) is for relief against the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary in an involuntary case; (ii) appoints a custodian of the Company or any of its Restricted Subsidiaries or for all or substantially all of the property of the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary; or (iii) orders the liquidation of the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary; and the order or decree remains unstayed and in effect for 60 consecutive days; 23 (g) except as permitted by this Indenture, any Security Guarantee relating to such series of Securities is held in any final, non-appealable judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or any Guarantor relating to such series of Securities, or any Person acting on behalf of any such Guarantor, shall deny or disaffirm its obligations under such Guarantor's Security Guarantee (unless such Guarantor could be released from its Guarantee in accordance with this Indenture and as specified pursuant to Section 2.03(a) hereof); or (h) any other Event of Default provided with respect to the Securities of that series, which is specified in a supplemental indenture hereto or an Officers' Certificate, in accordance with Section 2.03(a) hereof. Section 6.02 Acceleration. If any Event of Default (other than an Event of Default specified in clause (e) or (f) of Section 6.01 hereof with respect to the Company) occurs and is continuing, the Trustee or the Holders of at least 25% in principal amount of the then outstanding Securities of that series may declare all the Securities of that series to be due and payable immediately. Upon any such declaration, the Securities of that series shall become due and payable immediately. Notwithstanding the foregoing, if an Event of Default specified in clause (e) or (f) of Section 6.01 hereof occurs with respect to the Company, all outstanding Securities of that series shall be due and payable immediately without further action or notice. The Holders of a majority in aggregate principal amount of the then outstanding Securities of a series by written notice to the Trustee may on behalf of all of the Holders of such series of Securities rescind an acceleration and its consequences if all existing Events of Default (except nonpayment of principal, interest or premium that has become due solely because of the acceleration) have been cured or waived. Section 6.03 Other Remedies. If an Event of Default with respect to a series of Securities occurs and is continuing, the Trustee may pursue any available remedy to collect the payment of principal, premium, if any, and interest on the Securities of such series or to enforce the performance of any provision of the Securities of such series or this Indenture. The Trustee may maintain a proceeding even if it does not possess any of the Securities of a series or does not produce any of them in the proceeding. A delay or omission by the Trustee or any Holder of a Security of such series in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. All remedies are cumulative to the extent permitted by law. Section 6.04 Waiver of Past Defaults. Holders of not less than a majority in aggregate principal amount of the then outstanding Securities of a series by notice to the Trustee may on behalf of the Holders of all of the Securities of such series waive an existing Default or Event of Default and its consequences hereunder, except a continuing Default or Event of Default in the payment of the principal of, premium, if any, or interest on, the Securities of that series (including in connection with an offer to purchase) (provided, however, that the Holders of a majority in aggregate principal amount of the then outstanding Securities of a series may rescind an acceleration and its consequences, including any related payment default that resulted from such acceleration). Upon any such waiver, such Default shall cease to exist, and any Event of Default arising therefrom shall be deemed to have been cured for every purpose of this Indenture; but no such waiver shall extend to any subsequent or other Default or impair any right consequent thereon. 24 Section 6.05 Control by Majority. Holders of a majority in principal amount of the then outstanding Securities of any series may direct the time, method and place of conducting any proceeding for exercising any remedy available to the Trustee or exercising any trust or power conferred on it. However, the Trustee may refuse to follow any direction that conflicts with law or this Indenture that the Trustee determines may be unduly prejudicial to the rights of other Holders of such Securities or that may involve the Trustee in personal liability. Section 6.06 Limitation on Suits. A Holder of any Security of any series may pursue a remedy with respect to this Indenture or such series of Securities only if: (a) the Holder of a Security of such series gives to the Trustee written notice of a continuing Event of Default; (b) the Holders of at least 25% in principal amount of the then outstanding Securities of such series make a written request to the Trustee to pursue the remedy; (c) the Holder of a Security of such series or Holders of Securities of such series offer and, if requested, provide to the Trustee indemnity satisfactory to the Trustee against any loss, liability or expense; (d) the Trustee does not comply with the request within 60 days after receipt of the request and the offer and, if requested, the provision of indemnity; and (e) during such 60-day period the Holders of a majority in principal amount of the then outstanding Securities of such series do not give the Trustee a direction inconsistent with the request. A Holder of any Security may not use this Indenture to prejudice the rights of another Holder or to obtain a preference or priority over another Holder. Section 6.07 Rights of Holders of Securities to Receive Payment and Convert. Notwithstanding any other provision of this Indenture, the Holder of any Security shall have the right to receive payment of principal of, premium, if any, and interest on such Security, on or after the respective due dates expressed in such Security (including in connection with an offer to purchase), or to bring suit for the enforcement of any such payment on or after such respective dates shall not be impaired or affected without the consent of such Holder. Section 6.08 Collection Suit by Trustee. If an Event of Default specified in Section 6.01(a) or (b) hereof occurs and is continuing, the Trustee is authorized to recover judgment in its own name and as trustee of an express trust against the Company for the whole amount of principal of, premium, if any, and interest remaining unpaid on the Securities of any series and interest on overdue principal and, to the extent lawful, interest and such further amount as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel. 25 Section 6.09 Trustee May File Proofs of Claim. The Trustee is authorized to file such proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and the Holders of the Securities of any series allowed in any judicial proceedings relative to the Company (or any other obligor upon the Securities of that series), its creditors or its property and shall be entitled and empowered to collect, receive and distribute any money or other property payable or deliverable on any such claims and any custodian in any such judicial proceeding is hereby authorized by each Holder to make such payments to the Trustee, and in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.07 hereof. To the extent that the payment of any such compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.07 hereof out of the estate in any such proceeding, shall be denied for any reason, payment of the same shall be secured by a Lien on, and shall be paid out of, any and all distributions, dividends, money, securities and other properties that the Holders may be entitled to receive in such proceeding whether in liquidation or under any plan of reorganization or arrangement or otherwise. Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Securities or the rights of any Holder, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding. Section 6.10 Priorities. If the Trustee collects any money pursuant to this Article 6, it shall pay out the money in the following order: First: to the Trustee, its agents and attorneys for amounts due under Section 7.07 hereof, including payment of all compensation, expense and liabilities incurred, and all advances made, by the Trustee and the costs and expenses of collection; Second: to Holders of Securities for amounts due and unpaid on the Securities of any series for principal, premium, if any, and interest, ratably, without preference or priority of any kind, according to the amounts due and payable on the Securities of that series for principal, premium, if any and interest, respectively; and Third: to the Company or to such party as a court of competent jurisdiction shall direct. The Trustee may fix a record date and payment date for any payment to Holders of Securities pursuant to this Section 6.10. Section 6.11 Undertaking for Costs. In any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken or omitted by it as a Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys' fees, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section 6.11 does not apply to a suit by the Trustee, a suit by a Holder of a Security of any series pursuant to Section 6.07 hereof, or a suit by Holders of more than 10% in principal amount of the then outstanding Securities of any series. 26 ARTICLE 7. TRUSTEE Section 7.01 Duties of Trustee. (a) If an Event of Default with respect to the Securities of any series has occurred and is continuing, the Trustee shall exercise such of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in its exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person's own affairs. (b) With respect to the Securities of any series, except during the continuance of an Event of Default with respect to Securities of such series: (i) the duties of the Trustee shall be determined solely by the express provisions of this Indenture and the Trustee need perform only those duties that are specifically set forth in this Indenture and no others, and no implied covenants or obligations shall be read into this Indenture against the Trustee; and (ii) in the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture. However, the Trustee shall examine the certificates and opinions to determine whether or not they conform to the requirements of this Indenture. (c) The Trustee may not be relieved from liabilities for its own negligent action, its own negligent failure to act, or its own willful misconduct, except that: (i) this paragraph does not limit the effect of paragraph (b) of this Section 7.01; (ii) the Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer, unless it is proved that the Trustee was negligent in ascertaining the pertinent facts; and (iii) the Trustee shall not be liable with respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 6.05 hereof. (d) Whether or not therein expressly so provided, every provision of this Indenture that in any way relates to the Trustee is subject to paragraphs (a), (b), and (c) of this Section 7.01. (e) No provision of this Indenture shall require the Trustee to expend or risk its own funds or incur any liability. The Trustee shall be under no obligation to exercise any of its rights and powers under this Indenture at the request of any Holders, unless such Holder shall have offered to the Trustee security and indemnity satisfactory to it against any loss, liability or expense. (f) The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law. 27 Section 7.02 Rights of Trustee. (a) The Trustee may conclusively rely upon any document believed by it to be genuine and to have been signed or presented by the proper Person. The Trustee need not investigate any fact or matter stated in the document. (b) Before the Trustee acts or refrains from acting, it may require an Officers' Certificate or an Opinion of Counsel or both. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on such Officers' Certificate or Opinion of Counsel. The Trustee may consult with counsel and the written advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection from liability in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon. (c) The Trustee may act through its attorneys and agents and shall not be responsible for the misconduct or negligence of any agent appointed with due care. (d) The Trustee shall not be liable for any action it takes or omits to take in good faith that it believes to be authorized or within the rights or powers conferred upon it by this Indenture. (e) Unless otherwise specifically provided in this Indenture, any demand, request, direction or notice from the Company or any Guarantor, if applicable, shall be sufficient if signed by an Officer of the Company or Guarantor, as applicable. (f) The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request or direction of any of the Holders unless such Holders shall have offered to the Trustee reasonable security or indemnity against the costs, expenses and liabilities that might be incurred by it in compliance with such request or direction. Section 7.03 Individual Rights of Trustee. The Trustee in its individual or any other capacity may become the owner or pledgee of Securities and may otherwise deal with the Company or any Affiliate of the Company with the same rights it would have if it were not Trustee. However, in the event that the Trustee acquires any conflicting interest, it must eliminate such conflict within 90 days, apply to the SEC for permission to continue as Trustee or resign. Any Agent may do the same with like rights and duties. The Trustee is also subject to Sections 7.10 and 7.11 hereof. Section 7.04 Trustee's Disclaimer. The Trustee shall not be responsible for and makes no representation as to the validity or adequacy of this Indenture or the Securities, it shall not be accountable for the Company's use of the proceeds from the Securities or any money paid to the Company or upon the Company's direction under any provision of this Indenture, it shall not be responsible for the use or application of any money received by any Paying Agent other than the Trustee, and it shall not be responsible for any statement or recital herein or any statement in the Securities or any other document in connection with the sale of the Securities or pursuant to this Indenture other than its certificate of authentication. Section 7.05 Notice of Defaults. If a Default or Event of Default occurs and is continuing with respect to a series of Securities and if it is known to the Trustee, the Trustee shall mail to Holders of Securities of such series a notice of the Default or Event of Default within 90 days after it occurs. Except in the case of a Default or Event of 28 Default in payment of principal of, premium, if any, or interest on any Security, the Trustee may withhold the notice if and so long as a committee of its Responsible Officers in good faith determines that withholding the notice is in the interests of the Holders of the Securities. Section 7.06 Reports by Trustee to Holders of the Securities. Within 60 days after each ________ beginning with the ________ following the date of this Indenture, and for so long as Securities of any series remain outstanding, the Trustee shall mail to the Holders of the Securities of such series a brief report dated as of such reporting date that complies with TIA 'SS'313(a) (but if no event described in TIA 'SS'313(a) has occurred within the twelve months preceding the reporting date, no report need be transmitted). The Trustee also shall comply with TIA 'SS'313(b)(2). The Trustee also shall transmit by mail all reports as required by TIA 'SS' 313(c). A copy of each report at the time of its mailing to the Holders of Securities shall be mailed to the Company and filed with the SEC and each stock exchange on which the Securities are listed in accordance with TIA 'SS' 313(d). The Company shall promptly notify the Trustee when the Securities are listed on any stock exchange. Section 7.07 Compensation and Indemnity. The Company shall pay to the Trustee from time to time reasonable compensation for its acceptance of this Indenture and services hereunder. The Trustee's compensation shall not be limited by any law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee promptly upon request for all reasonable disbursements, advances and expenses incurred or made by it in addition to the compensation for its services. Such expenses shall include the reasonable compensation, disbursements and expenses of the Trustee's agents and counsel. The Company shall indemnify the Trustee against any and all losses, liabilities or expenses incurred by it arising out of or in connection with the acceptance or administration of its duties under this Indenture, including the costs and expenses of enforcing this Indenture against the Company (including this Section 7.07) and defending itself against any claim (whether asserted by the Company or any Holder or any other person) or liability in connection with the exercise or performance of any of its powers or duties hereunder, except to the extent any such loss, liability or expense may be attributable to its negligence or bad faith. The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. Failure by the Trustee to so notify the Company shall not relieve the Company of its obligations hereunder. The Company shall defend the claim and the Trustee shall cooperate in the defense. The Trustee may have separate counsel and the Company shall pay the reasonable fees and expenses of such counsel. The Company need not pay for any settlement made without its consent, which consent shall not be unreasonably withheld. The obligations of the Company under this Section 7.07 shall survive the satisfaction and discharge of this Indenture. To secure the Company's payment obligations in this Section 7.07, the Trustee shall have a Lien prior to the Securities on all money or property held or collected by the Trustee, except that held in trust to pay principal and interest on particular Securities. Such Lien shall survive the satisfaction and discharge of this Indenture. When the Trustee incurs expenses or renders services after an Event of Default specified in Section 6.01(e) or (f) hereof occurs, the expenses and the compensation for the services (including the fees and expenses of its agents and counsel) are intended to constitute expenses of administration under any Bankruptcy Law. 29 The Trustee shall comply with the provisions of TIA 'SS'313(b)(2) to the extent applicable. Section 7.08 Replacement of Trustee. A resignation or removal of the Trustee and appointment of a successor Trustee shall become effective only upon the successor Trustee's acceptance of appointment as provided in this Section 7.08. The Trustee may resign in writing at any time and be discharged from the trust hereby created by so notifying the Company. The Holders of a majority in principal amount of the then outstanding Securities of any series may remove the Trustee by so notifying the Trustee and the Company in writing. The Company may remove the Trustee if: (a) the Trustee fails to comply with Section 7.10 hereof; (b) the Trustee is adjudged a bankrupt or an insolvent or an order for relief is entered with respect to the Trustee under any Bankruptcy Law; (c) a custodian or public officer takes charge of the Trustee or its property; or (d) the Trustee becomes incapable of acting. If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any reason, the Company shall promptly appoint a successor Trustee. Within one year after the successor Trustee takes office, the Holders of a majority in principal amount of the then outstanding Securities of any series may appoint a successor Trustee to replace the successor Trustee appointed by the Company. If a successor Trustee does not take office within 60 days after the retiring Trustee resigns or is removed, the retiring Trustee, the Company, or the Holders of at least 10% in principal amount of the then outstanding Securities of any series may petition any court of competent jurisdiction for the appointment of a successor Trustee. If the Trustee, after written request by any Holder who has been a Holder for at least six months, fails to comply with Section 7.10 hereof, such Holder may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Thereupon, the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee under this Indenture. The successor Trustee shall mail a notice of its succession to Holders. The retiring Trustee shall promptly transfer all property held by it as Trustee to the successor Trustee, provided all sums owing to the Trustee hereunder have been paid and subject to the Lien provided for in Section 7.07 hereof. Notwithstanding replacement of the Trustee pursuant to this Section 7.08, the Company's obligations under Section 7.07 hereof shall continue for the benefit of the retiring Trustee. 30 Section 7.09 Successor Trustee by Merger, etc. If the Trustee consolidates, merges or converts into, or transfers all or substantially all of its corporate trust business to, another corporation, the successor corporation without any further act shall be the successor Trustee. Section 7.10 Eligibility; Disqualification. There shall at all times be a Trustee hereunder that is a corporation organized and doing business under the laws of the United States of America or of any state thereof that is authorized under such laws to exercise corporate trustee power, that is subject to supervision or examination by federal or state authorities and that has a combined capital and surplus of at least $100 million as set forth in its most recent published annual report of condition. This Indenture shall always have a Trustee who satisfies the requirements of TIA 'SS'310(a)(1), (2) and (5). The Trustee is subject to TIA 'SS' 310(b). Section 7.11 Preferential Collection of Claims Against Company. The Trustee is subject to TIA 'SS'311(a), excluding any creditor relationship listed in TIA 'SS'311(b). A Trustee who has resigned or been removed shall be subject to TIA 'SS'311(a) to the extent indicated therein. ARTICLE 8. LEGAL DEFEASANCE AND COVENANT DEFEASANCE Section 8.01 Option to Effect Legal Defeasance or Covenant Defeasance. Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to Securities of a particular series, the Company may elect, at its option, at any time, to have either Section 8.02 or 8.03 hereof be applied to all outstanding Securities of any series designated pursuant to Section 2.03(a) hereof as being defeasible (the "Defeased Securities") in accordance with any additional requirements provided pursuant to Section 2.03(a) hereof and upon compliance with the conditions set forth below in this Article 8. Any such election shall be evidenced by a Board Resolution set forth in an Officers' Certificate or in another manner specified as contemplated by Section 2.03(a) hereof for such Securities. Section 8.02 Legal Defeasance and Discharge. Upon the Company's exercise under Section 8.01 hereof of the option (if any) to have this Section 8.02 applied to any Securities of any series, the Company shall, subject to the satisfaction of the conditions set forth in Section 8.04 hereof, be deemed to have been discharged from its obligations with respect to all outstanding Defeased Securities on the date the conditions set forth below are satisfied (hereinafter, "Legal Defeasance"). For this purpose, Legal Defeasance means that the Company shall be deemed to have paid and discharged the entire Indebtedness represented by the outstanding Defeased Securities, which shall thereafter be deemed to be "outstanding" only for the purposes of Section 8.05 hereof and the other Sections of this Indenture referred to in (a) and (b) below, and to have satisfied all its other obligations under such Defeased Securities and this Indenture (and the Trustee, on demand of and at the expense of the Company, shall execute proper instruments acknowledging the same), except for the following provisions which shall survive until otherwise terminated or discharged hereunder: (a) the rights of Holders of outstanding Defeased Securities to receive solely from the trust fund under Section 8.04 hereof, and as more fully set forth in such Section, payments in respect of the principal of, premium, if any, and interest on such Defeased Securities when such payments are due, (b) the Company's 31 obligations with respect to such Defeased Securities under Article 2 and Section 4.01 hereof, (c) the rights, powers, trusts, duties and immunities of the Trustee hereunder and the Company's obligations in connection therewith and (d) this Article 8. Subject to compliance with this Article 8, the Company may exercise its option under this Section 8.02 notwithstanding the prior exercise of its option under Section 8.03 hereof. Section 8.03 Covenant Defeasance. Upon the Company's exercise under Section 8.01 hereof of the option (if any) to have this Section 8.03 applied to any Securities of any series the Company and, if applicable, each Guarantor shall, subject to the satisfaction of the conditions set forth in Section 8.04 hereof, be released from its obligations under Sections 4.03, 4.05 and 4.06 hereof and Articles 5 and 12 hereof and such other provisions as may be provided as contemplated by Section 2.03(a) hereof with respect to Securities of a particular series and with respect to the outstanding Defeased Securities on and after the date the conditions set forth in Section 8.04 hereof are satisfied (hereinafter, "Covenant Defeasance"), and the Defeased Securities shall thereafter be deemed not "outstanding" for the purposes of any direction, waiver, consent or declaration or act of Holders of such Defeased Securities (and the consequences of any thereof) in connection with such covenants, but shall continue to be deemed "outstanding" for all other purposes hereunder (it being understood that such Defeased Securities shall not be deemed outstanding for accounting purposes). For this purpose, Covenant Defeasance means that, with respect to the outstanding Defeased Securities, the Company and, if applicable, each Guarantor may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth in any such covenant, whether directly or indirectly, by reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other document and such omission to comply shall not constitute a Default or an Event of Default under Section 6.01 hereof, but, except as specified above, the remainder of this Indenture and such Defeased Securities shall be unaffected thereby. In addition, upon the Company's exercise under Section 8.01 hereof of the option applicable to this Section 8.03 hereof, subject to the satisfaction of the conditions set forth in Section 8.04 hereof and Sections 6.01(c), (d) and (g) hereof shall not constitute Events of Default. Section 8.04 Conditions to Legal or Covenant Defeasance. The following shall be the conditions to the application of either Section 8.02 or 8.03 hereof to a series of outstanding Securities: Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to any series of Securities, in order to exercise either Legal Defeasance or Covenant Defeasance: (a) the Company must irrevocably deposit with the Trustee, in trust, for the benefit of the Holders, cash, non-callable Government Securities, or a combination thereof, in such amounts as will be sufficient to pay the principal of, premium, if any, and interest on the outstanding Securities of such series on the stated date for payment thereof or on the applicable redemption date, as the case may be; (b) in the case of an election under Section 8.02 hereof, the Company shall have delivered to the Trustee an Opinion of Counsel confirming that (A) the Company has received from, or there has been published by, the Internal Revenue Service a ruling or (B) since the date this Indenture was first executed, there has been a change in the applicable federal income tax law, in either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, the Holders of the outstanding Securities of such series will not recognize income, gain or loss for federal income tax purposes as a result of such Legal Defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not occurred; and 32 (c) in the case of an election under Section 8.03 hereof, the Company shall have delivered to the Trustee an Opinion of Counsel confirming that the Holders of the outstanding Securities of such series will not recognize income, gain or loss for federal income tax purposes as a result of such Covenant Defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Covenant Defeasance had not occurred. Section 8.05 Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous Provisions. Subject to Section 8.06 hereof, all money and non-callable Government Securities (including the proceeds thereof) deposited with the Trustee (or other qualifying trustee, collectively for purposes of this Section 8.05, the "Trustee") pursuant to Section 8.04 hereof in respect of the outstanding Defeased Securities shall be held in trust and applied by the Trustee, in accordance with the provisions of such Defeased Securities and this Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as Paying Agent) as the Trustee may determine, to the Holders of such Defeased Securities of all sums due and to become due thereon in respect of principal, premium, if any, and interest, but such money need not be segregated from other funds except to the extent required by law. The Company shall pay and indemnify the Trustee against any tax, fee or other charge imposed on or assessed against the cash or non-callable Government Securities deposited pursuant to Section 8.04 hereof or the principal and interest received in respect thereof other than any such tax, fee or other charge which by law is for the account of the Holders of the outstanding Defeased Securities. Anything in this Article 8 to the contrary notwithstanding, the Trustee shall deliver or pay to the Company from time to time upon the request of the Company any money or non-callable Government Securities held by it as provided in Section 8.04 hereof which in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee are in excess of the amount thereof that would then be required to be deposited to effect an equivalent Legal Defeasance or Covenant Defeasance. Section 8.06 Repayment to Company. Any money deposited with the Trustee or any Paying Agent, or then held by the Company, in trust for the payment of the principal of, premium, if any, or interest on any Securities of a series and remaining unclaimed for two years after such principal, and premium, if any, or interest has become due and payable shall be paid to the Company on its request or (if then held by the Company) shall be discharged from such trust; and the Holder of such series of Securities shall thereafter look only to the Company for payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust money, and all liability of the Company as trustee thereof, shall thereupon cease; provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment, may at the expense of the Company cause to be published once, in The New York Times and The Wall Street Journal (national edition), notice that such money remains unclaimed and that, after a date specified therein, which shall not be less than 30 days from the date of such notification or publication, any unclaimed balance of such money then remaining will be repaid to the Company. Section 8.07 Reinstatement. If the Trustee or Paying Agent is unable to apply any cash or non-callable Government Securities in accordance with Section 8.02 or 8.03 hereof, as the case may be, by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, then the Company's obligations under this Indenture and the Defeased Securities shall be revived and 33 reinstated as though no deposit had occurred pursuant to Section 8.02 or 8.03 hereof until such time as the Trustee or Paying Agent is permitted to apply all such money in accordance with Section 8.02 or 8.03 hereof, as the case may be; provided, however, that, if the Company makes any payment of principal of, premium, if any, or interest on any Defeased Securities following the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Defeased Securities to receive such payment from the money held by the Trustee or Paying Agent. ARTICLE 9. AMENDMENT, SUPPLEMENT AND WAIVER Section 9.01 Without Consent of Holders of Securities. Notwithstanding Section 9.02 hereof, the Company, the Guarantors, if any, and the Trustee at any time and from time to time may amend this Indenture or enter into one or more indentures supplemental hereto without the consent of any Holder of a Security for any of the following purposes: (a) to cure any ambiguity, defect or inconsistency; (b) to provide for uncertificated Securities in addition to or in place of certificated Securities in a manner that does not materially adversely affect any Holder; (c) to provide for the assumption of the Company's or, if applicable, a Guarantor's obligations to the Holders of the Securities or a series by a successor pursuant to Article 5 or 12 hereof; (d) to make any change that would provide any additional rights or benefits to the Holders or that does not adversely affect the legal rights hereunder of any Holder; (e) to comply with requirements of the SEC in order to effect or maintain the qualification of this Indenture under the TIA; (f) to add a Guarantor with respect to Securities of any series; (g) to evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to the Securities of one or more series and to add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee, pursuant to the requirements of Section 7.08 hereof; (h) to mortgage, pledge, hypothecate or grant a security interest in favor of the Trustee for the benefit of the Holders of Securities of any series as additional security for the payment and performance of the Company's or, if applicable, a Guarantor's obligations herein in any property or assets; (i) to add to, change or eliminate any of the provisions of this Indenture (which addition, change or elimination may apply to one or more series of Securities), provided that, any such addition, change or elimination (A) shall neither (i) apply to any Security of any series created prior to the execution of such supplemental indenture and entitled to the benefit of such provision nor (ii) modify the rights of the Holder of any such Security with respect to such provision or (B) shall become effective only when there is no such outstanding Security; or (j) to establish the form and terms of Securities of any series permitted by Sections 2.01 and 2.03(a) hereof, respectively. 34 Upon the request of the Company accompanied by a Board Resolution authorizing the execution of any such amended or supplemental Indenture, and upon receipt by the Trustee of the documents described in Section 7.02 hereof, the Trustee shall join with the Company and, if applicable, the Guarantors in the execution of any amended or supplemental Indenture authorized or permitted by the terms of this Indenture and to make any further appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to enter into such amended or supplemental Indenture that affects its own rights, duties or immunities under this Indenture or otherwise. Section 9.02 With Consent of Holders of Securities. Except as provided below in this Section 9.02, the Company and the Trustee may amend this Indenture or the Securities of any series with the consent of the Holders of at least a majority in principal amount of the Securities of such series then outstanding voting as a single class (including consents obtained in connection with a tender offer or exchange offer for, or purchase of, such Securities), and, subject to Sections 6.04 and 6.07 hereof, any existing Default or Event of Default with respect to a particular series of Securities (other than a Default or Event of Default in the payment of the principal of, premium, if any, or interest on such Securities, except a payment default resulting from an acceleration that has been rescinded) or compliance with any provision of this Indenture or such Securities may be waived with the consent of the Holders of a majority in principal amount of the then outstanding Securities of such series voting as a single class (including consents obtained in connection with a tender offer or exchange offer for, or purchase of, such Securities). Upon the request of the Company accompanied by a Board Resolution authorizing the execution of any such amended or supplemental Indenture, and upon the filing with the Trustee of evidence satisfactory to the Trustee of the consent of the Holders of Securities as aforesaid, and upon receipt by the Trustee of the documents described in Section 7.02 hereof, the Trustee shall join with the Company and, if applicable, the Guarantors in the execution of such amended or supplemental Indenture unless such amended or supplemental Indenture directly affects the Trustee's own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such amended or supplemental Indenture. It shall not be necessary for the consent of the Holders of Securities under this Section 9.02 to approve the particular form of any proposed amendment or waiver, but it shall be sufficient if such consent approves the substance thereof. After an amendment, supplement or waiver under this Section 9.02 becomes effective, the Company shall mail to the Holders of Securities affected thereby a notice briefly describing the amendment, supplement or waiver. Any failure of the Company to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such amended or supplemental indenture or waiver. Subject to Sections 6.04 and 6.07 hereof and except as otherwise provided below in this Section 9.02, the Holders of a majority in aggregate principal amount of the Securities of any series then outstanding voting as a single class may waive compliance in a particular instance by the Company with any provision of this Indenture or the Securities of such series. However, without the consent of each Holder affected, an amendment or waiver under this Section 9.02 may not (with respect to any Securities of such series held by a non-consenting Holder): (a) change the Stated Maturity of, the principal of, or any installment of principal or interest on, any such Security, or reduce the principal amount thereof or the rate of interest thereon or any premium payable upon redemption thereof or reduce the amount of principal of or premium, if any, on any such Discount Security that would be due and payable upon a declaration of acceleration of maturity thereof pursuant to Section 6.02 hereof, or change the place of payment where, or change the coin or currency in which, any principal of, or any installment of interest on, any such Security is payable, or 35 impair the right to institute suit for the enforcement of any such payment on or after the Stated Maturity thereof (or, in the case of redemption, on or after the Redemption Date); (b) reduce the percentage in principal amount of the outstanding Securities of any series, the consent of whose Holders is required for any such amendment or supplemental indenture, or the consent of whose Holders is required for any waiver (of compliance with certain provisions of this Indenture or certain defaults hereunder and their consequences) with respect to the Securities of such series provided for in this Indenture; (c) modify any of the provisions of this Section 9.02 or Section 6.04 or 6.07 hereof, except to increase the percentage of outstanding Securities of such series required for such actions to provide that certain other provisions of this Indenture cannot be modified or waived without the consent of the Holder of each outstanding Security of a series affected thereby; (d) release any applicable Guarantor from any of its obligations under its Security Guarantee or this Indenture, except in accordance with the terms of this Indenture; or (e) change such other matters as may be specified pursuant to Section 2.03(a) hereof. Section 9.03 Compliance with Trust Indenture Act. Every amendment or supplement to this Indenture or the Securities of any series shall be set forth in a amended or supplemental Indenture that complies with the TIA as then in effect. Section 9.04 Revocation and Effect of Consents. Until an amendment, supplement or waiver becomes effective, a consent to it by a Holder of a Security is a continuing consent by the Holder of a Security and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting Holder's Security, even if notation of the consent is not made on any Security. However, any such Holder of a Security or subsequent Holder of a Security may revoke the consent as to its Securities if the Trustee receives written notice of revocation before the date the waiver, supplement or amendment becomes effective. An amendment, supplement or waiver becomes effective in accordance with its terms and thereafter binds every Holder. Section 9.05 Notation on or Exchange of Securities. The Trustee may place an appropriate notation about an amendment, supplement or waiver on any Security of a series thereafter authenticated. The Company in exchange for all Securities of a series may issue and the Trustee shall, upon receipt of a Company Order, authenticate new Securities of such series that reflect the amendment, supplement or waiver. Failure to make the appropriate notation or issue a new Security shall not affect the validity and effect of such amendment, supplement or waiver. Section 9.06 Trustee to Sign Amendments, etc. The Trustee shall sign any amended or supplemental Indenture authorized pursuant to this Article 9 if the amendment or supplement does not adversely affect the rights, duties, liabilities or immunities of the Trustee. The Company may not sign an amendment or supplemental Indenture until the Board of Directors approves it. In executing any amended or supplemental indenture, the Trustee shall be entitled to receive and (subject to Section 7.01 hereof) shall be fully protected in relying upon, in addition to the documents required by Section 14.04 hereof, an Officers' Certificate and an Opinion of Counsel stating that the execution of such amended or supplemental indenture is authorized or permitted by this Indenture. 36 Section 9.07 Effect of Supplemental Indentures. Upon the execution of any supplemental indenture under this Article 9, this Indenture shall be modified in accordance therewith, and such supplemental indenture shall form a part of this Indenture for all purposes; and every Holder of Securities theretofore or thereafter authenticated and delivered hereunder shall be bound thereby, except to the extent otherwise set forth thereon. ARTICLE 10. SINKING FUNDS Section 10.01 Applicability of Article. The provisions of this Article 10 shall be applicable to any sinking fund for the retirement of Securities of a series, except as otherwise specified as contemplated by Section 2.03(a) hereof for Securities of such series. The minimum amount of any sinking fund payment provided for by the terms of Securities of any series is herein referred to as a "Mandatory Sinking Fund Payment," and any payment in excess of such minimum amount provided for by the terms of Securities of any series is herein referred to as an "Optional Sinking Fund Payment." If provided for by the terms of Securities of any series, the cash amount of any sinking fund payment may be subject to reduction as provided in Section 10.02 hereof. Each sinking fund payment shall be applied to the redemption of Securities of any series as provided for by the terms of the Securities of such series. Section 10.02 Satisfaction of Sinking Fund Payments with Securities. The Company (a) may deliver outstanding Securities of a series with the same issue date, interest rate and Stated Maturity (other than any previously called for redemption) and (b) may apply as a credit Securities of a series with the same issue date, interest rate and Stated Maturity which have been redeemed either at the election of the Company pursuant to the terms of such Securities or through the application of permitted optional sinking fund payments pursuant to the terms of such Securities, in each case in satisfaction of all or any part of any mandatory sinking fund payment with respect to the Securities of such series with the same issue date, interest rate and Stated Maturity; provided, that such Securities have not been previously so credited. Such Securities shall be received and credited for such purpose by the Trustee at the Redemption Price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly. Section 10.03 Redemption of Securities for Sinking Fund. Not less than 60 days (or such shorter period as shall be acceptable to the Trustee) prior to each sinking fund payment date for any series of Securities, the Company will deliver to the Trustee an Officers' Certificate specifying the amount of the next ensuing sinking fund payment for that series pursuant to the terms of that series, the portion thereof, if any, which is to be satisfied by payment of cash and the portion thereof, if any, which is to be satisfied by delivering and crediting Securities of that series pursuant to Section 10.02 hereof and will also deliver to the Trustee any Securities to be so delivered. Not less than 30 days before each such sinking fund payment date the Trustee shall select the Securities to be redeemed upon such sinking fund payment date in the manner specified in Section 3.02 hereof and cause notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided in Section 3.03 hereof. Such notice having been duly given, the redemption of such Securities shall be made upon the terms and in the manner stated in Sections 3.04 and 3.06 hereof. 37 ARTICLE 11. SUBORDINATION Section 11.01 Agreement to Subordinate. The Company agrees, and each Holder by accepting a Security agrees that, unless otherwise specified as contemplated by Section 2.03(a) hereof, the Indebtedness evidenced by the Security is subordinated in right of payment, to the extent and in the manner provided in this Article 11, to the prior payment in full of all Senior Debt with respect to such Security (whether outstanding on the date hereof or hereafter created, incurred, assumed or guaranteed), and that the subordination is for the benefit of the holders of such Senior Debt. Section 11.02 Liquidation; Dissolution; Bankruptcy. Upon any distribution to creditors of the Company in a liquidation or dissolution of the Company or in a bankruptcy, reorganization, insolvency, receivership or similar proceeding relating to the Company or its property, in an assignment for the benefit of creditors or any marshaling of the Company's assets and liabilities: (a) holders of Senior Debt shall be entitled to receive payment in full of all Obligations due in respect of such Senior Debt (including interest after the commencement of any such proceeding at the rate specified in the applicable Senior Debt, whether or not allowable as a claim in such proceeding) before Holders of the Securities of a series shall be entitled to receive any payment with respect to such Securities (except that Holders may receive and retain (A) Permitted Junior Securities and (B) payments and other distributions made from any defeasance trust created pursuant to Section 8.01 hereof); and (b) until all Obligations with respect to Senior Debt (as provided in clause (a) above) are paid in full, any distribution to which Holders of Securities of such series would be entitled but for this Article 11 shall be made to holders of Senior Debt (except that Holders of Securities may receive and retain (A) Permitted Junior Securities and (B) payments and other distributions made from any defeasance trust created pursuant to Section 8.01 hereof), as their interests may appear. Section 11.03 Default on Designated Senior Debt. (a) The Company may not make any payment or distribution in respect of the Securities of such series (other than (A) Permitted Junior Securities and (B) payments and other distributions made from any defeasance trust created pursuant to Section 8.01 hereof) if: (i) a default in the payment of any principal or other Obligations with respect to Designated Senior Debt occurs and is continuing beyond any applicable grace period in the agreement, indenture or other document governing such Designated Senior Debt (a "payment default"); or (ii) a default, other than a payment default, on Designated Senior Debt occurs and is continuing that then permits holders of the Designated Senior Debt to accelerate its maturity and the Trustee receives a notice of the default (a "Payment Blockage Notice") from a Person who may give it pursuant to Section 11.12 hereof. If the Trustee receives any such Payment Blockage Notice, no subsequent Payment Blockage Notice shall be effective for purposes of this Section 11.03 unless and until (A) at least 360 days shall have elapsed since the delivery of the immediately prior Payment Blockage Notice and (B) all scheduled payments of principal, 38 premium, if any, and interest, if any, on the Securities that have come due have been paid in full in cash. No nonpayment default that existed or was continuing on the date of delivery of any Payment Blockage Notice to the Trustee shall be, or be made, the basis for a subsequent Payment Blockage Notice unless such default shall have been waived for a period of not less than 90 days. (b) The Company may and shall resume payments on and distributions in respect of the Securities of such series upon the earlier of: (i) the date upon which the default is cured or waived or such Designated Senior Debt is discharged or paid in full, or (ii) in the case of a default referred to in clause (ii) Section 11.04(a) hereof 179 days pass after notice is received if the maturity of such Designated Senior Debt has not been accelerated. Section 11.04 Acceleration of Securities. If payment of the Securities of such series is accelerated because of an Event of Default, the Company shall promptly notify holders of Senior Debt of the acceleration. Section 11.05 When Distribution Must Be Paid Over. In the event that the Trustee or any Holder receives any payment of any Obligations with respect to the Securities of a series at a time when such payment is prohibited by Section 11.04 hereof, such payment shall be held by the Trustee or such Holder, in trust for the benefit of, and shall be paid forthwith over and delivered, upon written request, to, the holders of Senior Debt with respect to Securities of such series as their interests may appear or their Representative under this Indenture or other agreement (if any) pursuant to which such Senior Debt may have been issued, as their respective interests may appear, for application to the payment of all Obligations with respect to such Senior Debt remaining unpaid to the extent necessary to pay such Obligations in full in accordance with their terms, after giving effect to any concurrent payment or distribution to or for the holders of such Senior Debt. With respect to the holders of Senior Debt, the Trustee undertakes to perform only such obligations on the part of the Trustee as are specifically set forth in this Article 11, and no implied covenants or obligations with respect to the holders of Senior Debt shall be read into this Indenture against the Trustee. The Trustee shall not be deemed to owe any fiduciary duty to the holders of Senior Debt, and shall not be liable to any such holders if the Trustee shall pay over or distribute to or on behalf of holders or the Company or any other Person money or assets to which any holders of Senior Debt shall be entitled by virtue of this Article 11, except if such payment is made as a result of the willful misconduct or negligence of the Trustee. Section 11.06 Notice by Company. The Company shall promptly notify the Trustee and the Paying Agent of any facts known to the Company that would cause a payment of any Obligations with respect to the Securities to violate this Article 11, but failure to give such notice shall not affect the subordination of the Securities to Senior Debt as provided in this Article 11. Section 11.07 Subrogation. After all Senior Debt is paid in full and until the Securities of a series are paid in full, Holders of Securities of such series shall be subrogated (equally and ratably with all other Indebtedness pari passu 39 with the Securities of such series) to the rights of holders of Senior Debt with respect to Securities of such series to receive distributions applicable to such Senior Debt to the extent that distributions otherwise payable to the Holders of Securities of such series have been applied to the payment of Senior Debt. A distribution made under this Article 11 to holders of Senior Debt that otherwise would have been made to Holders of Securities is not, as between the Company and Holders, a payment by the Company on the Securities. Section 11.08 Relative Rights. This Article 11 defines the relative rights of Holders of Securities and holders of Senior Debt. Nothing in this Indenture shall: (i) impair, as between the Company and Holders of Securities, the obligation of the Company, which is absolute and unconditional, to pay principal of, premium, if any, and interest on the Securities in accordance with their terms; (ii) affect the relative rights of Holders of Securities and creditors of the Company other than their rights in relation to holders of Senior Debt; or (iii) prevent the Trustee or any Holder of Securities from exercising its available remedies upon a Default or Event of Default, subject to the rights of holders and owners of Senior Debt to receive distributions and payments otherwise payable to Holders of Securities. If the Company fails because of this Article 11 to pay principal of, premium, if any, or interest on a Security on the due date, the failure is still a Default or Event of Default. Section 11.09 Subordination May Not Be Impaired by Company. No right of any holder of Senior Debt to enforce the subordination of the Indebtedness evidenced by the Securities shall be impaired by any act or failure to act by the Company or by the failure of the Company to comply with this Indenture. Section 11.10 Distribution or Notice to Representative. Whenever a distribution is to be made or a notice given to holders of Senior Debt, the distribution may be made and the notice given to their Representative. Upon any payment or distribution of assets of the Company referred to in this Article 11, the Trustee and the Holders of Securities shall be entitled to rely upon any order or decree made by any court of competent jurisdiction or upon any certificate of such Representative or of the liquidating trustee or agent or other Person making any distribution to the Trustee or to the Holders of Securities for the purpose of ascertaining the Persons entitled to participate in such distribution, the holders of the Senior Debt and other Indebtedness of the Company, the amount thereof or payable thereon, the amount or amounts paid or distributed thereon and all other facts pertinent thereto or to this Article 11. Section 11.11 Rights of Trustee and Paying Agent. Notwithstanding the provisions of this Article 11 or any other provision of this Indenture, the Trustee shall not be charged with knowledge of the existence of any facts that would prohibit the making of any payment or distribution by the Trustee, and the Trustee and the Paying Agent may continue to make payments on the Securities, unless the Trustee shall have received at its Corporate Trust Office at least one Business Day prior to the date of such payment written notice of facts that would cause the 40 payment of any Obligations with respect to the Securities to violate this Article 11. Only the Company or a Representative may give the notice. Nothing in this Article 11 shall impair the claims of, or payments to, the Trustee under or pursuant to Section 7.07 hereof. The Trustee in its individual or any other capacity may hold Senior Debt with the same rights it would have if it were not Trustee. Any Agent may do the same with like rights. Section 11.12 Authorization to Effect Subordination. Each Holder of Securities, by the Holder's acceptance thereof, authorizes and directs the Trustee on such Holder's behalf to take such action as may be necessary or appropriate to effectuate the subordination as provided in this Article 11, and appoints the Trustee to act as such Holder's attorney-in-fact for any and all such purposes. If the Trustee does not file a proper proof of claim or proof of debt in the form required in any proceeding referred to in Section 6.09 hereof at least 30 days before the expiration of the time to file such claim, the Representatives are hereby authorized to file an appropriate claim for and on behalf of the Holders of the Securities. ARTICLE 12. SECURITY GUARANTEES Section 12.01 Applicability of this Article. Except as otherwise specified as contemplated by Section 2.03(a) hereof, the provisions of this Article 12 will be applicable to any series of Securities which is to be guaranteed by one or more Guarantors. Section 12.02 Guarantee. Subject to this Article 12, each of the Guarantors hereby, jointly and severally, unconditionally guarantees to each Holder of Securities of a particular series as to which it is a Guarantor authenticated and delivered by the Trustee and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of this Indenture, the Securities of such series or the obligations of the Company hereunder or thereunder, that: (a) the principal of, premium, if any, and interest on the Securities of such series will be promptly paid in full when due, whether at maturity, by acceleration, redemption or otherwise, and interest on the overdue principal of and premium, if any, and interest on the Securities of such series, if any, if lawful, and all other obligations of the Company to the Holders or the Trustee hereunder or thereunder will be promptly paid in full or performed, all in accordance with the terms hereof and thereof; and (b) in case of any extension of time of payment or renewal of any Securities of such series or any of such other obligations, that same will be promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at stated maturity, by acceleration or otherwise. Failing payment when due of any amount so guaranteed or any performance so guaranteed for whatever reason, the Guarantors shall be jointly and severally obligated to pay the same immediately. Each Guarantor agrees that this is a guarantee of payment and not a guarantee of collection. Subject to this Article 12, the Guarantors hereby, jointly and severally, agree that their obligations hereunder shall be unconditional, irrespective of the validity, regularity or enforceability of the Securities of a series or this Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder of the Securities of such series with respect to any provisions hereof or thereof, the recovery of any judgment against the Company, any action to enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a guarantor. Each Guarantor hereby waives diligence, presentment, demand of payment, filing of claims with a court in the event of insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, 41 protest, notice and all demands whatsoever and covenant that this Security Guarantee shall not be discharged except by complete performance of the obligations contained in the Securities of such series and this Indenture. If any Holder or the Trustee is required by any court or otherwise to return to the Company, the Guarantors or any custodian, trustee, liquidator or other similar official acting in relation to either the Company or the Guarantors, any amount paid by either to the Trustee or such Holder, this Security Guarantee, to the extent theretofore discharged, shall be reinstated in full force and effect. Each Guarantor agrees that it shall not be entitled to any right of subrogation in relation to the Holders in respect of any obligations guaranteed hereby until payment in full of all obligations guaranteed hereby. Each Guarantor further agrees that, as between the Guarantors, on the one hand, and the Holders and the Trustee, on the other hand, (x) the maturity of the obligations guaranteed hereby may be accelerated as provided in Article 6 hereof for the purposes of this Security Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of the obligations guaranteed hereby, and (y) in the event of any declaration of acceleration of such obligations as provided in Article 6 hereof, such obligations (whether or not due and payable) shall forthwith become due and payable by the Guarantors for the purpose of this Security Guarantee. The Guarantors shall have the right to seek contribution from any non-paying Guarantor so long as the exercise of such right does not impair the rights of the Holders under the Security Guarantee. Section 12.03 Subordination of Security Guarantee. Unless otherwise specified as contemplated by Section 2.03(a) hereof, the Obligations of each Guarantor under any series of Securities which are to be guaranteed pursuant to this Article 12 shall be junior and subordinated to the Senior Debt of such Guarantor with respect to such series of Securities on the same basis as the Securities are junior and subordinated to Senior Debt of the Company with respect to such series of Securities. For the purposes of the foregoing sentence, the Trustee and the Holders shall have the right to receive and/or retain payments by any of the Guarantors only at such times as they may receive and/or retain payments in respect of the Securities pursuant to this Indenture, including Article 11 hereof. Section 12.04 Limitation on Guarantor Liability. Each Guarantor, and by its acceptance of Securities of a series, each Holder, hereby confirms that it is the intention of all such parties that the Security Guarantee of such Guarantor not constitute a fraudulent transfer or conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to any Security Guarantee. To effectuate the foregoing intention, the Trustee, the Holders and the Guarantors hereby irrevocably agree that the obligations of such Guarantor shall be limited to the maximum amount as will, after giving effect to all other contingent and fixed liabilities of such Guarantor that are relevant under such laws, and after giving effect to any collections from, rights to receive contribution from or payments made by or on behalf of any other Guarantor in respect of the obligations of such other Guarantor under this Article 12, result in the obligations of such Guarantor under its Security Guarantee not constituting a fraudulent transfer or conveyance. Section 12.05 Release of Guarantors. The Security Guarantee of a Guarantor with respect to any series of Securities will be released under the circumstances specified for such series of Securities pursuant to Section 2.03(a) hereof. 42 ARTICLE 13. SATISFACTION AND DISCHARGE Section 13.01 Satisfaction and Discharge. Except as otherwise contemplated by 2.03(a) hereof, this Indenture will cease to be of further effect with respect to any series of Securities specified by the Company, and the Trustee, at the expense of the Company, will execute proper instruments acknowledging satisfaction and discharge of this Indenture as to such series when: (a) either: (i) all Securities of such series that have been authenticated (except lost, stolen or destroyed Securities of such series that have been replaced or paid and Securities of such series for whose payment money has theretofore been deposited in trust and thereafter repaid to the Company) have been delivered to the Trustee for cancellation; or (ii) all Securities of such series that have not been delivered to the Trustee for cancellation have become due and payable by reason of the mailing of a notice of redemption or otherwise or will become due and payable within one year and the Company or, if applicable, any Guarantor has irrevocably deposited or caused to be deposited with the Trustee as trust funds in trust solely for the benefit of the Holders, cash, non-callable Government Securities, or a combination thereof, in such amounts as will be sufficient without consideration of any reinvestment of interest, to pay and discharge the entire indebtedness on the such Securities not delivered to the Trustee for cancellation for principal, premium, if any, and accrued interest to the date of maturity or redemption; (b) the Company or, if applicable, any Guarantor has paid or caused to be paid all sums payable by it under this Indenture; and (c) the Company or, if applicable, any Guarantor has delivered an Officers' Certificate and an Opinion of Counsel to the Trustee stating that all conditions precedent to satisfaction and discharge have been satisfied or waived. Notwithstanding the satisfaction and discharge of this Indenture, if money shall have been deposited with the Trustee pursuant to subclause (ii) of clause (a) of this Section 13.01, the provisions of Sections 13.02 and 8.06 hereof shall survive. Section 13.02 Application of Trust Money. Subject to the provisions of Section 8.06 hereof, all money deposited with the Trustee pursuant to Section 13.01 hereof shall be held in trust and applied by it, in accordance with the provisions of the Securities of a series and this Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as its own Paying Agent) as the Trustee may determine, to the Persons entitled thereto, of the principal (and premium, if any) and interest for whose payment such money has been deposited with the Trustee; but such money need not be segregated from other funds except to the extent required by law. If the Trustee or Paying Agent is unable to apply any money or Government Securities in accordance with Section 13.01 hereof by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company's obligations and, if applicable, any Guarantor's obligations under this 43 Indenture and the Securities of such series shall be revived and reinstated as though no deposit had occurred pursuant to Section 12.01 hereof; provided that if the Company has made any payment of principal of, premium, if any, or interest on any Securities of such series because of the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of Securities of such series to receive such payment from the money or Government Securities held by the Trustee or Paying Agent. ARTICLE 14. MISCELLANEOUS Section 14.01 Trust Indenture Act Controls. If any provision of this Indenture limits, qualifies or conflicts with the duties imposed by TIA 'SS'318(c), the imposed duties shall control. If any provision of this Indenture modifies or excludes any provision of the TIA that may be so modified or excluded, the latter provision shall be deemed to apply to this Indenture as so modified or excluded, as the case may be. Section 14.02 Notices. Any notice or communication by the Company, any Guarantor or the Trustee to the others is duly given if in writing and delivered in Person or mailed by first class mail (registered or certified, return receipt requested), telex, telecopier or overnight air courier guaranteeing next day delivery, to the others' address: If to the Company and/or any Guarantor: Omnicare, Inc. 100 East RiverCenter Boulevard Covington, Kentucky 41011 Telecopier No.: (859) 392-3360 Attention: General Counsel With a copy to: Dewey Ballantine LLP 1301 Avenue of the Americas New York, New York 10019 Telecopier No.: (212) 259-6333 Attention: Morton A. Pierce, Esq. If to the Trustee: [_____________] [_____________] [_____________] [_____________] Telecopier No.: [_____________] Attention: [_____________] The Company, any Guarantor or the Trustee, by notice to the others may designate additional or different addresses for subsequent notices or communications. Any notice or communication to a Holder shall be mailed by first class mail, certified or registered, return receipt requested, or by overnight air courier guaranteeing next day delivery to its address shown on the register kept by the Registrar. Any notice or communication also shall be so mailed 44 to any Person described in TIA 'SS'313(c), to the extent required by the TIA. Failure to mail a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders. If the Company mails a notice or communication to Holders, it shall mail a copy to the Trustee and each Agent at the same time. Section 14.03 Communication by Holders of Securities with Other Holders of Securities. Holders may communicate pursuant to TIA 'SS'312(b) with other Holders with respect to their rights under this Indenture or the Securities. The Company, the Trustee, the Registrar and anyone else shall have the protection of TIA 'SS'312(c). Section 14.04 Certificate and Opinion as to Conditions Precedent. Upon any request or application by the Company to the Trustee to take any action under this Indenture, the Company shall furnish to the Trustee: (a) an Officers' Certificate in form and substance reasonably satisfactory to the Trustee (which shall include the statements set forth in Section 14.05 hereof) stating that, in the opinion of the signers, all conditions precedent and covenants, if any, provided for in this Indenture relating to the proposed action have been satisfied or waived; and (b) an Opinion of Counsel in form and substance reasonably satisfactory to the Trustee (which shall include the statements set forth in Section 14.05 hereof) stating that, in the opinion of such counsel, all such conditions precedent and covenants have been satisfied or waived. Section 14.05 Statements Required in Certificate or Opinion. Each certificate or opinion with respect to compliance with a condition or covenant provided for in this Indenture (other than a certificate provided pursuant to TIA 'SS'314(a)(4)) shall comply with the provisions of TIA 'SS'314(e) and shall include: (a) a statement that the Person making such certificate or opinion has read such covenant or condition; (b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; (c) a statement that, in the opinion of such Person, he or she has made such examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been satisfied or waived; and (d) a statement as to whether or not, in the opinion of such Person, such condition or covenant has been satisfied or waived. In any case where several matters are required to be certified by, or covered by an opinion of, any specified Person, it is not necessary that all such matters be certified by, or covered by the opinion of, only one such Person, or that they be so certified or covered by only one document, but one such Person may certify or give an opinion with respect to some matters and one or more other such Persons as to other matters, and any such Person may certify or give an opinion as to such matters in one or several documents. 45 Any certificate or opinion of an Officer of the Company may be based insofar as it relates to legal matters, upon a certificate or opinion of, or representations by, counsel, unless such Officer knows, or in the exercise of reasonable care should know, that the certificate or opinion or representations with respect to the matters upon which his certificate or opinion or representations is based are erroneous. Any such certificate or opinion of counsel may be based, insofar as it relates to factual matters, upon a certificate or opinion of, or representations by, an officer or officers of the Company stating that the information with respect to such factual matters is in the possession of the Company, unless such counsel knows, or in the exercise of reasonable care should know, that the certificate or opinion or representations with respect to such matters are erroneous. Where any Person is required to make, give or execute two or more applications, requests, consents, certificates, statements, opinions or other instruments under this Indenture, they may, but need not, be consolidated and form one instrument. Section 14.06 Rules by Trustee and Agents. The Trustee may make reasonable rules for action by or at a meeting of Holders. The Registrar or Paying Agent may make reasonable rules and set reasonable requirements for its functions. Section 14.07 No Personal Liability of Directors, Officers, Employees and Stockholders. No past, present or future director, officer, employee, incorporator or stockholder of the Company or any Guarantor, as such, shall have any liability for any obligations of the Company or such Guarantor under the Securities, the Security Guarantees, this Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting a Security waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Securities. Section 14.08 Governing Law. THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS INDENTURE AND THE SECURITIES, WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY. Section 14.09 No Adverse Interpretation of Other Agreements. This Indenture may not be used to interpret any other indenture, loan or debt agreement of the Company or its Subsidiaries or of any other Person. Any such indenture, loan or debt agreement may not be used to interpret this Indenture. Section 14.10 Successors. All agreements of the Company in this Indenture and the Securities shall bind its successors. All agreements of the Trustee in this Indenture shall bind its successors. All agreements of each applicable Guarantor in this Indenture shall bind its successors, except as otherwise provided pursuant to Section 12.05 hereof. 46 Section 14.11 Severability. In case any provision in this Indenture or in the Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. Section 14.12 Counterpart Originals. The parties may sign any number of copies of this Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. Section 14.13 Table of Contents, Headings, etc. The Table of Contents, Cross-Reference Table and Headings of the Articles and Sections of this Indenture have been inserted for convenience of reference only, are not to be considered a part of this Indenture and shall in no way modify or restrict any of the terms or provisions hereof. [Signatures on following page] 47 SIGNATURES Dated as of [__________] OMNICARE, INC. By: ------------------------- Name: Title: Attest: - ------------------------ Name: Title: [______________] By: ------------------------- Name: Title: Attest - ---------------------------- Authorized Signatory Date: 48 EXHIBIT A [Face of Security] - -------------------------------------------------------------------------------- CUSIP ____________ [TITLE OF SECURITIES] No. ___ $____________ OMNICARE, INC. promises to pay to _______________________________________or registered assigns, the principal sum of ___________________________________________________________ Interest Payment Dates [____________] and [____________], commencing on [______] Record Dates: [______________] and [______________] Dated: _______________, ____ OMNICARE, INC. By: ------------------------- Name: Title: By: ------------------------- Name: Title: This is one of the Securities referred to in the within-mentioned Indenture: [______________], as Trustee By: ----------------------------------- Authorized Signatory - -------------------------------------------------------------------------------- A-1 [Back of Security] [TITLE OF SECURITIES] [Insert the Global Security Legend, if applicable pursuant to the provisions of this Indenture] [Insert any legend required by the Internal Revenue Code and the regulations thereunder] Capitalized terms used herein shall have the meanings assigned to them in this Indenture referred to below unless otherwise indicated. 1. Interest. Omnicare, Inc., a Delaware corporation (herein the "Company" which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to _____________________, or registered assigns, the principal sum of _________ [Dollars] [if other than Dollars, substitute other currency units] on ________, _____ [if the Security is to bear interest prior to Stated Maturity, insert -- , and to pay interest thereon from _______________ or from the most recent Interest Payment Date to which interest has been paid or duly provided for], [semiannually] [if other than semi-annual interest at a fixed rate, insert frequency of payment and payment dates] on _______ and _______ in each year, commencing ___________, and at the Stated Maturity thereof, at [if the Security is to bear interest at a fixed rate, insert -- the rate of __% per annum], [if the Security is to bear interest at a rate determined with reference to one or more formula, refer to description index below] until the principal hereof is paid or made available for payment] [if applicable, insert -- , and (to the extent that the payment of such interest shall be legally enforceable) at [if the Security is to bear interest at a fixed rate, insert -- the rate of % per annum on any overdue principal and premium and on any overdue installment of interest from the dates such amounts are due until they are paid or made available for payment]. Interest shall be computed on the basis of [a 360-day year of twelve 30-day months] [if another basis of calculating interest is to be different, insert a description of such method.] 2. Method of Payment. The Company will pay interest on the Securities on each [___] and [___] to the Persons who are registered Holders of the relevant Securities at the close of business on the [___] or [___] next preceding the Interest Payment Date, even if such Securities are canceled after such record date and on or before such Interest Payment Date, except as provided in Section 2.14 of this Indenture with respect to Defaulted Interest. The Securities will be payable as to principal, premium, if any, and interest at the office or agency of the Company maintained for such purpose in [___], [if applicable, insert --; provided, however, that at the option of the Company payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the list provided by the Company to the Registrar and provided, further, that if this Security is a Global Security, payment may be made pursuant to the applicable procedures of the Depositary as permitted in said Indenture]. Such payment shall be in such coin or currency of [the United States of America] [insert other currency or currency unit, if applicable] as at the time of payment is legal tender for payment of public and private debts. 3. Paying Agent and Registrar. Initially, the Trustee under this Indenture, will act as Paying Agent and Registrar. The Company may change any Paying Agent or Registrar without notice to any Holder. The Company or any of its Subsidiaries may act in any such capacity. A-2 4. Indenture. This Security is one of a duly authorized issue of Securities of the Company issued and to be issued in one or more series under an Indenture, dated as of ________, _____ (herein called the "Indenture"), between the Company and _______________, as Trustee (herein called the "Trustee" which term includes any successor trustee under the Indenture), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered. The terms of the Securities include those stated in this Indenture and those made part of this Indenture by reference to the Trust Indenture Act of 1939, as amended (15 U.S. Code 'SS''SS'77aaa-77bbbb). The Securities are subject to all such terms, and Holders are referred to this Indenture and such Act for a statement of such terms. To the extent any provision of this Security conflicts with the express provisions of this Indenture, the provisions of this Indenture shall govern and be controlling. 5. Redemption. [If applicable, insert -- The Securities of this series are subject to redemption upon not less than 30 days notice by mail, [if applicable, insert -- (1) on _________ in any year commencing with the year _____ and ending with the year _____ through operation of the sinking fund for this series at a Redemption Price equal to 100% of the principal amount, and (2)] at any time [if applicable, insert -- on or after ________, _____], as a whole or in part, at the election of the Company, at the following Redemption Prices (expressed as percentages of the principal amount): if redeemed [if applicable insert -- on or before ________, ___%, and if redeemed] during the 12-month period beginning of the ________ years indicated, Year Redemption Price Year Redemption Price and thereafter at a Redemption Price equal to ______% of the principal amount, together in the case of any such redemption [if applicable, insert -- (whether through operation of the sinking fund or otherwise)] with accrued interest to the Redemption Date, but interest installments whose Stated Maturity is on or prior to such Redemption Date will be payable to the Holders of such Securities, or one or more Predecessor Securities, of record at the close of business on the relevant Record Dates referred to on the face hereof, all as provided in the Indenture.] [If applicable, insert -- The Securities of this series are subject to redemption upon not less than 30 days notice by mail, (1) on ________ in any year commencing with the year _____ and ending with the year _____ through operation of the sinking fund for this series at the Redemption Prices for redemption through operation of the sinking fund (expressed as percentages of the principal amount) set forth in the table below, and (2) at any time [if applicable, insert -- on or after ____________], as a whole or in part, at the election of the Company, at the Redemption Prices for redemption otherwise than through operation of the sinking fund (expressed as percentages of the principal amount) set forth in the table below: If redeemed during the 12-month period beginning ___________ of the years indicated,
Redemption Price for Redemption Redemption Price for Redemption Otherwise Than Through Operation of the Year Through Operation of the Sinking Fund Sinking Fund ---- ------------------------------------- ---------------------------------------
A-3 and thereafter at a Redemption Price equal to ___% of the principal amount, together in the case of any such redemption (whether through operation of the sinking fund or otherwise) with accrued interest to the Redemption Date, but interest installments whose Stated Maturity is on or prior to such Redemption Date will be payable to the Holders of such securities, or one or more Predecessor Securities, of record at the close of business on the relevant Record Date referred to on the face hereof, all as provided in the Indenture.] [If applicable, insert -- The sinking fund for this series provides for the redemption on ________ in each year beginning with the year ____ and ending with the year _____ of [if applicable, insert -- not less than $_____________ ("mandatory sinking fund") and not more than] $___________ aggregate principal amount of Securities of this series. Securities of this series acquired or redeemed by the Company otherwise than through [mandatory] sinking fund payments may be credited against subsequent [if applicable, insert -- mandatory] sinking fund payments otherwise required to be made [if applicable, insert -- in the inverse order in which they become due].] [If applicable, insert -- The Securities are subject to redemption, as a whole at any time or in part from time to time, at the sole election of the Company, upon not less than 30 or more than 60 days notice by mail to the Trustee at a Redemption Price equal to $____.] [If applicable, insert -- The Holder of this Security shall have the right to require the Company to pay this Security in full on ____________, __ by giving the Company or the Registrar written notice of the exercise of such right not less than 30 or more than 60 days prior to such date.] [If the Security is subject to redemption, insert -- In the event of redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof.] [If applicable, insert -- This Security is not subject to redemption prior to maturity.] 6. Denominations, Transfer, Exchange. [If applicable, insert -- The Securities of this series are issuable only in registered form without coupons in denominations of $___________ and any integral multiple thereof.] As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering the same. A Holder may register the transfer or exchange of the Security as provided in the Indenture and subject to certain limitations therein set forth. The Registrar may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay any taxes and fees required by law or permitted by the Indenture. [If applicable, insert -- The Securities of this series will be represented by one or more Global Securities registered in the name of ____________, (the "Depositary"), or a nominee of the Depositary. So long as the Depositary, or its nominee, is the registered holder and owner of this Global Security, the Depositary or such nominee, as the case may be, will be considered the sole owner and holder of the Securities for all purposes under the Indenture. The Global Security may be transferred, in whole and not in part, only to the Depositary or another nominee of the Depositary. The Depositary will credit, on its book-entry registration and transfer system, the respective principal amounts of the Securities represented by such Global Security to the accounts of institutions that have accounts with the Depositary or its nominee ("participants"). Ownership of beneficial interests in a Global Security will be shown on, and the transfer of those ownership interests will be effected through, records maintained by the Depositary A-4 (with respect to participants' interests) and such participants (with respect to the owners of beneficial interests in such Global Security).] [If applicable, insert -- The Securities represented by this Global Security are exchangeable for Securities in permanent form of like tenor as such Global Security in denominations of $1,000 and in any greater amount that is an integral multiple thereof if (i) the Depositary notifies the Company that it is unwilling or unable to continue as Depositary for this Global Security or if at any time the Depositary ceases to be a clearing agency registered under the Securities Exchange Act of 1934, as amended, (ii) the Company in its discretion at any time determines not to have all of the Securities of this series represented by the Global Security and notifies the Trustee thereof, or (iii) an Event of Default has occurred and is continuing with respect to the Securities. Any Security that is exchangeable pursuant to the preceding sentence is exchangeable only for Securities of this series.] No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 7. Persons Deemed Owners. The registered Holder of a Security may be treated as its owner for all purposes. 8. Amendment, Supplement and Waiver. Subject to certain exceptions, this Indenture and the Securities may be amended or supplemented with the consent of the Holders of at least a majority in principal amount of the then outstanding Securities of each series affected by such amendment or supplement and any existing default or compliance with any provision may be waived with the consent of the Holders of a majority in principal amount of the then outstanding Securities of each series affected by such waiver. Without the consent of any Holder of a Securities of each series affected by such amendment or supplement, this Indenture and the Securities may be amended or supplemented to, among other things, (a) cure any ambiguity, defect or inconsistency; (b) provide for uncertificated Securities in addition to or in place of certificated Securities; (c) provide for the assumption of the Company's obligations to Holders of the Securities in case of a merger or consolidation; (d) to make any change that would provide any additional rights or benefits to the Holders of Securities or that does not adversely affect the legal rights under the Indenture of any Holder; (e) to comply with the requirements of the SEC in order to effect or maintain the qualification of this Indenture under the Trust Indenture Act; (f) to allow any Guarantor to execute a supplemental indenture to this Indenture; (g) evidence or provide for acceptance of appointment of a successor Trustee; (h) mortgage, hypothecate or grant a security interest in favor of the Trustee for the benefit of the Holders of Securities of any series as additional security for the payment and performance of the Company's or, if applicable, the Guarantor's obligations herein in any property or assets; or (i) add to, change or eliminate any of the provisions of this Indenture (which addition, change or elimination may apply to one or more series of Securities), provided that, any such addition, change or elimination set forth in clause (i) above (A) shall neither (x) apply to any Security of any series created prior to the execution of such supplemental indenture and entitled to the benefit of such provision nor (y) modify the rights of the Holder of any such Security with respect to such provision or (B) shall become effective only when there is no such outstanding Security. 9. Defaults and Remedies. Events of Default include: (a) default for 30 days in the payment when due of interest on the Securities; (b) default in payment when due of principal of or premium, if any, on the Securities; (c) A-5 failure by the Company to comply with Section 5.01 of the Indenture; (d) failure by the Company for 60 days to comply with certain other agreements in this Indenture or the Securities; (e) certain events of bankruptcy or insolvency with respect to the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary; and (f) except as permitted by the Indenture, any applicable Security Guarantee shall be held in any judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or any Guarantor or any Person acting on its behalf shall deny or disaffirm its obligations under such Guarantor's Security Guarantee. If any Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in principal amount of the then outstanding Securities may declare all the Securities to be due and payable. Notwithstanding the foregoing, in the case of an Event of Default arising from certain events of bankruptcy or insolvency involving the Company, all outstanding Securities will become due and payable without further action or notice. Holders may not enforce this Indenture or the Securities except as provided in the Indenture. Subject to certain limitations, Holders of a majority in principal amount of the then outstanding Securities may direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of the Securities notice of any continuing Default or Event of Default (except a Default or Event of Default relating to the payment of principal or interest) if it determines that withholding notice is in their interest. The Holders of a majority in aggregate principal amount of the Securities then outstanding by notice to the Trustee may on behalf of the Holders of all of the Securities waive any existing Default or Event of Default and its consequences under this Indenture except a continuing Default or Event of Default in the payment of interest on, or the principal of, the Securities. The Company is required to deliver to the Trustee annually a statement regarding compliance with this Indenture, and the Company is required upon becoming aware of any Default or Event of Default, to deliver to the Trustee a statement specifying such Default or Event of Default. 10. Trustee Dealings with Company. The Trustee, in its individual or any other capacity, may make loans to, accept deposits from, and perform services for the Company or its Affiliates, and may otherwise deal with the Company or its Affiliates, as if it were not the Trustee. 11. No Recourse Against Others. A director, officer, employee, incorporator or stockholder, of the Company, as such, shall not have any liability for any obligations of the Company or the Guarantors under the Securities or this Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting a Security waives and releases all such liability. The waiver and release are part of the consideration for the issuance of the Securities. 12. [If applicable, insert - Guarantees. The payment by the Company of the principal of and interest on the Security is fully and unconditionally guaranteed on a joint and several basis by each of the Guarantors on the terms set forth in the Indenture.] 13. Authentication. This Security shall not be valid until authenticated by the manual signature of the Trustee or an authenticating agent. 14. Abbreviations. A-6 Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 15. Subordination. Each Holder by accepting a Security agrees that the payment of principal, premium and if any, interest, on each Security is subordinated in right of payment, to the extent and in the manner provided in Article 11 of the Indenture, to the prior payment in full of all existing and future Senior Debt (whether outstanding on the date of the Indenture or thereafter created, incurred, assumed or guaranteed), and the subordination is for the benefit of holders of Senior Debt. 16. CUSIP Numbers. Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers to be printed on the Securities and the Trustee may use CUSIP numbers in notices of redemption as a convenience to Holders. No representation is made as to the accuracy of such numbers either as printed on the Securities or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. The Company will furnish to any Holder upon written request and without charge a copy of this Indenture. Requests may be made to: Omnicare, Inc. 100 East RiverCenter Boulevard Covington, Kentucky 41011 Attention: General Counsel A-7 ASSIGNMENT FORM To assign this Security, fill in the form below: (I) or (we) assign and transfer this Security to: ______________________________ (Insert assignee's legal name) ________________________________________________________________________________ (Insert assignee's soc. sec. or tax I.D. no.) ________________________________________________________________________________ ________________________________________________________________________________ ________________________________________________________________________________ ________________________________________________________________________________ (Print or type assignee's name, address and zip code) and irrevocably appoint ________________________________________________________ to transfer this Security on the books of the Company. The agent may substitute another to act for him. Date: _______________ Your Signature: ---------------------------------- (Sign exactly as your name appears on the face of this Security) Signature Guarantee*: ------------------------------ * Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). A-8 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL SECURITY* The following exchanges of a part of this Global Security for an interest in another Global Security or for a Definitive Security, or exchanges of a part of another Global Security or Definitive Security for an interest in this Global Security, have been made:
Principal Amount of this Amount of decrease in Amount of increase in Global Security Signature of authorized Principal Amount of Principal Amount of following such decrease officer of Trustee or Date of Exchange this Global Security this Global Security (or increase) Security Custodian - ---------------- --------------------- --------------------- ------------------------ -----------------------
- ---------- * This schedule should be included only if the Security is issued in global form. A-9
EX-4 5 ex4-10.txt EXHIBIT 4.10 Exhibit 4.10 CERTIFICATE OF TRUST OF OMNICARE CAPITAL TRUST I ------------------------ THIS CERTIFICATE OF TRUST of Omnicare Capital Trust I (the "Trust"), dated February 7, 2003, is being duly executed and filed to form a statutory trust under the Delaware Statutory Trust Act (12 Del. C. 'SS' 3801 et seq.)(the "Act"). 1. Name. The name of the statutory trust formed hereby is Omnicare Capital Trust I. 2. Delaware Trustee. The name and business address of the trustee of the Trust in the State of Delaware is Chase Manhattan Bank USA, National Association, 500 Stanton Christiana Road, FL3-OPS 4, Newark, Delaware, 19713, Attention: Institutional Trust Services. 3. Effective Date. This Certificate of Trust will be effective as of its filing. IN WITNESS WHEREOF, the undersigned has executed this Certificate of Trust as of the date first-above written in accordance with Section 3811(a) of the Act. CHASE MANHATTAN BANK USA, National Association, not in its individual capacity, but solely as trustee By: /s/ John J. Cashin ---------------------------------- Name: John J. Cashin Title: Vice President EX-4 6 ex4-11.txt EXHIBIT 4.11 Exhibit 4.11 TRUST AGREEMENT OF OMNICARE CAPITAL TRUST I THIS TRUST AGREEMENT is made as of February 7, 2003 (this "Agreement"), by and between Omnicare, Inc., a Delaware corporation, as sponsor (the "Sponsor"), and Chase Manhattan Bank USA, National Association, as trustee (the "Trustee"). The Sponsor and the Trustee hereby agree as follows: 1. The trust created hereby shall be known as "Omnicare Capital Trust I" (the "Trust"), in which name the Trustee or the Sponsor, to the extent provided herein, may conduct the business of the Trust, make and execute contracts, and sue and be sued. 2. The Sponsor hereby assigns, transfers, conveys and sets over to the Trust the sum of $10. Such amount shall constitute the initial trust estate. It is the intention of the parties hereto that the Trust created hereby constitute a statutory trust under Chapter 38 of Title 12 of the Delaware Code, 12 Del. C. 'SS''SS' 3801, et seq. (the "Trust Act"), and that this document constitute the governing instrument of the Trust. The Trustee is hereby authorized and directed to execute and file a certificate of trust with the Delaware Secretary of State in such form as the Trustee may approve. 3. The Sponsor and the Trustee will enter into an amended and restated Trust Agreement satisfactory to each such party to provide for the contemplated operation of the Trust created hereby and the issuance of the preferred securities and common securities referred to therein. Prior to the execution and delivery of such amended and restated Trust Agreement, the Trustee shall not have any duty or obligation hereunder or with respect of the trust estate, except as otherwise required by applicable law or as the Sponsor directs in order to obtain prior to such execution and delivery any licenses, consents or approvals required by applicable law or otherwise. Notwithstanding the foregoing, the Trustee may take all actions deemed proper as are necessary to effect the transactions contemplated herein. 4. The Sponsor, as agent of the Trust, is hereby authorized, in its sole discretion, (i) to file with the Securities and Exchange Commission (the "Commission") and to execute, in the case of the 1933 Act Registration Statement and 1934 Act Registration Statement (as herein defined), on behalf of the Trust, (a) a Registration Statement (the "1933 Act Registration Statement"), including all pre-effective or post-effective amendments thereto, relating to the registration under the Securities Act of 1933, as amended (the "1933 Act"), of the preferred securities of the Trust, (b) any preliminary prospectus or prospectus or supplement thereto relating to the preferred securities of the Trust required to be filed under the 1933 Act, and (c) if required, a Registration Statement on Form 8-A or other appropriate form (the "1934 Act Registration Statement"), including all pre-effective and post-effective amendments thereto, relating to the registration of the preferred securities of the Trust under Section 12(b) of the Securities Exchange Act of 1934, as amended; (ii) to file with the New York Stock Exchange or any other exchange (collectively, the "Exchange") and execute on behalf of the Trust a listing application and all other applications, statements, certificates, agreements and other instruments as shall be necessary or desirable to cause the preferred securities of the Trust to be listed on the Exchange; (iii) to file and execute on behalf of the Trust such applications, reports, surety bonds, irrevocable consents, appointments of attorney for service of process and other papers and documents as shall be necessary or desirable to register the preferred securities of the Trust under the securities or "Blue Sky" laws of such jurisdictions as the Sponsor, on behalf of the Trust, may deem necessary or desirable; (iv) to execute, deliver and perform on behalf of the Trust, an underwriting agreement with the Sponsor and the underwriter or underwriters of the preferred securities of the Trust; (v) to execute, deliver and perform a depository agreement with the initial clearing agency, relating to the preferred securities of the Trust; (vi) to apply for and obtain a tax identification number for the Trust; and (vii) to execute on behalf of the Trust any and all documents, papers and instruments as may be necessary or desirable in connection with any of the foregoing. In the event that any filing referred to in this Section 4 is required by the rules and regulations of the Commission, PORTAL, the Exchange or state securities or Blue Sky laws to be executed on behalf of the Trust by the Trustee, Chase Manhattan Bank USA, National Association, in its capacity as Trustee of the Trust, is hereby authorized and directed to join in any such filing and to execute on behalf of the Trust any and all of the foregoing, it being understood that Chase Manhattan Bank USA, National Association, in its capacity as Trustee of the Trust, shall not be required to join in any such filing or execute on behalf of the Trust any such document unless required by the rules and regulations of the Commission, PORTAL, the Exchange or state securities or Blue Sky laws. 5. In connection with all of the foregoing, the Sponsor hereby constitutes and appoints Edward L. Hutton, Joel F. Gemunder and Cheryl D. Hodges, each of them as its true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for the Sponsor or in the Sponsor's name, place and stead, in any and all capacities, to sign any and all amendments (including all pre-effective and post-effective amendments) to the 1933 Act Registration Statement and any 1934 Act Registration Statement and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as the Sponsor might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his respective substitute or substitutes, shall do or cause to be done by virtue hereof. 6. This Agreement may be executed in one or more counterparts. 7. The number of trustees of the Trust initially shall be one and thereafter the number of trustees of the Trust shall be such number as shall be fixed from time to time by a written instrument signed by the Sponsor which may increase or 2 decrease the number of trustees of the Trust; provided, however, that to the extent required by the Trust Act, one trustee of the Trust shall either be a natural person who is a resident of the State of Delaware or, if not a natural person, an entity which has its principal place of business in the State of Delaware. Subject to the foregoing, the Sponsor is entitled to appoint or remove without cause any Trustee of the Trust at any time. Any Trustee of the Trust may resign upon thirty days' prior notice to the Sponsor. 8. The Sponsor hereby agrees to (i) reimburse the Trustee for all reasonable expenses (including reasonable fees and expenses of counsel and other experts) and (ii) indemnify, defend and hold harmless the Trustee and any of the officers, directors, employees and agents of the Trustee (collectively, the "Indemnified Persons") from and against and all losses, damages, liabilities, claims, actions, suits, costs, expenses, disbursements (including the reasonable fees and expenses of counsel), taxes and penalties of any kind and nature whatsoever (collectively, "Expenses"), to the extent that such Expenses arise out of or are imposed upon or asserted at any time against such Indemnified Persons with respect to the performance of this Agreement, the creation, operation or termination of the Trust or the transactions contemplated hereby; provided, however, that the Sponsor shall not be required to indemnify any Indemnified Person for any Expenses which are a result of the willful misconduct, bad faith or gross negligence of such Indemnified Person. 9. The Trust may be dissolved and terminated before the issuance of the preferred securities of the Trust at the election of the Sponsor. 10. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware (without regard to conflict of laws principles). [SIGNATURES FOLLOW] 3 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the day and year first above written. OMNICARE, INC., as Sponsor By: /s/ David W. Froesel, Jr. -------------------------------------- Name: David W. Froesel, Jr. Title: Senior Vice President and Chief Financial Officer CHASE MANHATTAN BANK USA, NATIONAL ASSOCIATION, as Trustee By: /s/ John J. Cashin -------------------------------------- Name: John J. Cashin Title: Vice President 4 EX-4 7 ex4-12.txt EXHIBIT 4.12 Exhibit 4.12 CERTIFICATE OF TRUST OF OMNICARE CAPITAL TRUST II ------------------------- THIS CERTIFICATE OF TRUST of Omnicare Capital Trust II (the "Trust"), dated February 7, 2003, is being duly executed and filed to form a statutory trust under the Delaware Statutory Trust Act (12 Del. C. 'SS' 3801 et seq.)(the "Act"). 1. Name. The name of the statutory trust formed hereby is Omnicare Capital Trust II. 2. Delaware Trustee. The name and business address of the trustee of the Trust in the State of Delaware is Chase Manhattan Bank USA, National Association, 500 Stanton Christiana Road, FL3-OPS 4, Newark, Delaware, 19713, Attention: Institutional Trust Services. 3. Effective Date. This Certificate of Trust will be effective as of its filing. IN WITNESS WHEREOF, the undersigned has executed this Certificate of Trust as of the date first-above written in accordance with Section 3811(a) of the Act. CHASE MANHATTAN BANK USA, National Association, not in its individual capacity, but solely as trustee By: /s/ John J. Cashin -------------------------------------------- Name: John J. Cashin Title: Vice President EX-4 8 ex4-13.txt EXHIBIT 4.13 Exhibit 4.13 TRUST AGREEMENT OF OMNICARE CAPITAL TRUST II THIS TRUST AGREEMENT is made as of February 7, 2003 (this "Agreement"), by and between Omnicare, Inc., a Delaware corporation, as sponsor (the "Sponsor"), and Chase Manhattan Bank USA, National Association, as trustee (the "Trustee"). The Sponsor and the Trustee hereby agree as follows: 1. The trust created hereby shall be known as "Omnicare Capital Trust II" (the "Trust"), in which name the Trustee or the Sponsor, to the extent provided herein, may conduct the business of the Trust, make and execute contracts, and sue and be sued. 2. The Sponsor hereby assigns, transfers, conveys and sets over to the Trust the sum of $10. Such amount shall constitute the initial trust estate. It is the intention of the parties hereto that the Trust created hereby constitute a statutory trust under Chapter 38 of Title 12 of the Delaware Code, 12 Del. C. 'SS''SS' 3801, et seq. (the "Trust Act"), and that this document constitute the governing instrument of the Trust. The Trustee is hereby authorized and directed to execute and file a certificate of trust with the Delaware Secretary of State in such form as the Trustee may approve. 3. The Sponsor and the Trustee will enter into an amended and restated Trust Agreement satisfactory to each such party to provide for the contemplated operation of the Trust created hereby and the issuance of the preferred securities and common securities referred to therein. Prior to the execution and delivery of such amended and restated Trust Agreement, the Trustee shall not have any duty or obligation hereunder or with respect of the trust estate, except as otherwise required by applicable law or as the Sponsor directs in order to obtain prior to such execution and delivery any licenses, consents or approvals required by applicable law or otherwise. Notwithstanding the foregoing, the Trustee may take all actions deemed proper as are necessary to effect the transactions contemplated herein. 4. The Sponsor, as agent of the Trust, is hereby authorized, in its sole discretion, (i) to file with the Securities and Exchange Commission (the "Commission") and to execute, in the case of the 1933 Act Registration Statement and 1934 Act Registration Statement (as herein defined), on behalf of the Trust, (a) a Registration Statement (the "1933 Act Registration Statement"), including all pre-effective or post-effective amendments thereto, relating to the registration under the Securities Act of 1933, as amended (the "1933 Act"), of the preferred securities of the Trust, (b) any preliminary prospectus or prospectus or supplement thereto relating to the preferred securities of the Trust required to be filed under the 1933 Act, and (c) if required, a Registration Statement on Form 8-A or other appropriate form (the "1934 Act Registration Statement"), including all pre-effective and post-effective amendments thereto, relating to the registration of the preferred securities of the Trust under Section 12(b) of the Securities Exchange Act of 1934, as amended; (ii) to file with the New York Stock Exchange or any other exchange (collectively, the "Exchange") and execute on behalf of the Trust a listing application and all other applications, statements, certificates, agreements and other instruments as shall be necessary or desirable to cause the preferred securities of the Trust to be listed on the Exchange; (iii) to file and execute on behalf of the Trust such applications, reports, surety bonds, irrevocable consents, appointments of attorney for service of process and other papers and documents as shall be necessary or desirable to register the preferred securities of the Trust under the securities or "Blue Sky" laws of such jurisdictions as the Sponsor, on behalf of the Trust, may deem necessary or desirable; (iv) to execute, deliver and perform on behalf of the Trust, an underwriting agreement with the Sponsor and the underwriter or underwriters of the preferred securities of the Trust; (v) to execute, deliver and perform a depository agreement with the initial clearing agency, relating to the preferred securities of the Trust; (vi) to apply for and obtain a tax identification number for the Trust; and (vii) to execute on behalf of the Trust any and all documents, papers and instruments as may be necessary or desirable in connection with any of the foregoing. In the event that any filing referred to in this Section 4 is required by the rules and regulations of the Commission, PORTAL, the Exchange or state securities or Blue Sky laws to be executed on behalf of the Trust by the Trustee, Chase Manhattan Bank USA, National Association, in its capacity as Trustee of the Trust, is hereby authorized and directed to join in any such filing and to execute on behalf of the Trust any and all of the foregoing, it being understood that Chase Manhattan Bank USA, National Association, in its capacity as Trustee of the Trust, shall not be required to join in any such filing or execute on behalf of the Trust any such document unless required by the rules and regulations of the Commission, PORTAL, the Exchange or state securities or Blue Sky laws. 5. In connection with all of the foregoing, the Sponsor hereby constitutes and appoints Edward L. Hutton, Joel F. Gemunder and Cheryl D. Hodges, each of them as its true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for the Sponsor or in the Sponsor's name, place and stead, in any and all capacities, to sign any and all amendments (including all pre-effective and post-effective amendments) to the 1933 Act Registration Statement and any 1934 Act Registration Statement and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as the Sponsor might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his respective substitute or substitutes, shall do or cause to be done by virtue hereof. 6. This Agreement may be executed in one or more counterparts. 7. The number of trustees of the Trust initially shall be one and thereafter the number of trustees of the Trust shall be such number as shall be fixed from time to time by a written instrument signed by the Sponsor which may increase or 2 decrease the number of trustees of the Trust; provided, however, that to the extent required by the Trust Act, one trustee of the Trust shall either be a natural person who is a resident of the State of Delaware or, if not a natural person, an entity which has its principal place of business in the State of Delaware. Subject to the foregoing, the Sponsor is entitled to appoint or remove without cause any Trustee of the Trust at any time. Any Trustee of the Trust may resign upon thirty days' prior notice to the Sponsor. 8. The Sponsor hereby agrees to (i) reimburse the Trustee for all reasonable expenses (including reasonable fees and expenses of counsel and other experts) and (ii) indemnify, defend and hold harmless the Trustee and any of the officers, directors, employees and agents of the Trustee (collectively, the "Indemnified Persons") from and against and all losses, damages, liabilities, claims, actions, suits, costs, expenses, disbursements (including the reasonable fees and expenses of counsel), taxes and penalties of any kind and nature whatsoever (collectively, "Expenses"), to the extent that such Expenses arise out of or are imposed upon or asserted at any time against such Indemnified Persons with respect to the performance of this Agreement, the creation, operation or termination of the Trust or the transactions contemplated hereby; provided, however, that the Sponsor shall not be required to indemnify any Indemnified Person for any Expenses which are a result of the willful misconduct, bad faith or gross negligence of such Indemnified Person. 9. The Trust may be dissolved and terminated before the issuance of the preferred securities of the Trust at the election of the Sponsor. 10. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware (without regard to conflict of laws principles). [SIGNATURES FOLLOW] 3 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the day and year first above written. OMNICARE, INC., as Sponsor By: /s/ David. W. Froesel, Jr. --------------------------------- Name: David W. Froesel, Jr. Title: Senior Vice President and Chief Financial Officer CHASE MANHATTAN BANK USA, NATIONAL ASSOCIATION, as Trustee By: /s/ John J. Cashin --------------------------------- Name: John J. Cashin Title: Vice President 4 EX-4 9 ex4-14.txt EXHIBIT 4.14 Exhibit 4.14 CERTIFICATE OF TRUST OF OMNICARE CAPITAL TRUST III -------------------------- THIS CERTIFICATE OF TRUST of Omnicare Capital Trust III (the "Trust"), dated February 7, 2003, is being duly executed and filed to form a statutory trust under the Delaware Statutory Trust Act (12 Del. C. 'SS' 3801 et seq.)(the "Act"). 1. Name. The name of the statutory trust formed hereby is Omnicare Capital Trust III. 2. Delaware Trustee. The name and business address of the trustee of the Trust in the State of Delaware is Chase Manhattan Bank USA, National Association, 500 Stanton Christiana Road, FL3-OPS 4, Newark, Delaware, 19713, Attention: Institutional Trust Services. 3. Effective Date. This Certificate of Trust will be effective as of its filing. IN WITNESS WHEREOF, the undersigned has executed this Certificate of Trust as of the date first-above written in accordance with Section 3811(a) of the Act. CHASE MANHATTAN BANK USA, National Association, not in its individual capacity, but solely as trustee By: /s/ John J. Cashin -------------------------------------------- Name: John J. Cashin Title: Vice President EX-4 10 ex4-15.txt EXHIBIT 4.15 Exhibit 4.15 TRUST AGREEMENT OF OMNICARE CAPITAL TRUST III THIS TRUST AGREEMENT is made as of February 7, 2003 (this "Agreement"), by and between Omnicare, Inc., a Delaware corporation, as sponsor (the "Sponsor"), and Chase Manhattan Bank USA, National Association, as trustee (the "Trustee"). The Sponsor and the Trustee hereby agree as follows: 1. The trust created hereby shall be known as "Omnicare Capital Trust III" (the "Trust"), in which name the Trustee or the Sponsor, to the extent provided herein, may conduct the business of the Trust, make and execute contracts, and sue and be sued. 2. The Sponsor hereby assigns, transfers, conveys and sets over to the Trust the sum of $10. Such amount shall constitute the initial trust estate. It is the intention of the parties hereto that the Trust created hereby constitute a statutory trust under Chapter 38 of Title 12 of the Delaware Code, 12 Del. C. 'SS''SS' 3801, et seq. (the "Trust Act"), and that this document constitute the governing instrument of the Trust. The Trustee is hereby authorized and directed to execute and file a certificate of trust with the Delaware Secretary of State in such form as the Trustee may approve. 3. The Sponsor and the Trustee will enter into an amended and restated Trust Agreement satisfactory to each such party to provide for the contemplated operation of the Trust created hereby and the issuance of the preferred securities and common securities referred to therein. Prior to the execution and delivery of such amended and restated Trust Agreement, the Trustee shall not have any duty or obligation hereunder or with respect of the trust estate, except as otherwise required by applicable law or as the Sponsor directs in order to obtain prior to such execution and delivery any licenses, consents or approvals required by applicable law or otherwise. Notwithstanding the foregoing, the Trustee may take all actions deemed proper as are necessary to effect the transactions contemplated herein. 4. The Sponsor, as agent of the Trust, is hereby authorized, in its sole discretion, (i) to file with the Securities and Exchange Commission (the "Commission") and to execute, in the case of the 1933 Act Registration Statement and 1934 Act Registration Statement (as herein defined), on behalf of the Trust, (a) a Registration Statement (the "1933 Act Registration Statement"), including all pre-effective or post-effective amendments thereto, relating to the registration under the Securities Act of 1933, as amended (the "1933 Act"), of the preferred securities of the Trust, (b) any preliminary prospectus or prospectus or supplement thereto relating to the preferred securities of the Trust required to be filed under the 1933 Act, and (c) if required, a Registration Statement on Form 8-A or other appropriate form (the "1934 Act Registration Statement"), including all pre-effective and post-effective amendments thereto, relating to the registration of the preferred securities of the Trust under Section 12(b) of the Securities Exchange Act of 1934, as amended; (ii) to file with the New York Stock Exchange or any other exchange (collectively, the "Exchange") and execute on behalf of the Trust a listing application and all other applications, statements, certificates, agreements and other instruments as shall be necessary or desirable to cause the preferred securities of the Trust to be listed on the Exchange; (iii) to file and execute on behalf of the Trust such applications, reports, surety bonds, irrevocable consents, appointments of attorney for service of process and other papers and documents as shall be necessary or desirable to register the preferred securities of the Trust under the securities or "Blue Sky" laws of such jurisdictions as the Sponsor, on behalf of the Trust, may deem necessary or desirable; (iv) to execute, deliver and perform on behalf of the Trust, an underwriting agreement with the Sponsor and the underwriter or underwriters of the preferred securities of the Trust; (v) to execute, deliver and perform a depository agreement with the initial clearing agency, relating to the preferred securities of the Trust; (vi) to apply for and obtain a tax identification number for the Trust; and (vii) to execute on behalf of the Trust any and all documents, papers and instruments as may be necessary or desirable in connection with any of the foregoing. In the event that any filing referred to in this Section 4 is required by the rules and regulations of the Commission, PORTAL, the Exchange or state securities or Blue Sky laws to be executed on behalf of the Trust by the Trustee, Chase Manhattan Bank USA, National Association, in its capacity as Trustee of the Trust, is hereby authorized and directed to join in any such filing and to execute on behalf of the Trust any and all of the foregoing, it being understood that Chase Manhattan Bank USA, National Association, in its capacity as Trustee of the Trust, shall not be required to join in any such filing or execute on behalf of the Trust any such document unless required by the rules and regulations of the Commission, PORTAL, the Exchange or state securities or Blue Sky laws. 5. In connection with all of the foregoing, the Sponsor hereby constitutes and appoints Edward L. Hutton, Joel F. Gemunder and Cheryl D. Hodges, each of them as its true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for the Sponsor or in the Sponsor's name, place and stead, in any and all capacities, to sign any and all amendments (including all pre-effective and post-effective amendments) to the 1933 Act Registration Statement and any 1934 Act Registration Statement and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as the Sponsor might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his respective substitute or substitutes, shall do or cause to be done by virtue hereof. 6. This Agreement may be executed in one or more counterparts. 7. The number of trustees of the Trust initially shall be one and thereafter the number of trustees of the Trust shall be such number as shall be fixed from time to time by a written instrument signed by the Sponsor which may increase or 2 decrease the number of trustees of the Trust; provided, however, that to the extent required by the Trust Act, one trustee of the Trust shall either be a natural person who is a resident of the State of Delaware or, if not a natural person, an entity which has its principal place of business in the State of Delaware. Subject to the foregoing, the Sponsor is entitled to appoint or remove without cause any Trustee of the Trust at any time. Any Trustee of the Trust may resign upon thirty days' prior notice to the Sponsor. 8. The Sponsor hereby agrees to (i) reimburse the Trustee for all reasonable expenses (including reasonable fees and expenses of counsel and other experts) and (ii) indemnify, defend and hold harmless the Trustee and any of the officers, directors, employees and agents of the Trustee (collectively, the "Indemnified Persons") from and against and all losses, damages, liabilities, claims, actions, suits, costs, expenses, disbursements (including the reasonable fees and expenses of counsel), taxes and penalties of any kind and nature whatsoever (collectively, "Expenses"), to the extent that such Expenses arise out of or are imposed upon or asserted at any time against such Indemnified Persons with respect to the performance of this Agreement, the creation, operation or termination of the Trust or the transactions contemplated hereby; provided, however, that the Sponsor shall not be required to indemnify any Indemnified Person for any Expenses which are a result of the willful misconduct, bad faith or gross negligence of such Indemnified Person. 9. The Trust may be dissolved and terminated before the issuance of the preferred securities of the Trust at the election of the Sponsor. 10. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware (without regard to conflict of laws principles). [SIGNATURES FOLLOW] 3 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the day and year first above written. OMNICARE, INC., as Sponsor By: /s/ David. W. Froesel, Jr. ------------------------------------ Name: David W. Froesel, Jr. Title: Senior Vice President and Chief Financial Officer CHASE MANHATTAN BANK USA, NATIONAL ASSOCIATION, as Trustee By: /s/ John J. Cashin ------------------------------------ Name: John J. Cashin Title: Vice President 4 EX-4 11 ex4-16.txt EXHIBIT 4.16 Exhibit 4.16 OMNICARE CAPITAL TRUST [I/II/III] AMENDED AND RESTATED TRUST AGREEMENT among OMNICARE, INC., as Depositor, [ ], as Property Trustee, [ ], as Delaware Trustee, and [ ], [ ] and [ ], as Administrative Trustees Dated as of ________, 200_ OMNICARE CAPITAL TRUST [I/II/III] Certain Sections of this Trust Agreement relating to Sections 310 through 318 of the Trust Indenture Act of 1939: Trust Indenture Act Section Trust Agreement Section Section 310(a)(1)...........................................................8.07 (a)(2)..............................................................8.07 (a)(3)..............................................................8.09 (a)(4)....................................................Not Applicable (b).................................................................8.08 Section 311(a)............................................................. 8.13 (b) ................................................................8.13 Section 312(a)..............................................................5.07 (b).................................................................5.07 (c).................................................................5.07 Section 313(a)...........................................................8.14(a) (a)(4)...........................................................8.14(b) (b)..............................................................8.14(b) (c)..............................................................8.14(a) (d).....................................................8.14(a), 8.14(b) Section 314(a)..............................................................8.15 (b).......................................................Not Applicable (c)(1)........................................................8.15, 8.16 (c)(2)..............................................................8.16 (c)(3)..............................................................8.16 (d).......................................................Not Applicable (e).................................................................8.16 Section 315(a)..............................................................8.01 (b)........................................................8.02, 8.14(b) (c)..............................................................8.01(a) (d)...........................................................8.01, 8.03 (e).......................................................Not Applicable Section 316(a)....................................................Not Applicable (a)(1)(A)...........................................................8.19 (a)(1)(B)...........................................................8.19 (a)(2)....................................................Not Applicable (b).......................................................Not Applicable (c).......................................................Not Applicable Section 317(a)(1) ................................................Not Applicable (a)(2)....................................................Not Applicable (b).................................................................5.09 Section 318(a).............................................................10.10 Note: This Cross-Reference Table does not constitute part of the Trust Agreement and shall not affect the interpretation of any of its terms and provisions. TABLE OF CONTENTS Page ARTICLE I Defined Terms........................................................1 Section 1.01 Definitions.....................................................1 ARTICLE II Establishment of the Trust.........................................10 Section 2.01 Name...........................................................10 Section 2.02 Offices of the Trustees; Principal Place of Business...........10 Section 2.03 Initial Contribution of Trust Property; Organizational Expenses.......................................................11 Section 2.04 Issuance of the Preferred Securities...........................11 Section 2.05 Subscription and Purchase of Subordinated Debt Securities; Issuance of the Common Securities..............................11 Section 2.06 Declaration of Trust...........................................12 Section 2.07 Authorization to Enter into Certain Transactions...............12 Section 2.08 Assets of Trust................................................17 Section 2.09 Title to Trust Property........................................17 Section 2.10 Mergers and Consolidations of the Trust........................17 ARTICLE III Payment Account...................................................18 Section 3.01 Payment Account................................................18 ARTICLE IV Distributions; Redemption; Exchange................................19 Section 4.01 Distributions..................................................19 Section 4.02 Redemption.....................................................20 Section 4.03 Subordination of Common Securities.............................22 Section 4.04 Payment Procedures.............................................22 Section 4.05 Tax Returns and Reports........................................23 Section 4.06 Payment of Taxes, Duties, Etc. of the Trust....................23 Section 4.07 Payments under the Indenture...................................23 Section 4.08 Exchange of Preferred Securities...............................23 ARTICLE V Trust Securities Certificates.......................................24 Section 5.01 Initial Ownership..............................................24 Section 5.02 The Trust Securities Certificates..............................24 Section 5.03 Execution and Delivery of Trust Securities Certificates........24 Section 5.04 Registration of Transfer and Exchange of Preferred Securities Certificates........................................24 Section 5.05 Mutilated, Destroyed, Lost or Stolen Trust Securities Certificates...................................................25 Section 5.06 Persons Deemed Securityholders.................................26 Section 5.07 Access to List of Securityholders' Names and Addresses.........26 Section 5.08 Maintenance of Office or Agency................................26 i Section 5.09 Appointment of Paying Agent....................................26 Section 5.10 Ownership of Common Securities by Depositor....................27 Section 5.11 Book-Entry Preferred Securities Certificates; Common Securities Certificate.........................................27 Section 5.12 Notices to Clearing Agency.....................................28 Section 5.13 Definitive Preferred Securities Certificates...................28 Section 5.14 Rights of Securityholders......................................29 ARTICLE VI Acts of Securityholders; Meetings; Voting..........................29 Section 6.01 Limitations on Voting Rights...................................29 Section 6.02 Notice of Meetings.............................................30 Section 6.03 Meetings of Preferred Securityholders..........................30 Section 6.04 Voting Rights..................................................31 Section 6.05 Proxies, etc...................................................31 Section 6.06 Securityholder Action by Written Consent.......................31 Section 6.07 Record Date for Voting and Other Purposes......................31 Section 6.08 Acts of Securityholders........................................32 Section 6.09 Inspection of Records..........................................33 ARTICLE VII Representations and Warranties....................................33 Section 7.01 Representations and Warranties of the Bank and the Property Trustee........................................................33 Section 7.02 Representations and Warranties of the Delaware Bank and the Delaware Trustee...............................................34 Section 7.03 Representations and Warranties of the Depositor................35 ARTICLE VIII The Trustees.....................................................36 Section 8.01 Certain Duties and Responsibilities............................36 Section 8.02 Certain Notices................................................37 Section 8.03 Certain Rights of Property Trustee.............................37 Section 8.04 Not Responsible for Recitals or Issuance of Securities.........39 Section 8.05 May Hold Securities............................................39 Section 8.06 Compensation; Fees; Indemnity..................................39 Section 8.07 Trustees Required; Eligibility.................................40 Section 8.08 Conflicting Interests..........................................40 Section 8.09 Co-Trustees and Separate Trustee...............................40 Section 8.10 Resignation and Removal; Appointment of Successor..............42 Section 8.11 Acceptance of Appointment by Successor.........................43 Section 8.12 Merger, Conversion, Consolidation or Succession to Business....43 Section 8.13 Preferential Collection of Claims Against Depositor or Trust...44 Section 8.14 Reports by Property Trustee....................................44 Section 8.15 Reports to the Property Trustee................................44 Section 8.16 Evidence of Compliance with Conditions Precedent...............44 Section 8.17 Number of Trustees.............................................44 ii Section 8.18 Delegation of Power............................................45 Section 8.19 Voting.........................................................45 Section 8.20 Enforcement of Rights of Property Trustee by Securityholders................................................45 ARTICLE IX Termination and Liquidation........................................46 Section 9.01 Termination Upon Expiration Date...............................46 Section 9.02 Early Termination..............................................46 Section 9.03 Termination....................................................46 Section 9.04 Certificate of Cancellation....................................47 Section 9.05 Liquidation....................................................47 ARTICLE X Miscellaneous Provisions............................................48 Section 10.01 Limitation of Rights of Securityholders........................48 Section 10.02 Amendment......................................................49 Section 10.03 Separability...................................................50 Section 10.04 Governing Law..................................................50 Section 10.05 Successors.....................................................50 Section 10.06 Headings.......................................................50 Section 10.07 Notice and Demand..............................................50 Section 10.08 Conflict with Trust Indenture Act..............................51 EXHIBIT A Form of Common Securities Certificate EXHIBIT B Form of Expense Agreement EXHIBIT C Form of Preferred Securities Certificate iii AMENDED AND RESTATED TRUST AGREEMENT THIS AMENDED AND RESTATED TRUST AGREEMENT is made as of ________, 200_, by and among (i) Omnicare, Inc., a Delaware corporation (the "Depositor" or the "Company"), (ii) [ ], a banking corporation duly organized and existing under the laws of New York, as trustee (the "Property Trustee" and, in its separate corporate capacity and not in its capacity as Trustee, the "Bank"), (iii) [ ], as Delaware trustee (the "Delaware Trustee" and, in its separate corporate capacity and not in its capacity as Delaware Trustee, the "Delaware Bank"), (iv) [ ], an individual, [ ], an individual, and [ ], an individual, as administrative trustees (each an "Administrative Trustee" and together the "Administrative Trustees") (the Property Trustee, the Delaware Trustee and the Administrative Trustees referred to collectively as the "Trustees") and (v) the several Holders, as hereinafter defined. WITNESSETH: WHEREAS, the Depositor and the Delaware Trustee have heretofore duly declared and established a statutory trust pursuant to the Delaware Statutory Trust Act by the entering into that certain Trust Agreement, dated as of __________, 2003 (the "Original Trust Agreement"), and by the execution and filing by the Delaware Trustee with the Secretary of State of the State of Delaware of the Certificate of Trust, dated __________, 2003; and WHEREAS, the parties hereto desire to amend and restate the Original Trust Agreement in its entirety as set forth herein to provide for, among other things, (i) the addition of the Bank, [individual], [individual] and [individual] as trustees of the Trust, (ii) the acquisition by the Trust from the Depositor of all of the right, title and interest in the Subordinated Debt Securities, (iii) the issuance of the Common Securities by the Trust to the Depositor and (iv) the issuance and sale of the Preferred Securities by the Trust pursuant to the Underwriting Agreement. NOW THEREFORE, in consideration of the agreements and obligations set forth herein and for other good and valuable consideration, the sufficiency of which is hereby acknowledged, each party, for the benefit of the other parties and for the benefit of the Securityholders, hereby amends and restates the Original Trust Agreement in its entirety and agrees as follows: ARTICLE I Defined Terms Section 1.01 Definitions. For all purposes of this Trust Agreement, except as otherwise expressly provided or unless the context otherwise requires: (a) the terms defined in this Article have the meanings assigned to them in this Article and include the plural as well as the singular; (b) all other terms used herein that are defined in the Trust Indenture Act, either directly or by reference therein, have the meanings assigned to them therein; (c) unless the context otherwise requires, any reference to an "Article" or a "Section" refers to an Article or a Section, as the case may be, of this Trust Agreement; and (d) the words "herein," "hereof" and "hereunder" and other words of similar import refer to this Trust Agreement as a whole and not to any particular Article, Section or other subdivision. "Act" has the meaning specified in Section 6.08. "Administrative Trustee" means each of the individuals identified as an "Administrative Trustee" in the preamble to this Trust Agreement solely in their capacities as Administrative Trustees of the Trust formed and continued hereunder and not in their individual capacities, or such trustee's successor(s) in interest in such capacity, or any successor "Administrative Trustee" appointed as herein provided. "Affiliate" of any specified Person means any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, "control" when used with respect to any specified Person means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms "controlling" and "controlled" have meanings correlative to the foregoing. "Bank" has the meaning specified in the preamble to this Trust Agreement. "Bankruptcy Event" means, with respect to any Person: (i) the entry of a decree or order by a court having jurisdiction in the premises judging such Person a bankrupt or insolvent, or approving as properly filed a petition seeking reorganization, arrangement, adjudication or composition of or in respect of such Person under federal bankruptcy law or any other applicable federal or state law, or appointing a receiver, liquidator, assignee, trustee, sequestrator or other similar official of such Person or of any substantial part of its property, or ordering the winding up or liquidation of its affairs, and the continuance of such decree or order unstayed and in effect for a period of 60 consecutive days; or (ii) the institution by such Person of proceedings to be adjudicated a bankrupt or insolvent, or the consent by it to the institution of bankruptcy or insolvency proceedings against it, or the filing by it of a petition or answer or consent seeking reorganization or relief under federal bankruptcy law or any other applicable federal or state law, or the consent 2 by it to the filing of such petition or to the appointment of a receiver, liquidator, assignee, trustee, sequestrator or similar official of such Person or of any substantial part of its property, or the making by it of an assignment for the benefit of creditors, or the admission by it in writing of its inability to pay its debts generally as they become due, or the taking of action by such Person in furtherance of any such action. "Bankruptcy Laws" has the meaning specified in Section 10.09. "Board Resolution" means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Depositor to have been duly adopted by the Depositor's Board of Directors or a duly authorized committee thereof and to be in full force and effect on the date of such certification, and delivered to the Trustees. "Book-Entry Preferred Securities Certificates" means certificates representing Preferred Securities issued in global, fully registered form to the Clearing Agency as described in Section 5.11. "Business Day" means a day other than (i) a Saturday or a Sunday, (ii) a day on which banks in New York, New York are authorized or obligated by law or executive order to remain closed or (iii) a day on which the Corporate Trust Office or the Indenture Trustee's principal corporate trust office is closed for business. "Certificate Depository Agreement" means the agreement among the Trust, the Property Trustee and The Depository Trust Company, as the initial Clearing Agency, dated ________, ____, relating to the Preferred Securities Certificates, as the same may be amended and supplemented from time to time. "Clearing Agency" means an organization registered as a "clearing agency" pursuant to Section 17A of the Securities Exchange Act of 1934, as amended. The Depository Trust Company will be the initial Clearing Agency. "Clearing Agency Participant" means a broker, dealer, bank, other financial institution or other Person for whom from time to time a Clearing Agency effects book-entry transfers and pledges of securities deposited with the Clearing Agency. "Code" means the Internal Revenue Code of 1986, as amended. "Commission" means the Securities and Exchange Commission, as from time to time constituted, created under the Securities Exchange Act of 1934, or, if at any time after the execution of this instrument such Commission is not existing and performing the duties now assigned to it under the Trust Indenture Act, then the body performing such duties at such time. "Common Security" means an undivided beneficial ownership interest in the assets of the Trust having a Liquidation Amount of $___ and having the rights provided therefor in this Trust Agreement, including the right to receive Distributions and a Liquidation Distribution as provided herein. 3 "Common Securities Certificate" means a certificate evidencing ownership of a Common Security or Securities, substantially in the form attached as Exhibit A. "Company" has the meaning specified in the preamble hereto. "Corporate Trust Office" means the office of the Property Trustee at which its corporate trust business shall be principally administered. "Definitive Preferred Securities Certificates" means either or both (as the context requires) of (i) Preferred Securities Certificates issued in certificated, fully registered form as provided in Section 5.11(a) and (ii) Preferred Securities Certificates issued in certificated, fully registered form as provided in Section 5.13. "Delaware Bank" has the meaning specified in the preamble to this Trust Agreement. "Delaware Statutory Trust Act" means Chapter 38 of Title 12 of the Delaware Code, 12 Del. Code Section 3801 et seq., as it may be amended from time to time. "Delaware Trustee" means the commercial bank or trust company or any other Person identified as the "Delaware Trustee" and has the meaning specified in the preamble to this Trust Agreement solely in its capacity as Delaware Trustee of the Trust formed and continued hereunder and not in its individual capacity, or its successor in interest in such capacity, or any successor Delaware Trustee appointed as herein provided. "Depositor" means Omnicare, Inc., in its capacity as "Depositor" under this Trust Agreement. "Distribution Date" has the meaning specified in Section 4.01(a). "Distributions" means amounts payable in respect of the Trust Securities as provided in Section 4.01. "Event of Default" means any one of the following events (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body): (i) the occurrence of an Indenture Event of Default; or (ii) default by the Trust in the payment of any Distribution when it becomes due and payable, and continuation of such default for a period of 30 days; or 4 (iii) default by the Trust in the payment of any Redemption Price of any Trust Security when it becomes due and payable; or (iv) default in the performance, or breach, of any covenant or warranty of the Trustees in this Trust Agreement (other than a covenant or warranty a default in whose performance or breach is dealt with in clause (ii) or (iii) above) and continuation of such default or breach for a period of 60 days after there has been given, by registered or certified mail, to the Trustees by the Holders of at least 25% in aggregate Liquidation Amount of the Outstanding Preferred Securities a written notice specifying such default or breach and requiring it to be remedied and stating that such notice is a "Notice of Default" hereunder; or (v) the occurrence of a Bankruptcy Event with respect to the Property Trustee and the failure by the Depositor to appoint a successor Property Trustee within 60 days thereof. "Expense Agreement" means the Agreement as to Expenses and Liabilities between the Company and the Trust, substantially in the form attached as Exhibit B, as amended from time to time. "Exchange Act" means the Securities Exchange Act of 1934, as amended. "Extension Period" has the meaning provided in Section 2.03(a) of the Subordinated Indenture. "Guarantee" means the Guarantee Agreement executed and delivered by the Company and [ ], as Guarantee Trustee, contemporaneously with the execution and delivery of this Trust Agreement, for the benefit of the Holders of the Preferred Securities, as amended from time to time. "Indenture Event of Default" means an "Event of Default" as defined in the Subordinated Indenture. "Indenture Redemption Date" means "Redemption Date," as defined in the Subordinated Indenture. "Indenture Trustee" means the trustee under the Subordinated Indenture. "Investment Company Event" means the receipt by the Trust of an opinion of a nationally recognized independent counsel, to the effect that, as a result of the occurrence of an amendment to or change in applicable law or regulations, or a written change in interpretation or application of law or regulation by any legislative body, court, governmental agency or regulatory authority (a "Change in 1940 Act Law"), there is more than an insubstantial risk that the Trust is or will be considered an "investment company" that is required to be registered under the 1940 Act, which Change in 1940 Act Law becomes effective on or after the Issue Date. 5 "Issue Date" means the date of the delivery of the Trust Securities. "Lien" means any lien, pledge, charge, encumbrance, mortgage, deed of trust, adverse ownership interest, hypothecation, assignment, security interest or preference, priority or other security agreement or preferential arrangement of any kind or nature whatsoever. "Like Amount" means (i) Trust Securities having a Liquidation Amount equal to the principal amount of Subordinated Debt Securities to be contemporaneously redeemed in accordance with the Subordinated Indenture and the proceeds of which will be used to pay the Redemption Price of such Trust Securities and (ii) Subordinated Debt Securities having a principal amount equal to the Liquidation Amount of the Trust Securities of the Holder to whom such Subordinated Debt Securities are distributed. "Liquidation Amount" means the stated amount of $___ per Trust Security. "Liquidation Date" means the date on which Subordinated Debt Securities are to be distributed to Holders of Trust Securities in connection with a dissolution and liquidation of the Trust pursuant to Section 9.05. "Liquidation Distribution" has the meaning specified in Section 9.06. "Officers' Certificate" means a certificate signed by the Chairman of the Board, a Vice Chairman of the Board, the President or a Vice President, and by the Treasurer, an Assistant Treasurer, the Secretary or an Assistant Secretary, of the Depositor, and delivered to the appropriate Trustee. One of the officers signing an Officers' Certificate given pursuant to Section 8.16 shall be the principal executive, financial or accounting officer of the Depositor. An Officers' Certificate delivered with respect to compliance with a condition or covenant provided for in this Trust Agreement shall include: (a) a statement that each officer signing the Officers' Certificate has read the covenant or condition and the definitions relating thereto; (b) a brief statement of the nature and scope of the examination or investigation undertaken by each officer in rendering the Officers' Certificate; (c) a statement that each such officer has made such examination or investigation as is necessary, in such officer's opinion, to express an informed opinion as to whether or not such covenant or condition has been complied with; and (d) a statement as to whether, in the opinion of each such officer, such condition or covenant has been complied with. 6 "Opinion of Counsel" means a written opinion of counsel, who may be counsel for the Trust, the Trustees or the Depositor, but not an employee of the Trust or the Trustees, and who shall be reasonably acceptable to the Property Trustee. Any Opinion of Counsel pertaining to federal income tax matters may rely on published rulings of the Internal Revenue Service. "Original Trust Agreement" has the meaning specified in the recitals to this Trust Agreement. "Outstanding", when used with respect to Preferred Securities, means, as of the date of determination, all Preferred Securities theretofore delivered under this Trust Agreement, except: (i) Preferred Securities theretofore canceled by the Administrative Trustees or delivered to the Administrative Trustees for cancellation; (ii) Preferred Securities for whose payment or redemption money in the necessary amount has been theretofore deposited with the Property Trustee or any Paying Agent for the Holders of such Preferred Securities; provided that if such Preferred Securities are to be redeemed, notice of such redemption has been duly given pursuant to this Trust Agreement; and (iii) Preferred Securities in exchange for or in lieu of which other Preferred Securities have been delivered pursuant to this Trust Agreement; provided, however, that in determining whether the Holders of the requisite Liquidation Amount of the Outstanding Preferred Securities have given any request, demand, authorization, direction, notice, consent or waiver hereunder, Preferred Securities owned by the Depositor, the Holder of the Common Securities, any Trustee or any Affiliate of the Depositor or any Trustee shall be disregarded and deemed not to be Outstanding, except that (a) in determining whether any Trustee shall be protected in relying upon any such request, demand, authorization, direction, notice, consent or waiver, only Preferred Securities which such Trustee knows to be so owned shall be so disregarded and (b) the foregoing shall not apply at any time when all of the outstanding Preferred Securities are owned by the Depositor, the Holder of the Common Securities, one or more Trustees and/or any such Affiliate. Preferred Securities so owned which have been pledged in good faith may be regarded as Outstanding if the pledgee establishes to the satisfaction of the Administrative Trustees the pledgee's right so to act with respect to such Preferred Securities and that the pledgee is not the Depositor or any Affiliate of the Depositor. "Owner" means each Person who is the beneficial owner of a Book-Entry Preferred Securities Certificate as reflected in the records of the Clearing Agency or, if a Clearing Agency Participant is not the Owner, then as reflected in the records of a Person 7 maintaining an account with such Clearing Agency (directly or indirectly, in accordance with the rules of such Clearing Agency). "Paying Agent" means any paying agent or co-paying agent appointed pursuant to Section 5.09 and shall initially be the ________. "Payment Account" means a segregated non-interest-bearing corporate trust account maintained by the Property Trustee for the benefit of the Securityholders in which all amounts paid in respect of the Subordinated Debt Securities will be held and from which the Property Trustee shall make payments to the Securityholders in accordance with Sections 4.01 and 4.02. "Person" means an individual, corporation, partnership, joint venture, trust, limited liability company or corporation, unincorporated organization or government or any agency or political subdivision thereof. "Preferred Security" means an undivided beneficial ownership interest in the assets of the Trust having a Liquidation Amount of $___ and having rights provided therefor in this Trust Agreement, including the right to receive Distributions and a Liquidation Distribution as provided herein. "Preferred Securities Certificate" means a certificate evidencing ownership of a Preferred Security or Securities, substantially in the form attached as Exhibit C. "Property Trustee" means the commercial bank or trust company identified as the "Property Trustee" in the preamble to this Trust Agreement solely in its capacity as Property Trustee of the Trust formed and continued hereunder and not in its individual capacity, or its successor in interest in such capacity, or any successor "Property Trustee" as herein provided. "Redemption Date" means, with respect to any Trust Security to be redeemed, the date fixed for such redemption by or pursuant to this Trust Agreement; provided that each Indenture Redemption Date shall be a Redemption Date for a Like Amount of Trust Securities. "Redemption Price" means, with respect to any date fixed for redemption of any Trust Security, the Liquidation Amount of such Trust Security, plus accrued and unpaid Distributions to such date. "Relevant Trustee" shall have the meaning specified in Section 8.10. "Securities Register" and "Securities Registrar" are described in Section 5.04. "Securityholder" or "Holder" means a Person in whose name a Trust Security or Securities is registered in the Securities Register; any such Person is a beneficial owner within the meaning of the Delaware Statutory Trust Act. 8 "Special Event" means a Tax Event or an Investment Company Event. "Subordinated Debt Securities" means the $__________ aggregate principal amount of the Depositor's _______% Subordinated Debt Securities due __________, issued pursuant to the Subordinated Indenture, which may be increased by an additional amount not to exceed $__________ aggregate principal amount of the Depositor's _______% Subordinated Debt Securities due __________ issued pursuant to the Subordinated Indenture, the Underwriters' Over allotment Option and Section 2.05 herein. "Subordinated Indenture" means the Subordinated Debt Securities Indenture, dated as of ________, 200_, between the Depositor and the Indenture Trustee, as amended or supplemented from time to time. "Tax Event" means the receipt by the Trust of an independent Opinion of Counsel, to the effect that, as a result of (a) any amendment to, change in or announced prospective change in the laws (or any regulations thereunder) of the United States or any political subdivision or taxing authority thereof or therein, or (b) any official administrative written decision or pronouncement, or judicial decision interpreting or applying such laws or regulations, which amendment or change is effective or which pronouncement, or decision is announced on or after the Issue Date, there is more than an insubstantial risk that (i) the Trust is, or will be within 90 days of the date of such opinion, subject to the United States federal income tax with respect to income received or accrued on the Subordinated Debt Securities, (ii) interest payable by the Company on the Subordinated Debt Securities is not, or within 90 days of the date of such opinion will not be, deductible, in whole or in part, by the Company for United States federal income tax purposes, or (iii) the Trust is, or will be within 90 days of the date of such opinion, subject to more than a de minimis amount of other taxes, duties or other governmental charges. "Trust" means the Delaware Statutory Trust continued hereby and identified on the cover page to this Trust Agreement. "Trust Agreement" means this Amended and Restated Trust Agreement, as the same may be modified, amended or supplemented in accordance with the applicable provisions hereof, including all exhibits hereto, including, for all purposes of this Amended and Restated Trust Agreement and any modification, amendment or supplement, the provisions of the Trust Indenture Act that are deemed to be a part of and govern this Amended and Restated Trust Agreement and any such modification, amendment or supplement, respectively. "Trustees" means the Persons identified as "Trustees" in the preamble to this Trust Agreement solely in their capacities as Trustees of the Trust formed and continued hereunder and not in their individual capacities, or their successor in interest in such capacity, or any successor trustee appointed as herein provided. 9 "Trust Indenture Act" means the Trust Indenture Act of 1939 as in force at the date as of which this instrument was executed; provided, however, that in the event the Trust Indenture Act of 1939 is amended after such date, "Trust Indenture Act" means, to the extent required by any such amendment, the Trust Indenture Act of 1939 as so amended. "Trust Property" means (i) the Subordinated Debt Securities, (ii) any cash on deposit in, or owing to, the Payment Account, and (iii) all proceeds and rights in respect of the foregoing and any other property and assets for the time being held or deemed to be held by the Property Trustee pursuant to this Trust Agreement. "Trust Securities Certificate" means any one of the Common Securities Certificates or the Preferred Securities Certificates. "Trust Security" means any one of the Common Securities or the Preferred Securities. "Underwriters" means the underwriters named in the Underwriting Agreement. "Underwriters' Overallotment Option" means the Underwriters' option to purchase up to an additional _________ Preferred Securities pursuant to the Underwriting Agreement. "Underwriters' Overallotment Option Closing Date" means the closing of the transactions contemplated by the Underwriters' Overallotment Option. "Underwriting Agreement" means the Underwriting Agreement, dated ________, 200_, among the Trust, the Depositor and the Underwriters. ARTICLE II Establishment of the Trust Section 2.01 Name. The Trust continued hereby shall be known as "Omnicare Capital Trust [I/II/III]", in which name the Trustees may conduct the business of the Trust, make and execute contracts and other instruments on behalf of the Trust and sue and be sued. The Administrative Trustees may change the name of the Trust from time to time following written notice to the Holders. Section 2.02 Offices of the Trustees; Principal Place of Business. The address of the Property Trustee is _______________, or at such other address as the Property Trustee may designate by written notice to the Securityholders and the Depositor. The principal place of business of the Delaware Trustee is c/o ____________, Attn: __________, or at such other address in Delaware as the Delaware Trustee may designate by notice to the Depositor. The address of the Administrative Trustees is c/o Omnicare, Inc., 100 East 10 RiverCenter Boulevard, Covington, Kentucky 41011, Attention: Secretary. The principal place of business of the Trust is c/o Omnicare, Inc., 100 East RiverCenter Boulevard, Covington, Kentucky 41011. The Depositor may change the principal place of business of the Trust at any time by giving notice thereof to the Trustees. Section 2.03 Initial Contribution of Trust Property; Organizational Expenses. The Delaware Trustee acknowledges receipt in trust from the Depositor in connection with the Original Trust Agreement of the sum of $10, which constituted the initial Trust Property. The Depositor shall pay organizational expenses of the Trust as they arise or shall, upon request of the Trustees, promptly reimburse the Trustees for any such expenses paid by the Trustees. The Depositor shall make no claim upon the Trust Property for the payment of such expenses. Section 2.04 Issuance of the Preferred Securities. Contemporaneously with the execution and delivery of this Trust Agreement, the Administrative Trustees, on behalf of the Trust, shall execute and deliver to the Underwriters Preferred Securities Certificates, registered in the name of the nominee of the initial Clearing Agency, in an aggregate amount of __________ Preferred Securities having an aggregate Liquidation Amount of $__________, against receipt of the aggregate purchase price of such Preferred Securities of $__________, which amount the Administrative Trustees shall promptly deliver to the Property Trustee. In addition, in connection with the Underwriters' Overallotment Option, the Administrative Trustees, on behalf of the Trust, may execute and deliver to the Underwriters Preferred Securities Certificates, registered in the name of the nominee of the initial Clearing Agency, in an additional aggregate amount of up to __________ Preferred Securities having an aggregate Liquidation Amount of $__________, against receipt of the aggregate purchase price of such Preferred Securities, which amount the Administrative Trustees shall promptly deliver to the Property Trustee. Section 2.05 Subscription and Purchase of Subordinated Debt Securities; Issuance of the Common Securities. (a) Contemporaneously with the execution and delivery of this Trust Agreement, the Administrative Trustees, on behalf of the Trust, shall execute and deliver to the Depositor Common Securities Certificates, registered in the name of the Depositor, in an aggregate amount of __________ Common Securities having an aggregate Liquidation Amount of $__________, against payment by the Depositor of such amount. Contemporaneously therewith, the Administrative Trustees, on behalf of the Trust, shall subscribe to and purchase from the Depositor Subordinated Debt Securities, registered in the name of the Property Trustee, on behalf of the Trust and the Holders, and having an aggregate principal amount equal to $__________ Subordinated Debt Securities, and in satisfaction of the purchase price for such Subordinated Debt Securities, the Property Trustee, on behalf of the Trust, shall deliver to the Depositor the sum of $__________ Subordinated Debt Securities. (b) If the Underwriters' Overallotment Option is exercised and there is an Option Closing Date, then an Administrative Trustee, on behalf of the Trust, shall execute and deliver to the Depositor, Common Securities Certificates, registered in the 11 name of the Depositor, in an additional aggregate amount of Common Securities having an aggregate Liquidation Amount of up to $________ against payment by the Depositor of such amount. Contemporaneously therewith, an Administrative Trustee, on behalf of the Trust, shall subscribe to and purchase from the Depositor, additional Subordinated Debt Securities, registered in the name of the Trust and having an aggregate principal amount of up to $________, and, in satisfaction of the purchase price of such Subordinated Debt Securities, the Property Trustee, on behalf of the Trust, shall deliver to the Depositor an amount equal to the sum of the amounts received from one of the Administrative Trustees pursuant to the last sentence of Section 2.04. Section 2.06 Declaration of Trust. The exclusive purposes and functions of the Trust are (i) to issue and sell the Trust Securities and use the proceeds from such sale to acquire the Subordinated Debt Securities, and (ii) to engage in those activities necessary, incidental, appropriate or convenient thereto. The Depositor hereby appoints each of the Bank, the Delaware Bank, [Individual], [Individual] and [Individual] as trustees of the Trust, to have all the rights, powers and duties to the extent set forth herein. The Property Trustee hereby declares that it will hold the Trust Property in trust upon and subject to the conditions set forth herein for the benefit of the Trust and the Securityholders. The Trustees shall have all rights, powers and duties set forth herein and in accordance with applicable law with respect to accomplishing the purposes of the Trust. The Delaware Trustee shall not be entitled to exercise any powers, nor shall the Delaware Trustee have any of the duties and responsibilities, of the Property Trustee or the Administrative Trustees set forth herein. The Delaware Trustee shall be one of the Trustees for the sole and limited purpose of fulfilling the requirements of Section 3807(a) of the Delaware Statutory Trust Act. Section 2.07 Authorization to Enter into Certain Transactions. The Trustees shall conduct the affairs of the Trust in accordance with the terms of this Trust Agreement. Subject to the limitations set forth in paragraph C of this Section, and in accordance with the following paragraphs A and B, the Trustees shall have the authority to enter into all transactions and agreements determined by the Trustees to be appropriate in exercising the authority, express or implied, otherwise granted to the Trustees under this Trust Agreement, and to perform all acts in furtherance thereof, including without limitation, the following: A. As among the Trustees, the Administrative Trustees, acting singly or jointly, shall have the exclusive power, duty and authority to act on behalf of the Trust with respect to the following matters: (i) to acquire the Subordinated Debt Securities with the proceeds of the sale of the Trust Securities; provided, however, the Administrative Trustees shall cause legal title to all of the Subordinated Debt Securities to be vested in, and the Subordinated Debt Securities to be held of record in the name of, the Property Trustee for the benefit of the Trust and Holders of the Trust Securities; 12 (ii) to establish a record date with respect to all actions to be taken hereunder that require a record date be established, including for the purposes of ss. 316(c) of the Trust Indenture Act and with respect to Distributions, voting rights, redemptions, and exchanges, and to issue relevant notices to Holders of the Trust Securities as to such actions and applicable record dates; (iii) to bring or defend, pay, collect, compromise, arbitrate, resort to legal action, or otherwise adjust claims or demands of or against the Trust ("Legal Action"), unless pursuant to Section 2.07(B)(v), the Property Trustee has the power to bring such Legal Action; (iv) to employ or otherwise engage employees and agents (who may be designated as officers with titles) and managers, contractors, advisors, and consultants and pay reasonable compensation for such services; (v) to cause the Trust to comply with the Trust's obligations under the Trust Indenture Act; (vi) to give the certificate to the Property Trustee required by ss. 314(a)(4) of the Trust Indenture Act, which certificate may be executed by any Administrative Trustee; (vii) to take all actions and perform such duties as may be required of the Administrative Trustees pursuant to the terms of this Trust Agreement; (viii) to take all action that may be necessary or appropriate for the preservation and the continuation of the Trust's valid existence, rights, franchises and privileges as a statutory Statutory Trust under the laws of the State of Delaware and of each other jurisdiction in which such existence is necessary to protect the limited liability of the Holders of the Trust Securities or to enable the Trust to effect the purposes for which the Trust has been created; (ix) to take all action necessary to cause all applicable tax returns and tax information reports that are required to be filed with respect to the Trust to be duly prepared and filed by the Administrative Trustees, on behalf of the Trust; (x) to issue and sell the Trust Securities; (xi) to cause the Trust to enter into, and to execute, deliver and perform on behalf of the Trust, the Expense Agreement and the Certificate Depository Agreement and such other agreements as may be necessary or desirable in connection with the consummation hereof; 13 (xii) to assist in the registration of the Preferred Securities under the Securities Act of 1933, as amended, and under state securities or blue sky laws, and the qualification of this Trust Agreement as a trust indenture under the Trust Indenture Act; (xiii) to assist in the listing of the Preferred Securities upon such securities exchange or exchanges as shall be determined by the Depositor and the registration of the Preferred Securities under the Exchange Act, and the preparation and filing of all periodic and other reports and other documents pursuant to the foregoing; (xiv) to send notices (other than notices of default) and other information regarding the Trust Securities and the Subordinated Debt Securities to the Securityholders in accordance with this Trust Agreement; (xv) to appoint a Paying Agent (subject to Section 5.09), authenticating agent and Securities Registrar in accordance with this Trust Agreement; (xvi) to assist in, to the extent provided in this Trust Agreement, the winding up of the affairs of and termination of the Trust and the preparation, execution and filing of the certificate of cancellation with the Secretary of State of the State of Delaware; and (xvii) to take any action incidental to the foregoing as the Administrative Trustees may from time to time determine is necessary, appropriate, convenient or advisable to protect and conserve the Trust Property for the benefit of the Securityholders (without consideration of the effect of any such action on any particular Securityholder). B. As among the Trustees, the Property Trustee shall have the exclusive power, duty and authority to act on behalf of the Trust with respect to the following matters: (i) engage in such ministerial activities as shall be necessary or appropriate to effect promptly the redemption of the Trust Securities to the extent the Subordinated Debt Securities are redeemed or mature; (ii) upon notice of distribution issued by the Administrative Trustees in accordance with the terms of this Trust Agreement, engage in such ministerial activities as shall be necessary or appropriate to effect promptly the distribution pursuant to terms of this Trust Agreement of Subordinated Debt Securities to Holders of Trust Securities; (iii) subject to the terms hereof, exercise all of the rights, powers and privileges of a holder of the Subordinated Debt Securities under the Subordinated Indenture and, if an Event of Default occurs and is continuing, shall enforce for the benefit of, and subject to the rights of, the 14 Holders of the Trust Securities, its rights as holder of the Subordinated Debt Securities under the Subordinated Indenture; (iv) take all actions and perform such duties as may be specifically required of the Property Trustee pursuant to the terms of this Trust Agreement; (v) take any Legal Action specifically required of the Property Trustee pursuant to the terms of this Trust Agreement which arises out of or in connection with an Event of Default or the Property Trustee's duties and obligations under this Trust Agreement, the Delaware Statutory Trust Act or the Trust Indenture Act; (vi) the establishment and maintenance of the Payment Account; (vii) the receipt of and holding of legal title to the Subordinated Debt Securities as described herein; (viii) the collection of interest, principal and any other payments made in respect of the Subordinated Debt Securities in the Payment Account; (ix) the distribution of amounts owed to the Securityholders in respect of the Trust Securities; (x) the sending of notices of default and other information regarding the Trust Securities and the Subordinated Debt Securities to the Securityholders in accordance with this Trust Agreement; (xi) the distribution of the Trust Property in accordance with the terms of this Trust Agreement; (xii) as provided in this Trust Agreement, the winding up of the affairs of and termination of the Trust and the preparation, execution and filing of the certificate of cancellation with the Secretary of State of Delaware; and (xiii) the taking of any action incidental to the foregoing as the Property Trustee may from time to time determine is necessary, appropriate, convenient or advisable to protect and conserve the Trust Property for the benefit of the Securityholders (without consideration of the effect of any such action on any particular Securityholder). C. So long as this Trust Agreement remains in effect, the Trust (or the Trustees acting on behalf of the Trust) shall not undertake any business, activities or transaction except as expressly provided herein or contemplated hereby. In particular, the Trustees shall not (i) acquire any investments or engage in any activities not authorized 15 by this Trust Agreement, (ii) sell, assign, transfer, exchange, pledge, set-off or otherwise dispose of any of the Trust Property or interests therein, including to Securityholders, except as expressly provided herein, (iii) take any action that would cause the Trust to fail or cease to qualify as a grantor trust for United States federal income tax purposes, (iv) incur any indebtedness for borrowed money, (v) take or consent to any action that would result in the placement of a Lien on any of the Trust Property, (vi) issue any securities other than the Trust Securities, or (vii) have any power to, or agree to any action by the Depositor that would, vary the investment (within the meaning of Treasury Regulation Section 301.7701-4(c)) of the Trust or of the Securityholders. The Trustees shall defend all claims and demands of all Persons at any time claiming any Lien on any of the Trust Property adverse to the interest of the Trust or the Securityholders in their capacity as Securityholders. D. In connection with the issue and sale of the Preferred Securities, the Depositor shall have the right and responsibility to assist the Trust with respect to, or effect on behalf of the Trust, the following (and any actions taken by the Depositor in furtherance of the following prior to the date of this Trust Agreement are hereby ratified and confirmed in all respects): (i) to prepare for filing by the Trust with the Commission a registration statement on Form S-3 under the Securities Act of 1933, as amended, in relation to the Preferred Securities, including any amendments thereto; (ii) to determine the states in which to take appropriate action to qualify or register for sale all or part of the Preferred Securities and to do any and all such acts, other than actions which must be taken by or on behalf of the Trust, and advise the Trustees of actions they must take on behalf of the Trust, and prepare for execution and filing any documents to be executed and filed by the Trust or on behalf of the Trust, as the Depositor deems necessary or advisable in order to comply with the applicable laws of any such States; (iii) to prepare for filing by the Trust, and to execute on behalf of the Trust, an application to the New York Stock Exchange or any other national stock exchange or the NASDAQ National Market for listing upon notice of issuance of any Preferred Securities; (iv) to prepare for filing by the Trust, and to execute on behalf of the Trust, with the Commission a registration statement on Form 8-A relating to the registration of the Preferred Securities under Section 12(b) of the Exchange Act, including any amendments thereto; (v) to negotiate the terms of the Underwriting Agreement providing for the sale of the Preferred Securities and to execute, deliver and perform the Underwriting Agreement on behalf of the Trust; and 16 (vi) any other actions necessary, incidental, appropriate or convenient to carry out any of the foregoing activities. E. Notwithstanding anything herein to the contrary, the Administrative Trustees are authorized and directed to conduct the affairs of the Trust and to operate the Trust so that the Trust will not be deemed to be an "investment company" required to be registered under the Investment Company Act of 1940, as amended, or taxed as other than a grantor trust for United States federal income tax purposes and so that the Subordinated Debt Securities will be treated as indebtedness of the Depositor for United States federal income tax purposes. In this connection, the Depositor and the Administrative Trustees are authorized to take any action, not inconsistent with applicable law, the Certificate of Trust or this Trust Agreement, that each of the Depositor and the Administrative Trustees determines in its discretion to be necessary or desirable for such purposes, as long as such action does not materially and adversely affect the interests of the Holders of the Preferred Securities. Section 2.08 Assets of Trust. The assets of the Trust shall consist of the Trust Property. Section 2.09 Title to Trust Property. Legal title to all Trust Property shall be vested at all times in the Property Trustee (in its capacity as such) and shall be held and administered by the Property Trustee for the benefit of the Securityholders and the Trust in accordance with this Trust Agreement. The right, title and interest of the Property Trustee to the Subordinated Debt Securities shall vest automatically in each Person who may thereafter be appointed as Property Trustee in accordance with the terms hereof. Such vesting and cessation of title shall be effective whether or not conveyancing documents have been executed and delivered. Section 2.10 Mergers and Consolidations of the Trust. The Trust may not consolidate, amalgamate, merge with or into, or be replaced by, or convey, transfer or lease its properties and assets substantially as an entirety to any corporation or other body, except as described below or otherwise provided in this Trust Agreement. The Trust may at the request of the Company, with the consent of the Administrative Trustees and without the consent of the Holders of the Trust Securities, the Delaware Trustee or the Property Trustee, consolidate, amalgamate, merge with or into, or be replaced by a trust organized as such under the laws of any state; provided, that (i) such successor entity either (x) expressly assumes all of the obligations of the Trust with respect to the Trust Securities or (y) substitutes for the Preferred Securities other securities having substantially the same terms as the Trust Securities (herein referred to as the "Successor Securities") so long as the Successor Securities rank the same as the Trust Securities rank in priority with respect to Distributions and payments upon liquidation, redemption and otherwise, (ii) the Company expressly appoints a trustee of such successor entity possessing the same powers and duties as the Property Trustee as the holder of legal title to the Subordinated Debt Securities, (iii) the Preferred Securities or any Successor Securities are listed, or any Successor Securities will be listed upon notification of issuance, on any national securities exchange or other organization on which the Preferred Securities are then listed, (iv) such merger, consolidation, amalgamation or 17 replacement does not cause the Preferred Securities (including any Successor Securities) to be downgraded by any nationally recognized statistical rating organization, (v) such merger, consolidation, amalgamation or replacement does not adversely affect the rights, preferences and privileges of the Holders of the Trust Securities (including any Successor Securities) in any material respect, other than with respect to any dilution of the holders' interest in the new entity, (vi) such successor entity has a purpose substantially identical to that of the Trust, (vii) prior to such merger, consolidation, amalgamation, or replacement, the Company has received an Opinion of Counsel to the effect that (A) such merger, consolidation, amalgamation or replacement does not adversely affect the rights, preferences and privileges of the Holders of the Trust Securities (including any Successor Securities) in any material respect, other than with respect to any dilution of the holders' interest in the new entity, and (B) following such merger, consolidation, amalgamation or replacement, neither the Trust nor such successor entity will be required to register as an investment company under the Investment Company Act of 1940, and (viii) the Company guarantees the obligations of such successor entity under the Successor Securities at least to the extent provided by the Guarantee. Notwithstanding the foregoing, the Trust shall not, except with the consent of Holders of 100% in Liquidation Amount of the Trust Securities, consolidate, amalgamate, merge with or into, or be replaced by any other entity or permit any other entity to consolidate, amalgamate, merge with or into, or replace it if, in the opinion of tax counsel, such consolidation, amalgamation, merger or replacement would cause the Trust or the successor entity to be classified as other than a grantor trust for federal income tax purposes. ARTICLE III Payment Account Section 3.01 Payment Account. (a) On or prior to the Issue Date, the Property Trustee shall establish the Payment Account. The Property Trustee and an agent of the Property Trustee shall have exclusive control and sole right of withdrawal with respect to the Payment Account for the purpose of making deposits in and withdrawals from the Payment Account in accordance with this Trust Agreement. All monies and other property deposited or held from time to time in the Payment Account shall be held by the Property Trustee in the Payment Account for the exclusive benefit of the Securityholders and for distribution as herein provided, including (and subject to) any priority of payments provided for herein. (b) The Property Trustee shall deposit in the Payment Account, promptly upon receipt, all payments of principal or interest on, and any other payments or proceeds with respect to, the Subordinated Debt Securities. Amounts held in the Payment Account shall not be invested by the Property Trustee pending distribution thereof. 18 ARTICLE IV Distributions; Redemption; Exchange Section 4.01 Distributions. (a) Distributions on the Trust Securities shall be cumulative and accrue from the Issue Date and, except in the event that the Depositor exercises its right to an Extension Period, shall be payable [quarterly] [semi-annually] in arrears on [ ], [ ], [ ] and [ ] of each year, commencing on ______ __, 200_. If any date on which Distributions are otherwise payable on the Trust Securities is not a Business Day, then the payment of such Distribution shall be made on the next succeeding day which is a Business Day (and without any interest or other payment in respect of any such delay) except that, if such Business Day is in the next succeeding calendar year, payment of such Distribution shall be made on the immediately preceding Business Day, in each case, with the same force and effect as if made on such date (each such date, a "Distribution Date"). (b) Distributions payable on the Trust Securities shall be fixed at a rate of _____% per annum of the Liquidation Amount of the Trust Securities. The amount of Distributions payable for any full [quarterly] [semi-annually] period shall be computed on the basis of twelve 30-day months and a 360-day year. If the Company exercises its rights to an Extension Period, then the rate per annum at which Distributions on the Trust Securities accumulate shall be increased by an amount such that the aggregate amount of Distributions that accumulate on all Trust Securities during any such Extension Period is equal to the aggregate amount of interest (including interest payable on unpaid interest at the percentage rate per annum set forth above, compounded [quarterly] [semi-annually], to the extent permitted by applicable law) that accrues during any such Extension Period on the Subordinated Debt Securities. The payment of such deferred interest, together with interest thereon, will be distributed to the Holders of the Trust Securities as received at the end of any Extension Period. (c) Distributions on the Trust Securities shall be made and shall be deemed payable on each Distribution Date only to the extent that the Trust has legally and immediately available funds in the Payment Account for the payment of such Distributions. (d) Distributions on the Trust Securities on each Distribution Date shall be payable to the Holders thereof as they appear on the Securities Register for the Trust Securities on the relevant record date, which shall be the close of business on (i) the Business Day prior to the relevant Distribution Date if the Preferred Securities are represented by Book-Entry Preferred Securities Certificates or (ii) the fifteenth calendar day prior to the relevant Distribution Date if the Preferred Securities are represented by Definitive Preferred Securities Certificates. 19 Each Trust Security upon registration of transfer of or in exchange for or in lieu of any other Trust Security shall carry the rights of Distributions accrued and unpaid, and to accrue, which were carried by such other Trust Security. Section 4.02 Redemption. (a) On each Redemption Date with respect to the Subordinated Debt Securities, whether at the stated maturity of the Subordinated Debt Securities or upon earlier redemption as provided in the Subordinated Debt Securities and the Subordinated Indenture, including pursuant to a Special Event, the Trust will be required to redeem a Like Amount of Trust Securities at the Redemption Price. (b) Notice of redemption shall be given by the Property Trustee by first-class mail, postage prepaid, mailed not less than 30 nor more than 60 days prior to the Redemption Date to each Holder of Trust Securities to be redeemed, at such Holder's address appearing in the Securities Register. All notices of redemption shall state: (i) the Redemption Date; (ii) the Redemption Price; (iii) the CUSIP number; (iv) if less than all the Outstanding Trust Securities are to be redeemed, the total Liquidation Amount of the Trust Securities to be redeemed; (v) that on the Redemption Date the Redemption Price will become due and payable upon each such Trust Security to be redeemed and that Distributions thereon will cease to accrue on and after such date; and (vi) the place where the Trust Securities are to be surrendered for the payment of the Redemption Price. (c) The Trust Securities redeemed on each Redemption Date shall be redeemed at the Redemption Price with the proceeds from the contemporaneous redemption of Subordinated Debt Securities. Redemptions of the Trust Securities shall be made and the Redemption Price shall be deemed payable on each Redemption Date only to the extent that the Trust has funds legally and immediately available in the Payment Account for the payment of such Redemption Price. (d) If the Property Trustee gives a notice of redemption in respect of any Preferred Securities, then, by 12:00 noon New York time, on the Redemption Date, subject to Section 4.02(c), the Property Trustee will, so long as the Preferred Securities are in book-entry only form, irrevocably deposit with the Clearing Agency for the Preferred Securities funds sufficient to pay the applicable Redemption Price. If the Preferred Securities are no longer in book-entry only form, the Property Trustee, subject 20 to Section 4.02(c), shall irrevocably deposit with the Paying Agent funds sufficient to pay the applicable Redemption Price and will give the Paying Agent irrevocable instructions to pay the Redemption Price to the Holders thereof upon surrender of their Preferred Securities Certificates. Notwithstanding the foregoing, Distributions payable on or prior to the Redemption Date for any Trust Securities called for redemption shall be payable to the Holders of such Trust Securities as they appear on the Securities Register for the Trust Securities on the relevant record dates for the related Distribution Dates. If notice of redemption shall have been given and funds deposited as required, then upon the date of such deposit, all rights of Securityholders holding Trust Securities so called for redemption will cease, except the right of such Securityholders to receive the Redemption Price, but without interest, and such Securities will cease to be outstanding. In the event that any date on which any Redemption Price is payable is not a Business Day, then payment of the Redemption Price payable on such date shall be made on the next succeeding day which is a Business Day (and without any interest or other payment in respect of any such delay) except that, if such Business Day is in the next succeeding calendar year, payment of such Redemption Price shall be made on the immediately preceding Business Day, in each case, with the same force and effect as if made on such date. In the event that payment of the Redemption Price in respect of Trust Securities is improperly withheld or refused and not paid either by the Trust or by the Depositor pursuant to the Guarantee, Distributions on such Trust Securities will continue to accrue at the then applicable rate, from such Redemption Date originally established by the Trust for such Preferred Securities to the date such Redemption Price is actually paid. (e) Subject to Section 4.03(a), if less than all the Outstanding Trust Securities are to be redeemed on a Redemption Date, then the aggregate Liquidation Amount of Trust Securities to be redeemed shall be allocated on a pro rata basis (based on Liquidation Amounts) among the Common Securities and the Preferred Securities. The particular Preferred Securities to be redeemed shall be selected on a pro rata basis (based on liquidation amounts) not more than 60 days prior to the Redemption Date by the Property Trustee from the Outstanding Preferred Securities not previously called for redemption, by such method (including, without limitation, by lot) as the Property Trustee shall deem fair and appropriate and which may provide for the selection for a redemption of portions equal to the Liquidation Amount or integral multiple thereof) of the Liquidation Amount of Preferred Securities of a denomination larger than such Liquidation Amount; provided, however, that before undertaking redemption of the Preferred Securities on other than a pro rata basis, the Property Trustee shall have received an Opinion of Counsel that the status of the Trust as a grantor trust for federal income tax purposes would not be adversely affected. The Property Trustee shall promptly notify the Securities Registrar in writing of the Preferred Securities selected for redemption and, in the case of any Preferred Securities selected for partial redemption, the Liquidation Amount thereof to be redeemed. For all purposes of this Trust Agreement, unless the context otherwise requires, all provisions relating to the redemption of Preferred Securities shall relate, in the case of any Preferred Securities redeemed or to be redeemed only in part, to the portion of the Liquidation Amount of Preferred Securities which has been or is to be redeemed. 21 (f) If, at any time, a Special Event shall occur and be continuing, the Depositor shall have the right, upon not less than 30 nor more than 60 days' notice, to redeem the Subordinated Debt Securities, in whole but not in part, for cash within 90 days following the occurrence of such Special Event, and, following such redemption, a Like Amount of Preferred Securities shall be redeemed by the Trust at the Redemption Price. (g) Subject to the foregoing provisions of Section 4.02 and to applicable law (including, without limitation, United States federal securities laws), the Company or its Affiliates may, at any time and from time to time, purchase outstanding Preferred Securities by tender, in the open market or by private agreement. Section 4.03 Subordination of Common Securities. (a) Payment of Distributions on, and the Redemption Price of, the Trust Securities, as applicable, shall be made pro rata based on the Liquidation Amount of the Trust Securities; provided, however, that if on any Distribution Date or Redemption Date an Indenture Event of Default shall have occurred and be continuing, no payment of any Distribution on, or Redemption Price of, any Common Security, and no other payment on account of the redemption, liquidation or other acquisition of Common Securities, shall be made unless payment in full in cash of all accrued and unpaid Distributions on all Outstanding Preferred Securities for all distribution periods terminating on or prior thereto, or in the case of payment of the Redemption Price the full amount of such Redemption Price on all Outstanding Preferred Securities, shall have been made or provided for, and all funds immediately available to the Property Trustee shall first be applied to the payment in full in cash of all Distributions on, or Redemption Price of, Preferred Securities then due and payable. (b) In the case of the occurrence of any Indenture Event of Default, the Holder of Common Securities will be deemed to have waived any such Event of Default under this Trust Agreement until the effect of all such Events of Default with respect to the Preferred Securities have been cured, waived or otherwise eliminated. Until any such Events of Default under this Trust Agreement with respect to the Preferred Securities have been so cured, waived or otherwise eliminated, the Property Trustee shall act solely on behalf of the Holders of the Preferred Securities and not the Holder of the Common Securities, and only the Holders of the Preferred Securities will have the right to direct the Property Trustee to act on their behalf. Section 4.04 Payment Procedures. Payments in respect of the Preferred Securities shall be made by check mailed to the address of the Person entitled thereto as such address shall appear on the Securities Register or, if the Preferred Securities are held by a Clearing Agency, such Distributions shall be made to the Clearing Agency, which shall credit the relevant Persons' accounts at such Clearing Agency on the applicable Distribution Dates. Payments in respect of the Common Securities shall be made in such manner as shall be mutually agreed between the Property Trustee and the Holder of the Common Securities. 22 Section 4.05 Tax Returns and Reports. The Administrative Trustee(s) shall prepare (or cause to be prepared), at the Depositor's expense, and file all United States federal, state and local tax and information returns and reports required to be filed by or in respect of the Trust. The Administrative Trustee(s) shall (a) prepare and file (or cause to be prepared and filed) the appropriate Internal Revenue Service form required to be filed in respect of the Trust in each taxable year of the Trust; and (b) prepare and furnish (or cause to be prepared and furnished) to each Securityholder the appropriate Internal Revenue Service form required to be furnished to such Securityholder or the information required to be provided on such form. The Administrative Trustees shall provide the Depositor with a copy of all such returns and reports promptly after such filing or furnishing. The Property Trustee shall comply with United States federal withholding and backup withholding tax laws and information reporting requirements with respect to any payments to the Securityholders under the Trust Securities. Section 4.06 Payment of Taxes, Duties, Etc. of the Trust. Upon receipt under the Subordinated Debt Securities of Additional Payments, the Property Trustee, at the direction of an Administrative Trustee or the Depositor, shall promptly pay any taxes, duties or governmental charges of whatsoever nature (other than withholding taxes) imposed on the Trust by the United States or any other taxing authority. Section 4.07 Payments under the Indenture. Any amount payable hereunder to any Holder of Preferred Securities shall be reduced by the amount of any corresponding payment such Holder has directly received under the Subordinated Indenture pursuant to Section _____ thereof. Section 4.08 Exchange of Preferred Securities. (a) If at any time the Company or any of its Affiliates is the Holder of any Preferred Securities, the Company and such Affiliate(s) shall have the right to deliver to the Property Trustee all or such portion of their Preferred Securities as they elect and receive, in exchange therefor, Subordinated Debt Securities in an aggregate principal amount equal to the aggregate stated Liquidation Amount of, with an interest rate identical to the distribution rate of, and accrued and unpaid interest equal to accumulated and unpaid Distributions on, such Preferred Securities. Such election (i) shall be exercisable effective on any Distribution Date by the Company or its Affiliate(s) delivering to the Property Trustee a written notice of such election specifying the aggregate Liquidation Amount of the Preferred Securities with respect to which such election is being made and the Distribution Date on which such exchange shall occur, which Distribution Date shall be not less than ten Business Days after the date of receipt by the Property Trustee of such election notice and (ii) shall be conditioned upon the Company or its Affiliate(s) having delivered or caused to be delivered to the Property Trustee or its designee the Preferred Securities which are the subject of such election by 10:00 a.m. New York City time, on the Distribution Date on which such exchange is to occur. After the exchange, such Preferred Securities will be canceled and will no longer be deemed to be Outstanding and all rights of the Company or its Affiliate(s) with respect to such Preferred Securities will cease. 23 (b) In the case of an exchange described in (a) above, the Trust will, on the date of such exchange, exchange Subordinated Debt Securities having a principal amount equal to a proportional amount of the aggregate Liquidation Amount of the Outstanding Common Securities based on the ratio of the aggregate Liquidation Amount of the Preferred Securities exchanged pursuant to (a) above divided by the aggregate Liquidation Amount of the Preferred Securities Outstanding immediately prior to such exchange, for such proportional amount of Common Securities held by the Company (which contemporaneously shall be canceled and no longer be deemed to be Outstanding); provided, that the Company delivers or causes to be delivered to the Property Trustee or its designee the required amount of Common Securities to be exchanged by 10:00 a.m. New York City time on the Distribution Date on which such exchange is to occur. ARTICLE V Trust Securities Certificates Section 5.01 Initial Ownership. Upon the creation of the Trust by the contribution by the Depositor pursuant to Section 2.03 and until the issuance of the Trust Securities, and at any time during which no Trust Securities are outstanding, the Depositor shall be the sole beneficial owner of the Trust. Section 5.02 The Trust Securities Certificates. Each of the Preferred and Common Securities Certificates shall be issued in minimum denominations of the Liquidation Amount and integral multiples of such Liquidation Amount in excess thereof. The Trust Securities Certificates shall be executed on behalf of the Trust by manual or facsimile signature of at least one Administrative Trustee. Trust Securities Certificates bearing the manual or facsimile signatures of individuals who were, at the time when such signatures shall have been affixed, authorized to sign on behalf of the Trust, shall be validly issued and entitled to the benefits of this Trust Agreement, notwithstanding that such individuals or any of them shall have ceased to be so authorized prior to the delivery of such Trust Securities Certificates or did not hold such offices at the date of delivery of such Trust Securities Certificates. A transferee of a Trust Securities Certificate shall become a Securityholder, and shall be entitled to the rights and subject to the obligations of a Securityholder hereunder, upon due registration of such Trust Securities Certificate in such transferee's name pursuant to Section 5.04. Section 5.03 Execution and Delivery of Trust Securities Certificates. On the Issue Date and the Underwriters' Overallotment Option Closing Date, the Administrative Trustees shall cause Trust Securities Certificates, in an aggregate Liquidation Amount as provided in Sections 2.04 and 2.05, to be executed on behalf of the Trust and delivered to or upon the written order of the Depositor signed by its Chairman of the Board, its President or any Vice President, without further corporate action by the Depositor, in authorized denominations. Section 5.04 Registration of Transfer and Exchange of Preferred Securities Certificates. The Securities Registrar shall keep or cause to be kept, at the 24 office or agency maintained pursuant to Section 5.08, a Securities Register in which, subject to such reasonable regulations as it may prescribe, the Securities Registrar shall provide for the registration of Preferred Securities Certificates and the Common Securities Certificates (subject to Section 5.10 in the case of the Common Securities Certificates) and registration of transfers and exchanges of Preferred Securities Certificates as herein provided. The Property Trustee shall be the initial Securities Registrar. Upon surrender for registration of transfer of any Preferred Securities Certificate at the office or agency maintained pursuant to Section 5.08, the Administrative Trustees shall execute and deliver in the name of the designated transferee or transferees one or more new Preferred Securities Certificates in authorized denominations of a like aggregate Liquidation Amount dated the date of execution by such Administrative Trustee or Trustees. The Securities Registrar shall not be required to register the transfer of any Preferred Securities that have been called for redemption. At the option of a Holder, Preferred Securities Certificates may be exchanged for other Preferred Securities Certificates in authorized denominations of the same class and of a like aggregate Liquidation Amount upon surrender of the Preferred Securities Certificates to be exchanged at the office or agency maintained pursuant to Section 5.08. Every Preferred Securities Certificate presented or surrendered for registration of transfer or exchange shall be accompanied by a written instrument of transfer in form satisfactory to the Administrative Trustees and the Securities Registrar duly executed by the Holder or his attorney duly authorized in writing. Each Preferred Securities Certificate surrendered for registration of transfer or exchange shall be canceled and subsequently disposed of by the Securities Registrar in accordance with its customary practice. No service charge shall be made for any registration of transfer or exchange of Preferred Securities Certificates, but the Securities Registrar or the Administrative Trustees may require payment of a sum sufficient to cover any tax or governmental charge that may be imposed in connection with any transfer or exchange of Preferred Securities Certificates. Section 5.05 Mutilated, Destroyed, Lost or Stolen Trust Securities Certificates. If (a) any mutilated Trust Securities Certificate shall be surrendered to the Securities Registrar, or if the Securities Registrar shall receive evidence to its satisfaction of the destruction, loss or theft of any Trust Securities Certificate and (b) there shall be delivered to the Securities Registrar and the Administrative Trustees such security or indemnity as may be required by them to save each of them harmless, then in the absence of notice that such Trust Securities Certificate shall have been acquired by a protected purchaser, the Administrative Trustees or any one of them on behalf of the Trust shall execute and make available for delivery, in exchange for or in lieu of any such mutilated, destroyed, lost or stolen Trust Securities Certificate, a new Trust Securities Certificate of like class, tenor and denomination. In connection with the issuance of any new Trust Securities Certificate under this Section, the Administrative Trustees or the Securities Registrar may require the payment of a sum sufficient to cover any tax or other 25 governmental charge that may be imposed in connection therewith. Any duplicate Trust Securities Certificate issued pursuant to this Section shall constitute conclusive evidence of an ownership interest in the Trust, as if originally issued, whether or not the lost, stolen or destroyed Trust Securities Certificate shall be found at any time. Section 5.06 Persons Deemed Securityholders. Prior to due presentation of a Trust Securities Certificate for registration of transfer, the Trustees or the Securities Registrar shall treat the Person in whose name any Trust Securities Certificate shall be registered in the Securities Register as the owner of such Trust Securities Certificate for the purpose of receiving Distributions (subject to Section 4.01(d)) and for all other purposes whatsoever, and neither the Trustees nor the Securities Registrar shall be bound by any notice to the contrary. Section 5.07 Access to List of Securityholders' Names and Addresses. The Administrative Trustees shall furnish or cause to be furnished (unless the Property Trustee is acting as Securities Registrar with respect to the Trust Securities) to (i) the Property Trustee semi-annually, not later than [ ] and [ ] in each year, and (ii) the Property Trustee within 15 days after receipt by any Administrative Trustee of a request therefor from the Property Trustee in writing, a list, in such form as the Property Trustee may reasonably require, of the names and addresses of the Securityholders as of a date not more than 15 days prior to the time such list is furnished. If three or more Securityholders or one or more Holders of Trust Securities Certificates evidencing not less than 25% of the outstanding Liquidation Amount apply in writing to the Administrative Trustees, and such application states that the applicants desire to communicate with other Securityholders with respect to their rights under this Trust Agreement or under the Trust Securities Certificates and such application is accompanied by a copy of the communication that such applicants propose to transmit, then the Administrative Trustees shall, within five Business Days after the receipt of such application, afford such applicants access during normal business hours to the current list of Securityholders. Each Holder, by receiving and holding a Trust Securities Certificate, shall be deemed to have agreed not to hold either the Depositor, the Administrative Trustees or the Property Trustee accountable by reason of the disclosure of its name and address, regardless of the source from which such information was derived. Section 5.08 Maintenance of Office or Agency. The Administrative Trustees shall maintain in the Borough of Manhattan, New York, an office or offices or agency or agencies where Preferred Securities Certificates may be surrendered for registration of transfer or exchange and where notices and demands to or upon the Trustees in respect of the Trust Securities Certificates may be served. The Administrative Trustees initially designate [ ], as its principal agency for such purposes. The Administrative Trustees shall give prompt written notice to the Depositor and to the Securityholders of any change in the location of the Securities Register or any such office or agency. Section 5.09 Appointment of Paying Agent. The Paying Agent shall make Distributions and other payments provided hereby to Securityholders from the Payment Account and shall report the amounts of such Distributions and payments to the 26 Property Trustee and the Administrative Trustees. Any Paying Agent shall have the revocable power to withdraw funds from the Payment Account for the purpose of making the Distributions and payments provided hereby. The Administrative Trustees may revoke such power and remove the Paying Agent if such Trustees determine in their sole discretion that the Paying Agent shall have failed to perform its obligations under this Agreement in any material respect. The Paying Agent shall initially be the Property Trustee, and it may choose any co-paying agent that is acceptable to the Administrative Trustees and the Depositor. Any Person acting as Paying Agent shall be permitted to resign as Paying Agent upon 30 days' written notice to the Administrative Trustees and the Depositor. In the event that a Paying Agent shall resign or be removed, the Administrative Trustees shall appoint a successor that is acceptable to the Depositor to act as Paying Agent (which shall be a bank or trust company). The Administrative Trustees shall cause such successor Paying Agent or any additional Paying Agent appointed by the Administrative Trustees to execute and deliver to the Trustees an instrument in which such successor Paying Agent or additional Paying Agent shall agree with the Trustees that as Paying Agent, such successor Paying Agent or additional Paying Agent will hold all sums, if any, held by it for payment to the Securityholders in trust for the benefit of the Securityholders entitled thereto until such sums shall be paid to such Securityholders. The Paying Agent shall return all unclaimed funds to the Property Trustee and upon removal of a Paying Agent such Paying Agent shall also return all funds in its possession to the Property Trustee. The provisions of Sections 8.01, 8.03 and 8.06 shall apply to the Property Trustee also in its role as Paying Agent, for so long as the Property Trustee shall act as Paying Agent and, to the extent applicable, to any other paying agent appointed hereunder. Any reference in this Agreement to the Paying Agent shall include any co-paying agent unless the context requires otherwise. Section 5.10 Ownership of Common Securities by Depositor. On the Issue Date and the Underwriters' Overallotment Option Closing Date, the Depositor shall acquire, and thereafter retain, beneficial and record ownership of the Common Securities. Any attempted transfer of the Common Securities, except for transfers by operation of law or to an Affiliate of the Depositor or a permitted successor pursuant to Section 5.01 of the Subordinated Indenture, shall be void. The Administrative Trustees shall cause each Common Securities Certificate issued to the Depositor to contain a legend stating "THIS CERTIFICATE IS NOT TRANSFERABLE EXCEPT AS PROVIDED IN THE TRUST AGREEMENT REFERRED TO HEREIN". Section 5.11 Book-Entry Preferred Securities Certificates; Common Securities Certificate. (a) The Preferred Securities Certificates, upon original issuance, will be issued in the form of a typewritten Preferred Securities Certificate or Certificates representing Book-Entry Preferred Securities Certificates, to be delivered to The Depository Trust Company, the initial Clearing Agency, by, or on behalf of, the Trust. Such Preferred Securities Certificate or Certificates shall initially be registered on the Securities Register in the name of Cede & Co., the nominee of the initial Clearing Agency, and no Owner will receive a definitive Preferred Securities Certificate representing such beneficial owner's interest in such Preferred Securities, except as 27 provided in Section 5.13. Unless and until Definitive Preferred Securities Certificates have been issued to Owners pursuant to Section 5.13: (i) the provisions of this Section 5.11(a) shall be in full force and effect; (ii) the Securities Registrar and the Trustees shall be entitled to deal with the Clearing Agency for all purposes of this Trust Agreement relating to the Book-Entry Preferred Securities Certificates (including the payment of principal of and interest on the Book-Entry Preferred Securities and the giving of instructions or directions to Owners of Book-Entry Preferred Securities) as the sole Holder of Book-Entry Preferred Securities and shall have no obligations to the Owners thereof; (iii) to the extent that the provisions of this Section conflict with any other provisions of this Trust Agreement, the provisions of this Section shall control; and (iv) the rights of the Owners of the Book-Entry Preferred Securities Certificates shall be exercised only through the Clearing Agency and shall be limited to those established by law and agreements between such Owners and the Clearing Agency and/or the Clearing Agency Participants. Pursuant to the Certificate Depository Agreement, unless and until Definitive Preferred Securities Certificates are issued pursuant to Section 5.13, the Clearing Agency will make book-entry transfers among the Clearing Agency Participants and receive and transmit payments on the Preferred Securities to such Clearing Agency Participants. (b) A single Common Securities Certificate representing the Common Securities shall be issued to the Depositor in the form of a definitive Common Securities Certificate. Section 5.12 Notices to Clearing Agency. To the extent a notice or other communication to the Owners is required under this Trust Agreement, unless and until Definitive Preferred Securities Certificates shall have been issued to Owners pursuant to Section 5.13, the Trustees shall give all such notices and communications specified herein to be given to Owners to the Clearing Agency, and shall have no obligations to the Owners. Section 5.13 Definitive Preferred Securities Certificates. If (i) the Depositor advises the Trustees in writing that the Clearing Agency is no longer willing or able to properly discharge its responsibilities with respect to the Preferred Securities Certificates, and the Depositor is unable to locate a qualified successor, or (ii) the Depositor at its option advises the Trustees in writing that it elects to terminate the book-entry system through the Clearing Agency, then the Administrative Trustees shall notify the Clearing Agency and Holders of the Preferred Securities. Upon surrender to the 28 Administrative Trustees of the typewritten Preferred Securities Certificate or Certificates representing the Book-Entry Preferred Securities Certificates by the Clearing Agency, accompanied by registration instructions, the Administrative Trustees or any one of them shall execute the Definitive Preferred Securities Certificates in accordance with the instructions of the Clearing Agency. Neither the Securities Registrar nor the Trustees shall be liable for any delay in delivery of such instructions and may conclusively rely on, and shall be protected in relying on, such instructions. Upon the issuance of Definitive Preferred Securities Certificates, the Trustees shall recognize the Holders of the Definitive Preferred Securities Certificates as Securityholders. The Definitive Preferred Securities Certificates shall be printed, lithographed or engraved or may be produced in any other manner as is reasonably acceptable to the Administrative Trustees, as evidenced by the execution thereof by the Administrative Trustees or any one of them. Section 5.14 Rights of Securityholders. The legal title to the Trust Property is vested exclusively in the Property Trustee (in its capacity as such) in accordance with Section 2.09, and the Securityholders shall not have any right or title therein other than the beneficial ownership interest in the assets of the Trust conferred by their Trust Securities, and they shall have no right to call for any partition or division of property, profits or rights of the Trust except as described below. The Trust Securities shall be personal property giving only the rights specifically set forth therein and in this Trust Agreement. The Trust Securities shall have no preemptive or other similar rights and when issued and delivered to Securityholders against payment of the purchase price therefor, except as otherwise provided in the Expense Agreement and Section 10.01 hereof, will be fully paid and nonassessable by the Trust. Except as otherwise provided in the Expense Agreement and Section 10.01 hereof, the Holders of the Trust Securities shall be entitled to the same limitation of personal liability extended to stockholders of private corporations for profit organized under the General Corporation Law of the State of Delaware. ARTICLE VI Acts of Securityholders; Meetings; Voting Section 6.01 Limitations on Voting Rights. (a) Except as provided in this Trust Agreement, in the Subordinated Indenture, and as otherwise required by law, no Holder of Preferred Securities shall have any right to vote or in any manner otherwise control the administration, operation and management of the Trust or the obligations of the parties hereto, nor shall anything herein set forth, or contained in the terms of the Trust Securities Certificates, be construed so as to constitute the Securityholders from time to time as partners or members of an association. (b) So long as any Subordinated Debt Securities are held by the Property Trustee, the Trustees shall not (i) direct the time, method and place of conducting any proceeding for any remedy available to the Indenture Trustee, or executing any trust or power conferred on the Indenture Trustee with respect to such 29 Subordinated Debt Securities, (ii) waive any past default which is waivable under Article ___ of the Subordinated Indenture, (iii) exercise the remedies available to it under the Subordinated Indenture as a Holder of the Subordinated Debt Securities or (iv) consent to any amendment, modification or termination of the Subordinated Indenture or the Subordinated Debt Securities, where such consent shall be required, or to any other action, as holder of the Subordinated Debt Securities, under the Subordinated Indenture, without, in each case, obtaining the prior approval of the Holders of at least a majority in Liquidation Amount of the Preferred Securities; provided, however, that where a consent under the Subordinated Indenture would require the consent of each holder of Subordinated Debt Securities affected thereby, no such consent shall be given by the Trustees without the prior written consent of each Holder of Preferred Securities. The Trustees shall not revoke any action previously authorized or approved by a vote of the Holders of Preferred Securities, except pursuant to a subsequent vote of the Holders of Preferred Securities. The Property Trustee shall notify all Holders of the Preferred Securities of any notice of default received from the Indenture Trustee with respect to the Subordinated Debt Securities. In addition to obtaining the foregoing approvals of the Holders of the Preferred Securities, prior to taking any of the foregoing actions, the Trustees shall, at the expense of the Depositor, obtain an independent Opinion of Counsel to the effect that the Trust will not be classified as other than a grantor trust for United States federal income tax purposes on account of such action. (c) If any proposed amendment to this Trust Agreement provides for, or the Trustees otherwise propose to effect, (i) any action that would adversely affect in any material respect the powers, preferences or special rights of the Preferred Securities, whether by way of amendment to this Trust Agreement or otherwise, or (ii) the dissolution, winding-up or termination of the Trust, other than pursuant to the terms of this Trust Agreement, then the Holders of Outstanding Preferred Securities as a class will be entitled to vote on such amendment or proposal and such amendment or proposal shall not be effective except with the approval of the Holders of at least a majority in Liquidation Amount of the Outstanding Preferred Securities. In addition to obtaining the foregoing approvals of the Holders of the Preferred Securities, prior to taking any of the foregoing actions, the Trustees shall, at the expense of the Depositor, obtain an independent Opinion of Counsel to the effect that the Trust will not be classified as other than a grantor trust for United States federal income tax purposes on account of such action. Section 6.02 Notice of Meetings. Notice of all meetings of the Preferred Securityholders, stating the time, place and purpose of the meeting, shall be given by the Administrative Trustees pursuant to Section 10.07 to each Preferred Securityholder of record, at his registered address, at least 15 days and not more than 90 days before the meeting. At any such meeting, any business properly before the meeting may be so considered whether or not stated in the notice of the meeting. Any adjourned meeting may be held as adjourned without further notice. Section 6.03 Meetings of Preferred Securityholders. No annual meeting of Securityholders is required to be held. The Administrative Trustees, however, shall call a meeting of Securityholders to vote on any matter upon the written request of the 30 Preferred Securityholders of record of 25% of the Preferred Securities (based upon their Liquidation Amount) and the Administrative Trustees or the Property Trustee may, at any time in their discretion, call a meeting of Preferred Securityholders to vote on any matters as to which Preferred Securityholders are entitled to vote. Preferred Securityholders of record of 50% of the Preferred Securities (based upon their Liquidation Amount), present in person or by proxy, shall constitute a quorum at any meeting of Securityholders. If a quorum is present at a meeting, an affirmative vote by the Preferred Securityholders of record present, in person or by proxy, holding a majority of the Preferred Securities (based upon their Liquidation Amount) held by the Preferred Securityholders of record present, either in person or by proxy, at such meeting shall constitute the action of the Securityholders, unless this Trust Agreement requires a greater number of affirmative votes. Section 6.04 Voting Rights. Securityholders shall be entitled to one vote for each $___ of Liquidation Amount represented by their Trust Securities in respect of any matter as to which such Securityholders are entitled to vote. Section 6.05 Proxies, etc. At any meeting of Securityholders, any Securityholder entitled to vote may vote by proxy, provided that no proxy shall be voted at any meeting unless it shall have been placed on file with the Administrative Trustees, or with such other officer or agent of the Trust as the Administrative Trustees may direct, for verification prior to the time at which such vote shall be taken. Pursuant to a resolution of the Property Trustee, proxies may be solicited in the name of the Property Trustee or one or more officers of the Property Trustee. Only Securityholders of record shall be entitled to vote. When Trust Securities are held jointly by several Persons, any one of them may vote at any meeting in person or by proxy in respect of such Trust Securities, but if more than one of them shall be present at such meeting in person or by proxy, and such joint owners or their proxies so present disagree as to any vote to be cast, such vote shall not be received in respect of such Trust Securities. A proxy purporting to be executed by or on behalf of a Securityholder shall be deemed valid unless challenged at or prior to its exercise, and the burden of proving invalidity shall rest on the challenger. No proxy shall be valid more than three years after its date of execution. Section 6.06 Securityholder Action by Written Consent. Any action which may be taken by Securityholders at a meeting may be taken without a meeting if Securityholders holding a majority of all outstanding Trust Securities entitled to vote in respect of such action (or such other proportion thereof as shall be required by any express provision of this Trust Agreement) shall consent to the action in writing (based upon their Liquidation Amount). Section 6.07 Record Date for Voting and Other Purposes. For the purposes of determining the Securityholders who are entitled to notice of and to vote at any meeting or by written consent, or to participate in any Distribution on the Trust Securities in respect of which a record date is not otherwise provided for in this Trust 31 Agreement, or for the purpose of any other action, the Administrative Trustees may from time to time fix a date, not more than 90 days prior to the date of any meeting of Securityholders or the payment of Distribution or other action, as the case may be, as a record date for the determination of the identity of the Securityholders of record for such purposes. Section 6.08 Acts of Securityholders. Any request, demand, authorization, direction, notice, consent, waiver or other action provided or permitted by this Trust Agreement to be given, made or taken by Securityholders may be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such Securityholders in person or by an agent appointed in writing; and, except as otherwise expressly provided herein, such action shall become effective when such instrument or instruments are delivered to the Administrative Trustees. Such instrument or instruments (and the action embodied therein and evidenced thereby) are herein sometimes referred to as the "Act" of the Securityholders signing such instrument or instruments. Proof of execution of any such instrument or of a writing appointing any such agent shall be sufficient for any purpose of this Trust Agreement and (subject to Section 8.01) conclusive in favor of the Trustees, if made in the manner provided in this Section. The fact and date of the execution by any Person of any such instrument or writing may be proved by the affidavit of a witness of such execution or by a certificate of a notary public or other officer authorized by law to take acknowledgments of deeds, certifying that the individual signing such instrument or writing acknowledged to him the execution thereof. Where such execution is by a signer acting in a capacity other than his individual capacity, such certificate or affidavit shall also constitute sufficient proof of his authority. The fact and date of the execution of any such instrument or writing, or the authority of the Person executing the same, may also be proved in any other manner which the Trustees deem sufficient. The ownership of Preferred Securities shall be proved by the Securities Register. Any request, demand, authorization, direction, notice, consent, waiver or other Act of the Securityholder of any Trust Security shall bind every future Securityholder of the same Trust Security and the Securityholder of every Trust Security issued upon the registration of transfer thereof or in exchange therefor or in lieu thereof in respect of anything done, omitted or suffered to be done by the Trustees or the Trust in reliance thereon, whether or not notation of such action is made upon such Trust Security. Without limiting the foregoing, a Securityholder entitled hereunder to take any action hereunder with regard to any particular Trust Security may do so with regard to all or any part of the Liquidation Amount of such Trust Security or by one or more duly appointed agents each of which may do so pursuant to such appointment with regard to all or any part of such Liquidation Amount. If any dispute shall arise between the Securityholders of Trust Securities and the Administrative Trustees or among such Securityholders or Trustees with respect 32 to the authenticity, validity or binding nature of any request, demand, authorization, direction, consent, waiver or other Act of such Securityholder or Trustee under this Article VI, then the determination of such matter by the Property Trustee shall be conclusive with respect to such matter. Section 6.09 Inspection of Records. Upon reasonable notice to the Trustees, the records of the Trust shall be open to inspection by Securityholders during normal business hours for any purpose reasonably related to such Securityholder's interest as a Securityholder. ARTICLE VII Representations and Warranties Section 7.01 Representations and Warranties of the Bank and the Property Trustee. The Bank and the Property Trustee, each severally on behalf of and as to itself, as of the date hereof, and each successor Property Trustee at the time of the successor Property Trustee's acceptance of its appointment as Property Trustee hereunder (in the case of a successor Property Trustee, the term "Bank" as used herein shall be deemed to refer to such successor Property Trustee in its separate corporate capacity) hereby represents and warrants (as applicable) for the benefit of the Depositor and the Securityholders that: (a) the Bank is a banking corporation duly organized, validly existing and in good standing under the laws of its jurisdiction of incorporation; (b) the Bank has full corporate power, authority and legal right to execute, deliver and perform its obligations under this Trust Agreement and has taken all necessary action to authorize the execution, delivery and performance by it of this Trust Agreement; (c) this Trust Agreement has been duly authorized, executed and delivered by the Property Trustee and constitutes the valid and legally binding agreement of the Property Trustee enforceable against it in accordance with its terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors, rights and to general equity principles; (d) the execution, delivery and performance by the Property Trustee of this Trust Agreement has been duly authorized by all necessary corporate or other action on the part of the Property Trustee and does not require any approval of stockholders of the Bank and such execution, delivery and performance shall not (i) violate the Bank's charter or by-laws; (ii) violate any provision of, or constitute, with or without notice or lapse of time, a default under, or result in the creation of imposition of, any Lien on any properties included in the Trust Property pursuant to the provisions of, any indenture, mortgage, credit agreement, license or other agreement or instrument to which the Property Trustee or the Bank is a party or by which it is bound; or (iii) violate any law, 33 governmental rule or regulation of the United States or its jurisdiction of incorporation, as the case may be, governing the banking or trust powers of the Bank or the Property Trustee (as appropriate in context) or any order, judgment or decree applicable to the Property Trustee or the Bank; (e) neither the authorization, execution or delivery by the Property Trustee of this Trust Agreement nor the consummation of any of the transactions by the Property Trustee contemplated herein requires the consent or approval of, the giving of notice to, the registration with or the taking of any other action with respect to any governmental authority or agency under any existing federal law governing the banking or trust powers of the Bank or the Property Trustee, as the case may be, under the laws of the United States or its jurisdiction of incorporation; and (f) there are no proceedings pending or, to the best of the Property Trustee's knowledge, threatened against or affecting the Bank or the Property Trustee in any court or before any governmental authority, agency or arbitration board or tribunal which, individually or in the aggregate, would materially and adversely affect the Trust or would question the right, power and authority of the Property Trustee to enter into or perform its obligations as one of the Trustees under this Trust Agreement; and (g) the Property Trustee is a Person eligible pursuant to the Trust Indenture Act to act as such and has a combined capital and surplus of at least $50,000.000. Section 7.02 Representations and Warranties of the Delaware Bank and the Delaware Trustee. The Delaware Bank and the Delaware Trustee, each severally on behalf of and as to itself, as of the date hereof, and each successor Delaware Trustee at the time of the successor Delaware Trustee's acceptance of appointment as Delaware Trustee hereunder (the term "Delaware Bank" being used to refer to such successor Delaware Trustee in its separate corporate capacity), hereby represents and warrants (as applicable) for the benefit of the Depositor and the Securityholders that: (a) the Delaware Bank is a national banking corporation duly organized, validly existing and in good standing under the laws of the United States of America; (b) the Delaware Bank has full corporate power, authority and legal right to execute, deliver and perform its obligations under this Trust Agreement and has taken all necessary action to authorize the execution, delivery and performance by it of this Trust Agreement; (c) this Trust Agreement has been duly authorized, executed and delivered by the Delaware Trustee and constitutes the valid and legally binding agreement of the Delaware Trustee enforceable against it in accordance with its terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors, rights and to general equity principles; 34 (d) the execution, delivery and performance by the Delaware Trustee of this Trust Agreement has been duly authorized by all necessary corporate or other action on the part of the Delaware Trustee and does not require any approval of stockholders of the Delaware Bank and such execution, delivery and performance shall not (i) violate the Delaware Bank's charter or by-laws; (ii) violate any provision of, or constitute, with or without notice or lapse of time, a default under, or result in the creation or imposition of, any Lien on any properties included in the Trust Property pursuant to the provisions of, any indenture, mortgage, credit agreement, license or other agreement or instrument to which the Delaware Bank or the Delaware Trustee is a party or by which it is bound; or (iii) violate any law, governmental rule or regulation of the United States or the State of Delaware, as the case may be, governing the banking or trust powers of the Delaware Bank or the Delaware Trustee (as appropriate in context) or any order, judgment or decree applicable to the Delaware Bank or the Delaware Trustee; (e) neither the authorization, execution or delivery by the Delaware Trustee of this Trust Agreement nor the consummation of any of the transactions by the Delaware Trustee contemplated herein or therein requires the consent or approval of, the giving of notice to, the registration with or the taking of any other action with respect to any governmental authority or agency under any existing federal law governing the banking or trust powers of the Delaware Bank or the Delaware Trustee, as the case may be, under the laws of the United States or the State of Delaware; and (f) there are no proceedings pending or, to the best of the Delaware Trustee's knowledge, threatened against or affecting the Delaware Bank or the Delaware Trustee in any court or before any governmental authority, agency or arbitration board or tribunal which, individually or in the aggregate, would materially and adversely affect the Trust or would question the right, power and authority of the Delaware Trustee to enter into or perform its obligations as one of the Trustees under this Trust Agreement. Section 7.03 Representations and Warranties of the Depositor. The Depositor hereby represents and warrants for the benefit of the Securityholders that: (a) the Trust Securities Certificates issued on the Closing Date on behalf of the Trust have been duly authorized and, shall have been duly and validly executed, issued and delivered by the Administrative Trustees, on behalf of the Trust, pursuant to the terms and provisions of, and in accordance with the requirements of, this Trust Agreement and the Securityholders shall be, as of such date, entitled to the benefits of this Trust Agreement; and (b) there are no taxes, fees or other governmental charges payable by the Trust (or the Trustees on behalf of the Trust) under the laws of the State of Delaware or any political subdivision thereof in connection with the execution, delivery and performance by the Bank, the Property Trustee or the Delaware Trustee, as the case may be, of this Trust Agreement. 35 ARTICLE VIII The Trustees Section 8.01 Certain Duties and Responsibilities. (a) The rights, duties and responsibilities of the Trustees shall be as provided by this Trust Agreement and, in the case of the Property Trustee, the Trust Indenture Act. The Delaware Trustee and the Administrative Trustees shall have no liability under this Trust Agreement except for gross negligence, bad faith or willful misconduct. Notwithstanding the foregoing, no provision of this Trust Agreement shall require the Trustees to expend or risk their own funds or otherwise incur any financial liability in the performance of any of their duties hereunder, or in the exercise of any of their rights or powers, if they shall have reasonable grounds for believing that repayment of such funds or adequate indemnity against such risk or liability is not reasonably assured to them. Whether or not therein expressly so provided, every provision of this Trust Agreement relating to the conduct or affecting the liability of or affording protection to the Trustees shall be subject to the provisions of this Section. (b) All payments made by the Property Trustee in respect of the Trust Securities shall be made only from the income and proceeds from the Trust Property and only to the extent that there shall be sufficient income or proceeds from the Trust Property to enable the Property Trustee to make payments in accordance with the terms hereof. Each Securityholder, by its acceptance of a Trust Security, agrees that it will look solely to the income and proceeds from the Trust Property to the extent available for distribution to it as herein provided and that the Trustees are not personally liable to it for any amount distributable in respect of any Trust Security or for any other liability in respect of any Trust Security. This Section 8.01(b) does not limit the liability of the Trustees expressly set forth elsewhere in this Trust Agreement or, in the case of the Property Trustee, in the Trust Indenture Act. (c) No provision of this Trust Agreement shall be construed to relieve the Property Trustee from liability for its own negligent action, its own negligent failure to act, or its own willful misconduct, except that: (i) the Property Trustee shall not be liable for any error of judgment made in good faith by an authorized officer of the Property Trustee, unless it shall be proved that the Property Trustee was negligent in ascertaining the pertinent facts; (ii) the Property Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the Holders of not less than a majority in Liquidation Amount of the Trust Securities relating to the time, method and place of conducting any proceeding for any remedy available to the Property Trustee, or exercising any trust or power conferred upon the Property Trustee under this Trust Agreement; 36 (iii) the Property Trustee's sole duty with respect to the custody, safe keeping and physical preservation of the Debt Securities and the Payment Account shall be to deal with such property in a similar manner as the Property Trustee deals with similar property for its own account, subject to the protections and limitations on liability afforded to the Property Trustee under this Trust Agreement and the Trust Indenture Act; (iv) the Property Trustee shall not be liable for any interest on any money received by it except as it may otherwise agree with the Depositor and money held by the Property Trustee need not be segregated from other funds held by it except in relation to the Payment Account maintained by the Property Trustee pursuant to Section 301 and except to the extent otherwise required by law; and (v) the Property Trustee shall not be responsible for monitoring the compliance by the Administrative Trustees or the Depositor with their respective duties under this Trust Agreement, nor shall the Property Trustee be liable for the negligence, default or misconduct of the Administrative Trustees or the Depositor. Section 8.02 Certain Notices. (a) Within 90 days after the occurrence of any default actually known to the Property Trustee, the Property Trustee shall transmit, in the manner and to the extent provided in Section 10.07, notice of any default known to the Property Trustee to the Securityholders, the Administrative Trustees and the Depositor, unless such default shall have been cured or waived. For the purpose of this Section, the term "default" means any event which is, or after notice or lapse of time or both would become, an Event of Default. Within five Business Days after the receipt of notice of the Depositor's exercise of its right to defer the payment of interest on the Debentures pursuant to the Indenture, the Property Trustee shall transmit, in the manner and to the extent provided in Section 10.8, notice of such exercise to the Holders and the Administrators, unless such exercise shall have been revoked. Section 8.03 Certain Rights of Property Trustee. Subject to the provisions of Section 8.01 and except as provided by law: (i) the Property Trustee may rely and shall be protected in acting or refraining from acting in good faith upon any resolution, Opinion of Counsel, certificate, written representation of a Holder or transferee, certificate of auditors or any other certificate, statement, instrument, opinion, report, notice, request, consent, order, appraisal, bond or other paper or document believed by it to be genuine and to have been signed or presented by the proper party or parties; (ii) if (A) in performing its duties under this Trust Agreement the Property Trustee is required to decide between alternative courses of 37 action, or (B) in construing any of the provisions in this Trust Agreement the Property Trustee finds the same ambiguous or inconsistent with any other provisions contained herein, or (C) the Property Trustee is unsure of the application of any provision of this Trust Agreement, then, except as to any matter as to which the Preferred Securityholders are entitled to vote under the terms of this Trust Agreement, the Property Trustee shall deliver a notice to the Depositor requesting written instructions of the Depositor as to the course of action to be taken. The Property Trustee shall take such action, or refrain from taking such action, as the Property Trustee shall be instructed in writing to take, or to refrain from taking, by the Depositor; provided, however, that if the Property Trustee does not receive such instructions of the Depositor within ten Business Days after it has delivered such notice, or such reasonably shorter period of time set forth in such notice (which to the extent practicable shall not be less than two Business Days), it may, but shall be under no duty to, take or refrain from taking such action not inconsistent with this Trust Agreement as it shall deem advisable and in the best interests of the Securityholders, in which event the Property Trustee shall have no liability except for its own bad faith, negligence or willful misconduct; (iii) the Property Trustee may consult with counsel of its selection and the written advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon; (iv) the Property Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Trust Agreement at the request or direction of any of the Securityholders pursuant to this Trust Agreement, unless such Securityholders shall have offered to the Property Trustee reasonable security or indemnity against the costs, expenses and liabilities which might be incurred by it in compliance with such request or direction; (v) the Property Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order, approval, bond or other document, unless requested in writing to do so by one or more Securityholders; and (vi) the Property Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through its agents or attorneys, provided that the Property Trustee shall be responsible for its own negligence or recklessness with respect to selection of any agent or attorney appointed by it hereunder. 38 Section 8.04 Not Responsible for Recitals or Issuance of Securities. The recitals contained herein and in the Trust Securities Certificates shall be taken as the statements of the Trust, and the Trustees do not assume any responsibility for their correctness. The Trustees shall not be accountable for the use or application by the Trust of the proceeds of the Trust Securities in accordance with Section 2.05. The Property Trustee may conclusively assume that any funds held by it hereunder are legally available unless an officer of the Property Trustee assigned to its Institutional Trust Services Department shall have received written notice from the Company, any Holder or any other Trustee that such funds are not legally available. Section 8.05 May Hold Securities. Except as provided in the definition of the term "Outstanding" in Article I, any Trustee or any other agent of the Trustees or the Trust, in its individual or any other capacity, may become the owner or pledgee of Trust Securities and may otherwise deal with the Trust with the same rights it would have if it were not a Trustee or such other agent. Section 8.06 Compensation; Fees; Indemnity. (1) to pay to the Trustees from time to time reasonable compensation for all services rendered by the Trustees hereunder (which compensation shall not be limited by any provision of law in regard to the compensation of a trustee of an express trust); (2) except as otherwise expressly provided herein, to reimburse the Trustees upon request for all reasonable expenses, disbursements and advances incurred or made by the Trustees in accordance with any provision of this Trust Agreement (including the reasonable compensation and the expenses and disbursements of their agents and counsel), except any such expense, disbursement or advance as may be attributable to their negligence, bad faith or willful misconduct (or, in the case of the Administrative Trustees or the Delaware Trustee, any such expense, disbursement or advance as may be attributable to its, his or her gross negligence, bad faith or willful misconduct); and (3) to indemnify the Trustees for, and to hold the Trustees harmless against, any and all loss, damage, claims, liability or expense, arising out of or in connection with the acceptance or administration of this Trust Agreement, including the costs and expenses of defending themselves against any claim or liability in connection with the exercise or performance of any of their powers or duties hereunder except any such expense, disbursement or advance as may be attributable to such Trustee's negligence, bad faith or willful misconduct (or, in the case of the Administrative Trustees or the Delaware Trustee, any such expense, disbursement or advance as may be attributable to its, his or her gross negligence, bad faith or willful misconduct). The provisions of this Section 8.06 shall survive the termination of this Trust Agreement or the resignation or removal of any Trustee. Section 8.07 Trustees Required; Eligibility. 39 (a) There shall at all times be a Property Trustee hereunder with respect to the Trust Securities. The Property Trustee shall be a Person that has a combined capital and surplus of at least $50,000,000. If any such Person publishes reports of condition at least annually, pursuant to law or to the requirements of its supervising or examining authority, then for the purposes of this Section, the combined capital and surplus of such Person shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published. If at any time the Property Trustee with respect to the Trust Securities shall cease to be eligible in accordance with the provisions of this Section, it shall resign immediately in the manner and with the effect hereinafter specified in this Article. (b) There shall at all times be one or more Administrative Trustees hereunder with respect to the Trust Securities. Each Administrative Trustee shall be either a natural person who is at least 21 years of age or a legal entity that shall act through one or more persons authorized to bind such entity. (c) There shall at all times be a Delaware Trustee with respect to the Trust Securities. The Delaware Trustee shall either be (i) a natural person who is at least 21 years of age and a resident of the State of Delaware or (ii) a legal entity authorized to conduct a trust business and with its principal place of business in the State of Delaware that shall act through one or more persons authorized to bind such entity. Section 8.08 Conflicting Interests. If the Property Trustee has or shall acquire a conflicting interest within the meaning of the Trust Indenture Act, the Property Trustee shall either eliminate such interest or resign, to the extent and in the manner provided by, and subject to the provisions of, the Trust Indenture Act and this Trust Agreement. Section 8.09 Co-Trustees and Separate Trustee. At any time or times, for the purpose of meeting the legal requirements of the Trust Indenture Act or of any jurisdiction in which any part of the Trust Property may at the time be located, the Holder of the Common Securities and the Property Trustee shall have power to appoint, and upon the written request of the Property Trustee, the Depositor shall for such purpose join with the Property Trustee in the execution, delivery and performance of all instruments and agreements necessary or proper to appoint, one or more Persons approved by the Property Trustee either to act as co-trustee, jointly with the Property Trustee, of all or any part of such Trust Property, or to act as separate trustee of any such Trust Property, in either case with such powers as may be provided in the instrument of appointment, and to vest in such Person or Persons in the capacity aforesaid, any property, title, right or power deemed necessary or desirable, subject to the other provisions of this Section. If the Depositor does not join in such appointment within 15 days after the receipt by it of a request so to do, or in case an Indenture Event of Default has occurred and is continuing, the Property Trustee alone shall have power to make such appointment. Any co-trustee or separate trustee appointed pursuant to this Section shall satisfy the requirements of Section 8.07. 40 Should any written instrument from the Depositor be required by any co-trustee or separate trustee so appointed for more fully confirming to such co-trustee or separate trustee such property, title, right, or power, any and all such instruments shall, on request, be executed, acknowledged, and delivered by the Depositor. Every co-trustee or separate trustee shall, to the extent permitted by law, but to such extent only, be appointed subject to the following terms, namely: (i) The Trust Securities shall be executed and delivered and all rights, powers, duties, and obligations hereunder in respect of the custody of securities, cash and other personal property held by, or required to be deposited or pledged with, the Trustees hereunder, shall be exercised, solely by the Trustees. (ii) The rights, powers, duties, and obligations hereby conferred or imposed upon the Property Trustee in respect of any property covered by such appointment shall be conferred or imposed upon and exercised or performed by the Property Trustee or by the Property Trustee and such co-trustee or separate trustee jointly, as shall be provided in the instrument appointing such co-trustee or separate trustee, except to the extent that under any law of any jurisdiction in which any particular act is to be performed, the Property Trustee shall be incompetent or unqualified to perform such act, in which event such rights, powers, duties, and obligations shall be exercised and performed by such co-trustee or separate trustee. (iii) The Property Trustee at any time, by an instrument in writing executed by it, with the written concurrence of the Depositor, may accept the resignation of or remove any co-trustee or separate trustee appointed under this Section, and, in case an Indenture Event of Default has occurred and is continuing, the Property Trustee shall have power to accept the resignation of, or remove, any such co-trustee or separate trustee without the concurrence of the Depositor. Upon the written request of the Property Trustee, the Depositor shall join with the Property Trustee in the execution, delivery, and performance of all instruments and agreements necessary or proper to effectuate such resignation or removal. A successor to any co-trustee or separate trustee so resigned or removed may be appointed in the manner provided in this Section. (iv) No co-trustee or separate trustee hereunder shall be personally liable by reason of any act or omission of the Property Trustee, or any other such trustee hereunder. (v) The Trustees shall not be liable by reason of any act of a co-trustee or separate trustee. 41 (vi) Any Act of Holders delivered to the Property Trustee shall be deemed to have been delivered to each such co-trustee and separate trustee. Section 8.10 Resignation and Removal; Appointment of Successor. No resignation or removal of any Trustee (the "Relevant Trustee") and no appointment of a successor Relevant Trustee pursuant to this Article shall become effective until the acceptance of appointment by the successor Relevant Trustee in accordance with the applicable requirements of Section 8.11. The Relevant Trustee may resign at any time by giving written notice thereof to the Securityholders. If the instrument of acceptance by a successor Relevant Trustee required by Section 8.11 shall not have been delivered to the Relevant Trustee within 30 days after the giving of such notice of resignation, the resigning Relevant Trustee may petition any court of competent jurisdiction for the appointment of a successor Relevant Trustee. Unless an Indenture Event of Default shall have occurred and be continuing, the Relevant Trustee may be removed at any time by Act of the Holder of the Common Securities. If an Indenture Event of Default shall have occurred and be continuing, the Relevant Trustee may be removed at such time by Act of the Securityholders of a majority in Liquidation Amount of the Preferred Securities Certificates, delivered to the Relevant Trustee (in its individual capacity and on behalf of the Trust). If the Relevant Trustee shall resign, be removed or become incapable of continuing to act as Trustee at a time when no Indenture Event of Default shall have occurred and be continuing, the Holder of the Common Securities, by Act of the Holder of the Common Securities delivered to the retiring Relevant Trustee, shall promptly appoint a successor Relevant Trustee or Trustees, and the retiring Relevant Trustee shall comply with the applicable requirements of Section 8.11. If the Relevant Trustee shall resign, be removed or become incapable of continuing to act as the Relevant Trustee at a time when an Indenture Event of Default shall have occurred and be continuing, the Holders of Preferred Securities, by Act of the Securityholders of a majority in Liquidation Amount of the Preferred Securities then outstanding delivered to the retiring Relevant Trustee, shall promptly appoint a successor Relevant Trustee or Trustees, and the Relevant Trustee shall comply with the applicable requirements of Section 8.11. If no successor Relevant Trustee shall have been so appointed in accordance with this Section 8.10 and accepted appointment in the manner required by Section 8.11, any Securityholder who has been a Securityholder of Trust Securities for at least six months may, on behalf of himself and all others similarly situated, petition any court of competent jurisdiction for the appointment of a successor Relevant Trustee. The retiring Relevant Trustee shall give notice of each resignation and each removal of the Relevant Trustee, and each appointment of a successor Trustee to all Securityholders in the manner provided in Section 10.07 and shall give notice to the 42 Depositor. Each notice shall include the name of the successor Relevant Trustee and the address of its Corporate Trust Office if it is the Property Trustee. Notwithstanding the foregoing or any other provision of this Trust Agreement, in the event any Administrative Trustee or a Delaware Trustee who is a natural person dies or becomes incompetent or incapacitated, the vacancy created by such death, incompetence or incapacity may be filled by (i) the act of the remaining Administrative Trustee or (ii) otherwise by the Depositor (with the successor in each case being an individual who satisfies the eligibility requirement for Administrative Trustees set forth in Section 8.07). Additionally, notwithstanding the foregoing or any other provision of this Trust Agreement, in the event the Depositor believes that any Administrative Trustee has become incompetent or incapacitated, the Depositor, by notice to the remaining Trustees, may terminate the status of such Person as an Administrative Trustee (in which case the vacancy so created will be filled in accordance with the preceding sentence). Section 8.11 Acceptance of Appointment by Successor. In case of the appointment hereunder of a successor Relevant Trustee, every such successor Relevant Trustee so appointed shall execute, acknowledge and deliver to the Trust and to the retiring Relevant Trustee an instrument accepting such appointment, and thereupon the resignation or removal of the retiring Relevant Trustee shall become effective and such successor Relevant Trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Relevant Trustee; but, on the request of the Depositor or the successor Relevant Trustee, such retiring Relevant Trustee shall, upon payment of its charges, execute and deliver an instrument transferring to such successor Relevant Trustee all the rights, powers and trusts of the retiring Relevant Trustee and shall duly assign, transfer and deliver to such successor Relevant Trustee all property and money held by such retiring Relevant Trustee hereunder. Upon request of any such successor Relevant Trustee, the Trust shall execute any and all instruments for more fully and certainly vesting in and confirming to such successor Relevant Trustee all such rights, powers and trusts referred to in the preceding paragraph. No successor Relevant Trustee shall accept its appointment unless at the time of such acceptance such successor Relevant Trustee shall be qualified and eligible under this Article. Section 8.12 Merger, Conversion, Consolidation or Succession to Business. Any Person into which the Property Trustee, Delaware Trustee or any Administrative Trustee which is not a natural person may be merged or converted or with which it may be consolidated, or any Person resulting from any merger, conversion or consolidation to which such Relevant Trustee shall be a party, or any Person succeeding to all or substantially all the corporate trust business of such Relevant Trustee, shall be the successor of such Relevant Trustee hereunder, provided such Person shall be otherwise qualified and eligible under this Article, without the execution or filing of any paper or any further act on the part of any of the parties hereto. 43 Section 8.13 Preferential Collection of Claims Against Depositor or Trust. If and when the Property Trustee shall be or become a creditor of the Depositor or the Trust (or any other obligor upon the Subordinated Debt Securities or the Trust Securities), the Property Trustee shall be subject to the provisions of the Trust Indenture Act regarding the collection of claims against the Depositor or Trust (or any such other obligor). Section 8.14 Reports by Property Trustee. (a) Within 60 days after ________ of each year commencing with ________, ____, if required by Section 313(a) of the Trust Indenture Act, the Property Trustee shall transmit a brief report dated as of such ________ with respect to any of the events specified in such Section 313(a) that may have occurred since the later of the date of this Trust Agreement or the preceding __________. (b) The Property Trustee shall transmit to Securityholders the reports required by Section 313(b) of the Trust Indenture Act at the times specified therein. (c) Reports pursuant to this Section shall be transmitted in the manner and to the Persons required by Sections 313(c) and (d) of the Trust Indenture Act. Section 8.15 Reports to the Property Trustee. The Depositor and the Administrative Trustees on behalf of the Trust shall provide to the Property Trustee such documents, reports and information as required by Section 314 of the Trust Indenture Act (if any) and the compliance certificate required by Section 314(a)(4) of the Trust Indenture Act in the form and in the manner required by Section 314 of the Trust Indenture Act. Section 8.16 Evidence of Compliance with Conditions Precedent. Each of the Depositor and the Administrative Trustees on behalf of the Trust shall provide to the Property Trustee such evidence of compliance with any conditions precedent, if any, provided for in this Trust Agreement that relate to any of the matters set forth in Section 314(c) of the Trust Indenture Act. Any certificate or opinion required to be given pursuant to Section 314(c)(1) of the Trust Indenture Act shall comply with Section 314(e) of the Trust Indenture Act. Section 8.17 Number of Trustees. (a) The number of Trustees shall initially be five, provided that the Depositor by written instrument may increase or decrease the number of Administrative Trustees. (b) If a Trustee ceases to hold office for any reason and the number of Administrative Trustees is not reduced pursuant to Section 8.17(a), or if the number of Trustees is increased pursuant to Section 8.17(a), a vacancy shall occur. The vacancy shall be filled with a Trustee appointed in accordance with Section 8.10. 44 (c) The death, resignation, retirement, removal, bankruptcy, incompetence or incapacity to perform the duties of a Trustee shall not operate to annul the Trust. Whenever a vacancy in the number of Administrative Trustees shall occur, until such vacancy is filled by the appointment of an Administrative Trustee in accordance with Section 8.10, the Administrative Trustees in office, regardless of their number (and notwithstanding any other provision of this Trust Agreement), shall have all powers granted to the Administrative Trustees and shall discharge the duties imposed upon the Administrative Trustees by this Trust Agreement. Section 8.18 Delegation of Power. (a) Any Administrative Trustee may, by power of attorney consistent with applicable law, delegate to any other natural person over the age of 21 his or her power for the purpose of executing any documents contemplated in Section 2.07(A), including any registration statement or amendment thereto filed with the Commission, or making any other governmental filing; and (b) The Administrative Trustees shall have power to delegate from time to time to such of their number the doing of such things and the execution of such instruments either in the name of the Trust or the names of the Administrative Trustees or otherwise as the Administrative Trustees may deem expedient, to the extent such delegation is not prohibited by applicable law or contrary to the provisions of the Trust, as set forth herein. Section 8.19 Voting. Except as otherwise provided in this Trust Agreement, the consent or approval of the Administrative Trustees shall require consent or approval by not less than a majority of the Administrative Trustees, unless there are only two, in which case both must consent. Section 8.20 Enforcement of Rights of Property Trustee by Securityholders. If an Event of Default occurs and is continuing, then the Holders of Preferred Securities will rely on the enforcement by the Property Trustee of its rights against the Company as the holder of the Subordinated Debt Securities. In addition, the Holders of a majority in aggregate Liquidation Amount of the Preferred Securities will have the right to direct the time, method, and place of conducting any proceeding for any remedy available to the Property Trustee or to direct the exercise of any trust or power conferred upon the Property Trustee under this Trust Agreement, including the right to direct the Property Trustee to exercise the remedies available to it as a holder of the Subordinated Debt Securities, provided that such direction shall not be in conflict with any rule of law or with this Trust Agreement, and could not involve the Property Trustee in personal liability in circumstances where reasonable indemnity would not be adequate. If the Property Trustee fails to enforce its rights under the Subordinated Debt Securities, a Holder of Preferred Securities may, to the fullest extent permitted by applicable law, institute a legal proceeding against the Company to enforce its rights under this Trust Agreement without first instituting any legal proceeding against the Property Trustee or any other Person, including the Trust; it being understood and intended that no one or more of such Holders shall have any right in any manner whatsoever by virtue of, or by 45 availing of, any provision of this Trust Agreement to affect, disturb or prejudice the rights of any other of such Holders or to obtain or to seek to obtain priority or preference over any other of such Holders or to enforce any right under this Trust Agreement, except in the manner herein provided and for the equal and ratable benefit of all such Holders. Notwithstanding the foregoing, a Holder of Preferred Securities may institute a legal proceeding directly against the Company, without first instituting a legal proceeding against or requesting or directing that action be taken by the Property Trustee or any other Person, for enforcement of payment to such Holder of principal of or interest on the Subordinated Debt Securities having a principal amount equal to the aggregate stated liquidation amount of the Preferred Securities of such Holder on or after the due dates therefor specified or provided for in the Subordinated Debt Securities. The Company shall be subrogated to all rights of the Holders of Preferred Securities in respect of any amounts paid to such Holders by the Company pursuant to this Section. ARTICLE IX Termination and Liquidation Section 9.01 Termination Upon Expiration Date. The Trust shall automatically dissolve on _____________,____ (the "Expiration Date") or earlier pursuant to Section 9.02. Section 9.02 Early Termination. Upon the first to occur of any of the following events (such first occurrence, an "Early Termination Event"), the Trust shall be dissolved and terminated in accordance with the terms hereof: (a) the occurrence of a Bankruptcy Event in respect of, or the dissolution or liquidation of, the Depositor; (b) the delivery of written direction to the Property Trustee by the Depositor at any time (which direction is optional and wholly within the discretion of the Depositor) to terminate the Trust and distribute the Subordinated Debt Securities to Securityholders as provided in Section 9.05; (c) the payment at maturity or redemption of all of the Subordinated Debt Securities, and the consequent payment of the Preferred Securities; (d) the entrance of an order for dissolution of the Trust shall have been entered by a court of competent jurisdiction; (e) 90 days after the revocation of the Depositor's charter, but only if its charter is not reinstated during such 90-day period; and (f) if prior to the issuance of the Trust Securities, when the Depositor and the Administrative Trustees have consented to such dissolution. Section 9.03 Termination. The respective obligations and responsibilities of the Trust and the Trustees created hereby shall terminate upon the 46 latest to occur of the following: (a) the distribution by the Property Trustee to Securityholders upon the liquidation of the Trust pursuant to Section 9.05, or upon the redemption of all of the Trust Securities pursuant to Section 4.02, of all amounts or instruments required to be distributed hereunder upon the final payment of the Trust Securities; (b) the payment of any expenses owed by the Trust; and (c) the discharge of all administrative duties of the Administrative Trustees, including the performance of any tax reporting obligations with respect to the Trust or the Securityholders. Section 9.04 Certificate of Cancellation. A Certificate of Cancellation ("Certificate") to terminate the Trust (as permitted hereby) may be signed by any Administrative Trustee, individually, in such capacity so long as such Certificate fully complies with all legal requirements. Section 9.05 Liquidation. (a) If any Early Termination Event specified in clause (a), (b), (d) and (e) of Section 9.02 occurs, the Trust shall be liquidated and the Property Trustee shall distribute the Subordinated Debt Securities to the Securityholders as provided in this Section 9.05. (b) In connection with a distribution of the Subordinated Debt Securities, each Holder of Trust Securities shall be entitled to receive, after the satisfaction of liabilities to creditors of the Trust (as evidenced by a certificate of the Administrative Trustees), a Like Amount of Subordinated Debt Securities. Notice of liquidation shall be given by the Trustees by first-class mail, postage prepaid, mailed not later than 30 nor more than 60 days prior to the Liquidation Date to each Holder of Trust Securities at such Holder's address appearing in the Securities Register. All notices of liquidation shall: (i) state the Liquidation Date; (ii) state that from and after the Liquidation Date, the Trust Securities will no longer be deemed to be Outstanding and any Trust Securities Certificates not surrendered for exchange will be deemed to represent a Like Amount of Subordinated Debt Securities; and (iii) provide such information with respect to the mechanics by which Holders may exchange Trust Securities Certificates for Subordinated Debt Securities as the Administrative Trustees or the Property Trustee shall deem appropriate. (c) In order to effect the liquidation of the Trust and distribution of the Subordinated Debt Securities to Securityholders, the Property Trustee shall establish a record date for such distribution (which shall be not more than 45 days prior to the Liquidation Date) and, either itself acting as exchange agent or through the appointment of a separate exchange agent, shall establish such procedures as it shall deem appropriate to effect the distribution of Subordinated Debt Securities in exchange for the Outstanding Trust Securities Certificates. 47 (d) Except where Section 9.02(c) or 9.05(f) applies, after the Liquidation Date, (i) the Trust Securities will no longer be deemed to be Outstanding, (ii) certificates representing a Like Amount of Subordinated Debt Securities will be issued to Holders of Trust Securities Certificates, upon surrender of such certificates to the Administrative Trustees or their agent for exchange, (iii) any Trust Securities Certificates not so surrendered for exchange will be deemed to represent a Like Amount of Subordinated Debt Securities, accruing interest at the rate provided for in the Subordinated Debt Securities from the last Distribution Date on which a Distribution was made on such Trust Certificates until such certificates are so surrendered (and until such certificates are so surrendered, no payments of interest or principal will be made to Holders of Trust Securities Certificates with respect to such Subordinated Debt Securities) and (iv) all rights of Securityholders holding Trust Securities will cease, except the right of such Securityholders to receive Subordinated Debt Securities upon surrender of Trust Securities Certificates. (e) The Depositor will use its reasonable efforts to have the Subordinated Debt Securities that are distributed in exchange for the Preferred Securities to be listed on such securities exchange as the Preferred Securities are then listed. The Depositor may elect to have the Subordinated Debt Securities issued in book-entry form to the Clearing Agency or its nominee. (f) In the event that, notwithstanding the other provisions of this Section 9.05, whether because of an order for dissolution entered by a court of competent jurisdiction or otherwise, distribution of the Subordinated Debt Securities in the manner provided herein is determined by the Administrative Trustees not to be practical, in which event the Holders will be entitled to receive out of the assets of the Trust available for distribution to Securityholders, after satisfaction of liabilities to creditors, an amount equal to the Liquidation Amount per Trust Security plus accrued and unpaid Distributions thereon to the date of payment (such amount being the "Liquidation Distribution"). If such Liquidation Distribution can be paid only in part because the Trust has insufficient assets available to pay in full the aggregate Liquidation Distribution, then, subject to the next succeeding sentence, the amounts payable by the Trust on the Trust Securities shall be paid on a pro rata basis (based upon Liquidation Amounts). The Holder of the Common Securities will be entitled to receive Liquidation Distributions upon any such dissolution, winding-up or termination pro rata (determined as aforesaid) with Holders of Preferred Securities, except that, if an Indenture Event of Default has occurred and is continuing, the Preferred Securities shall have a priority over the Common Securities. ARTICLE X Miscellaneous Provisions Section 10.01 Limitation of Rights of Securityholders. The death or incapacity of any Person having an interest, beneficial or otherwise, in a Trust Security shall not operate to terminate this Trust Agreement, nor entitle the legal representatives or heirs of such Person or any Securityholder for such Person, to claim an accounting, take any action or bring any proceeding in and for a partition or winding up of the 48 arrangements contemplated hereby, nor otherwise affect the rights, obligations and liabilities of the parties hereto or any of them. Section 10.02 Amendment. (a) This Trust Agreement may be amended from time to time by the Trustees and the Depositor, without the consent of any Securityholders, (i) to cure any ambiguity, correct or supplement any provision herein which may be inconsistent with any other provision herein, or to add to the covenants, restrictions or obligations of the Depositor, or to make any other provisions with respect to matters or questions arising under this Trust Agreement, which shall not be inconsistent with the other provisions of this Trust Agreement, or (ii) to modify, eliminate or add to any provisions of this Trust Agreement to such extent as shall be necessary to ensure that the Trust will not be classified as other than a grantor trust for United States federal income tax purposes at any time that any Trust Securities are outstanding, or to ensure that the Trust will not be required to register as an investment company under the Investment Company Act of 1940, or to conform to any change in the Investment Company Act of 1940 or the Trust Indenture Act or the rules and regulations under either law; provided, however, that, except in the case of clause (i), such action shall not adversely affect in any material respect the interests of any Securityholder, and any such amendments of this Trust Agreement shall become effective when notice thereof is given to the Securityholders. (b) Except as provided in Section 10.02(c) hereof, any provision in this Trust Agreement may be amended by the Trust or the Trustees with (i) the consent of Trust Securityholders representing a majority (based upon Liquidation Amounts) of the Trust Securities then Outstanding and (ii) receipt by the Trustees of an Opinion of Counsel to the effect that such amendment or the exercise of any power granted to the Trustees in accordance with such amendment will not affect the Trust's status as a grantor trust for United States federal income tax purposes or the Trust's exemption from status of an "investment company" under the Investment Company Act of 1940, as amended. (c) In addition to and notwithstanding any other provision in this Trust Agreement, without the consent of each affected Securityholder (such consent being obtained in accordance with Section 6.03 or 6.06 hereof), this Trust Agreement may not be amended to (i) change the amount or timing of any Distribution on the Trust Securities or otherwise adversely affect the amount of any Distribution required to be made in respect of the Trust Securities as of a specified date, (ii) restrict the right of a Securityholder to institute suit for the enforcement of any such payment on or after such date, or (iii) change the consent required pursuant to Section 10.02. (d) Notwithstanding any other provisions of this Trust Agreement, the Trustees shall not enter into or consent to any amendment to this Trust Agreement which would cause the Trust to fail or cease to qualify for the exemption from status of an "investment company" under the Investment Company Act of 1940, or cease to be classified as a grantor trust for United States Federal income tax purposes. 49 (e) Without the consent of the Depositor, this Trust Agreement may not be amended in a manner which imposes any additional obligation on the Depositor. In executing any amendment permitted by this Trust Agreement, the Trustees shall be entitled to receive, and (subject to Section 8.01) shall be fully protected in relying upon an Opinion of Counsel stating that the execution of such amendment is authorized or permitted by this Trust Agreement. Any Trustee may, but shall not be obligated to, enter into any such amendment which affects such Trustee's own rights, duties, immunities or liabilities under this Trust Agreement or otherwise. (f) In the event that any amendment to this Trust Agreement is made, the Administrative Trustees shall promptly provide to the Depositor a copy of such amendment. Section 10.03 Separability. In case any provision in this Trust Agreement or in the Trust Securities Certificates shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. Section 10.04 Governing Law. THIS TRUST AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF EACH OF THE SECURITYHOLDERS, THE TRUST AND THE TRUSTEES WITH RESPECT TO THIS TRUST AGREEMENT AND THE TRUST SECURITIES SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE INTERNAL LAWS OF THE STATE OF DELAWARE. Section 10.05 Successors. This Trust Agreement shall be binding upon and shall inure to the benefit of any successor to both the Trust and the Trustees, including any successor by operation of law. Section 10.06 Headings. The Article and Section headings are for convenience only and shall not affect the construction of this Trust Agreement. Section 10.07 Notice and Demand. Any notice, demand or other communication which by any provision of this Trust Agreement is required or permitted to be given or served to or upon any Securityholder or the Depositor may be given or served in writing by deposit thereof, first-class postage prepaid, in the United States mail, hand delivery or facsimile transmission, in each case, addressed, (i) in the case of a Preferred Securityholder, to such Preferred Securityholder as such Securityholder's name and address appear on the Securities Register and (ii) in the case of the Common Securityholder or the Depositor, to Omnicare, Inc., 100 East RiverCenter Boulevard, Covington, Kentucky 41011, Attention: Corporate Secretary, Facsimile No. [ ]. Such notice, demand or other communication to or upon a Securityholder shall be deemed to have been sufficiently given or made, for all purposes, upon hand delivery, mailing or transmission. Any notice, demand or other communication which by any provision of this Trust Agreement is required or permitted to be given or served to or upon the Trust 50 or the Trustees shall be given in writing addressed (until another address is published by the Trust) as follows: (i) with respect to the Property Trustee and the Delaware Trustee, [ ], Attention: Institutional Trust Services; [ ], Attention: Institutional Trust Services, as the case may be; and (ii) with respect to the Administrative Trustees, to them at the address above for notices to the Depositor, marked Attention: Administrative Trustees of Omnicare Capital Trust [I/II/III] c/o Corporate Secretary. Such notice, demand or other communication to or upon the Trust or the Trustees shall be deemed to have been sufficiently given or made only upon actual receipt of the writing by the applicable Trustee. Section 10.08 Conflict with Trust Indenture Act. (a) This Trust Agreement is subject to the provisions of the Trust Indenture Act that are required to be part of this Trustee Agreement and shall, to the extent applicable, be governed by such provisions. (b) The Property Trustee shall be the only Trustee which is a Trustee for the purposes of the Trust Indenture Act. (c) If any provision hereof limits, qualifies or conflicts with another provision hereof which is required to be included in this Trust Agreement by any of the provisions of the Trust Indenture Act, such required provision shall control. (d) The application of the Trust Indenture Act to this Trust Agreement shall not affect the nature of the Trust Securities as equity securities representing undivided beneficial interests in the assets of the Trust. THE RECEIPT AND ACCEPTANCE OF A TRUST SECURITY OR ANY INTEREST THEREIN BY OR ON BEHALF OF A SECURITYHOLDER OR ANY BENEFICIAL OWNER, WITHOUT ANY SIGNATURE OR FURTHER MANIFESTATION OF ASSENT, SHALL CONSTITUTE THE UNCONDITIONAL ACCEPTANCE BY THE SECURITYHOLDER AND ALL OTHERS HAVING A BENEFICIAL INTEREST IN SUCH TRUST SECURITY OF ALL THE TERMS AND PROVISIONS OF THIS TRUST AGREEMENT AND AGREEMENT TO THE SUBORDINATION PROVISIONS AND OTHER TERMS OF THE GUARANTEE AND THE SUBORDINATED INDENTURE AND THE AGREEMENT OF THE TRUST, SUCH SECURITYHOLDER AND SUCH OTHERS THAT THOSE TERMS AND PROVISIONS SHALL BE BINDING, OPERATIVE AND EFFECTIVE AS BETWEEN THE TRUST AND SUCH SECURITYHOLDER AND SUCH OTHERS. 51 IN WITNESS WHEREOF, the parties hereto have executed this Trust Agreement or have caused this Trust Agreement to be executed on their behalf, all as of the day and year first above written. OMNICARE, INC., as Depositor By: __________________________________ Name: Title: [ ], as Property Trustee By: __________________________________ Name: Title: [ ], as Delaware Trustee By: __________________________________ Name: Title: __________________________________ [ ], as Administrative Trustee __________________________________ [ ], as Administrative Trustee __________________________________ [ ], as Administrative Trustee 52 EXHIBIT A THIS CERTIFICATE IS NOT TRANSFERABLE EXCEPT AS PROVIDED IN THE TRUST AGREEMENT REFERRED TO HEREIN Certificate Number Number of Common Securities C-1 _______ Certificate Evidencing Common Securities of OMNICARE CAPITAL TRUST [I/II/III] Common Securities (Liquidation Amount $___ per Common Security) Omnicare Capital Trust [I/II/III], a statutory Statutory Trust created under the laws of the State of Delaware (the "Trust"), hereby certifies that Omnicare, Inc. (the "Holder") is the registered owner of ______________ (______) common securities of the Trust representing undivided beneficial interests in the assets of the Trust and designated the Common Securities (Liquidation Amount $___ per Common Security) (the "Common Securities"). In accordance with Section 5.10 of the Trust Agreement (as defined below) the Common Securities are not transferable, except by operation of law or as permitted by the Trust Agreement referred to herein, and any attempted transfer hereof shall be void. The designations, rights, privileges, restrictions, preferences and other terms and provisions of the Common Securities are set forth in, and this certificate and the Common Securities represented hereby are issued and shall in all respects be subject to the terms and provisions of, the Amended and Restated Trust Agreement of the Trust dated as of ________, 200_, as the same may be amended from time to time (the "Trust Agreement"), including the designation of the terms of the Common Securities as set forth therein. The Trust will furnish a copy of the Trust Agreement to the Holder without charge upon written request to the Trust at its principal place of business or registered office. Upon receipt of this certificate, the Holder is bound by the Trust Agreement and is entitled to the benefits thereunder. A-1 IN WITNESS WHEREOF, the Administrative Trustees of the Trust have executed this certificate this ____ day of _______, ____. OMNICARE CAPITAL TRUST [I/II/III] By:___________________________ [ ], as Administrative Trustee By:___________________________ [ ], as Administrative Trustee By:___________________________ [ ], as Administrative Trustee A-2 EXHIBIT B AGREEMENT AS TO EXPENSES AND LIABILITIES THIS AGREEMENT AS TO EXPENSES AND LIABILITIES (this "Agreement") is made as of ________, 200_, between Omnicare, Inc., a Delaware corporation (the "Company"), and Omnicare Capital Trust [I/II/III], a Delaware Statutory Trust (the "Trust"). WHEREAS, the Trust intends to issue its Common Securities (the "Common Securities") to and receive Subordinated Debt Securities from the Company and to issue and sell Omnicare Capital Trust [I/II/III] ____% Trust Preferred Securities (the "Preferred Securities") with such powers, preferences and special rights and restrictions as are set forth in the Amended and Restated Trust Agreement of the Trust dated as of ________, 200_ as the same may be amended from time to time (the "Trust Agreement"); and WHEREAS, the Company is the issuer of the Subordinated Debt Securities. NOW, THEREFORE, in consideration of the purchase by each holder of the Preferred Securities, which purchase the Company hereby agrees shall benefit the Company and which purchase the Company acknowledges will be made in reliance upon the execution and delivery of this Agreement, the Company and the Trust hereby agree as follows: ARTICLE I Section 1.01. Guarantee by the Company. Subject to the terms and conditions hereof, the Company hereby irrevocably and unconditionally guarantees to each person or entity to whom the Trust is now or hereafter becomes indebted or liable (the "Beneficiaries") the full payment, when and as due, of any and all Obligations (as hereinafter defined) to such Beneficiaries. As used herein, "Obligations" means any indebtedness, expenses or liabilities of the Trust, other than obligations of the Trust to pay to holders of any Preferred Securities or other similar interests in the Trust the amounts due such holders pursuant to the terms of the Preferred Securities. This Agreement is intended to be for the benefit of, and to be enforceable by, all such Beneficiaries, whether or not such Beneficiaries have received notice hereof. Section 1.02. Term of Agreement. This Agreement shall terminate and be of no further force and effect upon the date on which there are no Beneficiaries remaining; provided, however, that this Agreement shall continue to be effective or shall be reinstated, as the case may be, if at any time any holder of Preferred Securities or any Beneficiary must restore payment of any sums paid under the Preferred Securities, under any Obligation, under the Guarantee Agreement dated the date hereof by the Company and [ ], as guarantee trustee, or under this Agreement for any reason B-1 whatsoever. Except as set forth in this Section 1.02, this Agreement is continuing, irrevocable, unconditional and absolute. Section 1.03. Waiver of Notice. The Company hereby waives notice of acceptance of this Agreement and of any Obligation to which it applies or may apply, and the Company hereby waives presentment, demand for payment, protest, notice of nonpayment, notice of dishonor, notice of redemption and all other notices and demands. Section 1.04. No Impairment. The obligations, covenants, agreements and duties of the Company under this Agreement shall in no way be affected or impaired by reason of the happening from time to time of any of the following: (a) the extension of time for the payment by the Trust of all or any portion of the Obligations or for the performance of any other obligation under, arising out of, or in connection with, the Obligations; (b) any failure, omission, delay or lack of diligence on the part of the Beneficiaries to enforce, assert or exercise any right, privilege, power or remedy conferred on the Beneficiaries with respect to the Obligations or any action on the part of the Trust granting indulgence or extension of any kind; or (c) the voluntary or involuntary liquidation, dissolution, sale of any collateral, receivership, insolvency, bankruptcy, assignment for the benefit of creditors, reorganization, arrangement, composition or readjustment of debt of, or other similar proceedings affecting, the Trust or any of the assets of the Trust. There shall be no obligation of the Beneficiaries to give notice to, or obtain the consent of, the Company with respect to the happening of any of the foregoing. Section 1.05. Enforcement. A Beneficiary may enforce this Agreement directly against the Company and the Company waives any right or remedy to require that any action be brought against the Trust or any other person or entity before proceeding against the Company. Section 1.06. Subrogation. Omnicare shall be subrogated to all rights (if any) of the Trust in respect of any amounts paid to the Beneficiaries by Omnicare under this Agreement; provided, however, that Omnicare shall not (except to the extent required by mandatory provisions of law) be entitled to enforce or exercise any rights which it may acquire by way of subrogation or any indemnity, reimbursement or other agreement, in all cases as a result of payment under this Agreement, if, at the time of any such payment, any amounts are due and unpaid under this Agreement. ARTICLE II Section 2.01. Binding Effect. All guarantees and agreements contained in this Agreement shall bind the successors, assigns, receivers, trustees and representatives of the Company and shall inure to the benefit of the Beneficiaries. B-2 Section 2.02. Amendment. So long as there remains any Beneficiary or any Preferred Securities of any series are outstanding, this Agreement shall not be modified or amended in any manner adverse to such Beneficiary or to the holders of the Preferred Securities. Section 2.03. Notices. Any notice, request or other communication required or permitted to be given hereunder shall be given in writing by delivering the same against receipt therefor by facsimile transmission (confirmed by mail), telex or by registered or certified mail, addressed as follows (and if so given, shall be deemed given when mailed or upon receipt of an answer-back, if sent by telex), to-wit: Omnicare Capital Trust [I/II/III] c/o [Guarantee Trustee] [ ] [ ] Facsimile No.: Attention: Omnicare, Inc. 100 East RiverCenter Boulevard Covington, Kentucky 41011 Facsimile No.: Attention: Section 2.04. Counterparts. This Agreement may be executed in any number of counterparts and by the parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Section 2.05. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE. B-3 THIS AGREEMENT is executed as of the date and year first above written. OMNICARE, INC. By: __________________________ Name: Title: OMNICARE CAPITAL TRUST [I/II/III] By: __________________________ [ ], as Administrative Trustee B-4 Exhibit C Unless this certificate is presented by an authorized representative of The Depository Trust Company, a New York corporation ("DTC"), to Georgia Power Capital Trust V or its agent for registration of transfer, exchange, or payment, and any certificate issued is registered in the name of Cede & Co. or in such other name as is requested by an authorized representative of DTC (and any payment made to Cede & Co. or to such other entity as is requested by an authorized representative of DTC), any transfer, pledge, or other use hereof for value or otherwise by or to any person is wrongful inasmuch as the registered owner thereof, Cede & Co., has an interest herein. Certificate Number Number of Preferred Securities [ ] P-__ CUSIP NO. Certificate Evidencing Preferred Securities of Omnicare Capital Trust [I/II/III] ___% Trust Preferred Securities (Liquidation Amount $25 per Preferred Security) Omnicare Capital Trust [I/II/III], a statutory Statutory Trust created under the laws of the State of Delaware (the "Trust"), hereby certifies that Cede & Co. (the "Holder") is the registered owner of _________ (_______) preferred securities of the Trust representing undivided beneficial interests in the assets of the Trust and designated the Omnicare Capital Trust [I/II/III] ___% Trust Preferred Securities (Liquidation Amount $____ per Preferred Security) (the "Preferred Securities"). The Preferred Securities are transferable on the books and records of the Trust, in person or by a duly authorized attorney, upon surrender of this certificate duly endorsed and in proper form for transfer as provided in Section 5.04 of the Trust Agreement (as defined below). The designations, rights, privileges, restrictions, preferences and other terms and provisions of the Preferred Securities are set forth in, and this certificate and the Preferred Securities represented hereby are issued and shall in all respects be subject to the terms and provisions of, the Amended and Restated Trust Agreement of the Trust, dated as of ___________, 200__, as the same may be amended from time to time (the "Trust Agreement"), including the designation of the terms of Preferred Securities as set forth therein. The holder of this certificate is entitled to the benefits of a guarantee by Omnicare, Inc., a Delaware corporation (the "Company"), pursuant to a Guarantee Agreement between the Company and [ ], as guarantee trustee, dated as of ___________, 200__, as the same may be amended from time to time (the "Guarantee"), to the extent provided therein. The Trust will furnish a copy of the Trust Agreement and the Guarantee to the holder of this certificate without charge upon written request to the Trust at its principal place of business or registered office. Upon receipt of this certificate, the holder of this certificate is bound by the Trust Agreement and is entitled to the benefits thereunder. C-1 IN WITNESS WHEREOF, the Administrative Trustees of the Trust have executed this certificate this ____ day of ________, ____. OMNICARE CAPITAL TRUST [I/II/III] By:___________________________ [ ], as Administrative Trustee By:___________________________ [ ], as Administrative Trustee By:___________________________ [ ], as Administrative Trustee C-2 ASSIGNMENT FOR VALUE RECEIVED, the undersigned assigns and transfers this Preferred Security to: (Insert assignee's social security or tax identification number) (Insert address and zip code of assignee) and irrevocably appoints agent to transfer this Preferred Securities Certificate on the books of the Trust. The agent may substitute another to act for him or her. Date: ________________________________________ Signature: ____________________________________ (Sign exactly as your name appears on the other side of this Preferred Securities Certificate) EX-4 12 ex4-18.txt EXHIBIT 4.18 Exhibit 4.18 GUARANTEE AGREEMENT By and Between OMNICARE, INC., as Guarantor and [ ], as Trustee Dated as of ________ __, 200_ Cross Reference Table* Section of Section of Trust Indenture Act of 1939, as amended Guarantee Agreement --------------------------------------- ------------------- 310(a).......................................... 4.1 310(b).......................................... 2.8; 4.1 310(c).......................................... Inapplicable 311(a).......................................... 2.2(b) 311(b).......................................... 2.2(b) 311(c).......................................... Inapplicable 312(a).......................................... 2.2(a); 2.9 312(b).......................................... 2.2(b); 2.9 312(c).......................................... 2.9 313(a).......................................... 2.3 313(b).......................................... 2.3 313(c).......................................... 2.3 313(d).......................................... 2.3 314(a).......................................... 2.4 314(b).......................................... Inapplicable 314(c).......................................... 2.5 314(d).......................................... Inapplicable 314(e).......................................... 2.5; 9.5 314(f).......................................... Inapplicable 315(a).......................................... 3.1(d) 315(b).......................................... 2.7 315(c).......................................... 3.1(c) 315(d).......................................... 3.1(e) 316(a).......................................... 2.6; 5.4(a) 316(b).......................................... 5.3 316(c).......................................... Inapplicable 317(a).......................................... 2.10 317(b).......................................... Inapplicable 318(a).......................................... 2.1(b) 318(b).......................................... 2.1 318(c).......................................... 2.1(a) - ---------- * This cross-reference table does not constitute part of the agreement and shall not have any bearing upon the interpretation of any of its terms or provisions. i Table of Contents ARTICLE I INTERPRETATION AND DEFINITIONS.......................................1 Section 1.1 Definitions...................................................1 Section 1.2 Incorporation by Reference of Trust Indenture Act.............4 Section 1.3 Rules of Construction.........................................5 ARTICLE II TRUST INDENTURE ACT.................................................5 Section 2.1 Trust Indenture Act; Application..............................5 Section 2.2 Lists of Holders..............................................5 Section 2.3 Reports by Guarantee Trustee..................................6 Section 2.4 Periodic Reports to Guarantee Trustee.........................6 Section 2.5 Evidence of Compliance with Conditions Precedent..............6 Section 2.6 Guarantee Event of Default; Waiver............................6 Section 2.7 Guarantee Event of Default; Notice............................6 Section 2.8 Conflicting Interests.........................................7 ARTICLE III POWERS, DUTIES AND RIGHTS OF GUARANTEE TRUSTEE.....................7 Section 3.1 Duties of Guarantee Trustee...................................7 Section 3.2 Rights of Guarantee Trustee...................................8 ARTICLE IV GUARANTEE TRUSTEE..................................................10 Section 4.1 Eligibility; Disqualification................................10 Section 4.2 Replacement of Guarantee Trustee.............................10 ARTICLE V GUARANTEE ..........................................................11 Section 5.1 Guarantee....................................................11 Section 5.2 Waiver of Notice and Demand..................................11 Section 5.3 Obligations Not Affected.....................................11 Section 5.4 Rights of Holders............................................12 Section 5.5 Guarantee of Payment.........................................13 Section 5.6 Subrogation..................................................13 Section 5.7 Independent Obligations......................................13 ARTICLE VI LIMITATIONS ON TRANSACTIONS; SUBORDINATION.........................14 Section 6.1 Limitations on Transactions..................................14 Section 6.2 Subordination................................................14 ARTICLE VII TERMINATION ......................................................15 Section 7.1 Termination..................................................15 ARTICLE VIII INDEMNIFICATION..................................................15 Section 8.1 Exculpation..................................................15 Section 8.2 Compensation and Indemnity...................................16 ARTICLE IX MISCELLANEOUS......................................................16 Section 9.1 Successors and Assigns.......................................16 Section 9.2 Amendments...................................................16 ii Section 9.3 Notices......................................................17 Section 9.4 Counterparts.................................................17 Section 9.5 Benefit......................................................17 Section 9.6 Governing Laws...............................................17 iii GUARANTEE AGREEMENT WHEREAS, pursuant to the Trust Agreement (as defined herein), the Omnicare Capital Trust [I / II / III] (the "Trust") is issuing on the date hereof $________ aggregate liquidation amount of preferred securities, having a liquidation amount of $____ per security and designated the "____% Trust Preferred Securities" of the Trust (the "Trust Preferred Securities") and $________ aggregate liquidation amount of common securities, having a liquidation amount of $____ per security and designated the "____% Trust Common Securities" of the Trust (together with the Trust Preferred Securities, the "Trust Securities"); WHEREAS, as incentive for the Holders (as defined herein) to purchase the Trust Preferred Securities, Omnicare, Inc. (the "Guarantor"), desires irrevocably and unconditionally to agree, to the extent set forth in this Guarantee, to pay to the Holders of the Trust Preferred Securities the Guarantee Payments (as defined herein) and to make certain other payments on the terms and conditions set forth herein; and NOW, THEREFORE, in consideration of the purchase by each Holder of Trust Preferred Securities, which purchase the Guarantor hereby agrees shall benefit the Guarantor, the Guarantor executes and delivers this Guarantee for the benefit of such Holders. ARTICLE I INTERPRETATION AND DEFINITIONS Section 1.1 Definitions. "Affiliate" of any specified Person means any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, "control" when used with respect to any specified Person means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms "controlling" and "controlled" have meanings correlative to the foregoing. "Business Day" has the meaning specified in the Trust Agreement. "Covered Person" means a Holder or beneficial owner of Trust Preferred Securities. "Depositor" has the meaning specified in the Trust Agreement. "Distributions" has the meaning specified in the Trust Agreement. "Event of Default" has the meaning specified in the Indenture. "Extension Period" means such period or periods as the Guarantor shall defer the payment of interest on the Subordinated Debt Securities pursuant to the terms thereof and pursuant to the Indenture. "Global Security" has the meaning specified in the Trust Agreement. "Guarantee Event of Default" means a default by the Guarantor on any of its payment or other obligations under this Guarantee. "Guarantee Payments" means the following payments or distributions, without duplication, with respect to the Trust Preferred Securities, to the extent not paid by or on behalf of the Trust: (i) any accrued and unpaid Distributions that are required to be paid on such Trust Preferred Securities to the extent the Trust has sufficient funds legally and immediately available therefor at the time, (ii) the Redemption Price, including all accrued and unpaid Distributions to the date of redemption, with respect to any Trust Preferred Securities called for redemption by the Trust, to the extent the Trust shall have sufficient funds legally and immediately available therefor at the time or (iii) upon a voluntary or involuntary dissolution, winding-up or termination of the Trust (other than in connection with the distribution of Subordinated Debt Securities to the holders of Trust Securities as provided in the Trust Agreement or the redemption of all the Trust Preferred Securities), the lesser of (a) the sum of the liquidation amount and all accrued and unpaid Distributions on the Trust Preferred Securities to the date of payment, to the extent the Trust has sufficient funds legally and immediately available therefor and (b) the amount of assets of the Trust remaining available for distribution to Holders of Trust Preferred Securities in liquidation of the Trust (in either case, the "Liquidation Distribution"). "Guarantee Trustee" means [ ], a national banking association organized under the laws of the United States, until a successor Guarantee Trustee has been appointed and has accepted such appointment pursuant to the terms of this Guarantee and thereafter means each such Successor Guarantee Trustee. "Guarantor" has the meaning specified in the recitals hereto. "Holder" shall mean any holder, as registered on the books and records of the Trust, of any Trust Preferred Securities; provided, however, that in determining whether the holders of the requisite percentage of Trust Preferred Securities have given any request, notice, consent or waiver hereunder, "Holder" shall not include the Guarantor or any Affiliate of the Guarantor. "Indemnified Person" means the Guarantee Trustee, or any officers, directors, employees, shareholders or agents of the Guarantee Trustee. "Indenture" means the Subordinated Debt Securities Indenture, dated as of ________ __, 200_, between the Guarantor and ________, as Trustee, pursuant to which the Subordinated Debt Securities are issued and as thereafter amended or supplemented from time to time. 2 "Liquidation Distribution" has the meaning specified in the definition of "Guarantee Payments" above. "List of Holders" has the meaning assigned to it in Section 2.2 hereof. "Majority in Liquidation Amount" means Holders of outstanding Trust Preferred Securities, voting separately as a class, who are the record owners of more than 50% of the aggregate liquidation amount (including the stated amount that would be paid on redemption, liquidation or otherwise, plus accrued and unpaid Distributions to the date upon which the voting percentages are determined) of all outstanding Trust Preferred Securities. In determining whether the Holders of the requisite amount of Trust Preferred Securities have voted, Trust Preferred Securities which are owned by the Guarantor or any Affiliate of the Guarantor or any other obligor on the Trust Preferred Securities shall be disregarded for the purpose of any such determination. "Officer" means the Chairman of the Board, any Vice Chairman, the Chief Executive Officer, the President, any Vice President, the Treasurer, the Secretary, any Assistant Treasurer or any Assistant Secretary of the Depositor. "Officers' Certificate" means a certificate signed by the Chairman of the Board, the President or a Vice President, and by the Treasurer, an Assistant Treasurer, the Secretary or an Assistant Secretary, of the Guarantor, and delivered to the Trustee. Any Officers' Certificate delivered with respect to compliance with a condition or covenant provided for in this Guarantee shall include: (a) a statement that each officer signing the Officers' Certificate has read the covenant or condition and the definitions relating thereto; (b) a brief statement of the nature and scope of the examination or investigation undertaken by each officer in rendering the Officers' Certificate; (c) a statement that each such officer has made such examination or investigation as, in such officer's opinion, is necessary to enable such officer to express an informed opinion as to whether or not such covenant or condition has been complied with; and (d) a statement as to whether, in the opinion of each such officer, such condition or covenant has been complied with. "Person" means an individual, corporation, partnership, joint venture, trust, limited liability company or corporation, unincorporated organization or government or any agency or political subdivision thereof. "Property Trustee" has the meaning specified in the Trust Agreement. "Redemption Price" has the meaning specified in the Trust Agreement. "Registrar" has the meaning specified in the Trust Agreement. 3 "Responsible Officer" means, with respect to the Guarantee Trustee, any officer with direct responsibility for the administration of this Guarantee and also means, with respect to a particular corporate trust matter, any other officer to whom any corporate trust matter is referred because of his or her knowledge of and familiarity with a particular subject. "Senior Indebtedness" has the meaning specified in the Indenture. "Subordinated Debt Securities" means the series of subordinated debt securities issued by the Guarantor designated the "____% Subordinated Debt Securities due ____" held by the Property Trustee. "Successor Guarantee Trustee" means a successor Guarantee Trustee possessing the qualifications to act as Guarantee Trustee under Section 4.1. "Trust" has the meaning specified in the Trust Agreement. "Trust Agreement" means the Amended and Restated Trust Agreement, dated as of __________ __, 200_, as the same may be modified, amended or supplemented in accordance with the applicable provisions thereof, including all exhibits thereto, including, for all purposes of such Amended and Restated Trust Agreement and any modification, amendment or supplement, the provisions of the Trust Indenture Act that are deemed to be a part of and govern such Amended and Restated Trust Agreement and any such modification, amendment or supplement thereto, respectively. "Trust Preferred Securities" has the meaning specified in the recitals hereto. In the event that pursuant to the Trust Agreement, the Trust and the Depositor grant an Underwriters' Overallotment Option (as defined in the Trust Agreement) to certain underwriters or initial purchasers, as the case may be, such that an additional amount of Trust Preferred Securities may be issued pursuant to the terms of the Trust Agreement, then the defined term "Trust Preferred Securities" shall include such additional Trust Preferred Securities. "Trust Securities" has the meaning specified in the recitals hereto. "TIA" means, to the extent required by any such amendment, the Trust Indenture Act of 1939 as so amended. Section 1.2 Incorporation by Reference of Trust Indenture Act. Whenever this Guarantee refers to a provision of the TIA, the provision is incorporated by reference in and made a part of this Guarantee. All terms used in this Guarantee that are defined by the TIA, defined by the TIA's reference to another statute or defined by Securities and Exchange Commission rule under the TIA and not otherwise defined herein are used herein as so defined. 4 Section 1.3 Rules of Construction. Unless the context otherwise requires: (a) a term has the meaning assigned to it; (b) "or" is not exclusive; (c) words in the singular include the plural, and in the plural include the singular; and (d) provisions apply to successive events and transactions. ARTICLE II TRUST INDENTURE ACT Section 2.1 Trust Indenture Act; Application. (a) This Guarantee is subject to the provisions of the TIA that are required to be part of this Guarantee and shall, to the extent applicable, be governed by such provisions. (b) If and to the extent that any provision of this Guarantee limits, qualifies or conflicts with the duties imposed by Sections 310 to 317, inclusive, of the TIA, such imposed duties shall control. Section 2.2 Lists of Holders. (a) The Guarantor shall furnish to the Guarantee Trustee a list of the names and addresses of the Holders ("List of Holders") in such form and as of such date as the Guarantee Trustee may reasonably require. The Guarantor shall furnish such List of Holders (i) within 30 days after receiving a written request from the Guarantee Trustee, such list to be as of a date no more than 15 days before such list is provided to the Guarantee Trustee, and (ii) unless the Trust Preferred Securities are represented by one or more Global Securities, at least one Business Day prior to the date for payment of Distributions, such list to be as of the record date relating to the payment of such Distributions. However, the Guarantor shall not be obligated to provide such List of Holders at any time the List of Holders does not differ from the most recent List of Holders given to the Guarantee Trustee by the Guarantor or at any time the Guarantee Trustee is the Registrar under the Trust Agreement. The Guarantee Trustee shall preserve, in as current a form as is reasonably practicable, all information contained in any List of Holders given to it, provided that the Guarantee Trustee may destroy any List of Holders previously given to it on receipt of a new List of Holders. (b) The Guarantee Trustee shall comply with its obligations under Sections 311(a), 311(b) and 312(b) of the TIA. 5 Section 2.3 Reports by Guarantee Trustee. Within 60 days after ________ of each year (commencing with the year of the first anniversary of the issuance of the Trust Preferred Securities), the Guarantee Trustee shall provide to the Holders such reports as are required by Section 313(a) of the TIA (if any) in the form and in the manner provided by Section 313 of the TIA. The Guarantee Trustee shall also comply with the other requirements of Section 313 of the TIA. The Guarantor shall promptly notify the Guarantee Trustee when the Trust Preferred Securities are listed on any stock exchange. Section 2.4 Periodic Reports to Guarantee Trustee. The Guarantor shall provide to the Guarantee Trustee such documents, reports and information as required by Section 314(a) (if any) of the TIA and the compliance certificate required by Section 314(a)(4) of the TIA in the form, in the manner and at the times required by Section 314(a) of the TIA, provided that such compliance certificate shall be delivered on or before 120 days after the end of each fiscal year of the Guarantor. Section 2.5 Evidence of Compliance with Conditions Precedent. The Guarantor shall provide to the Guarantee Trustee such evidence of compliance with any conditions precedent, if any, provided for in this Guarantee that relate to any of the matters set forth in Section 314(c) of the TIA. Any certificate or opinion required to be given by an officer pursuant to Section 314(c)(1) may be given in the form of an Officers' Certificate. Section 2.6 Guarantee Event of Default; Waiver. The Holders of a Majority in Liquidation Amount of the Trust Preferred Securities may, by vote or written consent, on behalf of all of the Holders, waive any past Guarantee Event of Default and its consequences. Upon such waiver, any such Guarantee Event of Default shall cease to exist, and any Guarantee Event of Default arising therefrom shall be deemed to have been cured, for every purpose of this Guarantee, but no such waiver shall extend to any subsequent or other default or Guarantee Event of Default or impair any right consequent thereon. Section 2.7 Guarantee Event of Default; Notice. (a) If a Guarantee Event of Default occurs and is continuing and if it is known to a Responsible Officer of the Guarantee Trustee, the Guarantee Trustee shall mail to each Holder notice of a Guarantee Event of Default within 90 days after it occurs or, if later, after a Responsible Officer of the Guarantee Trustee has knowledge of such Guarantee Event of Default. The Guarantee Trustee may withhold the notice if and so long as its corporate trust committee or a committee of its Responsible Officers in good faith determines that withholding the notice is in the interests of the Holders. 6 (b) The Guarantee Trustee shall not be deemed to have knowledge of any Guarantee Event of Default unless the Guarantee Trustee shall have received written notice, or a Responsible Officer charged with the administration of the Trust Agreement shall have obtained written notice, of such Guarantee Event of Default. Section 2.8 Conflicting Interests. The Trust Agreement shall be deemed to be specifically described in this Guarantee for the purposes of clause (i) of the first proviso contained in Section 310(b) of the TIA. ARTICLE III POWERS, DUTIES AND RIGHTS OF GUARANTEE TRUSTEE Section 3.1 Duties of Guarantee Trustee (a) This Guarantee shall be held by the Guarantee Trustee on behalf of the Trust for the benefit of the Holders, and the Guarantee Trustee shall not transfer this Guarantee to any Person except a Holder exercising his or her rights pursuant to Section 5.4(b) or to a Successor Guarantee Trustee on acceptance by such Successor Guarantee Trustee of its appointment to act as Successor Guarantee Trustee. The right, title and interest of the Guarantee Trustee in and to this Guarantee shall automatically vest in any Successor Guarantee Trustee, and such vesting and succession of title shall be effective upon acceptance of appointment whether or not conveyance documents have been executed and delivered pursuant to the appointment of such Successor Guarantee Trustee. (b) If a Guarantee Event of Default has occurred and is continuing, the Guarantee Trustee shall enforce this Guarantee for the benefit of the Holders. (c) The Guarantee Trustee, before the occurrence of any Guarantee Event of Default and after the curing or waiving of all Guarantee Events of Default that may have occurred, shall undertake to perform only such duties as are specifically set forth in this Guarantee, and no implied covenants shall be read into this Guarantee against the Trustee. If a Guarantee Event of Default has occurred and is continuing, the Guarantee Trustee shall exercise the rights and powers vested in it by this Guarantee and use the same degree of care and skill in its exercise thereof as a prudent man would exercise or use under the circumstances in the conduct of his own affairs. (d) No provision of this Guarantee shall be construed to relieve the Guarantee Trustee from liability for its own negligent action, its own negligent failure to act, or its own willful misconduct, except that: (i) prior to the occurrence of any Event of Default and after the curing or waiving of all such Guarantee Events of Default that may have occurred: 7 (A) the duties and obligations of the Guarantee Trustee shall be determined solely by the express provisions of this Guarantee, and the Guarantee Trustee shall not be liable except for the performance of such duties and obligations as are specifically set forth in this Guarantee; and (B) in the absence of bad faith on the part of the Guarantee Trustee, the Guarantee Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon any certificates or opinions furnished to the Guarantee Trustee and conforming to the requirements of this Guarantee; but in the case of any such certificates or opinions that by any provision hereof are specifically required to be furnished to the Guarantee Trustee, the Guarantee Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Guarantee; (ii) the Guarantee Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer of the Guarantee Trustee, unless it shall be proved that the Guarantee Trustee was negligent in ascertaining the pertinent facts upon which such judgment was made; (iii) the Guarantee Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the Holders of a Majority in Liquidation Amount of the Trust Preferred Securities relating to the time, method and place of conducting any proceeding for any remedy available to the Guarantee Trustee, or exercising any trust or power conferred upon the Guarantee Trustee under this Guarantee; and (e) no provision of this Guarantee shall require the Guarantee Trustee to expend or risk its own funds or otherwise incur personal financial liability in the performance of any of its duties or in the exercise of any of its rights or powers, if the Guarantee Trustee shall have reasonable grounds for believing that the repayment of such funds or liability is not reasonably assured to it under the terms of this Guarantee or adequate indemnity against such risk or liability is not reasonably assured to it. Section 3.2 Rights of Guarantee Trustee. (a) Subject to the provisions of Section 3.1: (i) the Guarantee Trustee may rely and shall be fully protected in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document believed by it to be genuine and to have been signed, sent or presented by the proper party or parties; (ii) any direction or act of the Guarantor contemplated by this Guarantee shall be sufficiently evidenced by an Officers' Certificate; 8 (iii) whenever, in the administration of this Guarantee, the Guarantee Trustee shall deem it desirable that a matter be proved or established before taking, suffering or omitting any action hereunder, the Guarantee Trustee (unless other evidence is herein specifically prescribed) may, in the absence of bad faith on its part, request and rely upon an Officers' Certificate which, upon receipt of such request, shall be promptly delivered by the Guarantor; (iv) The Guarantee Trustee may consult with counsel of its choice, and the written advice or opinion of such counsel with respect to legal matters shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in accordance with such advice or opinion; such counsel may be counsel to the Guarantor or any of its Affiliates and may include any of its employees, the Guarantee Trustee shall have the right at any time to seek instructions concerning the administration of this Guarantee from any court of competent jurisdiction; (v) the Guarantee Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document, but the Guarantee Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit; (vi) the Guarantee Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys, and the Guarantee Trustee shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed with due care by it hereunder; and (vii) The Guarantee Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Guarantee at the request or direction of any of the Holders unless such Holders shall have offered to the Guarantee Trustee reasonable security or indemnity against the costs, expenses and liabilities which might be incurred by it in compliance with such request or direction, including such reasonable advances as may be requested by the Guarantee Trustee; provided, that nothing contained in this Section 3.2(f) shall be taken to relieve the Guarantee Trustee, upon the occurrence of a Guarantee Event of Default, of its obligation to exercise the rights and powers vested in it by this Guarantee in the manner provided by Section 3.1(c). (viii) Whenever in the administration of this Guarantee, the Guarantee Trustee shall deem it desirable to receive instructions with respect to enforcing any remedy or right or taking any other action hereunder, the Guarantee Trustee (A) may request written instructions from the Holders of a Majority in Liquidation Amount of the Trust Preferred Securities, (B) may refrain from enforcing such remedy or right or taking such other action until such written 9 instructions are received and (C) shall be protected in conclusively relying on or acting in accordance with such written instructions. (b) No provision of this Guarantee shall be deemed to impose any duty or obligation on the Guarantee Trustee to perform any act or acts or exercise any right, power, duty or obligation conferred or imposed on it in any jurisdiction in which it shall be illegal, or in which the Guarantee Trustee shall be unqualified or incompetent to act in accordance with applicable law, to perform any such act or acts or to exercise any such right, power, duty or obligation. No permissive power or authority available to the Guarantee Trustee shall be construed to be a duty. ARTICLE IV GUARANTEE TRUSTEE Section 4.1 Eligibility; Disqualification. This Guarantee shall always have a Guarantee Trustee who satisfies the requirements of Sections 310(a)(1), (2) and (5) of the TIA. The Guarantee Trustee shall always have a combined capital and surplus of at least $50,000,000 as set forth in its most recent published annual report of condition. The Guarantee Trustee shall comply with Section 310(b) of the TIA. Section 4.2 Replacement of Guarantee Trustee. (a) Subject to Section 4.2(b), the Guarantee Trustee may be appointed or removed without cause at any time by the Guarantor. (b) The Guarantee Trustee shall not be removed until a Successor Guarantee Trustee has been appointed and has accepted such appointment by written instrument executed by such Successor Guarantee Trustee and delivered to the Guarantor. (c) The Guarantee Trustee appointed to office shall hold office until a Successor Guarantee Trustee shall have been appointed or until its removal or resignation. The Guarantee Trustee may resign from office (without need for prior or subsequent accounting) by an instrument in writing executed by the Guarantee Trustee and delivered to the Guarantor, which resignation shall not take effect until a Successor Guarantee Trustee has been appointed and has accepted such appointment by instrument in writing executed by such Successor Guarantee Trustee and delivered to the Guarantor and the resigning Guarantee Trustee. (d) If a Successor Guarantee Trustee does not take office within 60 days after the retiring Guarantee Trustee resigns or is removed, the retiring Guarantee Trustee, may petition any court of competent jurisdiction for the appointment of a Successor Guarantee Trustee. 10 (e) If the Guarantee Trustee fails to comply with Section 4.1, any Holder may petition any court of competent jurisdiction for the removal of the Guarantee Trustee and the appointment of a Successor Guarantee Trustee. (f) A Successor Guarantee Trustee shall deliver a written acceptance of its appointment to the retiring Guarantee Trustee and to the Guarantor. Immediately after that, the retiring Guarantee Trustee shall transfer all property held by it as Guarantee Trustee to the Successor Guarantee Trustee, the resignation or removal of the retiring Guarantee Trustee shall become effective, and the Successor Guarantee Trustee shall have all the rights, powers and duties of the Guarantee Trustee under this Guarantee. A Successor Guarantee Trustee shall mail a notice of its succession to each Holder. Notwithstanding replacement of the Guarantee Trustee pursuant to this Section 4.2, the Guarantor's obligations under Section 8.2 hereof shall continue for the benefit of the retiring Guarantee Trustee with respect to expenses and liabilities incurred by it prior to such replacement. ARTICLE V GUARANTEE Section 5.1 Guarantee. The Guarantor irrevocably and unconditionally agrees to pay in full to the Holders the Guarantee Payments (without duplication of amounts theretofore paid by the Trust), as and when due, regardless of any defense, right of set-off or counterclaim that the Guarantor may have or assert against any Person. The Guarantor's obligation to make a Guarantee Payment may be satisfied by direct payment of the required amounts by the Guarantor to the Holders or by causing the Trust to pay such amounts to the Holders. Notwithstanding anything to the contrary herein, the Guarantor retains all of its rights to extend the interest payment period on the Subordinated Debt Securities to the extent permitted by the Indenture and the Guarantor shall not be obligated hereunder to make any Guarantee Payments during any Extension Period with respect to the Distributions on the Securities. Section 5.2 Waiver of Notice and Demand. The Guarantor hereby waives notice of acceptance of this Guarantee and of any liability to which it applies or may apply, presentment, demand for payment, any right to require a proceeding first against the Trust or any other Person before proceeding against the Guarantor, protest, notice of nonpayment, notice of dishonor, notice of redemption and all other notices and demands. Section 5.3 Obligations Not Affected. The obligations of the Guarantor to make the Guarantee Payments under this Guarantee shall in no way be affected or impaired by reason of the happening from time to time of any of the following: 11 (a) The release or waiver, by operation of law or otherwise, of the performance or observance by the Trust of any express or implied agreement, covenant, term or condition relating to the Trust Preferred Securities to be performed or observed by the Trust; (b) The extension of time for the payment by the Trust of all or any portion of the Distributions, Redemption Price, Liquidation Distribution or any other sums payable under the terms of the Trust Preferred Securities or the extension of time for the performance of any other obligation under, arising out of, or in connection with the Trust Preferred Securities (other than an extension of time for payment of Distributions, Redemption Price, Liquidation Distribution or other sum payable that results from the extension of any interest payment period on the Subordinated Debt Securities permitted by the Indenture); (c) Any failure, omission, delay or lack of diligence on the part of the Property Trustee or the Holders to enforce, assert or exercise any right, privilege, power or remedy conferred on the Property Trustee or the Holders pursuant to the terms of the Trust Preferred Securities, or any action on the part of the Trust granting indulgence or extension of any kind; (d) The voluntary or involuntary liquidation, dissolution, sale of any collateral, receivership, insolvency, bankruptcy, assignment for the benefit of creditors, reorganization, arrangement, composition or readjustment of debt of, or other similar proceedings affecting, the Trust or any of the assets of the Trust; (e) Any invalidity of, or defect or deficiency in, the Trust Preferred Securities; (f) The settlement or compromise of any obligation guaranteed hereby or hereby incurred; or (g) Any other circumstance whatsoever that might otherwise constitute a legal or equitable discharge or defense of a guarantor, it being the intent of this Section 5.3 that the obligations of the Guarantor hereunder shall be absolute and unconditional under any and all circumstances. There shall be no obligation of the Guarantee Trustee or the Holders to give notice to or obtain consent of the Guarantor or any other Person with respect to the happening of any of the foregoing. No setoff, counterclaim, reduction or diminution of any obligation, or any defense of any kind or nature that the Guarantor has or may have against any Holder shall be available hereunder to the Guarantor against such Holder to reduce the payments to it under this Guarantee. Section 5.4 Rights of Holders. (a) The Guarantor expressly acknowledges that: (i) this Guarantee Agreement will be deposited with the Guarantee Trustee to be held for the benefit of the Holders; (ii) the Guarantee Trustee has the right to enforce this Guarantee 12 Agreement on behalf of the Holders; (iii) the Holders of a Majority in Liquidation Amount of the Preferred Securities have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Guarantee Trustee in respect of this Guarantee Agreement or exercising any trust or power conferred upon the Guarantee Trustee under this Guarantee Agreement, provided that such direction shall not be in conflict with any rule of law or with this Guarantee Agreement, and could not involve the Guarantee Trustee in personal liability in circumstances where reasonable indemnity would not be adequate; and (iv) any Holder may institute a legal proceeding directly against the Guarantor to enforce its rights under this Guarantee Agreement, without first instituting a legal proceeding against or requesting or directing that action be taken by the Guarantee Trustee or any other Person; it being understood and intended that no one or more of such Holders shall have any right in any manner whatsoever by virtue of, or by availing of, any provision of this Guarantee Agreement to affect, disturb or prejudice the rights of any other of such Holders or to obtain or to seek to obtain priority or preference over any other of such Holders or to enforce any right under this Guarantee Agreement, except in the manner herein provided and for the equal and ratable benefit of all of such Holders. Section 5.5 Guarantee of Payment. This Guarantee creates a guarantee of payment and not of collection. Section 5.6 Subrogation. The Guarantor shall be subrogated to all (if any) rights of the Holders against the Trust in respect of any amounts paid to such Holders by the Guarantor under this Guarantee; provided, however, that the Guarantor shall not (except to the extent required by mandatory provisions of law) be entitled to enforce or exercise any right that it may acquire by way of subrogation or any indemnity, reimbursement or other agreement, in all cases as a result of payment under this Guarantee, if at the time of any such payment, any amounts are due and unpaid under this Guarantee. If any amount shall be paid to the Guarantor in violation of the preceding sentence, the Guarantor agrees to hold such amount in trust for the Holders and to pay over such amount to the Guarantee Trustee for the benefit of the Holders. Section 5.7 Independent Obligations. The Guarantor acknowledges that its obligations hereunder are independent of the obligations of the Trust with respect to the Trust Preferred Securities, and that the Guarantor shall be liable as principal and as debtor hereunder to make Guarantee Payments pursuant to the terms of this Guarantee notwithstanding the occurrence of any event referred to in subsections 5.3(a) through 5.3(g), inclusive, hereof. 13 ARTICLE VI LIMITATIONS ON TRANSACTIONS; SUBORDINATION Section 6.1 Limitations on Transactions. So long as any Trust Preferred Securities remain outstanding, if (i) there shall have occurred any Event of Default under the Indenture or any event of which the Guarantor has actual knowledge that (a) with the giving of notice or the lapse of time or both, would constitute an Event of Default under the Indenture and (b) in respect of which the Guarantor shall not have taken reasonable steps to cure, (ii) there shall be a Guarantee Event of Default or (iii) the Guarantor shall have given notice of its election of an Extension Period as provided in the certificate evidencing the Subordinated Debt Securities and shall not have rescinded such notice, or such Extension Period or any extension thereof shall be continuing, then the Guarantor shall not (x) declare or pay any dividends or distributions on, or redeem, purchase, acquire or make a liquidation payment with respect to, any of the Guarantor's capital stock or (y) make any payment of principal, interest or premium, if any, on or repay, repurchase or redeem any debt securities of the Guarantor that rank pari passu with or junior in interest to the Subordinated Debt Securities or make any guarantee payments with respect to any guarantee by the Guarantor of the debt securities of any subsidiary of the Guarantor if such guarantee ranks on a parity with or junior in interest to the Subordinated Debt Securities (other than (a) any dividend, redemption, liquidation, interest, principal or guarantee payment by the Guarantor where the payment is made by way of securities (including capital stock) that rank pari passu with or junior to the securities on which such dividend, redemption, interest, principal or guarantee payment is being made, (b) any declaration of a dividend in connection with the Guarantor's shareholders' rights plan or any successor to such plan, or the issuance of capital stock of any class or series under any such plan in the future, or the redemption or repurchase of any such rights pursuant thereto, (c) payments under this Guarantee, any other similar guarantee by the Guarantor in respect of Trust Preferred Securities issued by a trust holding Subordinated Debt Securities issued under the Indenture, (d) repurchases, redemptions or other acquisitions of capital stock in connection with any benefit plans or other similar arrangements with or for the benefit of its employees, officers, directors, consultants or advisors of the Guarantor or any of its subsidiaries, (e) as a result of a reclassification of the Guarantor's capital stock or the exchange or conversion of one series of class of the Guarantor's capital stock for another series or class of the Guarantor's capital stock or (f) the purchase of fractional interests in shares of the Guarantor's capital stock pursuant to the conversion or exchange provisions of such capital stock or the security being converted or exchanged). Section 6.2 Subordination. This Guarantee will constitute an unsecured obligation of the Guarantor and will rank (i) subordinate and junior in right of payment to all other liabilities of the Guarantor, including the Subordinated Debt Securities, except those obligations or liabilities made pari passu or subordinate by their terms, (ii) pari passu with the most senior preferred or preference stock now or hereafter issued by the Guarantor and with any guarantee now or 14 later issued by the Guarantor in respect of any preferred or preference stock of any Affiliate of the Guarantor, and (iii) senior to all common stock of the Guarantor. ARTICLE VII TERMINATION Section 7.1 Termination. This Guarantee shall terminate upon: (a) full payment of the Redemption Price of all Trust Preferred Securities, (b) distribution of the Subordinated Debt Securities to the Holders in exchange for all the outstanding Trust Preferred Securities, or (c) full payment of the amounts payable in accordance with the Trust Agreement upon liquidation of the Trust. Notwithstanding the foregoing, this Guarantee will continue to be effective or will be reinstated, as the case may be, if at any time any Holder must restore payment of any sums paid under the Trust Preferred Securities or under this Guarantee. ARTICLE VIII INDEMNIFICATION Section 8.1 Exculpation. (a) No Indemnified Person shall be liable, responsible or accountable in damages or otherwise to the Guarantor or any Covered Person for any loss, damage, liability, expense or claim incurred by reason of any act or omission performed or omitted by such Indemnified Person in good faith in accordance with this Guarantee and in a manner that such Indemnified Person reasonably believed to be within the scope of the authority conferred on such Indemnified Person by this Guarantee or by law, except that an Indemnified Person shall be liable for any such loss, damage or claim incurred by reason of such Indemnified Person's negligence or willful misconduct with respect to such acts or omissions. (b) An Indemnified Person shall be fully protected in relying in good faith upon the records of the Guarantor and upon such information, opinions, reports or statements presented to the Guarantor by any Person as to matters the Indemnified Person reasonably believes are within such other Person's professional or expert competence including information, opinions, reports or statements as to the value and amount of the assets, liabilities, profits, losses, or any other facts pertinent to the existence and amount of assets from which Distributions to Holders might properly be paid. 15 Section 8.2 Compensation and Indemnity. (a) The Guarantor shall pay to the Guarantee Trustee from time to time reasonable compensation for its services. The Guarantee Trustee's compensation shall not be limited by any law on compensation of a trustee of an express trust. The Guarantor shall reimburse the Guarantee Trustee upon request for all reasonable out-of-pocket expenses incurred by it. Such expenses shall include the reasonable compensation and expenses of the Guarantee Trustee's agents and counsel. (b) The Guarantor shall indemnify each of the Indemnified Persons (including the cost of defending itself) against any loss, liability or expense incurred by it except as set forth in the next paragraph in the performance of its duties under this Guarantee. An Indemnified Person shall notify the Guarantor promptly of any claim for which it may seek indemnity. The Guarantor shall defend the claim and the Indemnified Person shall cooperate in the defense. The Guarantor need not pay for any settlement made without its consent, which consent shall not be unreasonably withheld. (c) The Guarantor need not reimburse any expense or indemnify against any loss or liability incurred by an Indemnified Person through such Indemnified Person's negligence, bad faith or willful misconduct. ARTICLE IX MISCELLANEOUS Section 9.1 Successors and Assigns. All guarantees and agreements contained in this Guarantee shall bind the successors, assigns, receivers, trustees and representatives of the Guarantor and shall inure to the benefit of the Guarantee Trustee, any Successor Guarantee Trustee and the Holders of the Trust Preferred Securities then outstanding. Except in connection with a consolidation, merger, sale or conveyance involving the Guarantor that is permitted by Article - of the Indenture and pursuant to which the successor or assignee agrees in writing to perform the Guarantor's obligations hereunder, the Guarantor shall not assign its obligations hereunder. Section 9.2 Amendments. Except with respect to any changes that do not materially adversely affect the rights of the Holders (in which case no consent of the Holders will be required), this Guarantee may not be amended without the prior approval of the Holders of at least a Majority in Liquidation Amount of the Trust Preferred Securities. The provisions of Section 11.2 of the Trust Agreement with respect to meetings of, and action by written consent of, the Holders apply to the giving of such approval. 16 Section 9.3 Notices. Any notice or communication by the Guarantor or the Guarantee Trustee to the other is duly given if in writing and delivered in Person or mailed by first-class mail: (a) if to the Guarantor: Omnicare, Inc. 100 East RiverCenter Boulevard Covington, Kentucky 41011 Attention: Cheryl D. Hodges Senior Vice President and Secretary (b) if to the Guarantee Trustee: [ ] [ ] [ ] Attention: Corporate Trust Department The Guarantor or the Guarantee Trustee by notice to the other may designate additional or different addresses for subsequent notices or communications. Any notice or communication to a Holder shall be mailed by first-class mail to the address shown on the books and records of the Trust. Failure to mail a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders. If a notice or communication is mailed or published in the manner provided above, within the time prescribed, it is duly given, whether or not the Holder receives it. (c) If the Guarantor mails a notice or communication to Holders, it shall mail a copy to the Guarantee Trustee at the same time. Section 9.4 Counterparts. This Guarantee may be executed in any number of counterparts and by the parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Section 9.5 Benefit. This Guarantee is solely for the benefit of the Holders and, subject to Section 3.1(a), is not separately transferable from the Trust Preferred Securities. Section 9.6 Governing Laws. THIS GUARANTEE AGREEMENT SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE AND 17 TO BE PERFORMED IN SUCH STATE, WITHOUT REGARD TO THE CONFLICT OF LAWS PROVISIONS THEREOF. 18 IN WITNESS WHEREOF, the parties hereto have caused this Guarantee to be duly executed as of the day and year first above written. OMNICARE, INC., as Guarantor By: ---------------------------------- Name: Its: Attest: - ---------------------------- [ ], as Guarantee Trustee By: ---------------------------------- Name: Its: 19 EX-5 13 ex5-1.txt EXHIBIT 5.1 Exhibit 5.1 February 19, 2003 Omnicare, Inc. 100 East RiverCenter Boulevard Covington, Kentucky 41011 Re: Registration Statement on Form S-3 Ladies and Gentlemen: We have acted as counsel to Omnicare, Inc., a Delaware corporation (the "Company"), in connection with the preparation of the Registration Statement on Form S-3 filed with the Securities and Exchange Commission by the Company, and by Omnicare Capital Trust I, Omnicare Capital Trust II and Omnicare Capital Trust III, each a statutory trust formed under the laws of the State of Delaware (each a "Trust" and collectively, the "Trusts"), on February 12, 2003, as amended by Amendment No. 1 thereto filed with the Commission on February 19, 2003 (the "Registration Statement"). The Registration Statement relates to the issuance and sale from time to time, pursuant to Rule 415 of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended (the "Securities Act"), of the following securities with an aggregate initial public offering price of up to $850,000,000: (i) common stock, par value $1.00 per share, of the Company ("Common Stock"); (ii) one or more classes or series of preferred stock, no par value per share, of the Company ("Preferred Stock"), interests in which may be represented by depositary shares of the Company ("Depositary Shares"); (iii) one or more series of debt securities of the Company ("Debt Securities"), consisting of debentures, notes and/or other evidences of indebtedness, which may be unsubordinated ("Senior Debt Securities") or subordinated ("Subordinated Debt Securities") to certain other obligations of the Company; (iv) guarantees, if any, of the Debt Securities by certain of the Company's subsidiaries (the "Guarantees" and, such subsidiaries, the "Subsidiary Guarantors"); (v) warrants to purchase Securities (as hereinafter defined) of the Company ("Warrants"); (vi) trust preferred securities of one or more of the Trusts ("Trust Preferred Securities"), and related guarantees by the Company of the Trust Preferred Securities (individually, a "Trust Guarantee," and collectively, the "Trust Guarantees"); (vii) purchase contracts obligating holders to purchase Securities (as hereinafter defined) at a future date or dates ("Purchase Contracts"); and (viii) units comprised of one or more Securities (as hereinafter defined) in any combination ("Units," and together with the Common Stock, Preferred Stock, Depositary Shares, Debt Securities, Guarantees, Warrants, Trust Preferred Securities, Trust Guarantees and Purchase Contracts, "Securities"). The Senior Debt Securities may be issued under a senior debt securities indenture in the form filed as an exhibit to the Registration Statement, as amended or supplemented from time to time (the "Senior Indenture"), proposed to be entered into between the Company and one or more trustees (any such trustee, the "Senior Indenture Trustee"). The Subordinated Debt Securities may be issued under a subordinated debt securities indenture in the form filed as an exhibit to the Registration Statement, as amended or supplemented from time to time (the "Subordinated Indenture"), proposed to be entered into between the Company and one or more trustees chosen by the Company and qualified to act as such under the Trust Indenture Act of 1939, as amended (the "TIA") (any such trustee, the Omnicare, Inc. February 19, 2003 Page 2 "Subordinated Indenture Trustee"). The Senior Indenture and the Subordinated Indenture are sometimes hereinafter referred to individually as an "Indenture" and collectively as the "Indentures." The Warrants may be issued under a warrant agreement in a form that will be filed as an exhibit to a post-effective amendment to the Registration Statement or incorporated by reference therein (a "Warrant Agreement"). The Trust Preferred Securities may be issued by a Trust pursuant to an amended and restated trust agreement in the form filed as an exhibit to the Registration Statement, as amended or supplemented from time to time (a "Trust Agreement"), proposed to be entered into among the Company, as sponsor, a Property Trustee, a Delaware Trustee and the Administrative Trustees to be named therein, and each Trust Guarantee may be issued pursuant to a guarantee agreement in the form filed as an exhibit to the Registration Statement, as amended or supplemented from time to time (a "Guarantee Agreement"), proposed to be entered into between the Company and the trustee to be named therein. The Purchase Contracts may be issued under a purchase contract agreement in a form that will be filed as an exhibit to a post-effective amendment to the Registration Statement or incorporated by reference therein (a "Purchase Contract Agreement"). The Units may be issued under a unit agreement in a form that will be filed as an exhibit to a post-effective amendment to the Registration Statement or incorporated by reference therein (a "Unit Agreement"). This opinion is delivered in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act. We have examined (i) the Registration Statement; (ii) the form of Senior Indenture; (iii) the form of Subordinated Indenture; (iv) the form of Amended and Restated Trust Agreement; (v) the form of Guarantee Agreement; (vi) the Certificate of Incorporation of the Company, as amended and currently in effect (the "Certificate of Incorporation"); (vii) the By-laws of the Company as currently in effect (the "By-laws"); and (viii) the resolutions adopted by the Board of Directors of the Company (the "Board") relating to the Registration Statement and the issuance of the Securities (the "Board Resolutions"). We also have examined originals or copies, certified or otherwise identified to our satisfaction, of such certificates of officers or other representatives of the Company, and such other agreements, documents, certificates and records as we have deemed necessary or appropriate as a basis for the opinions set forth herein. In our examination, we have assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed or photostatic copies and the authenticity of the originals of such latter documents. In making our examination of documents executed by parties other than the Company and the Subsidiary Guarantors organized under the laws of the State of Delaware, we have assumed that such parties had the legal power to enter into and perform all their obligations thereunder and also have assumed the due authorization by all requisite action, corporate or other, and execution and delivery by such parties of such documents and the validity and binding effect thereof. As to any facts material to the opinions expressed herein which were not independently established or verified, we have relied upon oral or written statements and representations of officers and other representatives of the Company and others. In our capacity as your counsel in connection with the Registration Statement, we are familiar with the proceedings taken and proposed to be taken by the Company in connection with the Registration Statement and the authorization and issuance of the Securities. For purposes of this opinion, we have assumed that such proceedings will be timely and properly Omnicare, Inc. February 19, 2003 Page 3 completed, in accordance with all requirements of applicable Federal, New York and Delaware laws, in the manner presently proposed. Based upon the foregoing and in reliance thereon, and subject to the qualifications and limitations set forth herein, we are of the opinion that: 1. With respect to any offering of Common Stock (the "Offered Common Stock"), the shares of the Offered Common Stock (including any Offered Common Stock duly issued upon conversion, exchange or exercise of any other Securities) will be duly authorized, validly issued, fully paid and nonassessable, provided that the consideration therefor is not less than the par value thereof. 2. With respect to any offering of any series of Preferred Stock (the "Offered Preferred Stock"), when the Certificate of Designations (as hereinafter defined) has been duly filed with the Secretary of State of the State of Delaware, the shares of the Offered Preferred Stock (including any Offered Preferred Stock duly issued upon conversion, exchange or exercise of any other Securities), will be duly authorized, validly issued, fully paid and nonassessable, provided that the consideration therefor is not less than the par value thereof. 3. With respect to any offering of any series of Depositary Shares (the "Offered Depositary Shares"), when (i) the deposit agreement relating to the Offered Depositary Shares (the "Deposit Agreement") in the form filed as an exhibit to the Registration Statement has been duly executed and delivered as contemplated by the Board Resolutions or other action by the Board or a duly appointed committee thereof; and (ii) the Preferred Stock which is represented by the Offered Depositary Shares is duly authorized, validly issued and delivered to the Depositary in accordance with the laws of the State of Delaware, (a) the Offered Depositary Shares will be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms and (b) when the receipts evidencing the Offered Depositary Shares ("Receipts") are duly issued against the deposit of the Preferred Stock in accordance with the Deposit Agreement, such Receipts will be validly issued and will entitle the holders thereof to the rights specified therein and in the Deposit Agreement. 4. With respect to any offering of any series of Debt Securities offered under the Senior Indenture or the Subordinated Indenture (the "Offered Debt Securities"), when (i) the applicable Indenture has been qualified under the TIA and duly executed and delivered by the Company; and (ii) the applicable trustee has been qualified under the TIA and a Form T-1 has been properly filed as an exhibit to the Registration Statement, the Offered Debt Securities (including any Offered Debt Securities duly issued upon conversion, exchange or exercise of any other Securities) will be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms. 5. With respect to any offering of any Guarantees of any series of Debt Securities offered under the Senior Indenture or the Subordinated Indenture (the "Offered Guarantees"), when (i) the applicable Indenture has been qualified under the TIA and duly executed and delivered by the Company and the Subsidiary Guarantors; and (ii) the applicable trustee has been qualified under the TIA and a Form T-1 has been properly filed as an exhibit to the Registration Statement, the Offered Guarantees will be valid and binding obligations of the applicable Subsidiary Guarantors, enforceable against the applicable Subsidiary Guarantors in accordance with their terms. Omnicare, Inc. February 19, 2003 Page 4 6. With respect to any offering of any series of Warrants (the "Offered Warrants"), when the Warrant Agreement relating to the Offered Warrants, in the form to be filed as an exhibit to a post-effective amendment to the Registration Statement or incorporated by reference therein, has been duly executed and delivered as contemplated by the Board Resolutions or other action by the Board or a duly appointed committee thereof, the Offered Warrants will be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms. 7. With respect to any offering of any Trust Preferred Securities by a Trust (the "Offered Trust Preferred Securities") and any related Trust Guarantee by the Company (the "Offered Trust Guarantee"), when (i) the Offered Trust Preferred Securities have been executed, authenticated and delivered in accordance with the terms of the applicable Trust Agreement; (ii) the applicable trustees have been qualified under the TIA and a Form T-1 in respect of each trustee has been properly filed as an exhibit to the Registration Statement; (iii) the applicable Trust Agreement in the form filed as an exhibit to the Registration Statement has been qualified under the TIA and has been duly executed and delivered by the Company and the other parties thereto; and (iv) the applicable Guarantee Agreement in the form filed as an exhibit to the Registration Statement has been qualified under the TIA and the Offered Trust Guarantee has been duly executed and authenticated in accordance with the provisions of the applicable Guarantee Agreement, the Offered Trust Guarantee will be a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms. 8. With respect to any offering of Purchase Contracts (the "Offered Purchase Contracts"), when the Purchase Contract Agreement, in the form to be filed as an exhibit to a post-effective amendment to the Registration Statement or incorporated by reference therein, has been duly executed and delivered as contemplated by the Board Resolutions or other action by the Board or a duly appointed committee thereof, the Offered Purchase Contracts will be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms. 9. With respect to any offering of any series of Units (the "Offered Units"), when the Unit Agreement or other applicable agreement relating to the Offered Units, in the form to be filed as an exhibit to a post-effective amendment to the Registration Statement or incorporated by reference therein, has been duly executed and delivered as contemplated by the Board Resolutions or other action by the Board or a duly appointed committee thereof, the Offered Units will be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms. The opinions set forth herein are subject to the following assumptions, qualifications, limitations and exceptions being true and correct at or prior to the time of the delivery of any Securities offered pursuant to the Registration Statement (collectively, the "Offered Securities"): (i) the Board, including any appropriate committee appointed thereby, and appropriate officers of the Company shall have duly established the terms of the Offered Securities; (ii) the board of directors, including any appropriate committee appointed thereby, and appropriate officers of the Company and, with respect to any Guarantees or Trust Guarantees, the Subsidiary Guarantors or the Company, as the case may be, shall have duly authorized and taken any other necessary corporate action to approve the issuance and sale of the Offered Securities Omnicare, Inc. February 19, 2003 Page 5 and related matters (including without limitation with respect to Offered Preferred Stock, the execution, acknowledgment and filing of a Certificate of Designations (the "Certificate of Designations") in accordance with the applicable provisions of the General Corporation Law of the State of Delaware) and such authorizations and actions have not been rescinded; (iii) the terms of the issuance and sale of the Offered Securities have been duly established in conformity with the certificates of incorporation or organization, by-laws and other similar formation documents of the Company and any applicable Subsidiary Guarantors (collectively, the "Formation Documents"), any Deposit Agreement, Indenture, Warrant Agreement, Trust Agreement, Guarantee Agreement, Purchase Contract or Unit Agreement (collectively, the "Applicable Agreements"), and any other relevant agreement so as not to violate any applicable law, the Formation Documents (subject to the further assumption that such Formation Documents have not been amended from the date hereof in a manner that would affect the validity of any of the opinions rendered herein), or result in a default under or breach of any agreement or instrument binding upon the Company or any applicable Subsidiary Guarantor and so as to comply with any restriction imposed by any court or governmental body having jurisdiction over the Company or any applicable Subsidiary Guarantor; (iv) the Offered Securities (and, to the extent necessary, any securities which are a component of the Offered Purchase Contracts or Units), and any certificates or receipts representing the interests in the relevant Offered Securities, have been duly authenticated, executed, countersigned, registered and delivered upon payment of the agreed-upon consideration therefor and have been duly issued and sold in accordance with any relevant agreement (including any Applicable Agreements), any underwriting agreement with respect to the Offered Securities or any other duly authorized, executed and delivered, applicable, valid and binding purchase agreement, or as otherwise contemplated by the Registration Statement or any post-effective amendment thereto, and any Prospectus Supplement relating thereto; (v) the Registration Statement, as finally amended (including all necessary post-effective amendments) and any additional registration statement filed under Rule 462 will have been declared effective under the Act and such effectiveness shall not have been terminated or rescinded; (vi) an appropriate Prospectus Supplement will have been prepared, delivered and filed in compliance with the Securities Act and the applicable rules and regulations thereunder describing the Offered Securities offered thereby; (vii) the Offered Securities will be issued and sold in compliance with applicable Federal and state securities laws and solely in the manner stated in the Registration Statement and the applicable Prospectus Supplement and there will not have occurred any change in law affecting the validity of the opinions rendered herein; (viii) if the Offered Securities will be sold pursuant to a firm commitment underwritten offering, the underwriting agreement with respect to the Offered Securities in the form filed as an exhibit to the Registration Statement or any post-effective amendment thereto, or incorporated by reference therein, has been duly authorized, executed and delivered by the Company and the other parties thereto; and (ix) in the case of an Applicable Agreement or other agreement or instrument pursuant to which any Securities are to be issued, there shall be no terms or provisions contained therein which would affect the validity of any of the opinions rendered herein. We also have assumed that (i) the Senior Indenture and the Subordinated Indenture each will be duly authorized, executed and delivered by the respective trustees, and that any Debt Securities that may be issued will be authenticated by duly authorized officers of the applicable trustee; (ii) any Trust Agreement and Guarantee Agreement, respectively, will be duly authorized, executed and delivered by the applicable trustees; (iii) any Deposit Agreement will be duly authorized, executed and delivered by the Depositary, and the Depositary Receipts will be duly signed by the Depositary; and (iv) any Warrant Agreements, any Purchase Contracts and any Omnicare, Inc. February 19, 2003 Page 6 Unit Agreements will be duly authorized, executed, delivered and duly signed by the applicable parties thereto other than the Company. With respect to opinion (7) above, we have relied on the opinion of Richards, Layton & Finger, P.A., dated as of the date hereof, as to the Trusts and the validity and legality of the Trust Preferred Securities and related documents (other than the Trust Guarantees). Members of our firm are admitted to the Bar in the State of New York and we do not express any opinion as to the laws of any jurisdiction other than the laws of the State of New York, the General Corporation Law of the State of Delaware, the Delaware Limited Liability Act, the Delaware Revised Uniform Limited Partnership Act and the laws of the United States of America to the extent referred to specifically herein. We do not express any opinion with respect to the application of the Commodity Exchange Act, as amended, or the rules, regulations or interpretations of the Commodity Futures Trading Commission to Securities, the payment of principal or interest on which will be determined by reference to one or more currency exchange rates, commodity prices, equity indices or other factors. The Securities may be issued from time to time on a delayed or continuous basis, but this opinion is limited to the laws, including the rules and regulations thereunder, as in effect on the date hereof. We disclaim any obligation to advise you of any change in any of these sources of law or subsequent legal or factual developments which might affect any matters or opinions set forth herein. Any opinion set forth herein as to enforceability of obligations of the Company is subject to: (i) bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or similar laws affecting the enforcement of creditors' rights generally, and by general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law); (ii) provisions of law which may require that a judgment for money damages rendered by a court in the United States be expressed only in United States dollars; (iii) requirements that a claim with respect to any Debt Securities denominated other than in U.S. dollars (or a judgment denominated other than in U.S. dollars in respect of such claim) be converted into U.S. dollars at a rate of exchange prevailing on a date determined pursuant to applicable law; and (iv) governmental authority to limit, delay or prohibit the making of payments outside the United States or in foreign currency or composite currency. Rights to indemnification and contribution may also be limited by Federal and state securities laws. We express no opinion as to the validity, legally binding effect or enforceability of any provision in any agreement or instrument that (i) requires or relates to payment of any interest at a rate or in an amount which a court would determine in the circumstances under applicable law to be commercially unreasonable or a penalty or a forfeiture or (ii) relates to governing law and submission by the parties to the jurisdiction of one or more particular courts. We hereby consent to the filing of this opinion with the Securities and Exchange Commission as Exhibit 5.1 to the Registration Statement. We also consent to the reference to our firm under the heading "Legal Matters" in the Registration Statement. In giving this consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Securities and Exchange Commission promulgated thereunder. Very truly yours, /s/ Dewey Ballantine LLP EX-5 14 ex5-2.txt EXHIBIT 5.2 Exhibit 5.2 Richards, Layton & Finger a professional association One Rodney Square P.O. BOX 551 Wilmington, Delaware 19899 (302) 651-7700 Fax: (302) 651-7701 WWW.RLF.COM February 19, 2003 Omnicare Capital Trust I, Omnicare Capital Trust II, and Omnicare Capital Trust III, c/o Omnicare, Inc. 100 East RiverCenter Boulevard Covington, Kentucky 41011 Re: Omnicare Capital Trust I, Omnicare Capital Trust II and Omnicare ---------------------------------------------------------------- Capital Trust III ----------------- Ladies and Gentlemen: We have acted as special Delaware counsel for Omnicare, Inc., a Delaware corporation (the "Company"), Omnicare Capital Trust I, a Delaware statutory trust ("Trust I"), Omnicare Capital Trust II, a Delaware statutory trust ("Trust II"), and Omnicare Capital Trust III, a Delaware statutory trust ("Trust III")(Trust I, Trust II and Trust III are hereinafter collectively referred to as the "Trusts" and sometimes hereinafter individually referred to as a "Trust"), in connection with the matters set forth herein. At your request, this opinion is being furnished to you. For purposes of giving the opinions hereinafter set forth, our examination of documents has been limited to the examination of originals or copies of the following: (a) The Certificate of Trust of Trust I, as filed with the office of the Secretary of State of the State of Delaware (the "Secretary of State") on February 7, 2003; (b) The Certificate of Trust of Trust II, as filed with the Secretary of State on February 7, 2003; Omnicare Capital Trust I, et. al. February 19, 2003 Page 2 (c) The Certificate of Trust of Trust III, as filed with the Secretary of State on February 7, 2003; (d) The Trust Agreement of Trust I, dated as of February 7, 2003, between the Company and the trustee named therein; (e) The Trust Agreement of Trust II, dated as of February 7, 2003, between the Company and the trustee named therein; (f) The Trust Agreement of Trust III, dated as of February 7, 2003, between the Company and the trustee named therein; (g) The Registration Statement (the "Registration Statement") on Form S-3, including a preliminary prospectus (the "Prospectus"), relating to, among other things, the Trust Preferred Securities of the Trusts representing preferred undivided beneficial interests in the assets of the Trusts (each, a "Preferred Security" and collectively, the "Preferred Securities"), filed by the Company and the Trusts with the Securities and Exchange Commission on or about February 19, 2003; (h) A form of Amended and Restated Trust Agreement for each of the Trusts, to be entered into between the Company, the trustees of the Trust named therein, and the holders, from time to time, of the undivided beneficial interests in the assets of such Trust (collectively, the "Trust Agreements" and individually, a "Trust Agreement"), attached as an exhibit to the Registration Statement; and (i) A Certificate of Good Standing for each of the Trusts, dated February 11, 2003, obtained from the Secretary of State. Initially capitalized terms used herein and not otherwise defined are used as defined in the Trust Agreements. For purposes of this opinion, we have not reviewed any documents other than the documents listed in paragraphs (a) through (i) above. In particular, we have not reviewed any document (other than the documents listed in paragraphs (a) through (i) above) that is referred to in or incorporated by reference into the documents reviewed by us. We have assumed that there exists no provision in any document that we have not reviewed that is inconsistent with the opinions stated herein. We have conducted no independent factual investigation of our own but rather have relied solely upon the foregoing documents, the statements and information set forth therein and the additional matters recited or assumed herein, all of which we have assumed to be true, complete and accurate in all material respects. With respect to all documents examined by us, we have assumed (i) the authenticity of all documents submitted to us as authentic originals, (ii) the conformity with the Omnicare Capital Trust I, et. al. February 19, 2003 Page 3 originals of all documents submitted to us as copies or forms, and (iii) the genuineness of all signatures. For purposes of this opinion, we have assumed (i) that each of the Trust Agreements will constitute the entire agreement among the parties thereto with respect to the subject matter thereof, including with respect to the creation, operation and termination of the applicable Trust, and that the Trust Agreements and the Certificates of Trust will be in full force and effect and will not be amended, (ii) except to the extent provided in paragraph 1 below, the due organization or due formation, as the case may be, and valid existence in good standing of each party to the documents examined by us under the laws of the jurisdiction governing its organization or formation, (iii) the legal capacity of natural persons who are parties to the documents examined by us, (iv) that each of the parties to the documents examined by us has the power and authority to execute and deliver, and to perform its obligations under, such documents, (v) the due authorization, execution and delivery by all parties thereto of all documents examined by us, (vi) the receipt by each Person to whom a Preferred Security is to be issued by the Trusts (collectively, the "Preferred Security Holders") of a Preferred Security Certificate for such Preferred Security and the payment for such Preferred Security, in accordance with the Trust Agreements and the Registration Statement, and (vii) that the Preferred Securities are authenticated, issued and sold to the Preferred Security Holders in accordance with the Trust Agreements and the Registration Statement. We have not participated in the preparation of the Registration Statement or the Prospectus and assume no responsibility for their contents. This opinion is limited to the laws of the State of Delaware (excluding the securities laws of the State of Delaware), and we have not considered and express no opinion on the laws of any other jurisdiction, including federal laws and rules and regulations relating thereto. Our opinions are rendered only with respect to Delaware laws and rules, regulations and orders thereunder which are currently in effect. Based upon the foregoing, and upon our examination of such questions of law and statutes of the State of Delaware as we have considered necessary or appropriate, and subject to the assumptions, qualifications, limitations and exceptions set forth herein, we are of the opinion that: 1. Each of the Trusts has been duly created and is validly existing in good standing as a statutory trust under the Delaware Statutory Trust Act. 2. The Preferred Securities of each Trust will be validly issued and, subject to the qualifications set forth in paragraph 3 below, fully paid and nonassessable undivided beneficial interests in the assets of the applicable Trust. 3. The Preferred Security Holders, as beneficial owners of the applicable Trust, will be entitled to the same limitation of personal liability extended to stockholders of private corporations for profit organized under the General Corporation Law of the State of Delaware. We note that the Preferred Security Holders may be obligated to make payments as set forth in the Trust Agreements. Omnicare Capital Trust I, et. al. February 19, 2003 Page 4 We consent to the filing of this opinion with the Securities and Exchange Commission as an exhibit to the Registration Statement. We hereby consent to the use of our name under the heading "Legal Matters" in the Prospectus. In giving the foregoing consents, we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder. Very truly yours, /s/ Richard, Layton & Finger, P.A. EAM EX-23 15 ex23-3.txt EXHIBIT 23.3 Exhibit 23.3 Consent of Independent Accountants We hereby consent to the incorporation by reference in this Amendment No. 1 to Registration Statement on Form S-3 of our report dated February 1, 2002 relating to the financial statements and financial statement schedule, which appears in Omnicare Inc.'s Annual Report on Form 10-K for the year ended December 31, 2001. We also consent to the reference to us under the heading "Experts" in such Registration Statement. /s/ PricewaterhouseCoopers LLP Chicago, Illinois February 18, 2003
-----END PRIVACY-ENHANCED MESSAGE-----